S1 | Venture Capital

The Psychology of Investing | SALT Talks #150

“Entrepreneurship and innovation don’t know boundaries, so great ideas can surface anywhere.”

Jihan Bowes-Little is the co-founder and managing partner of Bracket Capital, an alpha-driven global investment firm. Lo Toney is the founder and managing partner of Plexo Capital, an institutional investment firm spun out of Google Ventures. 

Diversity within a VC firm is more likely to lead to a diverse portfolio of companies and founders. Investing in people of color and women naturally produces stronger results as they’re more likely to challenge conventional wisdom and identify unique opportunities. VC’s can more easily seek out diverse companies and founders regardless of proximity as technology has made remote work and collaboration easier. "We know based on data, if there’s a diverse set of investors around the table, their portfolios end up being diverse."  

With the growth of venture capital, there has been a rise in secondary markets where IPOs were once a company’s main liquidity event. This allows entrepreneurs to be more patient in going public while also providing investment realization to investors and the company’s early 

LISTEN AND SUBSCRIBE

SPEAKERS

Jihan Bowes-Little.jpeg

Jihan Bowes-Little

Managing Partner & Co-Founder

Bracket Capital

Lo Toney.jpeg

Lo Toney

Founding Managing Partner

Plexo Capital

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello, everyone and welcome back to SALT Talks. My name is John Darsie, I'm a managing director of SALT, which is a global thought leadership form and networking platform in the intersection of finance, technology, and public policy. SALT Talks or digital interview series that we started during this work from home period in 2020. It's gotten great tracks and we look forward to continuing it as we sort of embrace the digital future the way a lot of companies have. But what it is, is conversations with leading investors, creators, and thinkers. And our goal on these SALT Talks is the same as our goal in our SALT Conference Series, which is to provide a window in to the mind of subject matter experts, as well as provide a platform for what we think our big ideas that are shaping the future.

John Darsie: (00:52)
We're very excited today to welcome two guest, who have been active investors in a lot of those big ideas, Jihan Bowes-Little and Lo Toney to SALT Talks. Jihan Bowes-Little is the managing partner and co-founder of Bracket Capital, an alpha driven global investment manager focused on later stage technology-enabled companies with asymmetric risk reward profiles. Jihan began his investing career in London on Goldman Sachs' esteemed Global Macro Proprietary Trading desk. in 2006, he moved to credit trading where he managed a multi-billion dollar portfolio through the great financial crisis generating record profits and gaining invaluable expertise, investing in semi-liquid markets and emerging asset classes at scale. He then joined Millennium Capital as a portfolio manager and was later recruited to lead a multi-strategy portfolio for BlueCrest Capital.

John Darsie: (01:45)
Lo Toney is the managing partner and founder of Plexo Capital, which is an institutional investment firm that he incubated and spun out from GV or Google Ventures. Plexo Capital invests in emerging seed stage VCs led by diverse teams and invests directly into companies sourced from the portfolios of VCs where Plexo has an investment. Prior to funding Plexo Capital, Lo is a partner on the investing team at GV, where he focused on marketplaces, mobile, and consumer products. Before GV, Lo was a partner with Comcast Ventures, where he led the catalyst fund and worked with the main fund where he focused on mobile messaging and marketplaces.

John Darsie: (02:25)
And hosting today's talk is Anthony Scaramucci, the founder and managing partner of SkyBridge capital, a global alternative investment firm. He's also the chairman of SALT. And with that, I will turn it over to Anthony for the interview.

Anthony Scaramucci: (02:36)
Okay, well on behalf of Lo and Jihan, I just want to thank you for reading their bios the way their moms, their respective moms wrote the bio. I thought you did a great job, I mean...

John Darsie: (02:48)
Those were condensed bios [crosstalk 00:02:48]

Anthony Scaramucci: (02:51)
I know that your moms chipped in on that. It was unbelievable, if I had a bio like that, I'd be nailing it to the wall behind me. So congratulations to both of you. I want to start with both of you with a question I ask everybody. Our people love hearing about this and I'll start with you Lo just randomly. I need to hear something about your life I can't find on Wikipedia or from the bio that your mom wrote on your behalf, so tell me something about you that we need to know.

Lo Toney: (03:24)
Well, probably the thing that you can know is I love video games. And speaking of my mom, she probably is still holding on to some of my comics that I used to collect as a kid.

Anthony Scaramucci: (03:35)
Oh good for you. So, your mom is absolutely terrific then. My mother incinerated hundreds of thousands of dollars worth of comics. And I'll totally expose myself in my age. G.I. Joe dolls, you guys are probably not old enough to remember those but I've lost a fortune. I don't even go on eBay for the tears that I shed as a result of my mother's OCD and our cleanliness.

Anthony Scaramucci: (04:01)
What about you John what can we learn about you that we don't know?

Jihan Bowes-Little: (04:07)
I guess staying on the topic of kids, I got a three and a five year old so I'm deep in the business of parenting and juggling that with running the fun. I would say there's a-

Anthony Scaramucci: (04:17)
Boys, girls, what kind of kids you have?

Jihan Bowes-Little: (04:18)
A boy, girl.

Anthony Scaramucci: (04:19)
Okay, what about you Lo, you have kids?

Lo Toney: (04:21)
I do too.

Anthony Scaramucci: (04:23)
How old are they?

Lo Toney: (04:24)
22 and 20.

Anthony Scaramucci: (04:27)
All right good for you. Well, you guys look great, God bless.

Lo Toney: (04:30)
Thank you.

Anthony Scaramucci: (04:30)
I have five children, so you guys can catch up anytime you want, okay? You just have to catch up.

Lo Toney: (04:37)
No, thanks.

Anthony Scaramucci: (04:38)
No, thank you, I hear you.

John Darsie: (04:40)
The youngest is known to storm into the room while Anthony's on MSBNC and start bashing... it was a Santa Claus doll that he had.

Anthony Scaramucci: (04:47)
The youngest has a media contract, he came into the room one morning, "I told you not to work on Saturdays." He karate chopped me in the Adam's apple, he took out Santa, he pulled me out of it. It was a bad scene on live television but we get through these things.

Anthony Scaramucci: (05:02)
Okay, you both have these amazing careers and we have so many young people that listen in and they're looking at the two of you and saying, "Okay, my God. Congratulations on your careers but how do I get started?" Describe the early parts of your careers if you don't mind. And talk about the trials and tribulations, the successes and failures. But what was the arc and the mindset to help you get to where you are? Why don't we go with you Jihan first and then we'll have Lo follow-up.

Jihan Bowes-Little: (05:33)
Sure. So, I started my career in investment banking. I moved into trading very early, I became a proprietary trader for Goldman after my first year within the firm. At that point I'd never put on a single trade in my life.

Anthony Scaramucci: (05:48)
What year was it when you started Goldman?

Jihan Bowes-Little: (05:50)
2002.

Anthony Scaramucci: (05:52)
Okay.

Jihan Bowes-Little: (05:54)
So, I started 2002 in New York-

Anthony Scaramucci: (05:55)
You were still running London, Bob Steele? Was he still running London at that time?

Jihan Bowes-Little: (05:59)
It was Sherwood when I was there mainly.

Anthony Scaramucci: (06:01)
Oh, Mike Woody, yeah. Woody was actually in my training class.

Jihan Bowes-Little: (06:07)
Oh, yeah?

Anthony Scaramucci: (06:07)
Yeah. I'm an old-timer at Goldman back in-

John Darsie: (06:12)
Believe it or not, he worked at Goldman Sachs. They won't tell you that anymore but he actually did work at Goldman.

Anthony Scaramucci: (06:17)
Look, John's trying to hurt my feelings guys but it's okay. After I got my ass fired from The White House, there's really no way you can hurt my feelings. But yes, Goldman has more or less tried to erase me from their alumni network but it's sort of too bad because Solomon comes to my wine party in Davos every year. So, he won't erase me because he likes drinking 100-Point Robert Parker wine. But I would say the rest of the firm has totally written me off. All right. But go ahead Woody's a good guy so you work with Woody?

Jihan Bowes-Little: (06:45)
Yeah. Many layers below, I was a first-year, second-year analyst. Christian Siva-Jothy was running the prop desk at that time. A great group of some of the foremost traders probably in the firm's history I just was there to soak it up. I learned from experience, there's not a lot of you can teach people sometimes. I think about proprietary training a lot of it is about understanding yourself, your own personal psychology, philosophy, risk, limits, fear, tolerance, things like that. And I spent a few years there. Most of them went on to set up their own hedge funds or go work at hedge funds, and so I moved over to credit trading. I never really market made in my life so I'd never really had that experience of touching and feeling the market. Those people start on the sell side and with a significant experience move over to the prop side.

Jihan Bowes-Little: (07:31)
I was kind of doing the reverse. So, I moved into credit trading, 2006. The firm I think has always been very good at allocating its resources ahead of major market changes. Earlier in my career I noticed a lot of employees being moved into commodities before the big commodity boom, and the same thing happened in credit. So, they moved some of us over into credit. Obviously, the subprime crisis unfolded, we had a front row seat for that. That was obviously a real pivotal time in terms of me understanding risk, managing risk at scale, understanding unknowable risks, and convexity, et cetera. After that I ended up moving over to the buy side. Like John said, I spent some time on Millennium and BlueCrest, kind of going back to my proprietary trading routes. And so, I traded a mixed portfolio, some credit default swaps and options, equities as well. That's generally been the arc of my career before I came back to California which is where I'm from in 2017. To set up Bracket Capital, which is focused on private markets.

Anthony Scaramucci: (08:34)
Okay, terrific. So, Lo take us back and take us through some of these trials and tribulations.

Lo Toney: (08:41)
Sure not as fancy as Jihan. I was listening, that's pretty fancy. I almost had to go and dust off my finance book to understand what he's [crosstalk 00:08:50]

Anthony Scaramucci: (08:49)
Unbelievable Goldman Sachs humble-bragging, we'll get to that later. Unbelievable, there was like a potpourri of name dropping and even threw convexity in there Lo Toney, I mean "Come on." I've been on Wall Street for 33 years I still have no idea what convexity is. That's fine. [crosstalk 00:09:08] Rub it in, Jihan, rub it in.

Lo Toney: (09:12)
I learned about convexity actually, I was like "Wait, come back, okay. All right. Got it." So, my background goes all the way born and raised in Oakland, went to school in Virginia Hampton University, a historically black college. Decided that I wanted to enter finance as well. I wasn't fancy enough to go to Goldman or Morgan, so I ended up at some of the commercial banks. And I really discovered that the thing that was really interesting to me was more on the technology side. The reputation that I developed was... believe it or not, when I was in college I actually took Computer Science classes. I cannot use any of those languages anymore things like Cobol and Pascal. Although if you work for a financial institution, probably every now and then you have to break some emergency glass and pull a Cobol programmer out so your whole system doesn't crash. Because a lot of these infrastructure players are still running on them believe it or not.

Lo Toney: (10:07)
But nonetheless, decided that what I really was most interested in was just nerding out on technology and always looked for ways to see if I could do clever things with Excel pretty much at the time to solve some of the problems that I was tasked to do. Went back to grad school and during grad school I entered thinking, "Maybe now I actually will be able to go work for one of those fancy investment banks." I was a little more interested in the Hamricks and Quest, or the Robertson Stevens of the world. Because at the time, the four horsemen as they were called then were the ones that were taking the tech companies public. Because the fancier brokerages didn't really understand or maybe even believe in the power of these new technology companies that were coming to market.

Lo Toney: (10:56)
Now a funny thing happened, on my way to the coliseum, I ended up meeting a lot of venture capitalists. I was fortunate to go to Takao, I think that also played a role because just proximity-wise, there were a lot of VCs that would come in and just talk about what they were doing. And I have this epiphany that, "Wow, it's actually more interesting what they're doing. Which is at the front end as opposed to what the bankers do which is on the back end." So, I decided to completely shift gears and to focus on trying to get into Venture Capital. The eager beaver that I was, I would run up to every VC that came to speak to our class and ask how do I do it. Got some good advice, go be a product manager, run a P&L, see if you can be a CEO of a Venture-backed company.

Lo Toney: (11:46)
And that's the path that I set myself upon. And have some great experiences doing some of those things at companies like eBay. I was employee 2838 I think when I came in and four years later they were 15,000 people developed a great network there. And then was able to have some good experiences at companies like Zynga, the creator of FarmVille. I went there because I wanted to learn about game mechanics. I felt that game mechanics were going to be something big. And who would have ever thought that the combination of that eBay and marketplace experience, along with game mechanics would actually be able to help me understand some of these models that I see today? But I was also fortunate to finally enter Venture Capital through Comcast Ventures and then was pulled over into the GV, formerly Google Ventures.

Lo Toney: (12:43)
The early stage investing unit for alphabet is GV's goal. Saw a lot of amazing companies that came through, got to work with some incredible Venture capitalists that helped me really understand how to invest. And there was a strategy that was in place to kind of drive some alpha by working with GPs that were black and people of color and women. And decided to productize that strategy and kind of convinced the folks at GV that, "Hey, I think I want to just take this model that we've been using and then I'd like for you to keep paying me while I develop this into a platform." And then spun out with Plexo Capital.

John Darsie: (13:24)
You need to be my agent, Lo. That sounds like a pretty good deal.

Anthony Scaramucci: (13:28)
It's an amazing career. I have a relationship with David Drummond, you may or may not remember David was GC there.

Lo Toney: (13:36)
Absolutely. David was my internal sponsor when he was there [crosstalk 00:13:41] for Capital along with David Crane, the CEO of GV who reported into David Drummond at the alphabet level.

Anthony Scaramucci: (13:48)
I can't think of Jack's last name now but he's a guy from New York, maybe Jack Abernathy maybe? I'm not sure. But David was a terrific guy and David, he's good friends with Ronnie a lot. We do a number of Super Bowls together, which hopefully we can get back to those post pandemic, we can go back and party at the Super Bowl.

Anthony Scaramucci: (14:11)
Jihan, let's talk a little bit about the limited general partner relationships and could you share the way you partner and do co-investments and so on? I'll ask Lo Toney the same question, but what's your thought process and philosophy there?

Jihan Bowes-Little: (14:30)
Sure. I think a lot of things within Venture Capital and perhaps just in financial markets right now that, that relationship is really evolving. And I think our relationship with Plexo, and LP, and Bracket Capital, and Lo and I know each other very well. It's evolving to encompass more I think than perhaps what was traditionally the standard arms length. LP writes a check into the GP who operates kind of with full discretion and reports back on a quarterly or annual basis. I think that just as funds like ours are beginning to be more creative and thinking about ways to approach the market, probably talk about that more later. I think that LPs are thinking the same thing. Actually at Bracket, one of the main things that we've done is structure our fund not just to optimize returns on the company level but also to optimize the relationship between us and the LPs. One example of that, we kind of doubled down pretty heavily on and which Lo and Plexo have been involved in is the co-investment side that comes from some of that top of funnel activity that we do.

Jihan Bowes-Little: (15:35)
We're out looking at companies diligencing, researching, et cetera. Many of the LPs in our cap table are highly sophisticated as well. Some on the technology side like Lo, some from traditional hedge funds, institutional matter, etc cetera. They have their own view and there may be things they want to double and triple down on which make more sense in the context of their portfolio at their level than our level. We have an operation where we invest primarily from the fund, and we report, and kind of manage that relationship in a standard way. But we also bubble up co-investment opportunities on many of the deals that we do. LPs like Plexo, et cetera, can just take their pro rata allocation from the fund but they can also exercise a view. I think this trend towards the institutionalization of family offices, the trend towards being both an LP and a direct investor, I think this is all kind of ties into the blurring of the lines which is happening where people are becoming multi-stage, multi-asset, most multi-strategy.

Jihan Bowes-Little: (16:38)
Most of our investors are quite active on the co-investment side as well and this is a trend that I think that we're going to continue to see develop.

Anthony Scaramucci: (16:47)
Anything you want to add Lo Toney?

Lo Toney: (16:50)
That I think really encapsulates the way that we saw the opportunity. When we set out to execute on the strategy, the thing that i identified from our time at GV was we used the investment as an LP into some of these seed stage funds to really supplement our deal flow. It was another channel of deal flow and i think it's a strategy that's actually fairly widely used, it's just executed differently. I could think it's known that folks like Marc Andreessen, Chris Dixon and Andreessen Horowitz, they do it on an individual level. Folks like Lightspeed. they do it through both investments as well as through scout programs. Sequoia has a very robust scout program that bleeds over a little bit into some early stage folks. Then you have firms like Foundry Bradfeld's Group out of Colorado, they've done it so well through Brad's initial LP commitments. They actually brought in Lindel from UTIMCO and formalized a strategy around it. This is not something that's new I think the approach that we've taken at Plexo Capital and it's an approach that i think some of the family offices are looking at as well is to leverage investing as an LP as one of the sole sources of deal flow.

Lo Toney: (18:08)
We've got these GPs that are building amazing franchises, they're doing some heavy lifting looking at tens of thousands of companies on an annual basis. They invest into the top one to five percent or so. In essence, that's a curation of the best that they've seen in the market. It allows us at Plexo Capital to be able to use that group, that consideration set as our primary focus. And obviously we're spending a lot of time with our GPs like Jihan and others talking with them about where they see some opportunities. We're looking at all the reports and then that allows us to be able to operate in a much more leveraged approach and streamline manner in our operations and team building. But nonetheless, still have the ability to identify some amazing opportunities to invest into.

Anthony Scaramucci: (18:59)
Okay. It's brilliant stuff and I love the way you guys are describing it. And it's sort of the future of the cross-sectional investing where people are wearing many hats and doing different stages of investing to really... it's almost like you're getting diversity through the staging as well as through the different technological sectors and whatnot.

Lo Toney: (19:22)
That's exactly right.

Anthony Scaramucci: (19:24)
What are some the most important trends that you're seeing in Venture Capital in private markets right at this moment? Where's the money going?

Lo Toney: (19:34)
I think there's money that is available across a multitude... one of the things that we touched on a little bit is this trend in essence around secondaries. I think that is something that's really interesting, just looking at the evolution of the secondary market. You can kind of think kind of pre-early 90s. Around the 2000s, the secondary space was fairly small. Probably, think around the financial crisis around '08 or so when a lot of the rules changed from a regulatory perspective which had this natural extension effect on the timelines for companies to go public. Because it became a much more onerous process to do the IPO. Maybe even kind of almost kind of later on couple that with the interest from some of the non-traditional players to come into some of these companies at the growth stage. I think the combination of both of those things kind of allowed these companies to be able to operate a little more patiently and not have to rush to the markets to provide liquidity.

Lo Toney: (20:44)
Then you bring in the fact that in order to actually get some realization both for the early employees and founders, they could actually execute secondary strategies to kind of offset their eggs being entirely within that one basket of their company. That was also the case for their investors. The investors could also now use the secondary whether they were individuals where they weren't really that concerned about trying to drive anything back to other investors, it's just going to their own pocket. Or for folks like ourselves, where we actually need to drive some dollars back because often our investors may get a little impatient. So it's nice to be able to have a realization through an avenue other than a merger or an IPO.

Anthony Scaramucci: (21:30)
Jihan, that blurring between public and private markets, that's a hundred percent a positive development. It allows smaller and more diverse set of investors to get involved in some of these exciting tech companies early. Are there any downsides to that blurring or how do you think about sort of this democratization of access to private companies?

Jihan Bowes-Little: (21:53)
I think it's a great question. I think there's interesting points to explore on sort of the supply and demand side. I'd say one of the benefits to being new to a space is that sometimes, would you may lack an experience you may make up for the sort of clean eyes, right? So when we first entered the market after having spent so much time on the traditional side. One of the things that stood out most to me and this is kind of how my partner Yold and I began to zero in on this strategy was that every other developed market really is a secondary market, right? In Venture, you have this unusual bifurcation whereby the primary market is probably 100 times larger than the secondary market. Secondary market is generally an afterthought. What you think of is Venture Capital is primary market investing. But the stock market has a primary market as well, it's the IPO, right? And the bond market has a primary market which is the new issue. But neither of those markets are what fund managers spend their time trading, right? You actually operate almost exclusively in the secondary market in stocks, bonds, real estate, collectibles, et cera.

Jihan Bowes-Little: (22:55)
So, coming into Venture also thinking a lot about competitive advantage, right? And thinking about kind of transferring some of the skill sets which myself and the team had from other areas over into the private market landscape. The ideas struck out to us is quite obvious, right? That as companies, were extending their duration as low as referring to a company like Amazon went public sub 500 million dollar valuation. You have ByteDance now worth 250 billion, right? So, clearly the value creation is happening disproportionately in the private markets. The duration is extending because there are so many diverse capital sources helping to keep these companies private for longer. Which creates... in speaking of impatience, it creates an infeasibility for the average employee, right? For the first time entrepreneur, and also for the average employee, and often times for an early stage investor to wait 10, 12, 15, 17, years for a liquidity event is impossible in all but the most unusual circumstances, right?

Jihan Bowes-Little: (23:56)
I think that there was this view within Silicon Valley for a long time that if you were committed to your company, that you should be able to wait until a public market event. And I think that would be a three to five year timeline. It's probably reasonable, right, for alignment of interest? I think once you start talking about double digits, people start these companies and join these companies in their mid-20s. By the time they're in their mid-30s life has often changed and responsibilities have changed, et cetera. I think the outcropping of the secondary market is just an inevitability right as long as there is capital that wants to find its way into the primary markets, the private markets, which there is. This will continue and to your point, when you think about democratization, there's one side which is currently very topical obviously as we're recording this which is access to stocks and those might be public or private. That's sort of on the demand side.

Jihan Bowes-Little: (24:48)
But to Lo's point, democratization works in the other direction as well. I think if you feel like you want to join a startup, if you have that energy, if you want to create one, you want to be an entrepreneur or be involved in an entrepreneurial enterprise. And you realize that you're taking a thousand or a hundred thousand to one odds, right? But perhaps you're willing to do that. But you know that even if you create billions of dollars in enterprise value, you still won't be able to buy a home within driving distance of the office because you need to wait 10 to 20 years for a liquidity event. That turns off a certain kind of individual. There are certain kinds of risk tolerance and there's certain kind of inequities in the kinds of people who can afford to take a 10 or 20 year bet.

Jihan Bowes-Little: (25:30)
I think actually the development of the secondary market besides being in my mind... probably one of the most unique asymmetric risk reward opportunities that I've ever seen on the long side. I also think from a democratization and an ethical perspective. That it really gives access to being an entrepreneur, to being an early engineer in these kinds of places to know that if you do create value for your shareholders and your investors, even if it's paper wealth, then you won't be prohibited from monetizing some small portion of that along the way. I think that really opens up the funnel and the aperture for who can start companies and who can work at them. I do think that's good for everyone.

Anthony Scaramucci: (26:14)
Lo, I want to jump to you on a separate topic and it has to do with diversity within the whole financial industry and Venture Capital industry I think are both plagued by it. But you've seen a wave recently of companies whether it be Andreessen Horowitz with their cultural leadership fund bringing more diverse voices into the asset allocation side of things. And you're also probably as a result of that seeing I think more startups led by minority founders. What are you seeing and do you think things are improving in terms of the diversity and the allocation of capital to more diverse founders within the industry?

Lo Toney: (26:47)
This is a topic we're super passionate about is the thesis around the sourcing side for Plexo Capital and how we make our decisions on GPs. So, we have this insight around the ability for black GPs we started with and then extended it to females and other people of color. But at GV, what we saw was that there was an access to a particular type of network through black GPs and this indirect path they had into Venture Capital. It allowed us to be able to have this moment where we said, "Oh, we can actually turn this access into an alpha strategy." Because what deals were being financed by these diverse GPs at the early stages, it required a little bit of familiarity with the market since there was not an abundance of data. And it required a little bit of a different approach and lens to evaluate an entrepreneur, since to your point which I think you're alluding to, we know based on data if there's a diverse set of investors around the table. Their portfolios end up being diverse and it partially has to do with the networks.

Lo Toney: (27:54)
So, we saw an alpha opportunity. And I think the realization that i had with Plexo Capital is that I can build this firm into a brand name institutional investing franchise and focus on using that same strategy to deliver these returns. But our strategy has this interesting byproduct of increasing diversity within the ecosystem. And i think what we need to see more of is that flow of dollars down the stack of Capital from the limited partners into the hands of diverse GPs, which should then go into the hands of diverse entrepreneurs. We have seen it getting better, so recently we've had a couple of instances of unicorns actually led by black founders. Calendly is the one that that sticks out in the minds of most people was-

John Darsie: (28:41)
Based in Atlanta all right, Calendly?

Lo Toney: (28:41)
That's right it. Was sneaking around under the radar and had only taken one round of financing. I think for maybe less than, I don't know, call less than a million dollars and now Lo and Bohold, they just took in some money at what is rumored to be in excess of a three billion dollar valuation. So we're moving in the right direction. The more that we can have those events, as well as the liquidity events that come after them, will be able to put these diverse founders down the wealth creation path but also some of those early employees. And listen, the calculus changes when one has a significant financial backstop because then one's profile and optionality changes. An employee that's early that has that liquidity event can then take the risk, go start a company or go invest as an angel. And then capital goes back to those diverse GPs if they string along enough events that lead to liquidity. Capital goes back to the LPs, then the LPs can look at that and say, "Wow. We should double or triple down on this because it's working."

Lo Toney: (29:44)
That's what I get excited about is that leveraged approach to really kick start that flywheel. Look, this is not dissimilar to geographic ecosystems outside of places like the San Francisco-

John Darsie: (29:56)
That was my next question question because if you're on Twitter today and you follow a lot of people in Venture Capital, every other tweet is about Miami. Oh, Miami, everyone's moving Miami. There's a SoftBank has a hundred million dollar fund now to invest in Miami-based startups. But we have Steve Case, has been to our SALT conferences and been on SALT Talks. And he's more about the distribution of capital across a wide variety of sort of second tier cities in the U.S.. Geographically, where are you seeing opportunities, is it distributed or are you seeing a few Austin, Miami type of places that capital is flowing to?

Lo Toney: (30:33)
It's a combination. One thing that this pandemic has shown us is that we've changed on a psychological perspective, in our acceptance of being able to have a remote workforce, a distributed workforce. And also this notion around, "Do I necessarily need to go and visit a company in order to get comfortable?" For a long time, there was this thought that in order to be an investor you wanted to invest in your backyard, so that on your way home from the office you could pass by your entrepreneurs and see if their cars were still in the parking lot.

John Darsie: (31:07)
If you're on the Google bus, you're waving out the window at your companies you invested in? Okay.

Lo Toney: (31:12)
Exactly. But this things have changed and now we've become more comfortable with having remote workforces, making investments into ecosystems that aren't in our backyard. It's easier because we can hop on a Zoom call, we've now become accustomed to get comfortable doing this type of diligence and having these conversations. But I think another thing that's really important, right? So it used to be, "Hey, if you want to be a movie star you go to Los Angeles. If you want to be an entrepreneur you go to San Francisco." Well, look entrepreneurship and innovation don't know any boundaries and so great ideas can surface anywhere. Now obviously, there are some advantages that will remain over time in places like San Francisco, but in addition to the other obvious ecosystems Los Angeles, New York.

Lo Toney: (31:57)
We are seeing some exciting developments in places like Atlanta, in places like the Midwest. What we like to look for typically in an ecosystem is are there certain elements? We like to see there's a little bit of an entrepreneurial spirit or a counter culture that comes with certain political views or views around activism. And if we think those as important ingredients, we like to see an educational institution that's very research driven that can spawn off not only a number of well-trained engineers and business people but also the research that comes out of some of those institutions that can be commercialized.

Lo Toney: (32:31)
And then, we also like to see a few other things, exciting places to live that are going to be attractive to young people, and have the ability for there to be a nightlife when they're not at the office working. And then probably some type of element of an international type of vibe. The ability to kind of have a reason for that place to be on a road map, all of those things when they come together it creates magic. And then if you can add to that, an anchor industry that's undergoing digital transformation and today what industry is not, then you can have some interesting crossover for both companies looking for new innovative ideas. And for those companies that are at the startup phase to have access to customers and potential acquirers as well as potentially even employees that want to jump on the startup craze.

John Darsie: (33:22)
Right. We'll let Jihan jump in here. Jihan, I want to talk about investor psychology for a minute. You've lived at the hedge fund level [crosstalk 00:33:30] a little bit of an investment [inaudible 00:33:32].

Anthony Scaramucci: (33:31)
You see how the millennial just took over the whole-

John Darsie: (33:33)
I took over the conversation and my bonus [crosstalk 00:33:36] has gone down by about 20 percent as opposed to me monopolizing the conversation.

Anthony Scaramucci: (33:41)
My contract says I'm allowed to talk more than you but go ahead and keep going.

John Darsie: (33:44)
No, you ask Jihan a question.

Anthony Scaramucci: (33:46)
No, it's fine.

John Darsie: (33:49)
He gets mad when I get the fan mail, you know how it works.

Anthony Scaramucci: (33:52)
Oh, Toney I paid him his bonus last week. This is how he acts, he gets all a reverend for the next 50 or so weeks.

John Darsie: (33:58)
He's not wrong I [crosstalk 00:33:59]can now

John Darsie: (33:59)
talk back to him.

Anthony Scaramucci: (34:02)
He's only nice to meet the week prior to the bonus payment and you know how that happened at Goldman Sachs, right? You know exactly what I'm talking about. Go ahead Darsie, go ahead. My feelings aren't hurt.

John Darsie: (34:12)
Jihan, right now we see public markets are extremely hot, tech stocks have gone crazy partly due to the pandemic of this transition to remote work, and everything's digital. How has that affected valuations and just the entire climate in private markets as a result of sort of the I don't want to say froth but the the heat that we're seeing in public markets?

Jihan Bowes-Little: (34:35)
Yeah. The heat indeed. Look, I think private markets are in a period of price discovery to some extent, right? We're in sort of uncharted territory here with the digitization of everything with zero slash negative rates, with the kind of global economic, and political backdrop, et cetera. I think that common knowledge over the last few years felt like the majority of so-called traditional or institutional investors, sort of those industries that I came from, generally thought that Venture Capital was overvalued, right? They were looking at these companies and saying unprofitable, being valued on unbelievable forward multiples, IPO window was relatively closed. These companies were continuing to stay private and I think that the commonly perceived wisdom was that they were staying private because they had no opportunity to go public and here would be no appetite from public market investors. Who I think like to think of themselves as sort of more sober and more rational and perhaps more more quantitative than the dreamers from California.

Jihan Bowes-Little: (35:41)
I think what's happened in the last 12 months besides the future being pulled forward due to COVID, et cetera, is that public market performance by some of these highly-valued and commonly thought to believe overvalued late-stage private companies. The public market performance has been exceptional and you have examples like Snowflake, you have examples like Palantir, et cetera. Which have sort of defied many investors' expectations. And I think one of the things which is great about the public markets and which I think is unfortunate for investors who've only spent their time in private markets is that the short feedback loops in public markets force a kind of honesty on every investor.

Jihan Bowes-Little: (36:26)
You're talking about investor psychology, it's very difficult to continue to hold a view in public markets, which is wrong because the market tells you you're wrong, right? It's painful but you have to realize it on a day by day if not a minute or second by second basis. Private markets have very long feedback loops, right? Sometimes it can be five or ten years before you know if an investment has worked or not. That company may have pivoted two or three times in between the early stage investment and so you may not know if the reason you invested and the reason you profited is actually the same thesis that drove you to make the investment in the first place.

Jihan Bowes-Little: (36:59)
So, I think there are benefits. Strong benefits to a very long-term mindset that the private markets have and endorse. And I think the public markets can learn from that, but also I think there's a degree of humility and a degree of kind of transparency with respect to looking in the mirror on the public side. And so, I think anybody who's honest with themselves who has sort of a public market mandate needs to look back at the hypothesis and sort of the wisdom of the crowds from the institutional side over these last few years. And essentially admit that they were wrong, right? They were wrong at least in the near term about what these companies could do. Certainly they were wrong about the investor psychology from public market participants, right? Because the stock price on any given day can show you that. And so, what does that mean?

Jihan Bowes-Little: (37:45)
What does that mean for public market investors beginning to look at private markets. Can you use the same kind of valuation metrics, can you use the same sort of mental models, is it as useful to be able to perform a discounted cash flow model on a business which is growing 500 percent as it is on something growing five to seven percent a year and so? I think we are in this very interesting area of price discovery. Obviously, the innovation with specs and direct listings and things like that are continuing to blur the lines between public and private. In my sense and sort of our bet in some ways as a firm at Bracket, is that some of these distinctions are really going to be looked upon as artifacts, right? I think that you're increasingly going to have someone who's an equity investor.

Jihan Bowes-Little: (38:31)
Now whether or not that equity trades on the Nasdaq or not is really sort of sort of an illusion to some extent. I think you have startups certainly and those have a different risk reward profile. You have very large companies right like the FANGS. But you have this very interesting subset of late stage businesses which we almost focus exclusively on which are market dominant, large enough to be public, in many cases larger than the public companies they're competing with. Oligopolistic like pricing power SpaceX's, the ByteDances, the Stripes of the world. And to have an artificial distinction from such a large capital base of institutional investors that say that they can't buy that company until it's in S&P 500, really is just forfeiting a lot of alpha to people who can look across that blurred line. And so, increasingly, I think that we're going to have [crosstalk 00:39:26] multi-stage investors on both sides.

John Darsie: (39:28)
Is that line going to disappear completely?

Jihan Bowes-Little: (39:32)
I think so.

John Darsie: (39:32)
And what does that look like?

Jihan Bowes-Little: (39:33)
I think what it looks like to me is that... as we said earlier, secondary markets are the norm, right? And so there will always be primary market financing on both private and public stocks. But I think that the end game is a very liquid secondary market which is orders of magnitude larger than the primary market, which as we said is the case of pretty much every other developed asset. And I think that the ability to buy an Airbnb last year or a Stripe this year will probably not be as liquid as buying Amazon stock today but it might look something like the corporate bond market. And so increasingly, I think you're going to see these things changing hands once companies can get their head around the rules and regulations. And there are concerns about having people in private companies sell stock too early, there are more hazard issues that need to be worked through, et cetera.

Jihan Bowes-Little: (40:21)
But all those things are achievable and so I think eventually, you're going to have a stock market, right? And that stock market will span the gamut.

John Darsie: (40:32)
I mean with Stripe, it raised at a 36 billion valuation in, i don't know, was it September or was it earlier in the year? We call late in the year and interested in maybe buying some... oh, it's a hundred. Just the movement that you're seeing in private markets the magnitude of those moves I guess is a reflection almost magnified that you're seeing of the the heat as we said in in public markets. But great time to be where you are Jihan, for sure and Lo. You guys partnering as well. I wanna ask one more quick question. We'll get quick responses about government regulations. So, we've seen a wave of outcry about censorship on social media. We have a new administration coming in that potentially could be a little harder on the regulatory front as it relates to business and tech. What do you expect to change at all, if at all, in the new administration as it relates to regulation around tech companies and how do you expect that to affect public and private market prices? And we'll start with you Lo.

Lo Toney: (41:38)
What an interesting question, it's a tough one to answer fast. But I will just say that i think that we have just seen along with the change in the administration, we saw some of the forces that came to light that led to some of the issues that we had around political parties clashing. And clearly the platforms play a role in that. I go back to something that i think about which is, the first amendment is designed to protect individuals from the government. But when we look at the decision-making process that that Jack Dorsey went through on Twitter when he was making his decision around former President Trump. The one thing that came to light to surface to me was, "Oh, of course he can do whatever he wants to, it's a private company." But what happens, individuals have options you can go to another platform and start your own site. But what happens when that platform becomes so dominant that it's almost like a utility where everyone that has something to say is expected to go on? And so I think we're in this interesting point where, once again, we are seeing how technology evolves at such a rapid pace. It's almost impossible especially for documents that were written three, four hundred years ago to try and keep up.

John Darsie: (42:59)
All right. Jihan?

Jihan Bowes-Little: (43:02)
Yeah. I think what I'd add there is that from my perspective, I expect there to be substantial regulation on large public tech companies and the platforms in particular. I feel like that's coming. I also think that probably the positive side of tech recognizing that it has sort of a societal role and not trying to be entirely distant from government. But realizing the two need to work together now that technology businesses are effectively the incumbency and that they affect the lives of people every day. Is that many of the most important problems that need to be solved, now that we know how to deliver food to ourselves at the click of a button and shop on social media channels, et cera. The areas like healthcare, FinTech, these are highly regulated areas. It takes a special and a different kind of an entrepreneur to operate in these kinds of spaces. And so I think the recognition that technology companies need to find a way to cohabit with governments, national governments, and local governments.

Jihan Bowes-Little: (44:10)
There's a lot of wood to chop on that side but there's also a lot of opportunity because I think that the real promise of some of these Venture-backed businesses if they're really going to be transformational is to deal with some of the most important problems. And some of the most important problems in our society are in those heavily regulated industries. And so it won't be easy but I think that there's actually a cause for a lot of optimism or around governments and technology businesses learning how to work together.

John Darsie: (44:38)
Well, Lo and Jihan, thank you so much for joining us today on SALT Talks. Anthony, very sorry for taking over the conversation, it was too interesting that our guests today were too interesting I felt compelled to jump in. And next time we don't have time for it today but Jihan is going to show off his musical talents on SALT Talks here. He sort of had to keep his musical career on the down low, Toney, when he was at Goldman Sachs. But thankfully now, he can openly show off his multitude of skills.

Anthony Scaramucci: (45:08)
I mean this is some wise ass millennial though right you see how he used your name as a [inaudible 00:45:12]

Lo Toney: (45:13)
That was good. I've never heard that, it's not as good as Obama's.

Lo Toney: (45:15)
[crosstalk 00:45:15]

Anthony Scaramucci: (45:16)
Do you remember Ed McMahon? He's his own Ed Mcmahon where he laughs at his own jokes.

Lo Toney: (45:22)
I mean, look, it's not as good as President Obama when he asked me, "Oh, Lo Toney. So is there a High Toney?" That's the best one I've ever heard

Anthony Scaramucci: (45:31)
Sometimes, Low Toney was probably high though, right? Is that what you're talking about? I'm kidding man, I'm kidding.

John Darsie: (45:38)
All right. Well, thank you guys for joining us.

Anthony Scaramucci: (45:40)
God bless you, guys. Okay, I'm looking forward to watching the sensational career arcs that you guys are on and I wish you much great success in the future.

John Darsie: (45:49)
And I think we're going to end up co-investing together on a couple deals guys. Let's work on that and we'll get you back on SALT Talks.

Lo Toney: (45:55)
That'll be fun.

Jihan Bowes-Little: (45:57)
That was great. Thanks for having us.

Lo Toney: (45:59)
Thanks for having us. Take care.

John Darsie: (46:00)
All right. Thank you to everybody who tuned in to today's SALT Talk with Jihan Bowes-Little and Lo Toney. Just a reminder if you missed any of this episode or you want to watch some of our previous episodes, we have all of them on our website free and on demand at salt.org backslash talks backslash archive. And you can sign up for all of our upcoming talks at salt.org backslash talks. Please follow us on social media Instagram, LinkedIn, Facebook, and Twitter, we are on there please follow us. And please tell your friends about SALT Talk, we love growing the community we love today, getting to know our guests, Lo and Jihan. And we love meeting more people through these SALT Talks. But on behalf of the entire SALT team, this is John Darsie signing off for today. We'll see you back here again soon on SALT Talks.

The Future of Renewable Energy | SALT Talks #138

“Storage is the Holy Grail of the energy business… you figure out the storage problem, you win the trillion dollar prize.”

Louis Evans is the president and CEO of Commonwealth Energy Group. Ed Fortunato is the chief economist at Exelon Corporation.

For many years, renewable energy could be seen simply as a subsidized inferior product compared to fossil fuels. As the technology has improved, renewable energy is now not only independently viable, but superior in many ways. Energy storage represents the most important next step in the evolution of renewables. The proliferation of personal renewable energy like home solar panels can go a long way in avoiding that challenge because energy does not have to travel far or be stored as long. “About 60% of energy is used to transport energy from the power plant to your home.”

The growth of renewable energy will have major effects on the geo-political stage. By establishing energy independence through renewables, the United States will be less and less dependent on the Middle East and Russia for oil.

LISTEN AND SUBSCRIBE

SPEAKERS

Lou Evans.jpeg

Louis Evans

President & Chief Executive Officer

Commonwealth Energy Group

Edward J. Fortunato.jpeg

Ed Fortunato

Chief Economist

Exelon Corporation

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello, everyone and welcome back to SALT Talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy. SALT Talks are a digital interview series that we started in 2020 and look forward to continuing indefinitely because we've really enjoyed these conversations with a variety of different guests and we've loved the engagement from our community as well. But SALT Talks are a series of digital interviews with leading investors, creators, and thinkers, and what we're trying to do on these talks is the same thing we try to do at our conferences, which is provide a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. And we're very excited today to welcome Lou Evans and Ed Fortunato to SALT Talks.

John Darsie: (00:59)
Lou Evans is the president and CEO of Commonwealth Energy Group, a graduate of the Commonwealth of Pennsylvania Department of Labor and Industry, Pennsylvania Apprenticeship and Training Council, Louis is a highly skilled and licensed master electrician. In 2008, Louis founded CEG in an effort to assist companies in lowering their operating costs by lowering their energy consumption and carbon footprint. Louis is also an active member of the United States Green Building Council, Green Business Certification, Inc., and the Lead Green Associate. Lou serves on the committee for a local U.S. Congressman's military candidate selection board as well.

John Darsie: (01:40)
Ed Fortunato is the chief economist of Exelon Corporation, where he tracks global and domestic economic forces, forecasts future economic trends, and analyzes how these patterns and events impact the company. Over the last 17 years at Exelon, Ed has managed the proprietary trading book and the short-term analytics group, led the implementation of trading strategies in both the proprietary and hedging books, and has run the fundamental analysis group as well. Prior to working at Exelon, Ed served as the vice-president of natural gas trading at Merrill Lynch Global Commodities, and was a senior energy trader at Edison Mission Energy. He also serves on the board of directors for Partners in Excellent Scholarship Program and Marian House, and is the chair of the Loyola University of Maryland's Data Science and Science Board of Directors.

John Darsie: (02:35)
Hosting today's talk is Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, a global alternative investment firm. Anthony is also the chairman of SALT, and without further ado, I'll turn it over to Anthony for the interview.

Anthony Scaramucci: (02:50)
Okay, guys, I just want you to know, I'm going to start this interview with great disgust. Okay, I learned that John Darsie is getting fan mail for these SALT Talks. I haven't gotten one lick of fan mail yet, and it's just infuriating me, so I just wanted to mention that to you because you're both cheaper than my therapist, but let's get into the discussion about the two of you before we go into your business. And so Lou, Ed, tell us something about yourselves we couldn't find on the internet, Wikipedia. How did you get started? Why don't we start with you, Ed, and then we'll go to Lou.

Ed Fortunato: (03:23)
Well, it's funny. I was listening to your discussion with Andrew Cuomo a couple of weeks ago, and it seemed like you had a lot of similarities. You talking about wooden spoons, I couldn't stop laughing. I spent my life, my younger part of my life avoiding wooden spoons and laughing at my mom when she'd break them on us.

Anthony Scaramucci: (03:41)
Okay, so for the non-Italians listening in to the SALT Talks, what Ed's referring to is the grandmother, the nona, would come at you with a wooden spoon. She was stirring a pot of sauce. She cleaned it off with a dish towel and she started whacking you with it. And I like to tell people, some people say they got one strike in their family. Yet other people say they got three strikes. I got no strikes. I mean, she was starting to whack it before the pitch was thrown. You couldn't call it a ball or strike.

Ed Fortunato: (04:09)
We got a little bit bigger and you know, we break the wooden spoon and she threatened our father when he got home. And it was a disaster, but more than that, it was the faith, the family, the discipline that you guys talked about. And it just kind of struck a bell to me. It was really interesting. I just think we have a lot of similarities as far as that background goes. We were a little bit more working-class. I grew up in a Trump apartment, so I have a natural anti-Trump bias from a young age. So no offense to anybody on that.

Anthony Scaramucci: (04:37)
So that was in Jamaica? That was in Queens, Brooklyn?

Ed Fortunato: (04:41)
In Brooklyn.

Anthony Scaramucci: (04:42)
In Brooklyn. Yeah.

Ed Fortunato: (04:43)
Yeah. In fact, I cut out of seventh grade to go watch some film, Saturday Night Fever. And you know, I went to studio 54 for my high school prom. I got a scholarship to Brew College. I figured I'd give that a shot. My father would always say, "Go to college, go push a pencil when you get older." And I took a lot of odd manual labor jobs to motivate me to go push a pencil. So I graduated, I started on Wall Street after college. I studied finance. I fell in love with commodities and trading and a few companies later and 18 years at Exelon, and here I am.

Anthony Scaramucci: (05:12)
Well, Louis, go ahead. It's an amazing story. And this is one of the things that always gives me hope for our amazing country. Each of us have had these sort of backgrounds and upbringings, and we've got to keep that going, Ed. We've got to keep it going. Lou, tell us a little bit about yourself.

Lou Evans: (05:32)
I too have fell victim to the wooden spoon. I have a grandfather right off the boat from Perugia. So you know how my upbringing was. Graduated high school and I'm in the Northeastern Pennsylvania area. And in that summer, post high school, we had a terrible flood. And I got a part-time job which turned into a 60, 80 hour a week job.

Anthony Scaramucci: (06:12)
So let me interrupt you. That's Northeast Pennsylvania, is that Wilksberry, Scranton? Where was it exactly?

Lou Evans: (06:16)
It is. Yes, Scranton area.

Anthony Scaramucci: (06:18)
On the Susquehanna River, right?

Lou Evans: (06:18)
Yes.

Anthony Scaramucci: (06:19)
So my dad grew up in Plains, PA. And so his family immigrated there from Italy. They were obviously in those coal mines. Then as my grandfather got older, he started a small butcher shop. So I know the area very well, and you're referencing the Susquehanna river floods, which there were some very big ones in the mid seventies.

Lou Evans: (06:42)
'72, Agnes was worst on record up this way. I was 85 and it was interesting. My first paycheck was in the thousand plus dollar range. And I thought, at 18 years old, I fell in love.

Anthony Scaramucci: (07:03)
Amen.

Lou Evans: (07:03)
So I pursued a career. I got into an apprenticeship, went to school at night. Worked all day. And I was voted the most likely to not pursue a career, and very much so go in business. And everyone would kind of joke with me and say, "You're here to learn the business. We all know that you're going to go in business." And quite frankly, that's what I did a few years later around 22, 23 years old. Started out small and have started my own company, back then. And we did some commercial industrial work. And then I became a senior VP of another company doing major commercial industrial work. And then prior to the real estate bust in '08, the commercial markets for construction, they had dried up long before the bust and we couldn't buy a job. We couldn't buy a project back then. And I kept getting these magazines into my office on my desk, and they all had green covers. And you know, it was basically despair. And I opened up one of the magazines one day and started reading about green life, whatever you want to call it, the sustainability.

Lou Evans: (08:52)
And I took a chance with it, Pennsylvania had just deregulated, which means that you could now buy your electricity, kind of like the old mob bell deregulation. You could buy your electricity on the open market. And there were so many lawsuits that there were a lot of grant programs in play.

Lou Evans: (09:16)
So I put together a grant program. Used one of my close friends who still today owns a major call center, used him as my first customer. Once his grant money came through, he at that point set up a meeting for me with 11 investors. It was the day before Thanksgiving, 15 years ago. And I had hoped that one of the guys would write a check and I walked out of that room with 11 checks.

Lou Evans: (09:51)
So over the past 15 years through buy sell agreements, about four years ago, I've been able to take the company over 100%. And sustainability is a very broad word. Energy efficiency is more what we do, and we do it on a commercial, industrial, and municipal scale. I don't know if I can get into talking about my business model at this point, or save it for later.

Anthony Scaramucci: (10:29)
No, we want to talk about the business model. Let's talk about the business model, where you see it today in COVID. Where you see it post COVID. Tell people that don't know about Commonwealth Energy Group, what you guys do.

Lou Evans: (10:44)
So back in '08, we were a startup, and we had a great run for a good three, four years there because the incentives coming back from the utilities because of the lawsuits that I spoke of, they were very, very lucrative. A typical office light above your head would have a rebate in the same dollar amount that we would charge to put it in. So there was certainly no such thing as free, but we were getting a $50 rebate to put in a $50 fixture, labor and material.

Lou Evans: (11:26)
And that was a great run for a good five years. And as the incentive programs dried up, we dried up as well. And we knew that we had to make a pivot because we could show amazing return on investments. We could get projects to a two year return or less, and back in '08-'09, people would say, that's a beautiful thing, but we're not going to stroke a check.

Lou Evans: (12:03)
So we came up with a self-funding model because it was our biggest obstacle. At that point, we started very small, and we started to fund people and finance people. And we've grown with that model. So as of today, every project that we do, whether it's a sustainability plan or a retrofit as beautifully our new administration is talking about retrofitting many, many buildings throughout the country. We actually fund that project ourselves. So we put up the capital, we do the work, and we also guarantee the savings. It's pretty well a win-win win. It would be very hard for you to say no with us, giving you the capital, putting a guarantee on it, and doing the work for you. So it's very much a good model.

Anthony Scaramucci: (13:13)
So how do you guys connect? How do you guys partner up, Ed?

Ed Fortunato: (13:19)
So we have a little bit of everything in our company. We have a big umbrella. We have five utilities that serve parts of Chicago, Pennsylvania, Baltimore, Maryland, the Eastern shore of Maryland, New Jersey, Atlantic City electric, Washington, DC. And then we have a generation company. We're biggest carbon-free generator in the country. And we have a big retail arm. It's the biggest in the country. We sell more electric, more natural gas that anyone in the country.

Ed Fortunato: (13:46)
And Lou's company really just kind of comes in, and it's just another aspect of our retail business. It's not just, but it's a big part of our retail business. So we can use that as a marketing tool to get in the door and say, "Hey, we can come save you money." We can kind of make it more efficient. We can make your business run better. And not only can we do that, we'll sell you gas and power. And it's worked really, really well. I think it's been very lucrative for both Lou's company and our company too. So we continue that.

Ed Fortunato: (14:15)
And just to quantify how efficient lighting has gotten, and just using the lighting as an example, there's a measurement of BTUs per lumen. Lumen is the amount of light out there. And if you're burning a candle, you're burning some wood, it's like 0.2 lumens per BTU. A conventional light bulbs about 15 lumens per BTU. An LED bulb is in the tens of thousands of lumens per BTU. So it's gotten so much more efficient.

Ed Fortunato: (14:41)
And when I started in this business, you were talking about lighting demand would be about 20% of total demand overall. And you're down to 10 now, or eight or 10% now, and it's heading lower. So a lot of the low-hanging fruits been extracted, but there's still way more to go as far as just lighting alone goes as far as efficiency.

Anthony Scaramucci: (15:01)
When you look at the new administration and obviously Louis knows this, Joe Biden is from that area, Scranton, PA. He's thinking about things like the green new deal. He's thinking about things like addressing fracking and potentially curbing fracking. The Paris Accords, the reintroduction of the Paris Accords. Tell us about the impact that this would have on your business, if any, and how are you prepared and set up for the future? Given these things that are out there.

Ed Fortunato: (15:37)
Lou, me? Who are we talking?

Anthony Scaramucci: (15:38)
It doesn't matter. It's a free flowing conversation.

Ed Fortunato: (15:42)
Okay, good. I just didn't want to cut anybody off. The future is bright for energy. And I think there's a lot of reasons for it. I think one of the things that I was reading about over the course of the holidays, which is kind of new energy and renewables. And for the longest time, I always viewed them where they always seemed to be kind of subsidized inferior products compared to the fossil fuel business we have. And you look at GE, which is a major corporation. They're having trouble now, but they're a major corporation. The major acts as the capital. They're developing wind turbines with 13 megawatts. The average wind turbine in this country is about two megawatts. So you can drastically increase the amount of electricity coming from the wind.

Ed Fortunato: (16:23)
We have 60,000 wind turbines in this country. And if you start retrofitting some of those things, it'd be a vast difference. Hydrogen has been the darling of this whole pandemic, as far as energy goes. They've done a lot of work on that. And they're using that for energy storage purposes. You can take the wind, use it as electricity in off-peak hours, which is when wind blows, nighttime and spring and fall. And save it for a more peak day. And you can use hydrogen as that vehicle. And it's starting to make sense as far as pricing and as far as technology goes.

Ed Fortunato: (16:55)
And then you get a company like Quantum Scape, which went public back in November. That had a $5 billion market cap, went up to 40 billion and is somewhere around 20 billion now. But that's dues and solid state batteries in automobile applications. And that can kind of really change the game and challenge the Tesla and give an opportunity to places like Volkswagen and GM, to really kind of mass produce electric vehicles. And if they charge as quickly as they state they can, and they give you a range as large as they can, that would really kind of challenge the energy business. And I think that's important going forward.

Ed Fortunato: (17:27)
As far as Biden's work, we have a very balanced Senate right now. We have a really tight House of Representatives, and it is going to be hard for some of his more aggressive plans to get through. A guy like Joe Mansion or a senator like Murowski in Alaska can really kind of have an impact. Just moving one to the other because the Senate is so tight. And so it's going to keep very aggressive ideas more neutralized.

Ed Fortunato: (17:54)
Fracking on public lands is probably the most vulnerable, it's only 8% of our total output. And there's tons and tons of natural gas out there. In private lanes too. So it's not going to be a problem. Guess is going to be a transition fuel to the future. And yeah, I'll stop there.

Anthony Scaramucci: (18:12)
No, listen, it's fascinating. It's the reason why I wanted to have you guys on. Let's talk about the next 20 years in your business with everything that you just said, and I'll turn this over to Louis. What is the backdrop? How are you adjusting? How are you adapting to the landscape and the macro factors that Ed is laying out?

Lou Evans: (18:40)
That's a very interesting question because where we sit in the energy sector, whether it be commercial, industrial, or municipal, we will always always be the second largest expense next to people in an organization. So hydrogen is definitely the key to the future. Long-term battery and inexpensive battery is definitely just as good. If you look at the demographics on who's driving electric vehicles, it's mid thirties, over a hundred thousand dollar income, and that demographic has never changed. So something has to change, and lower price batteries, and maybe cars with a lot less bells and whistles that people will be able to afford them.

Lou Evans: (19:46)
You can look at a saturation point, whether it be new air conditioning, LED lighting, whatever that may be, but there's always something more. We're running, looking in our marketing, we came up with a bit of a plan where through COVID, I would drive weekly through Philadelphia and I would very much see all of these buildings lit up a 100% at dusk or at nighttime, but yet I knew there was no one in there.

Lou Evans: (20:27)
So if you take an LED and you've saved 70%, there is nothing cheaper than off. So lighting control now becomes the next thing. Why do you want to have a light on, even if it is 70 per cent cheaper, why do you want to have a light on if no one's there?

Lou Evans: (20:48)
Conditioning air, it is going to be massive. It's going to come out of this administration just because of COVID. There is going to be a great run on HVAC equipment. Everybody wants their air conditioned to be able to take COVID out of the air. They want that warm and comfortable feeling. So what we do, until there becomes a replacement for electricity, lighting and gas, we just need to get more efficient every day.

Lou Evans: (21:27)
And when it comes to sustainability, we do not approach sustainability the same way that let's say a Greenpeace tree hugger would. We look at it for the actual definition. We're here to help you sustain your company. And if it's financial, we'll bring in a financial person for you. We can certainly help you get your energy bills down, but we want that company to sustain themselves for many, many years to come.

Lou Evans: (22:02)
So I believe that the energy sector is in a great position because it is changing every day. We've got Steve Wozniak playing in the energy efficiency game now. So that's a great punch in the arm, a shot in the arm for the energy efficiency game. And we're what's called an energy services company, and now Woz is calling out ESCOs as the great new companies of the future. Everybody needs to be using ESCOs. So I believe that energy savings will never go away because HR looking to slash their costs will never go away. So we're number two.

Anthony Scaramucci: (22:59)
Mm-hmm (affirmative). Let me Ed, because you've done a lot of work on this over the years. The relationship with China that the US is going to have, and the energy draw that China has on the world in terms of its fossil fuel consumption, et cetera. Where do you think things are going to go in the Biden administration with that relationship? And [crosstalk 00:23:24].

Ed Fortunato: (23:25)
I'll give Trump credit for one thing, he's made our relationship with China a bipartisan issue. And he's brought it to the forefront and they seem to be a threat. And as long as that's the case, it's going to be fairly contentious and a little more than competitive. Before the tariffs were imposed, there was a lot of talk and a lot of work on LNG exports to China directly. And that's kind of gone by the wayside. That stopped right now.

Ed Fortunato: (23:51)
But even without us exporting gas to China, it's still an energy hungry world. And it's still a very energy hungry country. And energy globally is a logistics problem. So if China was going to buy LNG from us and they're not buying it from us, we'll sell it to Europe and Europe will ricochet it over to China. So there's still demand for it.

Ed Fortunato: (24:16)
I think the Biden administration is going to take some of the rhetoric out of the equation as far as China goes. It's going to be a little bit less in the headlines and possibly a little bit more kind of clandestine or behind the scenes. I think Biden's going to work hard with Europe and other allies to kind of formulate a strategy to kind of isolate China. Whether that's a reenactment of the transpacific partnership, whether that's an alliance for trade with Europe, whatever it is. I think that they're going to kind of try and counteract China's influence in the world that way.

Ed Fortunato: (24:54)
The Paris Accords, as you mentioned before, we're going to rejoin those. It's more of a ceremonial type of a pattern. The cheap gas that we have in this country has done more than hurt coal and carbon emissions than anything else. So the combination of things is going to hopefully our alliances, hopefully our growing LNG exports around the world will kind of offset China. And also Russia's kind of influence with China as far as gas sales with them go to.

Anthony Scaramucci: (25:22)
But it's interesting. And I think it dovetails from what Lewis is saying about energy conservation and timing of the lighting, timing of the energy, making it more efficient. It puts America in a power seat geopolitically, right? Because ultimately we're going to be able to have some level of energy independence going forward, which will help the countries footprint from a foreign policy perspective.

Ed Fortunato: (25:47)
It sure seems that way. For the last 10 years, everyone's expecting the US dollar to collapse as far as world currencies. And one of the biggest supports of that is we're not shipping a trillion or a trillion and a half dollars out every year to countries for oil anymore. It's a balance of trade and the energy is fairly flat now. And that combined with the rich resource now, has kind of taken us from going to countries who are basically our enemies on our knees to begging for energy to kind of be an independent.

Ed Fortunato: (26:15)
And it's really kind of changed the politics of the middle East. It's changed our relationship with Russia. And one of my fears initially was, with lithium ion, China controls most of the cobalt in the world, they control most of the lithium in the world. And as a result, we're kind of going from dealing with the Russians and Iranians for energy, to dealing with Chinese.

Ed Fortunato: (26:36)
And now if we do develop solid state batteries, they are much more just common materials like zinc and nickel and things like that, which China doesn't control. So we'll have more control of our independence energy-wise and go from there. I'll throw out a quick trivia stat for you. About 60% of the electricity produced in this country is produced to move the electricity from the power plant to your home. And just a change in that would just completely make things infinitely more efficient.

Ed Fortunato: (27:08)
And if we can get kind of scale on solar, scale on wind, where you can use it in your house or put it on your roof, that transportation fee goes away. And it makes the whole system, demand would plunge for that. So there's just a lot of opportunities out there. Financing, it has been there for about five or 10 years now, and we need to kind of push forward and kind of have these new developments kind of take hold, which is what we're starting to see.

Anthony Scaramucci: (27:34)
Well, I'm going to turn it over to the earth's wild millennial who's getting the fan mail, because this is the way we get our ratings up. Louis, what can I tell you? It's embarrassing to me, but go ahead, Darsie. I know you've got a ton of questions for these guys, so fire away.

John Darsie: (27:52)
I don't have a million Twitter followers like you showering praise on me every day. So I got to latch on to just the single piece of fan mail that I get to try to boost my ego and boost my confidence.

Anthony Scaramucci: (28:02)
Well, you didn't have to bring it up though. You didn't have to bring it up and hurt my feelings in front of my friends, but go ahead.

John Darsie: (28:09)
So I'm going to start with Lou on this one. So the vaccine is getting rolled out. We're starting to see travel pickup a little bit, and we're starting to see sort of light at the end of the tunnel. Dr. Fauci said that by April, he thinks at least within April, he thinks the majority of Americans who want the vaccine will be able to get the vaccine. So when in your view, are we going to see energy demand pick up back to normal levels? And what will be sort of the path to getting back to the normal levels?

Lou Evans: (28:41)
You say energy demand. I would say that you're talking about commercial industrial. I would say 12 to 18 months. It seems like a lot of large companies are going to stay with this work at home model for quite some time. So that is going to be, it's almost a real estate question at this point for a REIT. That seems to change every day. Are you going to work from home for the next two years? Are you going to get back in the office?

Lou Evans: (29:28)
I was actually, Ed hosted a call yesterday and the downfalls of not being in the office. So from our standpoint, it almost doesn't matter because we're poised to help whether you're in the building or not. So energy demand kicking back up in the commercial, industrial space. I would say gradually over the next 12 to 18 months.

John Darsie: (30:04)
What are the biggest drivers in commodities markets in general as we head sort of into 2021? And into a more normalized environment. Ed, you want to take that one?

Ed Fortunato: (30:14)
Yeah, let me just pile one for the energy demand question for a second. Lou did the commercial industrial, but you look at the transportation side and until air travel improves, jet fuel is going to be depressed. And you're going to have a lot of people driving around. You've seen gasoline demand rebound.

Ed Fortunato: (30:33)
We average about nine to 10 million barrels a day of demand. We went down to 3 million barrels in April, we're back to seven or eight now. That'll increase as things get better, but jet fuel is a couple million barrels a day. And we're a fraction of that. And so until we get back to that travel, and whether it's leisure or business, and business is going to take a while. Zoom calls are pretty efficient. You don't need to stay for two nights for a two hour meeting anymore.

John Darsie: (30:57)
Right.

Ed Fortunato: (30:57)
I think that's going to change a lot and take a while to rebound.

Ed Fortunato: (31:03)
But as far as commodity markets, liquidity in the markets and fed stimulus and things like that have had a big help. You can see money flowing into different commodities pretty aggressively. You take a look at gold. Gold's price has been very strong, as money's kind of flowed there.

Ed Fortunato: (31:21)
You've seen commodities like oil be depressed because of lack of demand, but lumber demand has been through the roof just based on all the building demand for people. People in the houses are tired of being in their small cramped house. They're going to expand it. They want to do a little bit of work in their house to improve it.

Ed Fortunato: (31:35)
Businesses have been very ingenious in kind of expanding outdoor restaurant space and seating. So you'll see an increase in demand for that.

Ed Fortunato: (31:48)
As far as commodity prices going forward, I think it's more lack of capital going to the market than anything else. If you look at oil, or capital spending in oil has been cut 30% in 2020 and 2021 also. And as a result, you just know, when this demand does come in '22 or '23, you won't have as many projects online to kind of have capacity. And without that capacity, you're going to see prices surge and that'll be the market signal to go out and kind of go drill for more.

John Darsie: (32:17)
Right. Who do you think will be the biggest winners and losers in the energy space this year? And Lou, we'll start with you on that one.

Lou Evans: (32:26)
In the energy space, as far as customer goes?

John Darsie: (32:31)
Yeah, broadly.

Lou Evans: (32:34)
I'm seeing a very big jump in data centers. Data centers are expanding hand over foot. And they are huge energy users, which obviously comes with our time, right? We're in Zoom, we're in Netflix. We need more cloud storage. So data centers are expanding. They will definitely be winners.

Lou Evans: (33:02)
I think the at homes will definitely be winners. And I think strong REITs will be winners. They're adjusting and they're being proactive and they're taking this COVID time, with half empty or empty buildings to make the modifications to make everyone comfortable. So that when the day comes, people will feel comfortable coming back.

John Darsie: (33:37)
Ed, what do you think?

Ed Fortunato: (33:38)
You know, as far as winners, we've seen hydrogen be the biggest winner. Any equity that's invested in hydrogen or is doing research in hydrogen, has kind of jumped up. We've seen some realizations on hydrogen limitations. We've seen some progress on it. We've seen a big progress, renewables. Like I mentioned with the wind turbines. We've seen solar panels improve, we've seen storage technology just really kind of improve at different levels. Whether that's batteries or that's wheels, things like that.

Ed Fortunato: (34:09)
I'll just diverge for a second. Storage is the holy grail of the energy business. And whether that's a battery to kind of threaten Exxon Mobil or the house of Saud on the gasoline side, or flatten out prices on power. You figure out the storage problem, you win the trillion dollar prize.

Ed Fortunato: (34:30)
And there's a lot of work being done on that. There's been some progress and I think there's going to continue to be more progress going forward. And that's going to be the most exciting part of the whole business. And we've seen trends accelerate, and this is all really kind of come to the forefront over the last year or so. And like I said, you can almost imagine a world now with renewables. Where a year ago, you just weren't seeing it.

John Darsie: (34:51)
Right. Well, we're going to leave it there. Thank you so much, Ed and Lou for joining us on SALT talks today. We have a lot of members of our community who are investors in the energy space. Obviously it was a challenging year in 2020 with the pandemic and other factors that help drive energy costs, energy prices down. So it'll be a fascinating thing to watch. And hopefully we'll have you back either back on SALT talks later in the year or at one of our in-person conferences. We're bringing the SALT conference back in 2021. We'll have an announcement on that in the next couple of weeks, but we look forward to keeping up with you guys and hopefully talking to you soon.

John Darsie: (35:27)
Anthony, do you have any final words before we let Lou and Ed go?

Anthony Scaramucci: (35:31)
Well Dorsey, you may be getting fan mail, but now that I know where Lou is from, him and I, we know where the best pizza is in the world. It happens to be in that area. Am I wrong Lou?

John Darsie: (35:42)
Brooklyn.

Lou Evans: (35:43)
Old Forge, Pennsylvania, pizza capital of the world.

Anthony Scaramucci: (35:46)
[inaudible 00:35:46] talking about Brooklyn, he doesn't know what he's talking about.

Ed Fortunato: (35:47)
We can take you guys for a pizza tour [inaudible 00:35:50].

Anthony Scaramucci: (35:50)
You remember Brutacos in Old Forge, Louis?

Lou Evans: (35:53)
Absolutely.

Anthony Scaramucci: (35:54)
See these guys don't know.

Lou Evans: (35:56)
Best [inaudible 00:35:56] in the world, Anthony.

Anthony Scaramucci: (35:57)
These guys don't know white pizza, Louis. They don't know white pizza again. They don't even know what they're missing. Look at how naive and uneducated they are on where the best pizza is.

Ed Fortunato: (36:05)
You need [inaudible 00:36:05] gardens in your life. We'll get you there after this pandemic.

Anthony Scaramucci: (36:10)
All right.

Lou Evans: (36:11)
Anthony, tripe and safrita.

Anthony Scaramucci: (36:13)
Amen. Amen, Lou. All right, well guys, thank you for coming on. And we'd love to get you at one of our live events and we'll see you guys soon right after the pandemic.

Ed Fortunato: (36:24)
Okay, happy new year.

Lou Evans: (36:25)
Thanks very much.

John Darsie: (36:26)
Thank you to everybody who tuned into today's SALT talk with Ed Fortunato and Lou Evans to discuss the energy markets and the future of the energy space heading into 2021. Just a reminder, you can access all of our talks on demand on our website at salt.org/talks/archive, and you can sign up for all of our future talks at salt.org/talks.

John Darsie: (36:49)
Please follow us on social media. SALT is on Twitter, LinkedIn, Facebook, and Instagram. And please tell your friends about SALT talks and about SALT. We love growing our community. We grew it tremendously in 2020 using these digital tools that we were sort of forced to use, with doing SALT talks rather than doing our conference series, but it turned out to be a blessing. And we're very excited to have all these new members of our community who are aware of SALT and everything that we're trying to do here. So very gratified by that. And please spread the word about SALT. This is John Darsie, on behalf of everyone at SALT, signing off for today. We'll see you back here again tomorrow on SALT talks.

Pandemic Venture Investment Series - Episode 7 | SALT Talks #134

“Because you've got a large audience [with the pandemic], it provides a large opportunity for nefarious actors to use it as a hook to either push new types of disinformation narratives or to connect longstanding disinformation narratives to exploit this new opportunity.”

Dan Brahmy is Co-Founder & CEO of Cyabra, software company designed to identify disinformation. Vincent O’Brien is a State Department Foreign Service Officer & Former US Army Special Operations Officer and recently worked at the Global Engagement Centers to identify Russian disinformation.

Misinformation and disinformation have been around long before the Internet and it’s existed on whatever medium corresponds to the time period. Social media represents the latest iteration in communication and has served as a uniquely effective medium for misinformation and disinformation. The global pandemic has only exacerbated the volume and effects of disinformation because so many people are paying attention. “Because you've got a large audience [with the pandemic], it provides a large opportunity for nefarious actors to use it as a hook to either push new types of disinformation narratives or to connect longstanding disinformation narratives to exploit this new opportunity.”

Russia, China and Iran represent the three major state actors engaged in disinformation intended to hurt the United States. Russia and Iran are more focused on simply creating chaos among other nations and exploiting any domestic political divisions. Beijing has the more explicit goal of shaping a new world order that sees China at the top.

LISTEN AND SUBSCRIBE

SPEAKERS

Dan Brahmy.jpeg

Dan Brahmy

Co-Founder & Chief Executive Officer

Cyabra

Dan Brahmy.jpeg

Vincent O'Brien

State Department Foreign Service Officer & Former US Army Special Operations Officer

EPISODE TRANSCRIPT

John Darsie: (00:08)
Hello, everyone. Welcome back to SALT Talks. My name is John Darcie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy. SALT Talks are a digital interview series with leading investors, creators, and thinkers. What we try to do on these SALT Talks is replicate the experience that we provide in our global conferences, the SALT Conference, which we hold twice a year, once in the United States and once internationally.

John Darsie: (00:40)
What we try to do at those conferences and what we're trying to do on these talks is provide a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. We are thrilled today to welcome you to the seventh and final installment of our pandemic venture investment series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arriving from the pandemic crisis and discuss breakthrough technologies that address issues from coronavirus prevention and cure to social distancing and food supply.

John Darsie: (01:17)
A reminder, this series is presented in partnership with our friends at OurCrowd, which is a leading global venture investment platform. Today's episode is called the tech cure for fake news and deepfakes. It features Dan Brahmy, who's the co-founder and chief executive officer of Cyabra, and Vincent O'Brien, the State Department Foreign Service Officer and a former US Army Special Operations Officer. Today's episode will be moderated by OurCrowd president and CIO, Andy Kaye. Just reminder, if you have any questions for any of today's panelists, you can enter them in the Q&A box at the bottom of your video screen on Zoom. And with that, I'll turn it over to Andy for the interview.

Andy Kaye: (01:57)
Thank you very much, John. As mentioned, I'm the president and CIO of OurCrowd. And joining us today are Dan Brahmy from Cyabra. Dan was born and raised in Paris, moved to Israel at the age of 14 and graduated from the IDC International Business School. During his career, he spent time at internship at Google and founded a startup called B2G and then went on to become a senior strategy consultant at Deloitte before founding in 2018 Cyabra. Cyabra is a platform that uses AI lens to detect disinformation and filter the real from the fake.

Andy Kaye: (02:39)
We're also joined by Vincent O'Brien from the US State Department. Vincent is a State Department Foreign Service Officer, a former US Special Army Operations Officer, and has spent a recent role as the Global Engagement Centers to identify counter-Russian disinformation. He served in many places around the globe, including Russia, China, Sweden, Germany, Estonia, Afghanistan, Southeast Asia, Africa, and Central Asia. Vincent got an MBA from Northwestern University – Kellogg School of Management. Today, will be representing in himself with his personal views and in no way is representing the views and opinions of the State Department. With that, thank you very much for joining us gentlemen. What I'd like to ask as the first question, Vince, and if you could lay out the guidelines and definition of misinformation and disinformation and provide some guidelines or examples for the audience.

Vincent O'Brian: (03:41)
Sure, and he can do. Thank you. Greetings from Washington D.C. as by the way. Let's just talk about misinformation, disinformation, propaganda and its history. Certain state actors have been weaponizing information for decades. Even today, there are new technologies that are being employed that make it easier and faster to do so. In the past, they used newspapers and television and word of mouth and the like, but social media has become, at this stage of its development, a really very useful medium for those who seek to achieve their goal through deception. Most of what we talk about now will be in the context of digital, media, social media, and basically the internet.

Vincent O'Brian: (04:27)
Let's make sure we're clear on terms. Misinformation is sometimes used when the speaker actually means disinformation. That's probably because this is a new field. But misinformation is actually when someone mistakenly passes on information that they think is true, but it's actually false, kind of like when a friend or a relative forward you an email that contains an urban legend that they think is real, or there are no alternative cure for the flu or even COVID and that information is wrong and it's actually harmful. The content actually can be a lie, but the intention of the center was not to lie or to harm.

Vincent O'Brian: (05:05)
Disinformation is different. That is when a group or a person deliberately creates and spreads a lie or a manipulated information in order to harm another person or group or to deflect attention away from an issue they believe to be detrimental to their own interests. Misinformation, I like to remember it as misinformation is a mistake, disinformation is deliberate. An example of disinformation, a recent one would be the US military created COVID-19 as a bio weapon, they brought it to Wuhan, China, and they released it. That's disinformation. Misinformation might be it's a bio weapon that was released from a lab. We're not sure about that. There you have it now.

Vincent O'Brian: (05:44)
Propaganda is something different. That's the act of arranging or organizing information in such a way as to bring about the perception or a perception that would not normally be held if the facts were presented in a straightforward way. I'll give you an example. It's an old example, but it's one that we've been dealing with in my lifetime of the US government because most of the time I've spent... much of it I spent really dealing with Russia.

Vincent O'Brian: (06:11)
Here's an old propaganda example. During the Soviet times, the Russian and the US national crew teams decided to engage in a race. There were no other competitors, just those two crew teams. The US team won. The headlines in the Russian state media outlets read this, "Russian rowing team takes second place in international contest. US team finished next to last." Now, that's propaganda. It's true in some ways, but if you look to the facts in a straightforward way, you know that the facts are totally different than what the impression was that you were left with. That's basically the definitions of the three areas of what we will say deception in social media.

Andy Kaye: (06:54)
Thank you very much. Dan, can you explain the difference between fake and deepfake?

Dan Brahmy: (06:59)
Thanks again for this opportunity. The way that we look at disinformation from our perspective and our own experience is the fact that it's sort of a triangle. And then when we look at the triangle, we see that the problem is divided within identity fraud, visual content fraud, and written content fraud. A lot of the people when they speak of fake news, for example, they may not necessarily understand that they relate to the written content aspect, meaning anyone can write anything and then go figure out if it's the truth or not. That's one aspect of disinformation.

Dan Brahmy: (07:36)
But the other two which are really interesting and are really big part of what it is, is the fact that you can... You spoke about deepfake. It's a broader topic around the ability to generate highly realistic visual pieces of content, pictures, and videos that may be generated from scratch. Absolutely nothing. You press a button on a publicly available website, and then you can create a picture of someone who never existed before, meaning the consequences for this are, of course, you can have a really great application for this, for the entertainment world, high net worth individuals, celebrities, that's wonderful. But there's a really bad side around this because that means that you can create identities and there's no backtrace around it. You can literally create people from the ground up.

Dan Brahmy: (08:27)
The other problem around deepfake is the video aspect of it, meaning I can make myself reenact someone else's facial expression, even words. I can do what we call face swaps or facial reconstructions of things and make me say things into Vincent's mouth. And that would be a catastrophe if this is something really negative in terms of a brand imagery, in terms of even other governmental agency or country as a whole. And so that's why we look at the problem of visual manipulation as a really uprising problem and threat under that larger umbrella called disinformation. Those are the two real distinction from our perspective.

Andy Kaye: (09:15)
Thank you. Now that we've explained these basic definitions, why is COVID or the pandemic exacerbated those effects? Maybe you want to take that, Vincent, initially.

Vincent O'Brian: (09:28)
Sure. Just unmuting myself. Well, it's a global interest, first of all. It provides an opportunity for anyone to comment on it and you'll have governments are commenting on it, you have pharmaceutical companies, you have political pundits. Like I said, because it's a global interest, everyone worldwide is tuning into it. Because you've got a large audience, it provides a large opportunity for nefarious actors to use it as a hook to either push new types of disinformation narratives or to connect longstanding disinformation narratives to exploit this new opportunity. I think I should have said in the beginning, I deal mostly with state-sponsored disinformation. So, many of my examples will be about state-sponsored disinformation.

Vincent O'Brian: (10:24)
For the longest time, Russia has spread disinformation about US assistance to countries in their near abroad, the Central and Eastern Europe, in developing biolabs, but Biolabs for health purposes to be able to detect cholera and other diseases, not for weapons or the like. And so because we have this global pandemic, now Russia is using it as a platform to push their narrative that these labs are actually a danger to the people in those countries and are an offensive weapon to be used against Russia, which is not true. That's one reason.

Andy Kaye: (11:11)
Do you want to add anything to that?

Dan Brahmy: (11:14)
Sure. On my end, obviously, it's a less elaborated and clever answer than what Vincent would say. But I think on the simpler side, I'd say that the fact that these actors that Vincent mentioned earlier they see an opportunity where people are staying at home, the fact that people are staying at home and they don't have to go to their work offices and they don't have activities outside or at least much less than pre-COVID 19, that represents an ocean of opportunity for good and for bad from a disinformation standpoint because people are what they called wired. They are wired constantly, they are much more consuming content and news and pieces of information much more broadly than they were previously. That's the simple explanation of the more people wired in, the more eyeballs I can draw to a certain snowball effect. And the larger the amount of eyeballs, then the higher the impact that can be created around things that I would like to create or things that I would like to promote actively.

Andy Kaye: (12:30)
Thank you. Who are the players in this world of deepfake and disinformation and what are they really out to gain?

Vincent O'Brian: (12:38)
Andy, actually, if I could just step back from it, something I'd like to add there, one of the other reasons why COVID is exacerbating these effects is because it's new, it's a new phenomenon and the actual information on it isn't clear. That's why it's a great space for disinformation because even the experts who are trying their very best to define it and to explain it and to help public don't have all the information. It's exacerbated by the fact that the point of origin of the virus, the country, that it came from, China has not been completely transparent about it. The learning curve has been a lot steeper than it should have been about this. I think that's just one more reason why COVID has exacerbated the effects of disinformation.

Vincent O'Brian: (13:22)
But then I'll go back to who are the players in the world of deepfakes and disinformation. From the US side, on the government side, the US and our allies have identified three major state players. And that would be Russia, China, and Iran. Jihadist extremists organizations also play a role, but theirs is mostly around recruiting through websites and they put out disinformation for that reason, but it's different. Russia and China generally have different goals in mind as well. I'll say the Kremlin often. When I say Russia, the Kremlin is interchangeable.

Vincent O'Brian: (13:55)
The Kremlin seeks to create chaos in order to just disrupt the current world order. Chaos is their goal. They want to weaken countries that they see as threats by manipulating their information environments to polarize domestic political conversations, to destroy the public faith in good governance and democratic principles, destroy the public faith in independent media and in science and in this case COVID. That's their general goal. In other words, more like if we can't have it, we want to make sure that you can't have it either.

Vincent O'Brian: (14:33)
Beijing's got another goal. They seek to deliberately reshape the current world order to their advantage because of their overall goals of expanding and getting access to resources and setting things in such a way that they would have uncongested global leadership. They deploy comprehensive, coordinated, kind of whole of government influence campaigns. They have the resources to do so and that's the way they do things. 1.4 billion people in China, so they do things big. The point of these global information campaigns is to promote and maintain the Chinese Communist Party's narratives domestically and globally. They use not just disinformation, but censorship, coercion, intimidation sometimes of dissidence and others to counter in silence criticism and portray the PRC, the People's Republic of China as a benign and positive and non-interventionist power when exactly the opposite is probably the direction they're heading.

Vincent O'Brian: (15:33)
Iran's goals are just similar to Russia's. But on a regional scale, they attempt to sow discord and mistrust in Iraq, especially between Kurds and other groups and in Syria and elsewhere in the Middle East in an effort to advance their goal of becoming a dominant regional power.

Andy Kaye: (15:49)
Understood. Thank you very much. Dan, anything, anyone from the private sector playing here or individuals?

Dan Brahmy: (15:55)
There is. I'd like to pick it up where Vincent left it and say Vincent was able to give an extremely detailed answer from a public sector, governmental sector perspective. I think that there are additional players. If we're trying to look at this from a different angle, there are companies like ours or private sector companies that are for-profit or sometimes even NGOs that are here to do some good and bring some transparency to the world. You also have what we would like to believe... There's a very thin line between the regulatory space, governmental space, academia space, and private companies. From our perspective as an early stage startup, it feels like there's a problem that is trying to be solved as we speak. Everyone has a play around this, but there seems to need a certain level of cooperation.

Dan Brahmy: (17:02)
Vincent was right again. Because of the fact that the problem is very new... Disinformation has probably existed for much longer than we're thinking of. But the methodologies that it's being applied today as we speak nowadays, thanks to the advance of social media platforms, of blogs and forums and so on and so forth, it makes everything more accessible. That's the problem. And so that's why we need probably deep technological companies like ours that are trying to build those technological solutions that can be used by the private sector, whether it's consumer brands, CPG, food and beverage and so on and so forth, but also sometimes be used by the public sector itself. Because as much as we would like to believe, sometimes the public sector also might turn to NGOs, academia, and private companies for the sake of strengthening their own internal capabilities up to a certain point. My point of view is there must be some sort of cooperation between the four. That's how we look at this.

Vincent O'Brian: (18:18)
If I can echo that real quickly, Dan brings up a great point. At the Global Engagement Center and with Department of State and Department of Defense and others, we do actually work with the private sector very closely and with NGOs and those in civil society who have over the course of the last five or six years have become real experts in identifying disinformation, kind of keeping track of it, keeping a database of it, and developing ways to counter it and to educate society. But we really couldn't do what we do without the private sector. I like to say there's the speed of government and there's the speed of relevance. And the private sector and companies like Dan's and others that are like it move at the speed of relevance. This is a partnership that's not going to go away. It's just going to make things better and we're going to work more and more closely in the future. I can see it coming.

Andy Kaye: (19:12)
Really, that is our way of protecting ourselves or are there any other technologies or methodologies out there which can help us?

Dan Brahmy: (19:22)
I think the more we move forward, from 2016 and forward, I'd like to say that people are starting to understand what is the meaning of that threat, slowly but surely. It might not be the role of a private company like ours, who's solely focusing on technology, but I think that someone should take the responsibility. The government is starting to do that really well, by the way, to educate people, to make them understand and teach them. I don't want to say what he's right from wrong because that's a subjective point of view. I would like to correct myself and say what is real from fake and how can you educate yourself really quickly to distinguish much better, because today the technology is out there, whether it's for the visual manipulation, where we spoke about deepfakes and such, or whether it's simply encountering a group of 50 bots and sock puppets that are aggressively promoting an agenda.

Dan Brahmy: (20:35)
I think that people need to understand that before you are engaging and before you are doing something, you ought to be able to be cautious, to read between the lines. It only takes a few seconds to be much, much more clever and more accurate, even as an individual. That's the one thing that is really important besides the technological advancements and all the AI that Cyabra or any other Cyabra could develop. I think there's a five seconds gap that people need to put into their minds and just implement that and say, "Wait a second, before I do something, should I?" That's a really good point, I think.

Andy Kaye: (21:20)
Okay. It sounds certainly we picked up on government companies and others. How would you best describe the ecosystem here and how should we really visualize that?

Vincent O'Brian: (21:36)
Yeah. That's interesting. From our perspective, from the Global Engagement Center, when I was with them, we put together a document and you can find it, it's out there in the public space. It's called Russia's Pillars of Propaganda and Disinformation. There are basically five pillars. We say that these five pillars make up an ecosystem because they work in concert with each other. Just from our analysis of the Russian disinformation system, we look at it and say these five pillars are on the one hand of the spectrum official government communication, which is open and out there, but may contain disinformation. And then on the other end of the spectrum, it's cyber-enabled disinformation.

Vincent O'Brian: (22:25)
I think the greatest example of that would be the 2016 US Democratic National Committee cyber hack were hacking release of emails from John Podesta that revealed a few things in the lead up to our election. That was cyber-enabled disinformation. Another recent example was the Lithuanian Ministry of Foreign Affairs website was hacked and a false press release was put on there that stated that the US government was moving assets from Incirlik Turkey up to Lithuania. It was completely made up and it was actually happened when our secretary of state was actually in Europe talking about similar issues.

Vincent O'Brian: (23:12)
That's kind of on the other end, cyber-enabled disinformation. Complete hack. The Lithuanian government was able to immediately identify that as disinformation. But that's something that takes a lot of assets. It's very deliberate. It takes more than one arm of government to do that. And really, only governments can accomplish that. No one else in the spectrum has the power. In the middle of that, you've got the federal government communications and cyber-enabled disinformation. On the other end, you've got state-funded global messaging like RT and Sputnik, which are outward-facing funded organizations by news organizations by Russia. And then you've got also proxy sources.

Vincent O'Brian: (23:52)
This is the hardest, murkiest area where you got websites that are consistently telling a narrative or policy line by a government, but they're not directly connected to the government. But their source of funding is murky. And oftentimes, they get it from advertising and they exist because they make money off of advertising. But they're always pushing a government line, whether it's a longstanding narrative issue or one that's very, very topical like, for example, COVID. And then finally, there's weaponization of social media. That's also in the center, also very difficult to find, where false personas on social media, perhaps they make two different false personas and they'll take opposite ends of an issue only to exacerbate the differences within the actual organic conversations in that particular platform.

Vincent O'Brian: (24:46)
That's kind of the ecosystem. All of this is fitting for creating chaos because it doesn't require any type of harmonization among the different pillars. Sometimes the story can start by government press release, or sometimes it could just start in the middle in a proxy site. And then because it goes viral, then you have a state-sponsored media organization talking about it. And then it could jump the traction to the mainstream media worldwide. This is why we call it an ecosystem. It doesn't require a memorandum or a secret, a dead drop to pick up and read and say, "Okay, let's all go do this." The system understands itself and just reacts at various times to whatever they know to be a direction that the state wants to take a narrative.

Andy Kaye: (25:39)
To understand the five pillars, is it directed toward the governments or is the private sector also a prime target for these attacks?

Vincent O'Brian: (25:53)
Dan, do you want to take that one?

Dan Brahmy: (25:55)
Yeah, absolutely. I can only speak, I assume, from the private sector. I don't know what's happening within the governmental sector once, but this is not an assumption. This is what we see on a weekly basis. We've been working with Fortune 500 companies in the news and media world which are the gatekeepers. They are the gatekeepers of information moving from the ones that are gathering them to the ones that are tuning in and listening to. Sometimes they are having a hard time filtering and vetting out what is going through that pipe.

Dan Brahmy: (26:36)
We're seeing consumer brands in the field of film production and celebrities and even high net worth individuals. None of them are government affiliated and a lot of them are suffering from... You would not imagine. Suddenly, you see a rumor around a football player and it's a rumor being propagated by tens of thousands of non-existing completely inauthentic profiles on social and traditional media that have the power to change and have an outcome that could be hurting tremendously from a financial standpoint, from a brand image as a sport athlete. That's something that we've been seeing.

Dan Brahmy: (27:28)
We've even seen e-commerce websites that have seen what we call decrease in their sales volume throughout the Black Friday period of time. It's absolutely insane. It's becoming more and more accessible, meaning that anyone can go in to that system of ours that has been created a few years ago and can skew with the public opinion for better or for worse. So, absolutely, the private companies are being targeted and are being skewed by bad and fake actors. No doubt in my mind. We're seeing this on a weekly basis.

Vincent O'Brian: (28:07)
[crosstalk 00:28:07]. Sorry, Andy, just to quickly... it's private sector... The question, is it directed at private sector or government? Obviously, it's directed at both. It's also directed at national strategic industries which are obviously run by private sector but have a great interest to governments as well. For example, you'll see lots of disinformation around, say, when... let's just say a Japanese and American and a Russian nuclear power plant development company up for a contract in South America. You're going to see lots of disinformation around that. But of course, it's of interest to... national interest, so many players there who gets that contract to develop that commercial nuclear power plant.

Vincent O'Brian: (28:59)
It'll also affect in the areas of oil and gas and other energies, Nord Stream 2, once again, it's a public private consortium to bring gas from Russia straight to Germany. But there's a lot of private sector business around that. There are very, very strong differing opinions in Europe about how gas should be coming to Western Europe and from what sources. It's something that really affects both sides. And so you'll see a lot of that in that area as well.

Andy Kaye: (29:35)
Thank you very much. Dan, starting with the private sector, what are the challenges and how can technology be used to solve this and what are the challenges? Is it the good versus the bad? Who's leading that race?

Dan Brahmy: (29:54)
That's a tricky question. I'll answer as humbly as I can. But I would say the following, I'd say that first and foremost, as much as technology can do a great work at raising the flag really fast and analyzing the authenticity of everything that's happening out there, I think that for the time being, and I hope Vincent agrees with me, for the time being, there will always need to be as the last mile of that trail to have some sort of context. And so while technology can do a lot of things, creating context around a vast amount of data is something that is, again, very difficult for technology to be able to do.

Dan Brahmy: (30:46)
I would say that currently technologies have the ability to gather around relevant pieces of information, create everything into one big pile of snowballs and start deep diving into just gigantic amount of data. And that is something that is within the technological boundaries that exist today and saves a lot of time for that one last mile, which is crucial and almost indispensable, which is now that the technology found what's the exposure, what's the level of impact and what's the level of realness, authenticity of a certain disinformation threat, the last mile will always be what are we going to do about it?

Dan Brahmy: (31:36)
The countermeasure is something that at least from my angle, we haven't seen companies that are doing the detection. You mentioned the good and the bad and I'm always joking about the subjectivity of it, but the good and the bad. We believe that Cyabra is doing the good side of it because we're not part of the system. We're trying to find a cure for it. We will never be cut and tangled with the countermeasuring aspect. I think there are other people, other players, other organizations that should be taking that aspect and there's a very clear line in the sand around this. That's how I look at this. I think the ability to go deep into vast amount of data and reach a certain high level of accuracy, 75%, 80%, 90% of accuracy and above, filtering between the real bad and fake is something that can tremendously help for the last mile and indispensable one.

Andy Kaye: (32:39)
Vincent, is this government relying on private sector or solving this on their own?

Vincent O'Brian: (32:45)
Well, we work in concert with private sector. I think I mentioned it before the private sector can move much more quickly. They're developing AI products and machine learning products and big data analysis products that government just simply by its very nature cannot go out and design themselves just like we don't go out and design the office furniture and the computers that we use. It's good that there is a private sector use for this. We work with certain private sector companies to go out to do this for us, but in a certain special kind of way.

Vincent O'Brian: (33:26)
A normal process would be if you're a company that sells shoes or you make movies and you have stars that you want to promote, you would go out and you would find a digital marketing company that has an ability to not so much manipulate social media but use social media to promote that product. Well, we have to do the opposite. When that product gets promoted, a cluster of conversation around that, the release of those basketball sneakers or around the release of a film in a certain country, all of that concentrates in a certain period of time, we see it differently.

Vincent O'Brian: (34:10)
What happens when we see disinformation is say there's a concentration of false personas around an election in a place like Chile, or in the Democratic Republic of Congo, or the like. We have to start at that point, look at it and say, "Okay, which of these are false personas that are attempting to direct the conversation and why?" These technology companies like Cyabra and like others that we use can help us identify that and then reverse engineer it and bring it back to the source. Whereas in the opposite and the totally legitimate world of capitalism, the world of commerce, you know the source. You're the company, you want to sell shoes. You purchase the services of a digital marketing company, and you go about and do what I just described.

Vincent O'Brian: (34:50)
It's very, very murky going in the other direction. And so we need the help of companies that have designed these systems to help reverse engineer them and get us back to the source. One of the things I also want to agree very strongly, Dan, and I go back a long way, in many ways, we've developed our views on these together as the situations develop. By all means, it comes down to the last mile. The data that the technology companies can put together and bring to you and hopefully describe in a way that your C-suite can make decisions on, it really just comes down to a decision from leadership, one way or the other, what to do about this.

Vincent O'Brian: (35:35)
It is a cost in many ways, it's a threat, but it's a cost to your company in many ways, like anything else is a cost. And so it comes down to an executive decision. The technology companies, what they can do is they can bring to you an interpretation of this data. But in the end, you got to be able to make a decision on it. I think the best technology companies are the ones that explain it to the leadership in a way that they can make the very best decision with the information that they have at the time. If it gets to it, I can talk about what I believe is a good protection plan for a company, a good way to go about that. If there's interest in that, I can talk in some detail on it.

Andy Kaye: (36:16)
That was very careful to say there is a handover. Do you see the governments as the body that will come back and deal with that threat once they've interpreted or would it be a different type of company that potentially jam or react to what's been described as being fake and dangering the corporation or the government?

Dan Brahmy: (36:40)
I assume that question was pointed at me this time.

Andy Kaye: (36:42)
Well, it's both. I think, yeah. But please start off and then [crosstalk 00:36:48].

Dan Brahmy: (36:47)
Sure, sure. I assume that there are things that the governmental sector is without any doubt able to do that a private sector company will never be able to do so. We've been working with a few public sector agencies and we've been working with a few private sector agencies and we see the difference in the remediation, the way that they would like to solve the problem. We understand that yes, of course, the governmental sector has the will and the power to solve the issue, and they are much, much more educated nowadays than the private sector is. They represent an excellent way in a sense to complete the equation. I absolutely believe that. I think that they are a major part of this equation in order to solve disinformation. Am I saying that the government has figured it out and count to 365, and puff, no disinformation? That that's not what I'm saying. Vincent knows I appreciate everything that is being done.

Dan Brahmy: (38:04)
I'm saying it's a tough problem. And it's so recent and so new that while we are figuring it out and researching it from a tech perspective, academic perspective and regulatory perspective, you need to remember that we all are on the same side of the boat. There's the other side of the boat, which is those bad and fake actors, which are getting better and better every time. While we learn from our mistakes, so while we learn from the gaps, these gaps are still out there for the reason that sometimes it is simply a cat and mouse play. We'll get better at something, but they will too. I hope it answers the question.

Andy Kaye: (38:54)
It does. Fascinating. Vincent, do you want to add anything to that?

Vincent O'Brian: (38:59)
Yeah. It is obviously the responsibility of government to respond to national threats and threats that are persistent and directed at... that are actually crimes. We run into... and this is kind of nefarious actors using our system of openness against us because we do run into an issue with... In the United States, we call it the First Amendment, but it's just freedom of speech and it exists in all democracies. And so it becomes difficult to say how do you go after this? Do you zap somebody and burn their IP address? They'll just start another one. And also, you have to look at it and say, "These are lies. But when in the course of human history, have we ever been able to stop people from lying?" They're just lying better, and they're lying on a medium that has a global reach and moves faster. But it still lies.

Vincent O'Brian: (40:00)
When you talk about trying to limit that, you also get into the area of trying to limit free speech, a limiting free speech. And that's a very, very slippery slope. I think the Supreme Court in the United States has had a lot of opinions on this. They've long-held the First Amendment, which is the freedom of speech in the United States to be sacred and it extends to political advocacy. But I think one Supreme Court's issue that I think sums it up perfectly is the remedy for speech that is false is speech that is true. And this is the ordinary course in a free society.

Vincent O'Brian: (40:43)
Now, that's hard to accept when you know someone is lying about you on the internet, in the chat room or on a website, and they're doing it deliberately to harm you. But in a society where we enjoy the great democratizer, the internet, it's advanced citizenship and it comes with advanced problems so we have to learn to accept. Now, getting around that, I think while there are certain legal recourses and there are certain things or the responsibility of government to do, the most important thing is to build resilience against it.

Vincent O'Brian: (41:21)
Dan touched on that earlier, where educating people... I think the real solution lies in education, critical thinking skills, critical analysis and a recognition on the part of individuals and on societies that someone out there in the digital space is trying to manipulate your decisions and your viewpoints through lies and through manipulated information, deepfakes, and the like. They appear to be plausible, but you have to recognize that indulging some type of natural reflex to only view information that confirms your existing bias or to believe what you see because it's easy and you feel as good to believe, it is intellectually lazy.

Vincent O'Brian: (42:03)
It is the individuals and societies responsibility really to develop the critical thinking skills, or at least the ones that we have and start applying them to what's happening in the digital space. And that will be able to help counter this much greater than laws or than decisive, kinetic countermeasures, the like, because the greatest way to defeat a lie is for everyone to know that it is a lie and for people to understand the truth and demand the truth.

Andy Kaye: (42:38)
One, it's extremely frustrating. Sure. How should we review this? What's a crime? What's not a crime? Where's the line? I certainly know from the world of finance we come from the... It's very well-defined where the red lines are and what the potential punishments are. Do you think the same should exist here or does it exist here?

Vincent O'Brian: (43:01)
Well, libel and slander is a crime in many countries and it's hard to find that. It's also hard to find the source in social media. I described that through the proxy sites are a great way to mask where it's coming from. It is really hard to get to who actually committed the crime. That's not to say that there shouldn't be a body of laws in countries and an agreed upon body of laws that are agreed upon internationally, just like there are in many other fields and human rights and the Geneva Convention and the conduct of warfare. There's maritime laws that we all agree upon. There can be laws or rules and regulations that we agree upon internationally about how information should be conducted in the internet.

Vincent O'Brian: (43:58)
But that's going to take some time to get to some consensus on that. I highly doubt that everyone will agree with it. I think in the end, it becomes what are you doing to build your resistance and resilience to it versus what are you doing to actually prosecute the purveyors of it? I don't think we should try to do that, but I think realistically, it will be a very, very hard to be able to get consensus on what is a crime in terms of disinformation and also what should the punishment be?

Andy Kaye: (44:32)
Dan, do you want to add anything to that?

Dan Brahmy: (44:36)
I think Vincent touched on the crucial points, really nothing to that.

Andy Kaye: (44:42)
Just from a country perspective and continuing on this line which I think is really fascinating, do you see the West at least reaching a consensus and is there a global acceptance that it really is Russia, China, and Iran against the rest of us, or are there other gray areas and gray countries and gray organizations as part of this too?

Vincent O'Brian: (45:06)
I think the latter. It's not just those three that they're the ones we focus on. I take the opportunity to put that out there because it's where most of it's coming from at the time. But if it proves to be an effective medium, others will have already gotten into the game. But it may not be as publicly available information or may be boring to actually read about it in the news, but the truth is that governments are actually working together really closely. We are working to have common playbook on how to deal with disinformation so that it works broadly across regions. I know in South and Central America countries are working together on this from a common approach. The Europeans, the Baltic states, the Nordic states, other Northern European countries have come together and worked informally to come from a common playbook on how to recognize, how to be resilient, how to respond to disinformation.

Vincent O'Brian: (46:13)
It's going to get harder when it comes from more than the sources that I've mentioned and also if those sources are murky and hidden inside proxy sites and inside false personas on social media. But there is a general consensus on how to go about this. I think it really comes down to... When organizations ask us, "What do we do about this?" I always say the three R's, recognition, resilience, and response. I think governments and other organizations and civil society organizations are getting really good at helping groups recognize what is disinformation and how to be resilient against it. That's where that's going and I think you'll see countries and groups across countries, especially civil society are working from a common playbook right now. Whether it's global or not, let's talk about that in a few years.

Andy Kaye: (47:16)
It really sounds as if you've teed up per Cyabra in many ways.

Vincent O'Brian: (47:21)
I didn't mean to, but it just comes so naturally because they really are right there. That's interesting point too. The private sector should probably be in the business of analyzing the data and getting it to the place where the decisions can be made. Anything past that is something that governments should do. But Cyabra is actually one of the organizations that have really done a good job at doing that, kind of identifying the information and just presenting it to you in a way that you can best make a decision about it. Dan, that was just a boldfaced plug for your company. I hope that's okay with you.

Dan Brahmy: (48:05)
Absolutely. Thank you.

Andy Kaye: (48:07)
Dan, anything you want to add?

Dan Brahmy: (48:12)
After the flooding words, why would I?

Andy Kaye: (48:15)
How big is the market though, from a private company perspective [inaudible 00:48:19], we're investors in your company too, how big is this market and how fast do you think it's growing from the private sector at least?

Dan Brahmy: (48:27)
Well, we've never had a doubt on the potential of the outreach of... what we call the TAM, the total addressable market that there is simply because the more we move forward, the easier it becomes to see the nefarious impact and outreach that is being created over largely super well-known brands, when we speak of CPG companies, when we speak of food and beverage companies, when we speak of automotive companies, and when we speak even of the financial sector, because imagine what would happen if there's a publicly traded stock that is being hurt by a very well-orchestrated snowball effect around a certain propaganda or a certain piece of information that is flying fast enough and deep enough and then you suddenly see the stock price dropping and then the valuation goes down by half a billion dollars.

Dan Brahmy: (49:36)
It happened in the past and it will continue to happen as long as we don't have a good filtering mechanism. The addressable market for a company like Cyabra or any other similar company like Cyabra is I'd like to say almost endless. As Cyabra, we're not currently targeting actively small and medium businesses, but anything that is mid-market and above that has the potential to be positively or negatively impacted by disinformation, so those bad and fake actors in question could be a potential customer of ours. Absolutely. We've started working with them back then.

Andy Kaye: (50:22)
That's highlighting the issue, but do you see the company evolving that you will take that next step which you're so careful not to go into and say, "We will develop an active tool in order to respond and maybe turn off the switch, such as the global sort of the Chinese Great Firewall or to react accordingly"?

Dan Brahmy: (50:45)
You're asking me as Cyabra or-

Andy Kaye: (50:46)
Yeah, definitely.

Dan Brahmy: (50:50)
If my co-founder was on the call, he would be dying from the inside of that question. Now, let me answer, let me answer. I do not see Cyabra getting into the remediation. Let me be clear on that. And everyone in that talk understands that we are living an enormous amount of money on the table by saying no to the countermeasure and to the active part of the remediation, but we are sleeping extremely well at nights because we've started the company with a moral compass that helps us understand and draw that line in the sand pretty easily. That was the longer version of the explanation.

Andy Kaye: (51:39)
No, we really appreciate that obviously and I think the audience will too. Vincent, do you want to add anything to that?

Vincent O'Brian: (51:45)
Yeah. I think from a government perspective, Cyabra is on the right track there as part of the reason why we are associates with them. I think on the government side, once you cross the tracks over to doing something like that, then it becomes difficult as a government to actually work with a private sector company because we're not sure who they took those active measures against in the past. But also, we have our own red lines as well. And so we appreciate companies that have those red lines, those moral and ethical red lines. We will never ever use disinformation as a tool against disinformers because when you do that, you're really no better than them and then your argument goes away completely.

Vincent O'Brian: (52:37)
Number two, the truth really is the best tool. Go to any US Embassy around the world at 9:00 AM and go to the consular section near the door where people line up to get visas and count the number of people that are waiting in line to come to the United States. We don't have to lie to push what we have to offer. The truth is so much stronger than that. And so we'll never ever step into that side of the business because then we are no better than the people that are our adversaries and we believe that we are. Once you get into that field, once you get into that world, once you start targeting people, you become a target. It's Murphy's Law of Combat. If the enemy is within the range of your weapons, then you're in the range of theirs. It's not a really good route to go down. We appreciate companies that don't do that kind of thing.

Andy Kaye: (53:39)
Thank you. As we sort of coming towards the end of our hour, I think your last statement certainly was very positive. But do you think we're on our way to having a good outcome here?

Vincent O'Brian: (53:52)
I do. I think we're in a lot better place than we were. I don't want to talk about elections. I certainly won't talk about current elections, but we'll go back to 2016. In the United States, the elections, it didn't come out to the public in a major way that states were attempting to alter the outcome of our election. There's no evidence they did, but they were attempting to until after the election. And so you had this entire electorate saying, "Wait, wait, was my vote manipulated? Did I vote based on false information?" Well, since then, a thriving counter-disinformation community has come up and Cyabra is a perfect example for me in 2018. So many other companies formed since then.

Vincent O'Brian: (54:36)
But this huge counter-disinformation community is comprised of governments that are cooperating, civil society organizations that have either come up out of this or completely repivoted and they're now 50% involved in how to recognize disinformation and how to promote critical thinking in the information space. Academia has moved in this direction, the press, the private sector, citizens around the world are refusing to tolerate these tactics and they're pushing back.

Vincent O'Brian: (55:07)
I think the evidence of that is going into our latest election and there's been many other elections around the world that we monitor through the State Department and through other... others monitor where everyone that goes into the vote knows now that they're being manipulated, someone's attempting to manipulate them. So they go in and they make their best choice. I think we're in a much better place than we were. Will we ever defeat it? Like I said, what's the chance of stopping people from lying? It's never been done before. I don't think we will, but we'll get a lot better at recognizing the lies and pushing back and preserving the integrity of the information space. I think we're on the right track.

Andy Kaye: (55:46)
Thank you. Dan, your closing thoughts?

Dan Brahmy: (55:50)
Look, Andy, I was born and raised in France. I'm a romantic by nature. I'm optimistic. No, jokes aside. I'm optimistic. I think that I agree with Vincent. There's actually an expression in France that says that we're seeing companies pop up like mushrooms under the rain in our field. It's a good thing. I don't see competition as being a bad thing because it only increases the exposure and the education side that Vincent so elegantly explained earlier that that's it. The more companies we have trying to solve that huge problem for the private and the public sector, the better we are at understanding it and the better we are at moving towards a more mature and getting to the last pieces of the puzzle to solve it through technology.

Dan Brahmy: (56:51)
I'm optimistic. I think we're on the right path. There's always that 1% in my heart because I'm always thinking as my co-founders taught me coming from this information warfare like cybersecurity background saying, "You're never sure. You're never sure, they always get better what they do. You always see small improvements." But we are optimistic and we can see that even from a Cyabra standpoint. We see that we're moving along the line really well. We've got wonderful investors to support us. We've got customers that are giving us the right proof. I am optimistic.

Andy Kaye: (57:33)
Thank you very much, gentlemen. It's been a pleasure. Thank you, Dan. Thank you, Vincent. I think we've really discussed some very interesting nuance points today and throughout the last seven episodes. Thank you to the speakers and thank you to our partners at SALT. If you want more information on OurCrowd, please go to www.ourcrowd.com. Thank you, John.

Lorenzo Thione: Elevating LGBTQ+ Leaders in Venture Capital | SALT Talks #131

“The moment you [come out]… you're also creating an opportunity for so many others to see themselves reflected into roles that they had not seen or imagined possible before.”

Lorenzo Thione is the Managing Director of Gaingels and a co-founding chairman of StartOut, two of the leading groups dedicated to supporting and elevating LGBTQ+ leaders in the venture startup ecosystem.

There is a negative business impact when a gay person is uncomfortable being open about their orientation. The time and attention dedicated to that issue takes away from time building out an idea or company without fear. Gaingels and StartOut help support that movement by increasing awareness and highlighting members of the LGBTQ+ community who hold top tech positions. As Apple CEO, Tim Cook famously came out publicly, after some hesitation, in support of this mission. “He came to the realization that the value of representation is the power of giving people an idea of what's possible for them and seeing themselves reflected as a source of strength and diversity as opposed to just a reason to be called other.”

LISTEN AND SUBSCRIBE

SPEAKER

Lorenzo Thione.jpeg

Lorenzo Thione

Managing Director

Gaingels

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

Joe Eletto: (00:07)
Hello, everyone, and welcome back to SALT Talks. My name is Joe Eletto, and I am the production manager of SALT, which is a global thought leadership forum and networking platform encompassing finance, technology, and geopolitics. SALT Talks is a series of digital interviews with the world's foremost investors, creators, and thinkers. And just as we do at our global SALT conferences, we aim to both empower big, important ideas, and provide our audience a window into the minds of subject matter experts. And today, we are quite excited to welcome Lorenzo Thione to SALT Talks.

Joe Eletto: (00:41)
Lorenzo is a serial entrepreneur with a passion for the intersection of technology, art, design, communication, and social value; a true Renaissance man. Lorenzo is the managing director of Gaingels and a cofounding chairman of StartOut, two of the leading groups dedicated to supporting and elevating LGBTQ+ leaders in the venture startup ecosystem. As the managing producer at Sing Out, Louise! Productions, Lorenzo is also a Tony Award and Drama Desk winning Broadway producer, Hadestown and The Inheritance, and the cocreator and lead producer of Allegiance, the Broadway musical starring George Takei and Lea Salonga, of which he also directed and produced the 2016 film.

Joe Eletto: (01:26)
In developing Allegiance, he spearheaded social media viral strategies that led to astounding growth and unprecedented awareness and audience engagement for George Takei, and to the founding of The Social Edge, for which he currently serves as chief executive officer. He previously cofounded startups Powerset and Artify.it. He is an investor, board member and advisor for startups such as Figure Eight, Weights & Biases, CrowdMed, Gobble, Just, and Lucid, and many more. He is an outspoken LGBT advocate and was named one of the most influential LGBT people in tech in 2014 and 2018 by Business Insider. He was born and raised in Milan and completed studies at the University of Texas at Austin, from which he holds an M.S. in computer engineering. If you have any questions for Lorenzo during today's talk, please enter them in the Q&A box at the bottom of your video screen. And now, I'm thrilled to turn over to Sarah Kunst, managing director of Cleo Capital, to conduct today's interview.

Sarah Kunst: (02:29)
Hi, thank you. Thanks, Joe. And Lorenzo, we're so excited to have you here today. So, let's jump in. That was a-

Lorenzo Thione: (02:38)
Sure.

Sarah Kunst: (02:38)
[crosstalk 00:02:38] background that Joe gave, but I always love to hear it from the horse's mouth, such as it were. So would love to just have you tell how we got here.

Lorenzo Thione: (02:51)
Sure. It's kind of a complicated story. I moved from Italy to Texas to study engineering, and then found myself sort of in the path of startups. I ended up starting my first company right in 2003, which was an artificial intelligence search engine, semantic search engine. And from there, we exited the company in 2008. I ended up really focusing on a number of different things, from venture investment to advocacy, and ended up cofounding StartOut, which was the first entrepreneurial network dedicated to helping LGBTQ entrepreneurs.

Lorenzo Thione: (03:44)
It's kind of like a crazy journey that took me from there to Broadway, and then back into venture. So I'm happy to go into any part of it that is interesting or talk about-

Sarah Kunst: (03:58)
Yeah. So, we're going to spend a lot of time on Broadway because I, despite being tone deaf, am a massive musical theater geek. Some of you might have missed my revival of Rent in my apartment the other night. It was accompanied by tequila, and it was fabulous. So, it's in previews now. So yeah, let's just jump in there, and then we'll work our way back. I have questions about how you think about the tech exodus to Austin and what AI looked like in 2003.

Lorenzo Thione: (04:27)
Amazing.

Sarah Kunst: (04:28)
But mainly, I just want to talk about Broadway. So, how did you get to be, in the immortal musical of Nathan Lane, a producer?

Lorenzo Thione: (04:37)
So, it's really interesting. I think the last year has given me a lot of opportunities to chart a path or sort of figure out what the thread was that led me to a lot of different decisions and a lot of different things that I've done. And it really is interesting that I think I can actually go back to the fact that I arrived in Texas sort of without knowing anybody and as a little bit of an adventure. But I arrived just a handful of months before September 11th happened. And it's really interesting, because even as a white dude from Europe with all that privilege, you look at being an immigrant as being something that is very much identify-forming. And all of a sudden, the rhetoric and the way in which people talked about immigration and immigrants had shifted.

Lorenzo Thione: (05:38)
And there's so much precariousness in the life of anybody that tries to establish a life and a job and a family and relationships in a different country, when you don't know exactly what is going to happen, and are you going to be able to say? And it took a long time. And the reason why I'm mentioning this, because it really had two major impact on things that had both personal and professional repercussions. One is, in a way that might sound pretty trite and sort of trope of a movie, it led me to come out. And it had a lot of an impact, of course, in not just personally, but on things that I ended up feeling like I wanted to do just in light of that experience and of understanding my identity better.

Lorenzo Thione: (06:29)
Which for example was after the exit of my first company, deciding that one of the things that I really had enjoyed was the mentorship I had received from people I had worked with, and the advice, and sort of had enjoyed the entrepreneurial journey so much. And had been talking to friends who were starting companies and running companies and still were feeling like they had to be in the closet with their investors and their board members and their employees. And really, StartOut was born out of that feeling like you wanted to give someone a reason for being sort of proudly and loudly part of their own community while at the same time building whichever vision for a better world all of these entrepreneurs were actually doing. It's really interesting because you realize how much of your mental energy is spent on this set of problems and layers that you otherwise would be dedicating to being a better founder.

Lorenzo Thione: (07:33)
And then the second thing that happened is completely unexpected and completely not something that was ever part of a grand plan, so to speak. One evening, I was in New York City in a theater, and I just happened to meet George Takei, who I and a friend of mine recognized as being the actor who had played Sulu on the original Star Trek series. And a little starstruck or whatever, we kind of struck up conversation. What I didn't expect was out of that conversation and out of the particular show we were seeing that evening came the recounting of his own personal experience and his own childhood, when he and his family, along with 120,000 other Japanese Americans, many of which were American citizens, were imprisoned; lost their jobs, their property, their freedom, and imprisoned in internment camps for no crime other than the fact that they looked like the people who had bombed Pearl Harbor.

Lorenzo Thione: (08:43)
And this was 2008. There were definitely a lot of echoes that still were fresh from September 11 in terms of how Arab Americans had been treated, and the Japanese Americans who had stood up at that time to denounce the risk of falling into the mistakes that the country had made already. But something really struck me. My own experience and having felt that sense of precariousness, and really, the kinship to the experience of people who had come here, building a better life for themselves and their families, and all of a sudden had lost everything. I just found, and my friend, who happens to be a very talented composer, found just this idea or this notion that this was a story that needed to be told.

Lorenzo Thione: (09:36)
And as crazy as anyone who's ever founding a company or starting a new enterprise, we had never worked in the theater before. And we're like, "We're going to write a show, and we're going to put you in it, and we're going to take this to Broadway." And it absolutely sounds nuts, but it took about seven and a half years. And on the path, added an incredible group of talented performers, including Tony Award winner Lea Salonga; gave their Tony debut to a number of other incredible performers and creatives. And took that idea, reading after reading, workshop after workshop, to its opening in San Diego in 2012, and then from there to Broadway in 2015, and then again onto sort of the screen of movie theaters around the world.

Lorenzo Thione: (10:37)
And the show continues its life, and it's one of the things that I'm the most proud of. A new production is going to actually be in Japan very soon in March, which I'm hoping the world will have resumed operations enough to allow me to actually be in person and see it in person as opposed to having to see it through some kind of screen component. But that is the story of how I got really started and connected to the world of Broadway. The connections to my own interests and passions I think can be drawn back to the power of storytelling, which is really critical for anybody, be it an entrepreneur or a salesperson or someone who's raising money for a living, or someone who's investing money, and of course someone who is telling stories for the purpose of telling stories on a stage or on a screen.

Lorenzo Thione: (11:37)
It's that really incredible arcane and from time immemorial, part of our own identity as human beings, as social beings, that really focuses in stories, the power to not just recount and pass information, but to allow others to inhabit empathetically the world of someone or somewhere that doesn't yet or doesn't exist, and allows them to imagine what life would be in those circumstances. That's how hearts and minds are changed, and that's also how great movement forward is made into humanity and society. That's because people have the vision of imagining the world that isn't yet and are able to tell the story of how much better the world would be if that came to pass.

Sarah Kunst: (12:35)
I love it. So, that is incredible. I also love that you're just so good at things. You move to America, start a company, sell it. You go to a play, see George Takei, and then seven years later have a Tony. You plus five to seven years equals success, it seems like.

Lorenzo Thione: (12:52)
I don't know. I actually have spent a lot of time in my life sort of thinking about what success is. There's all sorts of ways in which I could look at the facets of things that I've done and say, "I've been successful." And there are ways in which I can look at the things that I've done and say, "I have not been successful." And it's really interesting because Powerset was an amazing company that we had built some really awesome technology. More than anything else, we had brought together an incredible group of people, of which I'm really, really proud. And I continue to invest and follow in the companies that our Powerset family sort of went on and found.

Lorenzo Thione: (13:40)
But in a lot of other ways, it was not the success we had hoped it to be, or did not realize upon its vision or its mission of competing sort of in the market with the big search engines. It became a fortunate exit, with value for all involved. But it became also a reflection of its circumstance, right? It was 2008, we had a really great partnership with Microsoft. The Microsoft acquisition of Yahoo initially did not go through. That meant pressure for the company to look at other ways in which it could compete in search. We also ended up closing our deal a couple of months, not even, before the 2008 market crashed.

Lorenzo Thione: (14:26)
So just a few things off on which I hadn't necessarily not a lot of input, and the story could have been very different. And Allegiance is the same thing, too. Ultimately, it just showed that ... was seen by hundreds of thousands of people, changed tons of hearts and minds, and I'm so proud of it. But hey, we opened just a few weeks after Hamilton opened on Broadway. And it was a difficult season to compete in the market. Broadway, it's a wonderful business, but it's also a ruthless one. And you have to sell 10,000 tickets every week. 10,000 people have to come to the theater every week to actually make it financially valuable and success, from that point of view.

Lorenzo Thione: (15:18)
So, we have to close after six months because the business wasn't there. But that doesn't mean that the accomplishment of having taken it there and having been able to create something that remains and has an impact for years forward in other forms and other countries, isn't there to be appreciated, either. So, I don't know. I've spent a lot of time, especially in the aftermath of Allegiance, thinking about what's success and what's not success. And closing the show was heartbreaking, but at the same time, it just allowed for a new perspective on whose metrics one should use to evaluate your own success.

Sarah Kunst: (15:59)
Yeah. No, that is very true. Every success only looks that way in retrospect when you squint. So, I would love to hear about AI, right? 2003 is not necessarily a time I think of as being the heyday of artificial intelligence. Tell us a little bit about how you got into that space so early, and your thoughts on how it's evolved to the point where now it feels like Elon Musk is spending lots of money to figure out whether or not we live in an AI simulation. For the record [crosstalk 00:16:41]

Lorenzo Thione: (16:41)
Yeah. For the record, you think we do or we don't?

Sarah Kunst: (16:42)
I don't [crosstalk 00:16:42]

Lorenzo Thione: (16:42)
We don't, okay. Yeah. I mean, especially because if we lived in a simulation, 2020 would really have to have been someone spilling the coffee on their keyboard. But so, yeah, there's a lot of things that have happened in the last 20 years that create what we are seeing now, as we can call it a golden age of AI, but really is just the beginning of an exponential acceleration. And ultimately, people have been talking about the singularity and what that means for a very long time. And it's just realizing some very sort of intrinsic tendencies of computation power growing, data growing exponentially or over-exponentially. And sort of all of those things happening together at the same time lead us to where we are.

Lorenzo Thione: (17:37)
I also joke often that I've looked at the 2010, 2015 time as the time where I literally saw projects I worked on in school or in research; I was for a few years a researcher at Xerox PARC. I saw those things become reality in people's lives, so Siri and everything that dialogue systems we are doing in 2000 and ... I don't know, what is it, it was 2010 maybe, something along those lines, where literally, the sort of productization of things that we had been doing in the late '90s and early 2000s in schools and research laboratories.

Lorenzo Thione: (18:23)
But what really drove me to the work I did was primarily a combination of two passions, one in computer science, but the other one in linguistics. And actually, the fact that having grown up in the country with a different language, and always having had a passion for learning languages and analyzing them, led me to stumble on computational linguistics and natural language understanding as the field I then later decided to take on, initially for what I just felt like was a master's degree, and then became a research project. And it was just the right moment. And Xerox PARC and Fuji Xerox at that time were just centers of excellence for research that had been going on for decades, and that felt, along with computational power becoming cheaper, became the right thing to explore at the time.

Lorenzo Thione: (19:28)
Funny anecdote, Powerset was the absolute first pre-launch customer of Amazon EC2. So, it was like the perfect use case. Up until that moment, every single startup, every single company that was trying to do something that was computationally intensive, had to build their own data centers, right? They had to effectively buy their own metal and install it and manage it and all of that. And once you did, your computational power stayed inflexible until you decided to put more money into buying more machines and connecting them and all of that. And that was just a moment in which we started hearing and having this conversation from this super secret project that was going on. Amazon was building this cloud computing thing, and we were ultimately the very first users of EC2 ever, before they even launched the product.

Sarah Kunst: (20:29)
Wow. And so, that's amazing. I would love to understand sort of the connection ... At what point, with StartOut and Gaingels, was that you were already angel investing, you were already building these communities? How did you sort of decide, and walk us through what some of those organizations looked like, and how you work with them, because you do a ton to give back, and that's how we first connected. And it's so inspiring, so I'd just love to understand more about how you got involved with these organizations, and what you do with them.

Lorenzo Thione: (21:04)
Yeah. So, I think a lot of it goes back to some of the things I mentioned before, which is a lot of the things that I've done ended up not being big plans or sort of things that I had been thinking about for a long time, but rather the reaction to a circumstance and an opportunity, and something that was just right there in front of me at that moment. So for example, after the acquisition and after the exit, I basically just met a few other people who had been talking about similar things in terms of, "Hey, there's no network or group or connection for LGBT entrepreneurs." And everybody was coming from a different angle. Someone was coming from the angle, "Hey, this would have been a resource I would have liked to use," and some others were coming from ... I remember the point of view I really resonated with or I came from, which was, I mentioned it earlier, I had a couple of friends who kept on ... We had these debates or these conversations around the fact that they weren't out with their boards and their companies, and I was trying to understand why. What was so scary or what was so in the way of that process?

Lorenzo Thione: (22:23)
And obviously, you just never know how people are going to react. But at the fundamental core of it was a new balance between the perceived risks and the perceived opportunities. So what I felt was like, "Okay, if we assume that there is a value in getting these great entrepreneurs focused on building their businesses instead of constantly worried about not disclosing that they are gay or that they have a partner or whatever it is, then how do we create that opportunity? How do we create that upside for people to now rebalance that idea of risk and benefit?"

Lorenzo Thione: (23:03)
And it's not very different also to the fact of saying, "The moment you do, not only you're doing a favor to them, you're also creating an opportunity for so many others to see themselves reflected into roles that they had not seen or imagined possible before." And I think we started StartOut in 2008, and it was a few years from there to when, for example, Apple's CEO Tim Cook actually came out publicly. It wasn't that people didn't necessarily already know privately, but he had always held that there was no value, there was no bearing on his job as CEO from what his sexual orientation was. And that is true, on one face of it. But what he came to the realization is the value of representation, is the power of giving people an idea of what's possible for them and seeing themselves reflected as a source of strength and diversity as opposed to just a reason to be called other.

Lorenzo Thione: (24:17)
And that realization was really core both for StartOut and how I continued to see the impact I could have in ways that I was interested in in my own community, and in general in society. So one way is to really think about the venture capital ecosystem in a more broader sense than just who the entrepreneurs are. And that was actually from the StartOut community, that the two cofounders of Gaingels, I actually connected them. One of them was on the board of StartOut with me. And they came to me with the realization that there was all this other impact that we could have if we didn't only focus on the entrepreneur, but also focused on who's making the decisions about investing, who is negotiating deals and terms, who is ultimately writing the checks, that ... Whose value multiplied thousands of time in the venture world. And up until that moment, all of that wealth had only flowed down to the same people in the same educational, socioeconomic background, and largely ethnic and racial backgrounds, as well.

Lorenzo Thione: (25:33)
And so, Gaingels is one of many other groups of investors who focus on bringing more diversity at various strata and various layers in the venture capital ecosystem. We are a large venture syndicate. We are able to invest in LGBT-founded companies but also companies that promote and embrace and make visible their LGBT leadership. And all of that reflects also into, who are the check writers, who are the people who are writing the investment? And I'll just add one thing, which is how that also reflects into the work I have been interested in doing in the theater world, because almost everything that I've worked with or I've worked on or that we've worked on has always been about some form of increasing representation and inclusion in different ways. Allegiance was the first show on Broadway that not only featured a largely Asian American cast in an Asian American story, but also had lots of Asian American creatives, an Asian American director, an Asian American writer. So, that was one.

Lorenzo Thione: (26:50)
I'm working on a new show that is about a story of a young woman with autism. And really, we're so excited that we've cast an incredible actress who identifies on the spectrum for the role. And it's just realizing how visibility and representation matters in so many second, third, multiple order ways that you don't even imagine, initially.

Sarah Kunst: (27:17)
Yeah. No, I couldn't agree more, and love that you're doing that. And everyone, feel free to drop questions into the chat. But to totally switch topics, I would love to hear your thoughts on two very different tech ecosystems. One, you went to school in Austin at UT, and now it seems that half the tech world has decamped for Texas and their zero state income tax life. Little do they know their sales tax is incredible high, so you have to shop elsewhere.

Sarah Kunst: (27:56)
But would love to understand what your thoughts are on that tech ecosystem and what you saw there? And then on a totally different side, what does the European tech ecosystem look like? Do you still spend a lot of time in Italy? Have you gotten involved in tech there? I've spent a little bit of time in Eastern Europe in that tech ecosystem, and it feels like there's so many brilliant people, but we don't think of it as being as much of a place to go to look for investments or to start companies. So, everything outside of New York where you're based, Austin to Italy, what do you think?

Lorenzo Thione: (28:38)
Yeah. I mean, I think honestly, having lived in Silicon Valley from 2002 all the way until 2010, with starting to living a little bit of a bicoastal life across the last few years of that, I really remember the difference in how it felt coming from Italy and sort of having been in the sort of ... if not entrepreneurial, still the educational academic networks in the computer science engineering world in Italy, to coming to Silicon Valley. And I remember this thing that people called the network effect, of everybody being there. And everybody being there really meant so many things. It meant that you could interact with companies, you could interact with investors. You had these serendipitous moments of encounters where you would meet and people would come together across very different stages in their lives, in their careers, and all of that. And all of that happened right here.

Lorenzo Thione: (29:53)
And I believe really ... I mean, it's really clear that that was a big reason of why. And if you add to that the fact that Stanford and Berkeley are also there, so they become these basins and these feeders of talent in there. It's really why it emerged the way it did. New York, certainly in the last 10 years, really has come on strong as another center for tech excellence. And a lot of the same reasons apply. Once enough people started believing that that was a possibility, the physical presence of all of those different parties started to create these network effects.

Lorenzo Thione: (30:38)
So I don't think that the shift ... the shift to Austin, we've seen it in some parts for a number of years. It really has accelerated, the shift to Austin and the shift to Florida, really accelerated this year. And it would be silly to not point to the pandemic as a massive catalyst for the change and for the shift. And the biggest realization is that there is a lot of business that can be done without physically being present in a certain given place, which removes some of the necessity for some of those network components to all be locally there.

Lorenzo Thione: (31:23)
And so what I really do think it will do is it starts to level the playing field between places where people may move, as you mentioned, for tax reasons, but also for other regulatory reasons. There's all sorts of people, "Why would you start a company in places other than California?" There's all sorts of reasons for that that go beyond just taxes. And one of the reasons why this has kept, for example, Europe behind has been ... I remember how difficult friends that were trying to start companies in Italy, how just simply difficult it was to incorporate a business, which is literally something that you can do off of a website in the United States, right?

Lorenzo Thione: (32:08)
And so, you start to really chip away at all of those pieces and really allow people to cooperate effectively from a distance. And you start to see a leveling of the playing field. So the short answer is, I think Austin and Florida are going to be maybe a little bit ahead of the curve, but we're going to actually see acceleration in a lot of other places where talent is and where there might be the sort of regulatory and infrastructural conditions for innovation to happen. I love the ecosystem in Berlin, in Germany. I think London and the U.K. has an advanced ecosystem as well. One of the things that Gaingels does, and we actually had started doing before the pandemic had hit was to actually do twice a year ecosystem tours. We would take a group of investors to other cities and other countries and sort of interact with both the local sort of regulatory infrastructure, but also with the local entrepreneurs, investors, LGBT ecosystem. And we were planning several more for this year that we'll have to now shift off by at least a few months.

Sarah Kunst: (33:38)
Yeah, yeah. No, that is awesome. From Austin to Italy and Miami and everything in between, I think we're definitely seeing a shift that it's possible to start a company anywhere. And certainly, lots of places are slightly more tax-friendly and have nicer valleys than Silicon Valley. So, we have a great question from Peter. And he was asking back to my favorite topic, theater. He said, "With Allegiance, did you ever think about the geopolitical significance or history lesson of the Japanese internment, particularly during the start of the Trump presidency?"

Lorenzo Thione: (34:18)
Yeah. So, I mentioned how the work on Allegiance was not a work of months or weeks. It was a work of years, right? And so, we started the work on Allegiance and the inspiration for it came at a time when Trump just was not even something that people could have imagined. What felt relevant and what felt emotionally important was the memory of September 11, which was only seven or eight years old, and the fact that the country had almost gotten close to repeating the same type of mistakes in the name of fear and a fear of others that we had done in the '40s.

Lorenzo Thione: (35:04)
And we never, ever would have imagined that, fast-forward to when we're actually opening on Broadway, the world feels like this is exactly the reason why this story needs to be told. And I do think that, I mentioned it before, life is timing, and you can't ever get too upset about it. But we opened at the same time as another important historic musical about the sort of relevance of the time. And with Hamilton being the success it was, I think that the story and the message got lost a little. But it certainly resonated enough.

Lorenzo Thione: (35:50)
Funny thing that happened, I think we were in previews or we had already opened. And a couple of people in the Trump camp made some really remarkable sort of remarkably bad statements. One was Trump himself, who actually said at some point that he didn't know if the internment of Japanese Americans had, after all, been such a bad thing at the time. He would have needed to be there to know whether or not that was the right choice or the right thing to do, which is absolutely insane. And we took it as an opportunity to basically say, "Well, you don't actually have to have been there. You just have to learn about what happened. So why don't you come and see for yourself what it was like for real people, for families, and what kind of impact it had on real lives?" And we made it into a little bit of a marketing gimmick, and actually kept a seat in the orchestra open with Trump's name, with a Trump sign, "Reserved for Trump," on it for a number of different performances. And people would take pictures and tweet the pictures, too, with the Trump seat.

Lorenzo Thione: (37:08)
But also, the other thing that happened is the mayor of Roanoke, Virginia. I can't remember exactly what he said, but to the same extent of sort of having said that it was justified at the time what had been done. And a better story or a better resolution there, we facilitated a call between the mayor and George Takei. And I think that that at least led to an eye-opening conversation and at least a change of heart on the topic from him.

Lorenzo Thione: (37:48)
We had just closed, we had already close when the child separation policy was put in place, and literally had children in cages at the border. We fortunately were able to continue to tell the story through a movie. We shot a really wonderful live capture of Allegiance and released it in movie theaters all around the country and then around the world. And so that was at least able ... another way for more people to actually get a chance to see it.

Sarah Kunst: (38:23)
Yeah, yeah. I mean, history doesn't repeat itself, it rhymes. And you're living through that in real time, across all sectors of your professional life. That's amazing. So, what's next? 2020's been a crazy year, and what are you most excited about, particularly on the tech side? When it comes to investing, what do you think 2021 is going to bring for startups? And maybe we'll end with your tech predictions for the year ahead.

Lorenzo Thione: (38:58)
I mean, I think that there's going to be some really massive innovation happening in AI as it applies to more things that we have not really seen it applied to, just because the amount of data that we are producing and that we're able to train new models on is just astounding. I think the work that OpenAI has been doing and GPT-3 just gives us a little bit of a glimpse on the kind of exponential change and really revolution from the point of view of what's possible. We are going to see ... Things that excite me are autonomous vehicle, autonomous flying. There's lots of AI application to detection of disease. We're now seeing things that can be applied to anything from radiology to vision [inaudible 00:40:05] vision systems, applied to medicine. I'm personally a big fan of data science applied to health and wellness, and so lots and lots of health tech and wellness tech, more exciting things to basically improve and prolong people's lives, which I think is a big scientific next milestone or next frontier.

Lorenzo Thione: (40:31)
And I'm excited about other things happening. I'm excited about changes in medicine that are, for example, looking at the science of psychedelic and how those can really have a change and impact on people's lives. We're seeing the impact of gene therapy and CRISPR as being the very beginning of an absolute revolution. And actually, a lot of the investments we've made and we're making reflect a lot of those trends, so I'm expecting to see more ... Oh, and one other big trend is absolutely innovation, hardcore technical innovation to solve climate challenges. And so, we've been talking and there absolutely should be regulatory impact and legislative impact to how we deal with the question of climate change. But I think that what we are going to see in the next five to 10 years is an onslaught of new technology that really changes the ball game when it comes to how we deal with climate change.

Sarah Kunst: (41:46)
Couldn't agree more. I love it. Broadway, climate change, AI, you truly are a Renaissance man. And this has been so fun. Thank you so much for joining us. And Joe and the SALT team, thanks so much, as always, for having us.

Joe Eletto: (42:03)
Absolutely. I just want to say from my and Lorenzo, it's great that you're able to address this issue of diversity by being in the room and by also bringing the companies and having this two-sided focus on it. When we had Steve Case at SALT and on SALT Talks, he was talking about rise of the rest and how investment is now being distributed across the country. We had [Allyn 00:42:28] Shaw, who is chairing diversity at Bank of America, and he said people are prioritizing these things because diversity is good for business, at the end of the day.

Lorenzo Thione: (42:37)
Absolutely, absolutely.

Joe Eletto: (42:40)
So, just want to thank you for that. And to sort of also make this go into a little bit of overtime, you can give us a quick little thing if you want about how we evangelize those people who are already in those positions, too, at Andreessen Horowitz, at a Briar Capital, at these places that probably are emphasizing diversity, but how do we get those people to further emphasize what we're looking to do here?

Lorenzo Thione: (43:08)
This is a fantastic question, and it's one where I and my partners at Gaingels really think about all the time. The way that we've found and that we've found have really started to resonate is what you mentioned a moment ago, is just by simply being in the room and being a partner to those organizations that may have not in the past moved as quickly and as swiftly, you start presenting yourself and everything you would present and carry with you as a valuable partner, as a valuable piece of the conversation. And little by little, there are changes that happen.

Lorenzo Thione: (43:48)
For example, we ask all of the companies that we invest in to basically publicly state and sign a declaration of value, effectively. It's a letter, it's on our website. And it basically talks about all the things that we care about and that we expect our portfolio companies to care about too, from diversity in [inaudible 00:44:09] recruitment to diversity in board recruitment, to being good social citizens and looking at things like the 1% pledge of your profits and your equity to charitable causes that you and your stakeholders really care about. And one that is probably one of my favorite, it's an initiative that we didn't start, and we were so happy to be able to join as amongst founding members, and has so many of the VC organizations that may in the past have not seen this as an issue or a problem, also join as cofounding members. And we hope more will come onboard, too.

Lorenzo Thione: (44:49)
It's called the Diversity Term Sheet Rider for diverse investors or diverse check writers. And it's basically language that VCs and companies who are negotiating a term sheet can agree to include in their documents that basically commits them as investors, major investors and company, to make room in all future rounds for at least some portion that they can decide, an amount or an amount in percentage, for diversity-based check writers and investors. And that means creating access for people who traditionally have been left out of what ultimately are the most valuable and the most value-creating rounds, investment opportunities that exist ... We used to say in the Valley, and now hopefully it'll be everywhere.

Sarah Kunst: (45:42)
I love that. That's awesome.

Joe Eletto: (45:42)
That's fabulous.

Arjun Sethi: Venture Capital, Bitcoin & China | SALT Talks #130

“Instead of thinking about what's forward, it's about how do you see the present more clearly.”

Arjun Sethi is a co-founder of Tribe Capital, a venture capital firm built by engineers and scientists. Arjun sits on the board of Carta, Relativity, and Bolt. As a founder and operator, he has also been an active angel investor in over 100 companies, including Lyft, Opendoor, Gusto, and Front.

Success is never a straight line and involves failure and unsuccessful attempts. Achieving success requires exposure to the people and community where you’re involved. Ultimately, it’s then about the arrival of an inflection point where you decide whether to push forward or stagnate. Silicon Valley offers exposure because of the vast community of like-minded individuals in close proximity. Lessons learned from previous unsuccessful start-ups can help create an even stronger team, where each member brings distilled ideas. “There was a set of folks that I would say, had shared DNA around thinking about iterating innovation and what could you build that's different around looking at technology companies.”

When considering whether to invest in start-up companies, it is important to recognizes one’s own thought patterns and biases. Focusing on what is known about a company instead of a person’s background or network is important in avoid those pitfalls. “We have a motto internally, which is, ‘how do we focus on what versus who you know?’”

LISTEN AND SUBSCRIBE

SPEAKER

Arjun Sethi.jpeg

Arjun Sethi

Co-Founder & Partner

Tribe Capital

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello everyone, and welcome back to SALT Talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology and public policy. SALT Talks are a digital interview series that we started during this work from home period with leading investors, creators and thinkers. And what we're trying to do on these SALT Talks is replicate the experience that we provide in our global conferences, the SALT conference, which we host twice a year, one in the United States and one internationally. And at those conferences and on these talks, what we're really trying to do is provide a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. And today we're very excited to welcome Arjun Sethi to SALT Talks.

John Darsie: (00:57)
Arjun is a serial entrepreneur, investor and executive with deep roots in Silicon Valley. And more than a decade of experience building, sourcing and investing in high growth technology companies. Most notably, independently investing in companies, such as Opendoor, Gusto, Lyft, Postmates and True Color. Arjun also co-founded Tribe Capital, which is a venture capital firm with about $500 million in AUM built by engineers and data scientists, which have invested in fast growing and notable companies, such as Carta, Relativity, Applied Intuition, Instabase, Momentus and Bolt. Prior to founding Tribe, Arjun was a partner at Social Capital where he led the team that established a successful track record of backing high growth companies, such as Slack, CloudKitchens and Box. He also served on the executive team at Yahoo, where he grew product usage over one billion to over one billion monthly active users. He joined Yahoo as part of the acquisition of MessageMe a messaging app that he founded in 2012.

John Darsie: (02:05)
Prior to that Arjun co-founded LOL apps, a mobile gaming and applications company that he scaled to 100 million monthly users before he sold it to Six Waves, a subsidiary of Nexon. Just a reminder for anybody tuning into today's SALT Talk, if you have a question for Arjun, you can enter that in the Q and A box at the bottom of your video screen on Zoom. And hosting today's talk is Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, a global alternative investment firm. Anthony is also the chairman of SALT. And with that, we'll turn it over to Anthony for the interview.

Anthony Scaramucci: (02:40)
Well, first of all, congratulations on your career, and I'm going to out you a little bit. You said that you were in the lower quartile of the people in your five mile radius. Isn't that how we all think about life, but in all seriousness you're doing amazing Arjun. And I always ask these cliche questions in the beginning, like, what can I learn about you that you didn't know on the Wikipedia, but I'm not going to ask you that one. I got a different question for you, okay? What are the base ingredients for success, the distillation of your life that has allowed you to identify these companies and see where they could be years before they become what they have become?

Arjun Sethi: (03:30)
So first off, John Anthony and team, thanks for having me on board. Two, if I take a step back and try to think through your question, which is a hard one to answer, I think it comes down to a couple pieces. One is raw exposure. What do you see, what is the tribe of things that you see around you? Two, then what's the inflection point at which you decide to push forward or stay stagnant? People think about local, state and federal, but when I think about local, it's also just family. And so your exposure is what are you trying to get done? So I grew up in an immigrant family. My dad came from India with a couple of bucks in his pocket, and his whole goal in life was to survive first.

Arjun Sethi: (04:23)
And then from survival it's to push to the next phase. So I kind of grew up with that perspective, which is if we didn't try as hard as possible, we could be out in the streets. And while that might seem extreme, given where we are today, it didn't feel like it was that extreme as we were growing up. And so the exposure of the folks that were around you was around education, was around science, was around what could the world look like if you had replicators? Similar to what you see in Star Trek? So I think what happens is that when you have exposure to that type of community, we have a very large community here in Silicon Valley that thinks that way. And then we have our sub pockets. What does that allow you to do?

Arjun Sethi: (05:07)
And then how do you start thinking from there? And then the last piece I'd say from a pedestal is what's the speed at which you want to learn? So that the word university is supposed to be, a meaning of like an institution of learning. So if I think about the institution of learning here in the Silicon Valley, where we are based, that just gives you the ability if you want it, the toolkits to keep pushing. And I think that's like one of the privileges of why I liked staying here, being around the folks that are here, the universities that are here, the companies that keep pushing that mantra forward.

Anthony Scaramucci: (05:44)
My life experience has gone up and down. Obviously if you're having a bad day ever Arjun, I want you to imagine me getting fired from the White House in July of 2017, it will make you feel better about whatever kind of day you're having. But you seem to have a pretty amazing career. Tell me about a setback. Tell me about a shot that you've got hit with and then how did you recover from it and what lessons did you learn from it?

Arjun Sethi: (06:14)
I think what people read on biographies, LinkedIn, they'll look at that as a progressive success. What they won't see is, I grew up with a pretty hard family. My dad had lost his job twice, and he had gotten a job in like the semiconductor industry and he had to take a pay cut. In some cases, when we moved from Northern California to central California, to Southern California, we had experienced different forms of racism, and when I was younger I didn't know what that meant. And so as you grow older, you start kind of instilling that into your livelihood. But I got fired from almost every job. I wasn't a good employee. I got fired from Macy's. I got fired from Pfizer Electronics. I got fired from Radio Shack when it existed, all of these companies. And then I think just keep moving up the stack-

Anthony Scaramucci: (07:10)
So was there a common theme, Arjun, of the firing? I mean, my firing is usually I'm doing something really stupid and I'm saying something I'm not supposed to be saying and the next thing I'm in Pennsylvania Avenue. Was there a common theme to your firing?

Arjun Sethi: (07:25)
I think it was, and we can get to it at some point, but there was probably a lack of care, where there just wasn't an inflection point that it really mattered, that you need to start pushing forward and learning and being productive in some way. And that's a different philosophical tilt, but, and I also got kicked out of school. So this thing just keeps progressing, which is, I actually just had a progressive of failure routes, that at a certain point, I think it finally clicked, which is I can't continue to do this. And I think you can get stuck in that, but if I didn't have like a family support, if I didn't have folks around the table that had kept helping to propel me back up and saying that it's okay if you fail. These are not failures. These are unsuccessful attempts, you can figure it out.

Arjun Sethi: (08:13)
But then I wouldn't have had the 15, 16, 17 chances. And so what I took from that was how do you iterate test and design towards what you want to forge moving forward? And so, I appreciate the description of myself, but previous to those companies that I started, 10 failure companies with, founding teams that didn't work, because we weren't iterating towards something that could work. And it doesn't really happen if you don't have a North star. And so luckily I had like a vision of where we wanted to move forward with my co-founders and myself. And that's actually been sort of the emphasis. If you look at my career, doing what I do at Tribe is actually the same thing I was at Lolapps, MessageMe, at Yahoo. That's the exact same thing, it's just, now we're just building a technology company that's deploying capital into venture capital as an ecosystem. And so the mindset is different and the way in which we build is different the way in which we iterate is different.

Anthony Scaramucci: (09:12)
So you left Social Capital after working with the Chamath Palihapitiya and right now, John Darsie cannot believe I-

Arjun Sethi: (09:21)
Palihapitiya, Anthony. It's not that hard.

Anthony Scaramucci: (09:23)
All right, it's close enough.

Arjun Sethi: (09:24)
Chamath Palihapitiya.

Anthony Scaramucci: (09:25)
Chamath doesn't care, he knows I love him. And he knows I don't know how to pronounce his name. It was almost close enough. So you left after a couple of years, what did you learn there? What shaped you from that experience?

Arjun Sethi: (09:40)
Look, the first step, I'd say that, as I mentioned, instead of the five mile radius, go 50 miles. There's a set of folks that have worked with each other for a very long time. I actually met Chamath when he was at Facebook and I was at, Lolapps. He had tried to acquire my company and the apps that we were building on the platform. So there was a set of folks that I would say, had shared DNA around thinking about, iterating innovation. And what could you build that's different around looking at technology companies, right? Instead of thinking about what's forward, it's how do you see the present more clearly, what is there now? And then how do you forge your path forward? And that's the world we live in. And so, a lot of what I think we admire, with Chamath and other folks in the ecosystem and why we all work together in the first place and admired each other was that we were all forging a path towards the same direction, came from the same cohort, same clubs, same schools, in some case.

Arjun Sethi: (10:41)
And, what Social Capital was able to deliver was a collection of a lot of these individuals. You could say the Social Capital mafia. If you look at the folks that came out of the firm, and we all took what we distilled as the most important, and then forged ahead with that. So I took our data science and product approach towards what I think venture capital looks like in innovation. A couple of other folks took different pieces of that, Chamath himself took different pieces of that to the public markets. And then I think you just see a lot of us move in that direction because we had a collection of ideas that were really well-regarded in the firms. I think that's really special. You've seen that with companies like PayPal, you seen that with companies like Twitter, we have a very special collection of individuals and they go out to go do their new thing.

Anthony Scaramucci: (11:30)
It makes total sense. And obviously we had him on SALT and he was very impressive, and as are you. Let me go in this direction. You're an entrepreneur, you're in Silicon Valley, you're trying, start something, you have a vision for something, they come to see you. How do you know? You're the sort of like the Simon Cowell, you're at the desk, you're looking for the X factor. How do you know that they have the X factor?

Arjun Sethi: (12:11)
We don't. The whole point is that we don't, if you think about, what people do and what they build, I think what happens is, for example, you and I are chatting now and so you get, some sort of pattern recognition of your past 20 years of history of saying, "I think this person has it, or they don't." But you're, pattern matching to your biases may that be right or wrong. And so that happens a lot, right? Like you can just see that with the way in which people get funded, the capital they're deploying, that they're being infused. And our approach is, "Hey, I think we may not know, the collection of experiences where this person comes from." We have a motto internally, which is, how do we focus on what, versus who you know.

Arjun Sethi: (12:55)
And so let's forget where, what school they went to. Let's forget where they grew up. Let's forget all those pieces for just a second. Let's look at their team, let's look at the focus of what they've built. And especially in a world that's software and tech enabled, what can you measure, right? What can you measure from a ground truth perspective? It's kind of akin to financial accounting. When you look at the public markets and you look at a company, you look at their guts through financial accounting, balance sheets, [inaudible 00:13:19] income, et cetera, can you do that with software? And that's what we have been working on for our whole careers. And so it was a way of how do you articulate that for the next set of, Zuckerbergs or Dorseys that show up and say, I have this product, but there are outliers, there are extreme.

Arjun Sethi: (13:36)
You might not like the way in which they, articulate their vision. But the whole point is that, that's not the point. The point is what is it that they've built so far? What's their foundation? Let's forget where they come from. You just a second and see if there's any demand from customers, integrations. Is there anything that you can measure that will give you now insights into what the future could look like if could forecast? And that's the fine tuning that I think is really important to think, that's the approach that we take. So the answer is we don't know, but we start building conviction and starting off from a foundation of what they have built, and we morph around them rather than having them morph around us.

Anthony Scaramucci: (14:17)
You're in a very interesting high altitude ether, Reid Hoffman once said to me that if you're waiting for the website to be perfect, you're waiting too long. Let's launch the website and start figuring out as it goes. Do you share that philosophy? And if you do, how would you describe when is the right time to start a business or to try to scale a business?

Arjun Sethi: (14:46)
Yeah. So, I'll try to paraphrase here, but I think it was, if you're not embarrassed about your product, you're doing it wrong. And so while I think that's a good approach or certain types of companies, it's not the approach for every company. So if you kind of split the world into bits and atoms on the bit side, if you're building a mobile app, if you're building mobile infrastructure, you have fast iteration time and feedback. Yes, you can experiment at a faster pace and you shouldn't be embarrassed about what you're building, because you can do it cheaper, faster, better. And that's what that technology stack is all about. And when you move to the world of atoms, you can do that in some cases where if you're trying to build a spaceship or a rocket, if you're trying to help with climate change, if you're focused on drones that go out there, you can't iterate a drone that's gonna like drop in the middle of the sky.

Arjun Sethi: (15:38)
It's not the point. And so I think you kinda have to bifurcate between the two worlds and then say, okay, now, based off of these frameworks, what's the right way to approach the market, the product that you're building, and frankly, how much capital do you need, in order to hit the first iteration that might be embarrassing in that vertical that you're thinking through. So while I agree with that, that works when you're thinking in small terms of the internet, although the market obviously is quite, quite large for the internet in the world of bits.

Anthony Scaramucci: (16:15)
I'm late to the VC space. And I know that there are-

Arjun Sethi: (16:20)
Never late, never late.

Anthony Scaramucci: (16:22)
Never late, okay. So that's a good line, right? That's what people tell me about Bitcoin. We had planned B on yesterday, he said he felt that he was late, but now he realizes he's never late. So that's a good line, but let's say that I'm an old timer. I'm late to the VC space. I see the specs, I see these VC funds. I see these special partnerships, these SPVs, what would you recommend to me as someone that's a traditional stock and bond buyer, I own cash, stock, bonds and gold. What am I missing and how would you recommend that I enter the space?

Arjun Sethi: (17:04)
I think you're smarter than I am on this. And I've watched your talks before, so you take a macro perspective. Right? And say you think about, Hey, what are the financial policies that are being, projected worldwide? Not just here in the United States, but with ECP, the Japanese Central Bank here in the United States, just printing and then rates going down, and then you just continue to do that. Someone hiccups, you do the same thing over and over again. And so you take that traditional approach. It's okay, great. The traditional portfolio approach, traditionally, where you kept your capital may no longer have the same yields and you got to keep up with some aspects of inflation. And not aspects of inflation that are average, but aspects that are cumulative towards certain parts, California and places where you are and vice versa.

Arjun Sethi: (17:53)
If you go to African emerging markets and so, that's the high level macro, and then you go into micro and say, "Okay, well, what are the emerging classes of where you want to spend your time?" There's a power law in equities, there's a power law in alternatives, then there's a power law in certain human innovations. And part of it is, what does Bitcoin mean? As programmable money is what a lot of people call it. What does gold 2.0 mean? There's a lot of ways in which people kind of describe it. And then you keep going into, down the train. What does public equities mean and what is private equities that haven't gone public for so long with a lot of latent demand mean? And then what are the financial instruments to invest into this innovation?

Arjun Sethi: (18:36)
So I think it really comes down everything. I think, to not bury the lede, just comes down to growth. Where's growth going to happen? Is that innovation oriented? Is that incrementalization oriented? Is that stock buybacks oriented? And how do you kind of perceive your way around how you want to deploy our capital? So when you say you're late, I don't think you're late at all, because we've just starting to see, you can call it the ramifications, or sort of a new economy thought process, post 2008.

Anthony Scaramucci: (19:07)
I mean, you're making excellent points. And I do study the Dow and the S&P 500 and the rotation, and if you look at the top 50 names from 20 years ago, they are very different from the top 50 names today. If you look at the top 10 names, and of course you and I know that Tesla just got added to the S&P 500. And so my question to you is what are going to be those leaders, in five or 10 years? Are there private companies right now that you're looking at, you'll say, "Wow, in five or 10 years, they are going to be the Ford Motor Company of 1920, but they're the XYZ company of 2025 or 2030."

Arjun Sethi: (19:51)
Yeah. So, I think this is why I love technology. There's a concept that we talk about a lot. Peter Thiel talks about it, what our perfect monopolies versus innovation monopolies. Internally, we call that one of N versus N of one companies, which is, what's a special company that is just so special it's hard to compete with? And then what are the sectors that are all similar to each other, again, one of N, one of many companies.

Arjun Sethi: (20:17)
And so I think if you take a look of just, this is a good point, just going from atoms to bits and what are the industries that are moving and shaping the world forward. Payments, e-commerce, the retail to digital transformation. This is not just the United States, this is worldwide. Where are you going to be placing your bets? So if you just look at the power law of the public markets, now you can call it the FAANG, MF stocks, where there's different acronyms today. But it's really concentrated towards the future, right? Where those are the companies that are winning now, and that there's going to be a larger majority of them that are going to continue to win given that consumer demand is going that way, B2B demand is going that way and worldwide demand is going that way.

Arjun Sethi: (21:01)
So you just kind of trace route that and say, "Okay, well, where else is that going to happen? What are the ecosystems that need to be there to support them? And then what are the ecosystems that are going to actually just die over the next, let's call it five, 10, 20 years from now?" And I think you've seen that, where private equity went really hard. I don't know if you remember 2008 to 2014 into retail. Retail is coming back. We know that ship has sailed, it's not coming back. COVID has accelerated that, not just here in the United States, but worldwide. And so you kind of, again, trace route that down, say, "Okay, well, what are the next industries that need to be A reshaped, and then B supported?" And that's kind of how we think about it, within the Silicon Valley realm of what we think is going to happen in the future.

Arjun Sethi: (21:49)
And I think it really just comes down to the private companies that are being built today. What are they doing and how are they supporting that ecosystem? And are they special? Or are they just one of many companies that are going to be a part of that transformation? I would argue anything that's D2C or consumer demand related are just one of many companies, right? What's the next brand that you're going to buy from when you go on Shopify or Amazon? But then the next set is who's supporting those brands? Who's someone that monopolize that? Who owns the roads and the railroads of the future. And that's I think what we spend a lot of time thinking through. One, we don't know, two we've seen some of them, and then three, we got to figure out a way to identify them without us having a certain biases that we've had in the past.

Anthony Scaramucci: (22:34)
Tell me one sector. You don't have to give me a name of a company, just say, "Look, this is an unstoppable force that's going to be with us in 10 years.

Arjun Sethi: (22:48)
Financial services, I think is completely and utterly being not only disruptive, but revolutionizing all over the world.

Anthony Scaramucci: (22:56)
So something like neo banking as an example, the revolutionizing the banking industry?

Arjun Sethi: (23:03)
Yeah. So if I walked down the street at 20 years ago, I would go to a retail branch and I would say, "I need these five things." And then depending on my purchasing power or status of, lower income, middle and above, those pieces would be fragmented, right? I'm privileged enough to have, the likes of Morgan Stanley to say, "Here's everything I'll do for you." But you don't have that for folks at a lower tier, and that's starting to change, right? Like I can send an email saying, "I want these five things." You can't do that if you're at the lower income or bracket and you can't do that if you're sitting in Mexico and if you can't and you can't do that if you're in India, driving an auto workshop. But that's starting to change where now they get the ability where the future was already there, but it wasn't evenly distributed and that's what technology allows us to do. And I think people use the word neo banking, but it's much more than that, right?

Arjun Sethi: (23:53)
Where that auto workshop individual wants a USD denominated account. He thinks about preserving his wealth in dollars. And I'll get to Bitcoin in a second and the same thing's happening in Latin American countries, the same thing's happening in Nigerian companies and you have this global influx of people moving back and forth. And so what does settlement look like? What do payments look like? What does banking look like? What does insurance look like? What does real estate look like when these products get bifurcated? And then a lot of people try to think and say, "Okay, Bitcoin is that piece, or crypto markets are going to be that piece." It's possible, but I think you have to think about it from an application perspective. What does the technology, the database, the settlement and the distribution allow you to build? And I think it's more people want trust security laws and you take those all together. Like we have here in the United States. And what are the products that get built off of that?

Anthony Scaramucci: (24:48)
All of a sudden I'm 100% with you and now I'm watching the neobanks take over. They've got no bricks and mortar. So they're offering the services at little to no cost and they're paying higher interest rates. And it becomes almost impossible longterm to compete with that. So I agree with you there. Let's talk about-

Arjun Sethi: (25:12)
Yeah. I think it's more than that. It's, we are willing to pay for a certain amount of experiences and products that they're able to say, in the world of negative and zero interest rates. Forget that for a second. Do you trust my experience to deliver you an outcome? Do you trust my experience to deliver you capital, lending and democratize that? Do you trust my product where you're willing to pay like a subscription fee for all these services that other people got? And then at scale, what people got at the higher tier you're now able to get at the lower tier as well. And I think that's actually the change, which is you can flip the pyramid and say at scale I can offer these services worldwide.

Anthony Scaramucci: (25:54)
Yeah. It's pretty fascinating before I turn it over to, John Darsie and our audience participation. I want to talk a little bit about SPACs. What is your feeling about the SPAC market, it relative to the IPO market? And do you think it's a viable long term solution SPACs or is it a by-product of the regulatory environment that we're in?

Arjun Sethi: (26:19)
It's a good question. If you take a step back and say in the '90s, what did we have? We had roughly eight, 10,000 companies going public, or sorry that were public, on the NYSE and NASDAQ, you had the ability for people to participate in the upside of these companies where they're at and certain valuations let's call it, 500 EV and up, and then what the regulatory regime in the 2000s, and then, again, the regime in 2008, while it may have been, protectionist is also created this mechanism where the regulatory regime just made companies go public later. And so I think you look at any entrepreneur to say, "Do you want to go public or private?" There's a set will say, "I want to stay private forever because I want to control it."

Arjun Sethi: (27:08)
But there's a large set that say, "Yeah, I want access to capital markets, but I can't because it's too expensive." Or you've actually just do the math. If you have 50 million in revenue and for you to go public, it's going to be five or 10% just to start, that just doesn't make any sense from a unit economics perspective. So you just, wait, wait and wait. And now you have, I'm on the board of a company called Carta. And the number one thing all of these companies are asking by the way, there's about 14,000 companies in their platform. It's about a trillion dollars of private equity just in the private markets that don't move. It means that it's just a stake of private investors like myself that are waiting for liquidity or dumping more capital into these companies because they're growing and we're participating in the upside, but the regular markets and an irregular individual is not, regardless of being accredited.

Arjun Sethi: (27:58)
So I think what you've seen now is that there's just a ton of latent demand for those enterprise value companies and not just companies that are in the United States, but worldwide, because worldwide liquidity also doesn't exist. If you're thinking about a growth perspective, if you're sitting in Taiwan or Indonesia or Southeast Asia, you don't really have any options. You're going to look at the US markets NYSE and NASDAQ because their growth mentality and frankly, an American mentality, where you can't go public and these other markets that want like four to five years of profitability. So there's this massive regulatory, I'd say down pressure of private companies where they can't go public, and SPAC I think it's become a mechanism where you can do that. And it's not just the SPACs. You have secondary liquidity. These exchanges have started popping up, we've invested in one, Carter being the one, at certain EV.

Arjun Sethi: (28:49)
And then you start thinking about, okay, well, these companies are still at their inflection point where they need help. They want other folks that are along with them. The world of activist investors in the public markets are gone. And so the SPACs allow people to partner with folks with a cash injection like they have in the private markets to think longterm. Now, while I don't think it's perfect, it's a mechanism, direct listing is another mechanism, and the traditional IPO is another mechanism. And as you know, these are all forms of raising capital or, getting access to the capital markets, for other forms of capital that they might need to grow. And so is it here to stay? I think so. Is it going to be at the peak of what we've had over the last two years? I'm not sure. But we're keenly watching it. A lot of our companies are now in their board decks saying here are my options. Raise capital, go public. And SPAC is a mechanism for that.

Anthony Scaramucci: (29:49)
All right. Well, listen, congratulations on all your success. I've got to turn it over to Darsie who's the millennial in charge, that's going to now try to outshine the two of us, so don't let him do that, Arjun. Okay? You and I have now bonded. Don't let them get the best of us. Go ahead, Darsie.

John Darsie: (30:07)
So Arjun, just following up on the SPAC question, you had a portfolio company recently that went public via SPAC. Was that a positive experience, and has led you to be more receptive to the idea that, SPACs are a long-term solution?

Arjun Sethi: (30:21)
Yeah. So while we were at Social Capital, Chamath and team, and the rest of us had thought of what are all the toolkits that we could provide on behalf of our companies. And one of them was SPAC and at the time it was a pretty dirty word, right? Like you just think of it as companies that aren't good enough should not go public. And that was a mechanism used, or the reverse merger and what we had seen over time, very accelerated by them. And I think COVID accelerated this even more, is that there were certain types of companies that need more capital. So as a private investor, investing into space, climate change, drones, heavy CapEx industries, these companies need 50, 100, 250, $500 million in order to hit their next milestones.

Arjun Sethi: (31:08)
They already have product market fit. We already know technologically their products work. They just need the capital to build it. So if you want to build a farm, right. A vertically integrated farm that deploys, food at a cheaper rate, how do you do that? Where are you going to get that capital from? It's harder to do it in the private markets. And I think I go back to the first question of, how do you know if these entrepreneurs have it or not? Well beyond that? What if they already have it? They don't have access to capital in the private markets. What do you do? And a lot of it is they just get fully diluted. It's really hard for them to get that capital in it and something that should have taken a year or two to accelerate will take five or 10 years.

Arjun Sethi: (31:47)
And so I think that SPAC became a mechanism for that, which is, are people willing to take the risk for certain types of these companies that are definable, there's a narrative to it, there's a team behind it. And someone has done the work that you either trust, or you don't to say, here are the types of companies and here's how much capital injection do you need. And so those are the companies in our portfolio that have been looking at that approach. And so Momentus, which is a first mile and mile delivery mechanisms. So that they've literally attached themselves like a parasite onto a star ship or a rocket. And then they go from point A to point B to point C for you. So it's kind of like a hub and spoke model. They need capital to build their satellites and their propulsion systems.

Arjun Sethi: (32:28)
The first one already works. They've already launched it. So, the technology works and the second one, the launch, with payload for their customers, and we'll be out in the next three to six months. Those are really well-defined companies that you can say, "Okay, great. Let's give them the capital. They already have product market fit. Now it's about how fast can they accelerate and where do you go from here?" The private markets value those companies lower as high risk where we don't think it is, the public markets think of it as a little bit less risk, and they're willing to give them the capital to make it happen. So I think it's been a good experience for those types of companies. It's still TBD for international companies and it's still TBD for generic software companies that are growing and they do have access to private and public capital.

John Darsie: (33:14)
Right. And you saw Chamath first, SPAC was Virgin Galactic, and you've seen it on a nice run lately. And it seems to be a really good solution that they've found, for that company. So, I mentioned in the open about how Tribe Capital was founded by yourself and a team of engineers and data scientists, and you guys are very data-driven, in terms of how you invest. And so you can take a lot of raw transaction data from companies and you synthesize it to create sort of a bottom up approach for private investing, the same way a Dodd Graham type of investor would take a bottom up approach in terms of analyzing a public company's financials. Why is a data driven approach important? And how do you combine that data with your own judgment intuition, from sort of a top down perspective on trends?

Arjun Sethi: (34:02)
Yeah. So there's a lot of questions in there. So I'll try to break those into pieces. Over the last 20 years, if you look at Facebook, Google, Yahoo, like the new order of technology companies, and you just go down the stack like Airbnb, we, we grew up in those companies, we helped those companies. We help them scale. We either through investment or starting them in some cases. So that's the team's DNA. And so you take that team's DNA and you take them to a traditional venture capital firm and you ask them to invest in companies. The first thing we think of, or when I entered venture capital, I'm why are we still using Excel? Why are we still using paper and pencil to make investment decisions? It doesn't make any sense to us.

Arjun Sethi: (34:48)
Because we've built all of these family of frameworks to invest our time, our capital, our products with the fast feedback loop, why can't we bring what we've done for the last 20 years and bring it to the investment side as a way for us to augment our decision-making? That's how it started. I'll call it seven to 10 years ago. It was just so archaic for us that we, when you get into venture, it becomes less team oriented and it becomes more solo oriented. So we flipped it. We flipped the script and we basically said, "Okay, great. Let's take that. As a bottoms up approach to understand a company the same way, we take a bottoms up approach to build products at least in the consumer and enterprise ecosystem."

Arjun Sethi: (35:34)
And I'd say that we have this motto internally. And if you take the dollar bill and you turn it around, I forgot what the exact symbol is, but I think it says like Novus ordo Cyclorama or something like that. It's like a new order of the ages. That's the exact way we think about where we are in venture, and capital allocation, which is you've had this tradition, where you looked at balance sheet, and accounting frameworks. Can you build those frameworks? And can you build systems and software to help you make better decisions? And can you flip the script in the way in which you can help these companies, partner with them. And so when we go to a company and I know this is a long-winded answer-

John Darsie: (36:17)
[crosstalk 00:36:17] like the long-winded answer.

Arjun Sethi: (36:18)
... the pitch literally is if you want the folks that helped scale Uber, Facebook, Yahoo, that the folks that built these companies from zero to billions of customers, that's us with capital. So we are a technology company that think about venture, and we build products, we build distribution products, we build analysis, we build data and analytics that we can serve you in that way, because that's the language you speak. That's how you're thinking about building your company. And those are the types of folks that you want around the table versus, talking to your grandfather. Your grandfather might be really smart, but they're taking a solo approach to helping you. And that's very, it's hard to scale that.

John Darsie: (37:01)
Yeah. One of the aha moments for me lately, and we don't have any financial interest in Stripe, but when Stripe basically started Stripe Capital and the idea that they're analyzing all the transaction data on the fundamentals of companies that are using their APIs and actually investing in businesses, that they noticed really positive trends related to revenues and profits and everything that's going on, on the underlying level at a company, about, the value of data, the exponential value of data in a technology first world. I want to go back to Anthony's question about, founders. So a founder comes to you, and they say, "Hey, I have this idea. I have some money. I could bootstrap it. I could take venture capital money and dilute myself." There's other sources of capital, first of all, how do you know for that founder, whether it's the right time for them to launch the startup and how do that they're ready to scale and how do you give them advice on the best source of capital, as well as the best partners to help them scale the business?

Arjun Sethi: (38:05)
This really comes down to underwriting risk. So if you and Anthony decided to start a company tomorrow, you have access to capital, proliferation of it at the pre-seed and seed stage. So it's called idea and concept. So there's a set of investors that focus on people and markets, tech, experience, et cetera. That's all over the world. That's awesome. Right? Like if you kind of think about it, there's a ecosystem that's being built that kind of mimics or romanticizes what you see here in the Silicon Valley. And so that we're going to adopt that in certain other sectors. That's a different type of risk that you're underwriting and that's become more and more proliferated with more people, right? So it's syndicated out, whereas before it was just in the hands of a couple of folks. And that's called pre-product market fit.

Arjun Sethi: (38:50)
Post-product market fit, that's a new set of investors in a different set of investors. So it's really about the gradients where you are in that life cycle of building. And so to answer your question is we don't know. I think we have to be more bold about investing into harder things and newer things, because it is cheaper, faster, and easier to build that. And so there's a set of investors that do that. We're not good at that. That's okay. We explicitly say that, but we do invest in certain ideas that we like, but we underwrite risk kind of appropriately, which is, we're not giving $20 million to someone that has an idea in concept. We might be giving them a couple of hundred thousand dollars to start, but there's a whole set of us, that you can say times 10, that are going to do the same thing.

Arjun Sethi: (39:34)
And then they have enough capital to start an experiment with. I think that's something that's been lost over time. Where you used to actually have that in the '20s, '50s, World War I, World War II. You had that from the '50s to '70s and it kind of stopped. And it might've not been this public and private partnership, but it was there for things that we wanted to do moving forward. That's not really measurable. And I think the important part here is that you need to invest, to try and have unsuccessful attempts. After that you have frameworks, right? You have people like us that come in and say, I now am able to quantify that you have something that works and it has product market fit. It may not have the same velocity that we might all think, but that's a different risk profile.

Arjun Sethi: (40:14)
I'm not underwriting risk in the same way. And so now it's all about value. What's the value of your enterprise? What's the value of your product? What's the value of your revenue? And that's not any different than financial accounting, the lagging indicators, but you can still do that with software. So again, long winded, but there's a lot of things that you can do. And what's the type of capital that needs to go into trying things and iterating and scientific things that you want to try that are hard. And then what's the capital that goes into it once it finally works, it's a two different states of mind, right?

John Darsie: (40:49)
So I want to end on a macro question that's pretty timely based on IPOs we've seen just this week. So you had DoorDash go public and pretty much doubled immediately before it even started trading. Airbnb is now a North of a hundred billion dollar company that back in March, we were talking about or not, the company was going to survive because the pandemic was supposedly gonna destroy any tourism type of business. But they obviously have rebounded from that spectacularly. Do you think, from a valuation perspective, when you look at these companies that are going public and the valuations we're seeing in a stock like Tesla, that technology is getting into that, B word territory that some people that are less familiar with the technology industry, they come to me and they say, "Oh, John, I know you work in finance. Are we in a bubble again? Is this another tech bubble?" And I sort of guide them to an answer, but I don't want to ask a leading question to you, but do you think things are getting a little bit frothy in the technology space or do you think we're just scratching the surface in terms of what the economy is going to look like in the future? And so these technology companies are still undervalued and you're not late.

Arjun Sethi: (42:00)
I'll preface my answer with, I don't know, but then I'll answer with frameworks that I think are important. So take a step back 20 years, you guys have experienced this, where we had talked about, irrationality and valuations. In the 2000s when we had the technology bubble, before the technology bubble, there were other things happening in the world, right? You had the issue with, Russia, you had longterm capital, I'm forgetting the name of the situation exactly. You had a multitude of things happening all over the world that were negative, not neutral to positive, just negative. And so everyone was rushing towards the next growth story, and that was .com. Anything .com, even if it had nothing to do with technology, you just put .com in your disclosures and you just skyrocketed, that was a different era of companies that had no revenue, no customers, and no substance, right?

Arjun Sethi: (42:58)
And that's the narrative. And then technology continued on its path. And you can argue that it was devalued and it took a longer time for, like the likes of Google to be sort of recognized the likes of Amazon to be recognized during that transition period. Same thing kind of happened in 2008, which is, it's a different bubble. It's a real estate bubble. And now we're entering a world where, again, macro you have negative, to low interest rates, depending on the area. You have a printing of cash and you don't have the yields that you used to have if you wanted to take your capital out of the tech where you could, get, six or seven percent back, in the 2000s up to the 2008 timeframe, you don't have that today. And so the question you kind of have to ask yourself is the value of these companies, the value of their growth, the speed at which they're growing exponentially, right?

Arjun Sethi: (43:48)
It's a super linear, right? It's not stagnant, it's not sub linear. What is the value of those companies that are retaining their customers, expanding with them revenue and engagement wise. And so from a software perspective, those are the questions you kind of have to ask. Do I think some of these companies are overvalued, of course. There's a power law to some of these companies where everyone's piling into what they believe is safe and the equities market, and the same thing happens in the private market. It's just about where do you enter and where do you exit. The great thing about what we do is we enter early and we just leave it up to you guys on the smart side, on the public markets to think about what's overvalued and what's not. But it's a hard one to answer because there's not a lot of downward pressure.

Arjun Sethi: (44:28)
Like where's that coming from? A company like Nikola, which is extremely fraudulent, is still valued at $7 billion. You know that there's something frothy there. And there's not a lot of downward pressure on that company, it's still, I think that's an issue. And then I could probably talk about 10, 11, 15 companies like that. Where that mechanism of downward pressure doesn't exist. So is the market frothy? There's some of it, but I think you're seeing it in pockets. And it's still yet to be determined where, 30% of our GDP was just printed. And what does that look like over the next three, five, 10 years? I'm not sure. It's hard to answer.

John Darsie: (45:06)
Yeah. I mean, I think about Bitcoin in the same way. I came at it for the last several years as a skeptic, but I'm thinking in my head now, look at all the new buyers that we have of Bitcoin, who are the sellers? I don't really see a lot of people that are eager to sell at these levels. And you have all types of companies from mass mutual, to other large investment institutions, Paul Tudor Jones coming out and buying this and buying 1% of their portfolios in Bitcoin. But those are massive astronomical sums of money. But Arjun, thanks so much for joining us. We'll leave it there. Anthony, do you have a final word for origin before we let him go?

Anthony Scaramucci: (45:40)
No, I think, look, it's a fascinating conversation, you're my crystal ball now, Arjun. So I'm going to be calling you from time to time. Like I need to look in there so you can tell me what the hell is going on with the world, okay? I'm counting on you.

Arjun Sethi: (45:54)
We call it the magic eight ball, I'll shake something and I'll give you an answer.

Anthony Scaramucci: (46:00)
Something tells me you're a little bit more precise than that, but I love that line. Well, you be well and thank you so much for joining us on SALT Talks, and congratulations. And I'm looking forward to the future successes for you and your firm.

Arjun Sethi: (46:12)
John, Anthony. Thanks for having me on board.

John Darsie: (46:15)
Thank you, Arjun. And thank you everybody who tuned in to today's SALT Talk.

Pandemic Venture Investment Series - Episode 6 | SALT Talks #128

“The world has seen a global transformation in our food supply where consumers are seeking more sustainable solutions in their diets.”

The latest installment of SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, looks at how Agri-FoodTech start-ups are not just reimagining the future of agriculture and food, but also the sustainability of our planet. 2019 saw the sector grow to a $20 billion venture capital sector. Technology has proven to be crucial during this global pandemic and highlighted our dependence on a global functioning food chain. The CEOs of Tevel, BlueNalu and Ripple Food reveal how they are innovating in this crucial space. Moderated by Laly David, Partner, OurCrowd.

With a growing base of environmentally-conscious consumers, we see greater calls for alternative dairy products like Ripple that requires less water to make, resulting in over 200 million gallons of water saved so far. Cell-based meat is one of the latest in the line of alternatives to animal-based products. BlueNalu is a leader in the cell-based seafood market, offering a solution to a traditional seafood industry that has put its ecosystem in peril. “Our global supply chain of seafood is the most vulnerable supply chain on the planet.”

Picking fruit requires a large source of manual labor, often requiring immigrant populations working for low wages. Employing these populations has become even more difficult during the pandemic due to travel restrictions. Tevel has developed drones equipped with AI that can identify ripe fruit and ultimately pick the fruit autonomously. The eliminated overhead produces 30-40% in cost saving for farmers.

LISTEN AND SUBSCRIBE

SPEAKERS

Laura Flanagan.jpeg

Laura Flanagan

Co-Chief Executive Officer

Ripple Foods

Yaniv Maor.jpeg

Yaniv Maor

Chief Executive Officer

Tevel

Lou Cooperhouse.jpeg

Lou Cooperhouse

President & Chief Executive Officer

BlueNalu

EPISODE TRANSCRIPT

John Darsie: (00:12)
Hello everyone, and welcome back to SALT talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of financial, technology, and public policy.

John Darsie: (00:26)
SALT talks are a digital interview series that we launched during the work from home period, with leading investors, creators, and thinkers. And what we're trying to do on these SALT talks is replicate the experience that we provide at our global SALT conferences, which we host twice a year, once in the United States and once internationally, most recently in Abu Dhabi in 2019.

John Darsie: (00:48)
On these SALT talks and at our conferences, what we're trying to do is provide our audience a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. And we're thrilled today to welcome you to the sixth installment of our pandemic venture investment series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arising from the pandemic crisis, and discuss breakthrough technologies that address issues, ranging from coronavirus prevention and cure, to social distancing and food supply.

John Darsie: (01:22)
A reminder, this series is presented in partnership with OurCrowd, a leading global venture investment platform based in Israel. Today's episode is the Agri-FoodTech explosion in an era of disruption. And it features Laura Flanagan, the co-chief executive officer of Ripple Foods, and before I went on I was telling Laura how I drink Ripple every morning and I put it every morning in my oatmeal. Has eight grams of plant based protein per serving, one cup, and also is a great source of calcium, 50% more calcium than dairy milk. I'm an unpaid promoter of Ripple and I'm sorry to the rest of our guests, so I don't use your products but I figured I had to show for Ripple because I've tried all kinds of different milk alternatives and Ripple is my go-to for my oatmeal every morning and my drinking during the day. So welcome, Laura.

John Darsie: (02:12)
Our other guests are Lou Cooperhouse, the president and CEO of BlueNalu, and Freddy Raitan, the chief commercial officer of Tevel. In today's talk we're moderated by OurCrowd vice-president of business development, Dan Fishel. Just a reminder, if you have any questions for any of our panelist during today's talk, you can enter... the Q&A box at the bottom of your video screen on zoom, and with that I'll turn it over to Dan for the interview.

Dan Fishel: (02:39)
Thanks John, and I have to start with my own confession, I'm also a big fan of Ripple, especially the chocolate milk one. But anyway, we're here to talk today about Agri-FoodTech. Now, up until about a couple of years ago this used to be two separate terms, Agri-Tech and FoodTech, but what the pandemic has showed us is how interconnected is the food we eat, the environment we live in, and our health. It doesn't show us just how interconnected it is but also how fragile and vulnerable it is. I assume that you would all agree with me that if humanity were to take better measures in terms of food safety and sustainability, better look after the environment, we wouldn't have been facing today the devastating consequences of COVID-19.

Dan Fishel: (03:30)
So after this grand statement, again, my name is Dan Fishel, I'm vice-president of business development at OurCrowd. OurCrowd, we're a global investment platform. We invest in startups and we invite accredited investors from around the world to invest alongside us on the exact same terms. We've been privileged to invest in over 200 portfolio companies, three of which are again here with us.

Dan Fishel: (03:54)
So once again, we have three companies that are on both ends on the Agri-FoodTech equation. On the agri side we have Tevel, they developed a fleet of autonomous drones that pick fruit, and basically address the global problem, the global challenge of hiring workers to pick fruit in the fields. We have BlueNalu, a company that has developed lab-grown seafood, and of course the company that is already commercial out there, Ripple that develops pea-based dairy alternatives.

Dan Fishel: (04:31)
So let's start with you, Laura. You already have a commercial product that's very, very successful in the stores. And I have to tell you, my wife about a year ago she started, every week we have a completely different brand of a meal alternative in the fridge. We started with soy and then she went to almond, and now it's the oat season. But we had the rice and oat, and almond, and cashews. There's so much selection out there, what makes Ripple unique in this very crowded market?

Laura Flanagan: (05:07)
Thank you, Dan. Thanks for having us and I want to thank both you and John for the wonderful endorsements of Ripple products. We're so glad to have you as part of the Ripple family. To answer your question, what makes Ripple unique? So Ripple is a portfolio, of those who aren't familiar with us. Ripple is a portfolio of foods and beverages that are plant-based dairy alternatives. So our largest product line today is the milk which you're both familiar with, and what makes Ripple so unique and special is that, yes today we use yellow peas as our source of protein. And our two co-founders, Neil Renninger and Adam Lowry, both former chemical engineers, developed a unique and proprietary process that is, we have filed patents for. That allows us to create a cleaner tasting plant protein.

Laura Flanagan: (05:58)
So that process and that protein we call Ripptein. It stands for Ripple, protein, put it together, called Ripptein. And we're able to create a cleaner tasting plant protein, which enables us to deliver better tasting products that deliver very high protein levels. So as John mentioned at the beginning, we have eight grams of protein per serving, which is just as much as dairy milk. We have 50% more calcium, and half the sugar of dairy milk. So we're able to deliver this very unique and wonderful combination of delicious tasting products, without any sacrifices. You get the nutrition of dairy milk, you get the taste and texture of dairy milk. And so you're able to get the best of both world in a very sustainable product.

Laura Flanagan: (06:44)
By using yellow peas, we're able to save a significant amount of water, versus dairy alternatives, and even versus other plant-based alternatives like almond milks that you mentioned that you had tried and experimented with. So on our website, ripplefoods.com, one of the first things that a consumer will see is what we call the ripple effect. And it's based on the truth that each of us can take very small actions that have a ripple effect on the world, and have a much bigger impact. So we have a count on our website that shows, every time a consumer purchases one of our products, how much water they've saved for the planet, how much plastic they've saved because we use recyclable plastic, how much carbon we've saved, and all the good things they've done for themselves on how much more protein is in their diet, how much less sugar. So it's a wonderful combination of a proprietary technology, great tasting products, and little decisions every consumer can make to do good for the planet.

Dan Fishel: (07:44)
Can you share some of this data? It's very interesting. So, how much plastic has the world saved? How much carbon emissions?

Laura Flanagan: (07:53)
It's in the millions and hundreds of millions, depending on the statistics. So there's over, I think we're now 200 million gallons of water saved. It's a very large number, so you'll see that on our counter on the ripple effect, and it's in real-time. And so you'll see that the numbers are changing based on how many consumers are becoming part of the Ripple family.

Dan Fishel: (08:14)
So what type of products you already have in stores?

Laura Flanagan: (08:19)
So we have our milk products, refrigerated milk products and those come in several flavors, unsweetened original, original vanilla, chocolate as you mentioned. We also have protein shakes, which have 20 grams of protein and tastes delicious. This past year we launched ice cream, which is a fan favorite, and so we have five different flavors of ice cream. And then we also have some coffee products, like half-and-half and coffee creamers as well.

Dan Fishel: (08:49)
Can you talk about the technology? Because I'm telling you, I've tried many, many milk alternatives, I've been forced by my wife, and Ripple by far is the best tasting milk I had in terms of again, the texture what makes the difference. Can you talk about the technology? How do you make this magic work?

Laura Flanagan: (09:07)
Yes. So as I mentioned, our protein is called Ripptein. So, a protein molecule by itself is tasteless. It's all of the impurities that surround the protein that are on the protein molecule that can give it a planty or beany taste. And what Adam and Neil developed was a proprietary process that's able to remove those impurities off the protein molecule better than anything else commercially available. And so with that process we're able to remove the impurities up to 99%, depending on which specific molecules you're looking at.

Laura Flanagan: (09:44)
We're able to create a much cleaner tasting protein, and that allows us to put it in products like milk. Where there's not much else that you can camouflage a planty or beany taste, which is why if you try some of the other plant-based alternatives, they don't taste the same as milk. And that was part of the inspiration for Adam and Neil in starting and founding the company, is they felt like no one was doing plant-based milks well at the time. And with this technology we were able to launch a milk into the market place that taste great, matches or exceeds the nutritional value of traditional milk, and still has a great creamy texture that everyone has come to know and expect from a milk product.

Dan Fishel: (10:27)
So you've been around for about four years.

Laura Flanagan: (10:30)
Ripple has been around for about four years, mm-hmm (affirmative).

Dan Fishel: (10:34)
Four years. And now in how many points of sale are you being, offering your products around the U.S.?

Laura Flanagan: (10:41)
So we're in about 17,000 traditional grocery stores here in the United States, and we're growing distribution every day. So we were able to get into Walmart this year and doing well there. We've been able to get into a major convenient store here in the United States. We tested it first, it was successful, and so we expanded that. We did a test in a major club chain, that's now being expanded. We just got distribution into Kroger stores in the Midwest here in the United States. So every day we're growing distribution. We actually just got some of our products into certain school systems here in the United States, given the importance of having highly nutritious plant-based alternatives for children that are very accessible and available. So every day we are increasing our [inaudible 00:11:30].

Dan Fishel: (11:32)
So, the sales of plant-based milk is growing. Can you share some data about traditional dairy milk versus plant-based milk?

Laura Flanagan: (11:43)
So the plant-based dairy alternatives category is on track to become over a $2 billion category. And we are continuing to grow every day. And Ripple continues to exceed the growth of the broader plant-based category. So we are growing and gaining share every day. And we expect those trends to continue. In fact, since COVID really hit the United States in March, we've seen an acceleration in the growth of the dairy alternative category, and Ripple has benefited from that as well.

Dan Fishel: (12:17)
Okay, great. So, a quick note to our audience. We have a little icon on the bottom of the screen, it says Q&A, we want to keep this conversation interactive, so please ask questions. We're going to leave enough time to take some questions from the audience, but please I already see two questions here. Please add some more and we're going to address them very, very shortly. So now we'd like to transition from plant-based protein to cell-based proteins, and I'd like to welcome Lou Cooperhouse from BlueNalu. How are you, Lou?

Lou Cooperhouse: (12:58)
No, great. Thank you very much for having us.

Dan Fishel: (13:01)
So, last week in Singapore the regulators for the first time in the world they have allowed the consumption of lab-grown chicken nuggets, and that's a world's first. But you are staying away from the classic chicken or beef scheme and are focusing on seafood, lab-grown seafood, why is that?

Lou Cooperhouse: (13:24)
A great question, Dan. I think maybe just even pick up on a term that Laura mentioned, the ripple effect. What the world has seen is obviously a beginning of global transformation in our food supply. Where consumers are seeking more sustainable solutions in their diets. That began with plant-based milks, and now we're seeing plant-based beef, life beyond an impossible and so many other categories, it's just on fire, Dan.

Lou Cooperhouse: (13:52)
And what happened in 2013 was another technology was really launched as proof of concept the first time. Another alternatives to manufacturing animal products without animals. That being cell-based. So proof of concept in actually beef was first demonstrated. And frankly Dan, I was so excited by this as a total game-changer for the global supply chain. Proteins to actually manufacture real products in vitro if you will, that's the same flavor, texture, mouthfeel, same experience as conventional food products.

Lou Cooperhouse: (14:27)
But frankly, Dan, I was really... I said to myself, the real opportunity of the greatest of them all is seafood. And you used the word in your introduction, you used the word vulnerability. Our global supply chain of seafood is in my opinion the most vulnerable supply chain on our planet. It's a $200 billion sector, where global demand is only increasing every year, it's the highest every, being really eclipsed by what's occurring in Asia as GDP increases. And around the world as consumers are shifting from read meat towards seafood, the problem of course is we have a global supply chain gap as our seafood supply is increasingly diminishing, and some cases disappearing. Due to warming oceans, acidification, and that's a human health side, micro plastics, environmental pollutants, toxins, and mercury. And there's as you know, warnings on fish by the EPA and FDA here in America about for pregnant nursing women to have zero or limited amounts of seafood in their diets.

Lou Cooperhouse: (15:34)
So, we could do something much better. We can actually manufacture a real seafood product a third way, wild farm raise, now cell-based. So what we're doing is really totally disrupting this whole supply chain by manufacturing the same product. It begins in the lab as all products do, whether it be oatmeal or almond milk, or pea-based milk, but it's made in a factory. So this looks a lot like a micro brewery, making a large-scale production of cell-based seafood products. And we're just about one year away from launching our products in commerce. Here in the United States we're under FDA regulatory environment, and we're very excited by what happened by the Singapore Food Agency approving this for cell-based chicken products.

Lou Cooperhouse: (16:21)
We're focused, Dan, on the filet, the higher value fin fish species, like mahi-mahi, red snapper, bluefin tuna, and even in the future Chilean sea bass. So these products will soon be on our plates in just a few years.

Dan Fishel: (16:38)
So I just want to understand the product. Because I think we need to visualize how it actually looks. It is just a filet, does it look like a filet? Does it smell like a filet? Does it taste like a real filet fish?

Lou Cooperhouse: (16:51)
It sure does. We actually have done a demonstration of that internally and for our investors last year. We're the first company globally to actually demonstrate the product perform the same. I think just like Laura was describing how important the sensory attributes are of making a product that replicates what people are used to conventionally. We similarly, when you think about seafood, how do you prepare it? In really three broad ways. I'm a food centric, culinary centric person coming from the food industry. And how do people prepare seafood? Well, either they cook it. What does that mean? They grill, they fry it, they saute it, they might deep fry it, they might steam it, microwave it. You get the idea. It needs to get caramelized, it needs to have all the same reactions as conventional seafood. Or they might put it in a, if you will, an acidified marinade, like in kimchi, or ceviche, or poke, or they might prepare it raw.

Lou Cooperhouse: (17:49)
We demonstrated every possible way, it performed the same, smelled the same, tasted the same, it is the same. The same nutritional composition, the same functional characteristics, and even genetically it is the same species. It actually comes from the same cells that are used in conventional seafood product. And that's what the FDA is looking for. They want us to demonstrate that our product really is the same as conventional products, and we're doing all those comparison works right now.

Dan Fishel: (18:21)
So Lou, I have to admit, the first time guttered you didn't invite me to that tasting last year.

Lou Cooperhouse: (18:26)
Next time. Next time.

Dan Fishel: (18:27)
There's always a second chance. But let's talk about the technology, because this to me or too many sounds like an act of witchery, how do you take... how do you create fish that is not naturally born in the sea in the water? How does it work? How does the technology work here?

Lou Cooperhouse: (18:45)
The food technology is used in every industry. People don't think about it that much, but whether it's candy, sausage, cheese, or plant-based milk, there's all kinds of technology that are used every day in the food industry. No witchery at all, it's just normal procedures that are used to manufacture products.

Lou Cooperhouse: (19:04)
As I described it, it's like a micro brewery. So if you think about that concept, what we're doing is we're... there's a two-step process. First we are doing something which is very critical, we're making what's called a stable cell line. So we're taking from a real fish, mahi-mahi for example, or bluefin tuna, you're isolating the cell types that are found naturally in a seafood that you might have for dinner. So in that seafood you have for dinner, if you think about it, has three... the flavor comes from three types of cell types. There's muscle, fat, and then there's connective tissue.

Lou Cooperhouse: (19:39)
So we have actually literally isolated those three cell types from fish, then we're propagating them and having them double numerous times. They double, and double, and double. So we are feeding them the same nutrients. Picture that micro brewery again, they're in a bath, the bath that these cells are in are nutrients. The nutrients are the same kind of nutrients that you might find in agriculture feed, like salt, sugars, amino acids, lipids, vitamins, minerals, supplemented by other ingredients that we add to really propagate growth and have them to continue double to get these larger, larger volumes. And then these muscle, fat, and connective tissue are then formed into the actually filet of product. It could be a cubed used in poke or it could be a filet.

Lou Cooperhouse: (20:26)
So we are using some again, food industry principles like extrusion to actually have the products layered in the same, or more homogeneous in structure, so we can replicate all the same sensory experiences that you would want. And what's really beautiful about what we're doing Dan, is our product is a 100% yield. We've talked about sustainability footprint. Today's seafood might be shipped from say, Southeast Asia to say, New York City, that's almost 10,000 miles.

Lou Cooperhouse: (20:56)
Along the way that fish that was caught, it might have been accompanied by 30 to 50% by catch, that's typically fish that's caught in nets that's thrown back typically dead. It's a lot of animal suffering, and certainly a lit of inefficiency, and then shipped long distances with huge transportation costs it involves. To then experience maybe a 50 or 60% yield, my food service operator because you have head, tale, bones, and skin. Our product is a fully yielded, just the filet. So we are displacing all that transportation, all that loss of life, all that loss of yield, with a 100% filet, totally sustainable solution with all the wonderful taste of seafood but without any of the negatives, mercury, micro plastics, et cetera.

Dan Fishel: (21:51)
Yeah, so it's safe for pregnant women basically?

Lou Cooperhouse: (21:54)
Absolutely. So as much as [crosstalk 00:21:57].

Dan Fishel: (21:57)
Sushi is now allowed, basically?

Lou Cooperhouse: (21:59)
Yes, and for children too, and older people that might be immunocompromised.

Dan Fishel: (22:04)
So, a quick question for you about market perception, we're looking right now there's finally the COVID vaccine received the FDA approval, but there's so many people that are still saying, I'm not going to get this vaccine, it's going to change my DNA, et cetera, et cetera. Aren't you concerned about what people would think about fish that has been grown in a lab and not in the sea? Would they consume it?

Lou Cooperhouse: (22:32)
Positively. With any new food product there's always early adopters. There was an early adopter to the first person who said, I don't want to go on a... I'm used to a horse drawing carriage, but no, here's a car. So here's a computer, here's an iPhone. So technology always has early adopters who really see the value. In our case human health, animal suffering, global sustainability are your reasons to make a difference and purchase this product.

Lou Cooperhouse: (23:04)
So again, we have no downsides to purchasing our product. Yes it's made differently, but if you really know more about how food is produced, you'll say no, it's actually made the same as a lot of other things that are produced in the food industry, you just don't know that.

Lou Cooperhouse: (23:19)
So yes, there's always early adopters. And we've actually done some consumer research that have already demonstrated at the restaurant level huge interest in our products, because right now their experience with seafood, tremendous losses in yields, inconsistent variables, supply chain. With us they get consistency which is a real game-changer. And for consumers they really have shown that the human health benefits are clearly motivating them to make the purchase. So we are not concerned at all.

Dan Fishel: (23:49)
Okay, thanks Lou. And now I'd like to transition from surf to turf. And welcome Freddy from Tevel Aerobotics. How are you, Freddy?

Freddy Raitan: (23:57)
I'm okay, thank you. Good morning. Thank you for having me.

Dan Fishel: (24:01)
So Freddy, you've developed a fleet of autonomous drones that pick fruit in the fields. So what type of problems are you trying to solve?

Freddy Raitan: (24:11)
Okay. So let me start by saying that food consumption around the world has grown to about 70 million tons, which is double what it used to be 20 years ago. But on the other side unfortunately what we see is that on the agricultural sector we are losing a lot of the workers that do the picking for these goods. Mainly because it's very hard work, it's done under harsh conditions. And the new generation is migrating to the urban jobs which are high paying and not seasonal.

Freddy Raitan: (24:45)
So what is happening is it's exactly the opposite. You have less people picking where you need more fruits to be picked. And then you have a serious shortage around the world. So we came up with this brilliant idea of having drones which are robots in a sense that identify the fruit on the trees. They approach it, pick it, and place it on bins that they don't damage obviously the fruit. And that is done completely autonomously.

Freddy Raitan: (25:19)
So I mean, obviously in the agricultural sector there's a lack of automation. We haven't seen much in the last 50 to 70 years. But because of these shortages that we're going to experience even more dramatically going forward, there's a clear necessity for inventions like ours to take a hold and for farmers to start using. And we're very excited about it, I think that the feedback we're getting from the farmers they cannot wait for us to be in the... I mean, helping them with this problem and looking forward to do so.

Dan Fishel: (25:59)
So there is a video on your website of Tevel Aerobotics, so how the product works. But for those who are... that would try to imagine how it looks. Can you describe how does the product look? What exactly happens in the field?

Freddy Raitan: (26:12)
Sure. What we have done is we have developed a drone. It's different than the drone that you see from DJI. It has four propellors and it has an arm. It's a robotic arm, and on top of that you have a lot of vision equipment. So you're combining three different technologies. Obviously the drone technology which is aerodynamics has a lot to do with flying. That's one technology that is very much done or developed for working inside the farm environment, with a lot of dust, inside leaves, so it has its serious challenges.

Freddy Raitan: (26:54)
The second portion of it is the artificial intelligence which needs to identify the fruit. It has to differentiate from leaves and fruit. And then it has to understand the best angle of attack to come to approach the fruit at the right angle to grab it in a very soft way. And that's where the third portion of it, which is a robotic arm comes into play. So you don't damage the fruit, you grab it, you bring it, you take it. And then the next portion of it is the land base which is also autonomous where you put the fruit in such a... you place the fruit in such a soft way so it's not damaged at all. And obviously this is done, like I said, in an autonomous way where the farm doesn't have to be supervising or watching as all this is done in parallel ways.

Dan Fishel: (27:55)
So how does the drone know whether a fruit is ripe or not?

Freddy Raitan: (28:00)
We have sensor. That's a very good question, because one of the things that the farmers are asking us is to differentiate between precisely when the fruit is ripe to be picked and not. Part of the problem right now is that when you have pickers and they are paid by the weight of the fruit, they just pick everything they have in front of them because that's more efficient. Regardless of whether the fruit is already ripe or not.

Freddy Raitan: (28:28)
In our case, we can determine the... we have sensors around the grippers of the robot that understands the size of the fruit and also the color of the fruit. And depending on the programming that was placed on each particular robot, you can decide to pick it if it's up to that level of size and color, and not pick it if it's not.

Freddy Raitan: (28:55)
The important thing is that if the robot decided not to pick it because it is not ripe yet, he knows exactly the location where all these unripe fruit were not picked, so then it can come back exactly to those locations and pick them at a later time. Which is extremely efficient, because obviously a ripe fruit or the right level of bricks for the farmer has a very different price at the market than one that it's not that will probably most likely end up going to concentrate or juices which pays probably a fraction of the fresh market. So that's a very important distinction that we can help the farmers with.

Dan Fishel: (29:41)
So can you talk a little bit about the expected business model? I assume you are developing a product that still has to make sense in terms of cost to the farmers.

Freddy Raitan: (29:51)
Sure. Sure. If I take for example, right now the base case let's say in apples, around the world on average would be $400 a ton, the cost. We anticipate that given our cost of operation which are significantly lower than the farmers, we could probably save the farmers around 30 to 40% of that cost. And the main reason for that is that there's a lot of overhead cost that farmers have to pay for bringing these pickers. You have to pay them traveling expenses, you have to hold them in hotels or houses that they built for them, you have to transport them, you have to feed them, you have to pay insurance. You have health insurance, you have sickness. All these kind of things are not relevant to us.

Freddy Raitan: (30:54)
As robots obviously you don't have to deal with any of this. And the second part of it is the flexibility to be able to pick. I mean, this is a season business. For example, apples are picked three months out of the year. Then you have citruses, you have stone fruits and so forth. Our drones offer us the flexibility to move. Instead of the farmers buying this equipment and using this as a capital expenditure. What we're going to the market was a model of renting this equipment. That you will lease it as many as you want for as long as you want, and then just you will use it for let's say the three months of the season, we will take them back and then we will move them to the citrus locations where they will be used for another three or four months, and then for stone fruits.

Freddy Raitan: (31:46)
So we have a year-round business where we take care of the usage of the drones, and not the farmer which only uses it for three or four months. So I think it's a win-win from their point of view and ours as well.

Dan Fishel: (31:59)
Great. Thanks, Freddy. So now I'd like to open a question for all three of you. We are in the midst of a global pandemic and I'm just wondering how it's been the implications on your business? We can start with you-

Freddy Raitan: (32:15)
Okay, I can start.

Dan Fishel: (32:17)
... yeah, start with you Freddy.

Freddy Raitan: (32:19)
It was pretty dramatic for our business because I think that what the world learned is that most of the pickers come from different regions of different countries. I'll give you an example, when France and Germany closed their boarders, they realized that there were no pickers for their fruits. So their whole supply of fruits in those two countries and many others was absolutely disrupted to such an extent that they thought that they would bring local employees or local people to, I mean, to pick the fruit. And they realized that either the money wasn't good enough for them to do it, or the conditions were too tough, and there was expertise to know how to do it. So they had no choice but to make the exception and allow having flights, charter flights in these two countries for flying from Eastern Europe these pickers to do the picking as they normally do.

Freddy Raitan: (33:16)
And that happens in the U.S. as well, because a lot of these pickers came from Mexico which has been disrupted by the COVID. In many other countries that we saw is that all this migration that was coming in and out for these jobs disappeared. So it's exacerbating the problem for his fruit farmers, because this supply has vanished in a lot of ways and prices have gone higher. Experts they're trying to teach locals to do it but they're finding it extremely difficult. So COVID has-

Dan Fishel: (33:54)
So I also understand that during COVID times you had a POC, a proof of concept ,in South Africa that has been canceled.

Freddy Raitan: (34:03)
Correct.

Dan Fishel: (34:03)
And you took this time to train the algorithm on additional types of fruits, so now we can pick actually pick not just apple but also peaches.

Freddy Raitan: (34:12)
Peaches. Yeah, peaches, we train on peaches and citrus fruit.

Dan Fishel: (34:15)
Favorite fruit, yeah.

Freddy Raitan: (34:16)
Correct.

Dan Fishel: (34:18)
Okay. Lou or Laura, the impact of COVID.

Laura Flanagan: (34:22)
Well, COVID for the Ripple business has been both headwind but to be honest more of a tail wind for the business. So back in the middle of March is where here in the United States the lockdowns and other more extreme measures started to happen. And we were getting panicked phone calls from our consumers, because Ripple was selling out in grocery stores all across America, and our consumers are very passionate and very loyal to our products and they couldn't find them because we were sold out.

Laura Flanagan: (34:51)
And so, knowing that the next several months were probably going to be a period of volatility, in both consumer demand and supply chain, and a more retailer supply chain. We very quickly and very adaptly developed and launched our own e-commerce direct to consumer website, and I'm so proud of the team effort who developed this. In less than two to three weeks we had our site up and running, so that a consumer no matter where they were and where they lived, they would have access to Ripple products. And so today we sell on our website our refrigerated, our frozen, and all of our shelf-stable products. And it opened up an entirely new channel for us that we really didn't have on our radar screen at the beginning of the year.

Laura Flanagan: (35:35)
So that's been the good news, is that it opened up a whole new channel for us. Our performance in stores has increased. As I've mentioned, COVID actually was a tailwind for he plant-based diary alternative category. So we've seen an increase of momentum there.

Laura Flanagan: (35:51)
The one headwind that we had was that as a growing company with launching new product... we were expecting to get distribution of many of our new products back in the second quarter of this year, and there was no grocery retailer who wanted to reset their shelves in the middle of that pandemic and in the middle of all the panic buying. So it delayed us getting distribution. Some of new distribution and new account, it's a one major retailer we were supposed to get in April, we ended up shipping in September and October. So it's performing really well now and for the long-term health of the business we'll be fine, but we did have some delays in getting some new distribution.

Dan Fishel: (36:33)
Okay. Lou?

Lou Cooperhouse: (36:36)
Hey Dan, I would just add. Maybe as Freddy and Laura mentioned. I think the whole world woke up to just how fragile our supply chain is in all categories through the pandemic. And I think we are very fortunate to continue working as in our company here in Southern California. But we were also frankly saw so much more excitement and enthusiasm from the investor community due to just an increased realization about this fragile vulnerable supply chain. And food security really became even a word that we hear more and more along with sustainability. The world needs to feed itself in the coming decades, and this fragile nature of our supply chain can only possible, God forbid, get worse.

Lou Cooperhouse: (37:30)
But should that happen, we need new solutions as you and I have talked before, Dan. We don't have a choice, we must create a new supply chain solution, particularly for seafood. So we're excited to be part of that equation.

Dan Fishel: (37:44)
Great. So unfortunately we're running out of time. We're into the last five minutes of the session. And I'm just wondering if you can quickly, one or two minutes, tell us about your view about the future of your sector. Where would we be in five years? Again, plant-based proteins, cell-based proteins, INFORM technologies.

Freddy Raitan: (38:11)
I'll give it a shot to start. There's no question that because of the issues I described before, the problems are going to be exacerbated in the next five years. So there's going to be no option but for automation to come into the farms and to help the farmers with all this dramatic shortages that they will be facing, which is only going to get worse.

Freddy Raitan: (38:34)
So we expect that if we do our job from our end in developing this to make it easy enough and autonomous enough for the farmers to use, then the challenge will be to deploy it for... I mean, obviously farmers are very traditional in the way of doing their businesses. So we have to have a simple enough solution so we can really expand it and grow it as fast as they need it, in as many countries as possible.

Dan Fishel: (39:05)
I fully agree with you, by the way. What we see and history suggests that after, that we will see a spike in automation following this crisis. It happened before in 2008, it happened in 2000, it happened in 1991. And what we see is that automation comes in spikes and it's centered around economic crises when the... and employees that are losing their job are simply replaced with a mix of technology and then highly skilled workers. But now of course we have AI which we didn't have in previous recessions. So we're definitely going to expect to see a spike in AI technology in the next five years. Lou or Laura?

Laura Flanagan: (39:49)
Yes. Dan, I think there will absolutely be a continued migration to plant-based or in Lou's case, cellular products. There's heightened awareness now of the climate change issues and with a new administration coming in in January here in the United States, I think there'll be more focus on climate change and sustainability issues. I serve on two boards of public companies, and not question that boards and investors, retailers and consumers are now far more interested and engaged in finding solutions, sustainable solutions for the products that they choose.

Laura Flanagan: (40:27)
So there will be a continued migration. And I think the pace of that will depend on how quickly Lou's company and companies like Ripple close the gap to animal-based products. So how quickly we close the taste gap, how quickly we close availability gaps, how quickly we close cost gaps to animal type products. And every day we are making strives in that area. So I think as we close those gaps and as consumers don't have to make sacrifices, either taste sacrifices, nutrition sacrifices, or financial sacrifices to choose sustainable products, we're going to see an acceleration in plant-based products.

Dan Fishel: (41:09)
Okay. Thanks. And Lou?

Lou Cooperhouse: (41:13)
Hey, Dan. In fact, they're having some projections. The one I'm thinking about is from the [inaudible 00:41:18] Consulting Group that actually has projected that by the year 2040, 60% of our global supply chain of protein will be either plant-based or cell-based, and that conventional meat products will go from roughly a 100% today down to 40, and become unconventional in just two decades. So to answer your question, we will start to see the first large-scale factories within five years. Again, we plan to launch in commerce in a limited capacity late next year, to be followed by factory one, two, and three.

Lou Cooperhouse: (41:50)
So just as plant-based has seen level of excitement in category, cell-based is right behind it with a second solution, giving consumers what they always want, options. And different products will find, or different categories, we'll have different optimal solutions. So we're just seeing again just tremendous choices coming and new sustainable solutions, and again, I think for all three of us, our panelist, we are really the front-end of just a global transformation. So the future is bright.

Dan Fishel: (42:26)
I assume as far as your concern although the cost would go down significantly, because now it's probably quite expensive to eat some lab-grown meat and fish.

Lou Cooperhouse: (42:36)
That's correct, Dan. Right. Now it's all very bench top scale. But what we will see clearly is, economies of scale will enter this space and make an enormous difference. This industry is looking from farmer graze, supply chain, cost modeling, to food grade. Very different, bizarrely different to [inaudible 00:42:58] structure involved. When you go down to food grade, all body of concept of scale. So yeah, as these large factories come into play we will be a price parody, or I believe better at... In the meantime, conventional seafood is only increasing in availability and cost, and our cost will continually decrease. So we actually believe we could be profitable in factory number one. So that's where we think this industry is going.

Dan Fishel: (43:28)
Great. Unfortunately our time is up. Lou, Laura, and Freddy, thank you very, very much for your time. I'm sure we could have continued this conversation for many long hours. But for more information about Ripple, BlueNalu, and Tevel Aerobotics, please go to the SALT website. Thank you very much Laura, Lou, and Freddy. And we look forward to seeing you in additional upcoming webinars. Thank you very much.

Freddy Raitan: (43:58)
Thank you.

Laura Flanagan: (43:59)
Thank you, Dan.

Dan Fishel: (44:00)
Bye-bye.

Pandemic Venture Investment Series - Episode 5 | SALT Talks #122

“AI will not replace radiologists; radiologists that use AI will replace radiologists that don't.”

In the latest installment of SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, leading digital health start-ups provide a unique view into the revolution in artificial intelligence and how it’s shaping MedTech trends, and where investment opportunity lies. Zebra Medical provides automated, accurate AI imaging diagnosis, Diagnostic Robotics’ AI offers a triage and clinical-predictions platform, and BrainQ is developing an AI-powered electromagnetic field therapy to reduce neuro-disorder related disabilities.

AI technology can read scans and identify potential diagnoses before the radiologist reviews them. The introduction of AI to radiology will help address the problem of volume control in healthcare. This issue has been exacerbated during the pandemic where increased resources dedicated to managing COVID diverts time and attention away from other patients. “I kind of liken it to shining a flashlight in a dark room. We can see what's in the spotlight, but you're missing things around the edges.”

AI can process billions of data points to provide medical providers key insights to increase positive patient outcomes. This modeling is custom to each population and its history of chronic health problems. The pandemic has accelerated the adoption of digital health practices like telehealth, and has given faster rise to the need for AI population health technology.

LISTEN AND SUBSCRIBE

SPEAKERS

Ohad Arazi.jpeg

Ohad Arazi

Chief Executive Officer

Zebra Medical Vision

Yotam Drechsler.jpeg

Yotam Drechsler

Chief Executive Officer

BrainQ

Maya Orlicky.png

Maya Orlicky

Vice President, Strategy

Diagnostic Robotics

EPISODE TRANSCRIPT

John Darsie: (00:12)
Hello, everyone, and welcome back to SALT Talks. My name is John Darsie. I'm the Managing Director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy. SALT Talks are a digital interview series with leading investors, creators, and thinkers. What we're trying to do during these SALT Talks is replicate the experience that we provide in our global conferences, the SALT Conference, which is to provide a window into the mind of subject matter experts as well as provide a platform for what we think are big ideas that are shaping the future.

John Darsie: (00:47)
We're very excited today to welcome you to the fifth installment of our Pandemic Venture Investment Series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arising from the pandemic crisis and discuss breakthrough technologies that are addressing issues ranging from coronavirus prevention and cure, to social distancing and food supply. This series is presented in partnership with OurCrowd, which is a leading global venture investment platform.

John Darsie: (01:17)
Today's episode is called Artificial Intelligence: Digital Health's Secret Weapon, and it features Ohad Arazi, the chief executive officer of Zebra Medical Vision, Maya Orlicky, the vice president of strategy for Diagnostic Robotics, and Yotam Drechsler, the chief executive officer for BrainQ. And the talk today will be moderated by OurCrowd Qure's managing partner Allen Kamer. If you have any questions for any of our panelists during today's talk, you can enter them in the Q&A box at the bottom of your video screen on Zoom. And with that, I'll turn it over to Allen for the interview.

Allen Kamer: (01:54)
Thank you very much John. This is Allen Kamer, managing partner of OurCrowd Qure, Israel's first digital health fund focused exclusively on digital health investments. I'm really excited to have this esteemed group with me today. As John mentioned, we're here to talk about artificial intelligence, digital health's secret weapon, and we have some really prominent companies and prominent people from those companies here to describe their weaponry, and how they're approaching the market, and how they're disrupting healthcare in a positive way.

Allen Kamer: (02:31)
And how we're going to start is I'm going to turn it over to each of the representatives on the panel to describe themselves, give a little bit of background about who they are, and then a little bit of background about their company. And then we'll go from there. So let's start with Yotam from BrainQ.

Yotam Drechsler: (02:51)
Hello everyone. Thank you for the intro. My name is Yotam, and I'm the cofounder and CEO of BrainQ. My background is in math, computer science, and cognitive science. I've actually worked for several years at the Boston Consulting Group here with Maya. So I'm very happy to see her with me again on this panel. And since 2016, I'm cofounder and CEO of BrainQ. BrainQ is developing a medical device that aims to reduce disability following stroke and other neuro-disorders. We do so with a wearable electromagnetic treatment, which is frequency tuned. And our novelty lies in the data science way that we retrieve the frequencies for the treatment. And this is where the AI comes in for us. That's in a very short.

Allen Kamer: (03:46)
Thanks, Yotam. Maya, tell us about yourself and Diagnostic Robotics.

Maya Orlicky: (03:51)
Sure, thank you so much Allen for the introduction. So hi everyone, very happy to be here. I'm Maya Orlicky, I'm the VP strategy and operations of Diagnostic Robotics. My background is biotechnology and biomedical engineering. I spent a few years, as Yotam mentioned, at BCG. Some time at fintech, travel tech, and then back to the digital health space. And what we're doing here at Diagnostic Robotics is we're developing medical grade AI products, for predicting both patient medical conditions, and guiding patients through their most appropriate medical journey. Our system was built using databases of tens of millions of EMRs, medical records, as well as tens of billions of claims data. And we support both healthcare providers, payers, and employers, by creating seamless data driven interactions, automate and optimize the patient journey through AI.

Allen Kamer: (04:50)
Super, I can't wait to get into this. Ohad from Zebra Medical, tell us about yourself and what Zebra Medical does.

Ohad Arazi: (04:58)
Hello everyone, my name is Ohad Arazi. I have the privilege of serving as the chief executive officer of Zebra Medical Vision. I've been in the medical imaging and health IT space for the past 14 years. I'm absolutely passionate about transforming healthcare with AI and medical imaging. Our company, Zebra Medical, was founded in 2014, and really since then we've been on a mission to transform patient care by teaching computers to automatically read and diagnose medical imaging studies. I'm sure you know medical imaging is already established as one of the most critical and influential domains in healthcare. Over 3.6 billion exams are taken across the globe every year, dealing with almost every type of medical condition. And the challenge with that is, with the continuous growth in medical imaging volumes and complexity, we're quickly reaching a human limit for effective interpretation of these images. So at Zebra Med, we're looking to empower healthcare providers to manage this ever increasing workload without compromising quality of care through the use of AI and machine learning.

Ohad Arazi: (05:57)
I think what's really unique about our approach is that we're the first company to use imaging AI to take on the challenge of population health, which is core to the triple aim framework and to value based healthcare at large. And our platform is proven to help assess and stratify risks for guiding clinical decisions, for interventions, for reimbursements, and most importantly, we're using images that have already been taken. You can imagine that dealing with population health has become even more critical since the outbreak of COVID, as the entire healthcare system has been really required to develop tunnel vision to deal with only what matters most. And as a result, many conditions that are non-acute are not getting diagnosed or treated. And I kind of liken it to shining a flashlight in a dark room. We can see what's in the spotlight, but you're missing things around the edges. And that's a very significant role that we'll talk about today, that I think AI can play.

Allen Kamer: (06:48)
Well thank you, all of you. I'm going to jump in and keep it with you, Ohad. We talk, the panel is titled AI: Digital Health's Secret Weapon. What's so special about your AI? What makes your AI really stand out, and how does it make an impact?

Ohad Arazi: (07:07)
First of all, we're looking to complement what radiologists do. When this industry broke out, there was a lot of conversation around, will AI replace radiologists? And I always like to say, AI will not replace radiologists, radiologists that use AI will replace radiologists that don't. And the reason for that is that the math is pretty simple, right? With this exploding volume in growth and complexity, if you just do very basic math, one radiologist on average reads 50 CT studies a day. Each study has at least 500 images. That's 25,000 images per day, which means that the radiologist spends roughly 1.2 seconds reviewing every image. So our AI solutions help radiologists by automating the interpretation of medical images for certain types of conditions.

Ohad Arazi: (07:53)
And the way that it works, very simply, is we receive a copy of all the scans that are taken at a particular hospital, and our software reviews the images and provides an initial diagnosis even before the radiologist has ever looked at the exam. And I think that complementary approach, the one that's really deeply embedded and truly seamless with a clinician's workflow, is the way to go. Because from my experience in health IT, it's as much a technology challenge as a change management challenge, right? And winning over the hearts and minds of our users, helping them bring AI and technology to standard of care, to the point of care, is often tied to really nailing the workflow and making it seamless for them to consume. And that's really one of the differentiators we put forward with Zebra Medical.

Allen Kamer: (08:38)
Thanks, Ohad. Now Maya, maybe you can tell us a little bit about your AI, and how is it used with physicians, how is it used in the field and in the real world?

Maya Orlicky: (08:51)
Sure, happy to. So I think our competitive advantage really relies on the fact that we have a very strong data sense capability, but it's also coupled with a very strong in house team of clinicians. So from a data science perspective, we really built our model based on tens of billions of data points in order to get the most accurate predictions, and improving our models at all times. In addition to that, we've also partnered with some of the world's leading medical institutions in order to make sure that we are really clinically validating our results. And we've started our work actually in the emergency department, where we think we were able to get the most clinical and rich data from a medical perspective.

Allen Kamer: (09:40)
That's great. And in terms of how that medical science, that medical practice, that knowledge base that you have in house comes into play in the product, can you tell us a little bit about what that entails?

Maya Orlicky: (09:56)
Definitely. So our work is essentially optimizing the user journey, and providing insights, both a decision support system for the physicians, and the medical setting navigation for the patients. So that's sort of one part where it really comes into play. And the other is all our work around population health management, where based on the data, we provide better risk stratification and interventions matching for different chronic populations.

Allen Kamer: (10:25)
Thank you. So Yotam, you talked about how your company is working with a specific patient subset and group. And tell us a little bit about, what is first of all electromagnetic field therapy, and how can AI be applied to that?

Yotam Drechsler: (10:48)
Right. So BrainQ is targeting the neuro-disorders world, an unmet need. Stroke, our leading indication, affects 15 million patients every single year. It's the number one cause of long-term disability. We are a therapy company, and maybe unlike Ohad and Maya, they use AI for diagnostics, which is I would say 95, 98% of usage of AI in the world is used for diagnostics. BrainQ is a therapeutic company. We use AI in order to distill biological insight that could not have been shown or revealed otherwise. It's often a matter of trust. So Ohad has mentioned before, it's a question about, would radiologists be replaced by AI yes or not? And I believe that we are getting more and more trust with AI. And BrainQ has taken it one step further. We have used AI in order to distill therapeutic insight from electrophysiology patterns, from a patient's brain waves compared to healthy individuals' brain waves, to find this kind of anomaly in patterns, and use it to direct the electromagnetic field toward the right systems.

Yotam Drechsler: (12:05)
To do so, we have accumulated a massive amount of electrophysiology, which we had to tailor ourselves, because this is virtually nonexistent data. And collecting this data in a very dedicated way allowed us then to use what's called explanatory machine learning tools. So without going into all the details, the first step is very similar to what typical machine learning does. We use supervised learning. We try to classify between different states. So it can be a patient that does a grip versus a patient that does a non-grip. And then we ask the algorithm, well why did you make something become a grip? Why do you think it is a grip? What features made you believe it is a grip? So we don't care about the classification, we care about the rationale behind the classification. And based on this rationale, we are able to inform then our treatment.

Allen Kamer: (12:59)
So that's very interesting. So it's a high touch point with patients. You work closely, you need to understand what's going on in each specific patient in order to make sure you can treat them appropriately. So how has your business been impacted during the pandemic? How has that really impacted your ability to connect with patients, to do research, to really progress as a business?

Yotam Drechsler: (13:33)
Is this addressed to me?

Allen Kamer: (13:35)
Yes, please. Please [crosstalk 00:13:36].

Yotam Drechsler: (13:38)
So I think that the first impact is not an AI impact, it's actually an interpersonal impact. As the CEO of a company, when the COVID-19 started, the world is shaken. And I needed to make sure that our speedboat is making it through this storm. It wasn't an easy one, to be honest. So I had clinical trials running in US and Asia. And the first thing that happened, and we realized is going to happen very soon, is a pause or a slowdown of all clinical trials. For a life science company, this is a very problematic situation. Second is you have your entire team under a lockdown here in Israel, and also abroad. And a lot of un-clarity from your stakeholders and so forth. So I think the first thing to realize, this is a lot about communication, a lot about making sure you are making the right judgment and the right calls in a relatively short time, and in very critical days.

Yotam Drechsler: (14:47)
Once we did get a good grasp of where we stand and how to take it forward, we also realized where the opportunities are, and they are. So in our case for example, BrainQ has developed a treatment for quite a while already, with the notion of what's called remote therapy. So the patients that we treat, actually have a very fragmented treatment pathway. A stroke patient in the US spends about four days in acute hospital, and then often he goes to a rehab center, and he spends another two weeks, and then he goes home, and so forth and so on. Several locations, several doctors, one patient. Every single treatment that's ever tried to kind of capture it by taking the patient, dragging him back and forth to hospital, always failed. We have had this notion for a while in our head, and we have been working on this IoT medical device. Again, a therapeutic medical device. Very easy to say when it comes to diagnostics, but not heard of when it comes to therapeutics.

Yotam Drechsler: (15:51)
And regulators and clinical and such were actually very cautious of making this move with us. They said, "Let's try it in clinic, and then let's realize if it works, and then we're going to go on." All of a sudden, now that the COVID is out, it's no longer a question of visibility of treatment. It's a matter of safety of the patient. Stroke patients are a risk group to COVID, as well as any other neuro-disorder other. They cannot be treated in hospitals. So having a remote therapy solution actually helps them engage into a treatment. So it's becoming an imminent need. Being able to leverage on this opportunity, accelerating the development of this product, and engaging with the right regulatory bodies is something that we have managed to do in a very short time.

Allen Kamer: (16:44)
That's amazing. That's amazing, and certainly good to hear that the remote capabilities are being accelerated by regulators. Ohad, over to you. The data about hospitals and some of their elective procedures, some of the other parts of their business that are non COVID-related are staggering in the sense of they're down significantly, as much as 60, 70% in terms of activities in some cases. How has that impacted you Ohad, and the Zebra team, in terms of the market's ability to work with you and to work with your products?

Ohad Arazi: (17:27)
Yeah, much like Yotam, we had to overcome initial challenges of kind of figuring out how to work in the new world, right? How to engage with hospitals, how to create mind share for them. They're very, very focused on one thing, and so a big learning exercise I think for our team culturally and professionally, but maybe to double click on what you talked on Allen, is the fact that especially as COVID broke out, many elective procedures were postponed or canceled. And we tend to think of elective procedures as something that's not needed. When I mean elective procedures, I mean mammography screening, I mean cancer screening that is deferred, right? So very, very substantial procedure types were deferred, and that really created a kind of a peak and valley environment, where we see now, especially across the US, where volume substantially dropped, massive pent up demand got built up and then that had to be dealt with in a very short timeframe.

Ohad Arazi: (18:20)
And to me, that really creates a very robust opportunity for AI to help normalize that curve, because of what I talked about upfront, of the increased volume and complexity that radiology has to deal with. Let's take the example of mammography. The outbreak of coronavirus, annual mammography tests during lockdown were postponed or canceled. I saw an amazing data point that every day from mid-March to mid-May, an average of 94,000 mammograms were deferred daily in the US alone. That means that over that period, almost six million patients experiencing increasing anxiety to be tested, and ran the risk of missing early detection as part of their annual screening during that period. And AI can solve that.

Ohad Arazi: (19:00)
And that same phenomenon is happening again now with the second wave, as the health systems need to refocus on COVID yet again. And so I think that the role of AI in being that aid inside the radiology cockpit, to help deal with peaks and valleys, with pent up demand that can build all of a sudden, and to allow the radiologist to focus at times on what matters most while AI can complete the picture and run routine mammo-scans, can do detection of chronic conditions and stratify the risk for them. I believe that's been a very important lesson, and I really encourage the health system, and we're trying to promote this with our vision, to make sure that the new normal is truly a different one, that the role of technology as an aid inside a clinical setting really does become different due to this compelling event that we're all experiencing.

Allen Kamer: (19:48)
And so does that mean that, Ohad, that the utilization of AI in radiology will likely build on this momentum, and that providers who historically may have been resistant or reluctant to change rapidly, now as they've gotten used to the new world order and gotten an understanding that the spike in demand may be coming in the short while post COVID, that it'll be more routine in their use of AI and the integration of tools into packs, or into other places in their workflow than they have been historically.

Ohad Arazi: (20:37)
I certainly believe so. I think it's causing health systems to retool, and they're needing to retool financially, because their volume, their inpatient volume has grown, which is a lower margin business. So their financial, the bottom lines are strapped, right? So that in and of itself is causing change. The workflow has changed, the peaks and valleys have changed. I think a good example of that is actually the role that AI imaging has played with COVID specifically. Because when COVID first broke out, most of the efforts to fight the pandemic were on testing, were on vaccinations or building immunity for it. There was very little to help the health system understand the potential for disease progression in patients, and really therefore help to create the best care plan.

Ohad Arazi: (21:17)
We know that one of the greatest drivers of coronavirus related mortality in the early days was the inability to detect early potential severe cases and provide critical care to those that needed it most. So healthcare providers need automated tools to support triage, and to determine how to best allocate ER capacity, ICU beds, ventilators, based on disease progression. And so the very first wave that challenged Italy or New York City truly served as a cautionary tale, where frontline workers had to make very difficult decisions on who they think had the greatest need to receive treatment. And then AI started to come in to play a role there, by analyzing CT scans. And our solution for this automatically detects and quantifies suspected COVID-19 findings, but more importantly, it provides a lung burden score, which really calculates the percentage of the affected lung volume, and enables better prediction of the trajectory of a patient with COVID as a decision support for the allocation of valuable ER or ICU resources.

Ohad Arazi: (22:21)
So to me, that's an example where a new need, which is understanding progression, not necessarily understanding classification, drove adoption behavior that we hadn't seen before. And to your point, I think that that new normal is going to look a little different in terms of the role that AI plays now, pre and post-pandemic.

Allen Kamer: (22:41)
Thanks, Ohad. Maya, talk to us about the emergency rooms, and talk to us about how, what you're seeing in the market, what you're hearing, and how that's impacted Diagnostic Robotics.

Maya Orlicky: (22:54)
Yeah, definitely. So I think we're seeing a lot of different changes, right? COVID had made a lot of impact on the entire healthcare space. I think on the one hand, it really was a huge accelerator for digital healthcare space, and really brought adoption of phenomenons that we thought would take decades in a matter of months, right? We're seeing telehealth is booming, and we're seeing really the need for remote monitoring. So I think that's sort of one thing that had a really huge impact for us, whereas the having the ability to really leverage AI in order to have the physicians focus only on what's most important, right? Only the life saving treatments, really the core of the physicians' work, I think that became very clear right? Whereas before, it seemed as maybe an added value, now it really became a necessity with the situation and everything that's been going on with the physicians. And we were seeing that both in the emergency department as well, right? In emergency department, optimizing the user's flow, making sure we identified those high risk patients and optimized the process, was really just, had a much bigger impact at this point.

Maya Orlicky: (24:16)
Another thing that we were seeing, so I think with the pandemic, there was an overall evolution. And we're seeing sort of the market react. So in the beginning, everyone was really interested in digital health with the focus on COVID, right? And we've collaborated initially with the Ministry of Healthcare in Israel, and with several states in the US and in India, to really try and provide risk assessments for COVID. However, as it progressed, we really understood that what's more important is thinking about the broader picture, looking at population health management, at the chronic populations, whereas you really need to find a solution to this new normal and make sure that they're monitored as well.

Allen Kamer: (25:01)
And so with these macro drivers you identified Maya, how does that change or alter your business plan moving forward? Do you have new-

Maya Orlicky: (25:12)
I think honestly... yeah.

Allen Kamer: (25:14)
Sorry, do you have new parameters of success, do you have new focus areas, do you expect things will return to normal post vaccine?

Maya Orlicky: (25:26)
First of all, I think that's the million dollar question, right? No one really knows what's going to be the new normal, but I think it will definitely not be as it was before. I think we don't see anywhere of this going back, the need for sort of digital elements and remote monitoring is going to increase. And I think we don't know if it's going to be exactly where we're at right now, but it's definitely going to increase dramatically from where it was pre-COVID, right? And so for us, what we're seeing is just everything is expedited in a sense, right? And some of the sort of chronic conditions, we're seeing an increase in those populations, right? So in our population health management, we're looking at behavioral health, which is really important right now. And [inaudible 00:26:18], and additional patient which are also in risk for COVID, so that has another sort of parameter which has an impact, and it just increase the need and the demand for that such monitoring.

Allen Kamer: (26:30)
Great, that's really interesting. And Yotam, on the clinical trials side, you mentioned that you had to pause some trials as a result of COVID. You mentioned some of the regulators' willingness to do some remote care. What changes in a post-COVID world for all of you?

Yotam Drechsler: (26:51)
Right. So COVID did change our plan, and honestly, I wouldn't expect this change in the plot originally. So we had too many indications we were running [inaudible 00:27:06]. One was in chronic tetraplegic spinal cord injury population, and the other one was on subacute ischemic stroke patients. And if you were to ask me a year ago, what is my first indication to market, I actually believed I'm going to do well on both. But my entire plan was develop based on the notion that spinal cord most likely going to make it faster to market. It's a niche market, it's a much kind of a slimmer penetration, and then go to the mass market of stroke. And this was my plan to the board, this was my presentation, the pitch that was there. And what happened is that spinal cord injury for patients is an elective procedure, as Ohad has mentioned before. Again, these are some of the most severe patients out there. They are paralyzed from their neck and down. Do they need help? They definitely need help.

Yotam Drechsler: (28:06)
But when it comes to hospitals' ability to treat them, even enroll them into a clinical trial right now, it just wasn't there. So things did slow down, and whenever there was kind of a slowdown in numbers of COVIDs in different states, okay, we had some more recruitment. And then it went down again. So things did slow down on that process. At the same time, we actually managed to complete our stroke study. And not just that, kind of get a two, three years jump, because our plan was to have a pivotal study in the US based on a clinic product just as a way to get to our ultimate product of one that could have a remote therapy. And all of a sudden, I don't need it anymore. So our plans have now changed to already engage with this remote therapeutics setting, and the doctors we work with, the sites, and also the regulators are much more adapted to it.

Yotam Drechsler: (29:10)
And we have already been experiencing this, kind of a move to remote therapeutics in the US, and it turns out highly successful. Again, things that were inconceivable just a few months ago, during the COVID we have taken our spinal cord injury patients and moved them home. And regardless of the efficacy side, which I cannot discuss that point, but patients were thrilled. They do not want to go back to clinic to receive the same treatment. Who wants to go in an ambulance back and forth three times a week if you can receive the same treatment at home? So these are, again, concepts that would've taken several years to mature, and now did mature.

Yotam Drechsler: (29:53)
I do want to make one more point. I think one of the challenges for a startup company in crisis times like COVID is also to make sure you don't de-focus. And you do, you adhere to your core values, and you make sure you stick to it. Because COVID will eventually, ultimately in a matter of months, maybe a year, maybe two, but we will overcome it most likely. And the startups, many of the startups I see around me and also us, we're established for a reason, and we develop often unmet needs, we develop therapies for unmet needs or diagnostics for unmet needs. Spreading around and placing too many times the COVID word in our value proposition also has the risk of losing the true value we're after.

Yotam Drechsler: (30:52)
So we do have to acknowledge it's COVID, we do have to take into account how do we speak to our stakeholders in times of COVID, but we also have to remember right, that whatever we target out there, most likely is still going to be a need. And not just that, it's most likely where we believe we have the best chances in order to I would say differentiate ourselves and maintain our competitive advantage. So for me, this was also an important lesson, not to go and develop my own COVID vaccine as well.

Allen Kamer: (31:26)
Right. Well there's certain some positive news on the vaccine side, so it's good that you've stayed focused on what's important, and it's really interesting to hear how you see an evolution in terms of the patients, in terms of what they want and how that's going to impact your strategy and your ability to progress post-COVID. Ohad, let me hear from you in terms of what you're projecting and forecasting as vaccinations start to spread hopefully in 2021, and the market begins to get back to potentially a new normal as Maya said. But tell me what you're thinking from a Zebra perspective.

Ohad Arazi: (32:21)
My view Allen is that this will drive a significant push, primarily in the US, from a fee for service model to a population health based model, or a value based model. Because one of the things that COVID really underscored is that kind of the cost and complexity to care for a patient needs to be viewed in its totality. And in the US historically, in a fee for service world, you're often looking at per procedure basis, right? And all of a sudden when you had to deal with very complex comorbidities that are tied to COVID or had to deal with a big influx of inpatients, it really stretched the finances of the health system, in particular because of the fact that we noted earlier, that the higher margin procedures were deferred. And all of a sudden, the hospitals lost a lot of their top line revenue. They were still doing the same number of procedures, even had more patients in house, but their revenue basis had substantially decreased.

Ohad Arazi: (33:13)
And so I think that's part of a broader trend that we're seeing in the US, of the move more towards population health. And I think it's also a theme in what Maya and Yotam talked about, because population health is often going to lead us towards a path where we can have early intervention, and that we can really link diagnostics and therapeutics, which I think is one of the key things that's emerging from each of the discussions we're having across our companies. And so I really think that this is a trend that we at Zebra Med have to understand how to capitalize on. It's been a big part of our strategy actually, moving from just dealing with acute care situations much more to population health.

Ohad Arazi: (33:50)
And I'll bring that to light for a moment of what that means. If I step off of a long international flight when I fly from Israel to the west coast of North America, which I often do, if I have chest pain and I've come off a long flight, I'll go to the ER and the physicians will want to rule out pulmonary embolism. So the radiologist will interpret a chest CT, and they'll look to either rule out or confirm PE. But what if it that same time that the radiologist is looking at the scan, an AI algorithm can run in the background, can identify additional findings that will have significant downstream impact on the patient's overall health like the fact that I might have subtle vertebral compression fractures, which are a leading indicator for osteoporosis, or I might have a buildup of plaque, of coronary calcium that is a risk factor for cardiovascular disease.

Ohad Arazi: (34:40)
And so the ability for AI to stratify the risks and to deal with my end to end health, even if it's not immediately, high degree of acuity, is I think where healthcare is going at large, again principally in the US, where it's been much more focused on treatment and less focused on prevention. And again, that's one of the main roles that I think AI can play, and maybe also Diagnostic Robotics and many other companies that are now looking at diagnostics with a broader lens of the complete picture, the complete comorbidities, the risks, that these patients bear, recognizing that even things that don't manifest right away can often have prophylactic treatments that we can deal with preventatively, and we can drive better outcomes as a health system in this post-COVID environment with greater adoption of technology and AI.

Allen Kamer: (35:31)
That's great. And do you see those population health trends emerging in other markets globally in short order? Are they advanced in certain markets before the US? What's the forecast there?

Ohad Arazi: (35:50)
Yeah, they're certainly more advanced in single payer markets. A really good example of that is [inaudible 00:35:55] Healthcare. [inaudible 00:35:56] Healthcare already works with us, with our both coronary calcium and our compression fracture product, because it's a payer provider. It holds both ends of the stick, right? It owns the provider and it owns the payer, the overall responsibility for the expense and the accountability for dealing with the outcome for that patient. We see that in many single payer systems. I'd say the UK and Australia for example have very progressive bone health programs. And bone health is just another disease. It's the most preventable cause of fractures, osteoporosis is. It impacts nearly half of women over the age of 50, and costs $52 billion to treat. And so it causes, just in the US, more than two million cases of broken bones annually.

Ohad Arazi: (36:35)
But it's also highly treatable if detected early, so if you can increase the detection rates for osteoporotic fractures, then you can get much better outcomes. And single payer systems have recognized that for years. The UK, the NHS is really outstanding in adopting this. They have a network of fracture liaison services, basically bone health clinics, that help support the older population with fracture prevention, and that's catching on rapidly in Australia. So certainly single payer jurisdictions I think are further along, but they're still working within the confines of cost saving.

Ohad Arazi: (37:08)
I think in the US, the shift from volume to value will also change some of the top line projections for the providers, because they realize that actually if they're intervening early and owning the end to end care for that patient, they can get not only better clinical outcomes, but also better financial outcomes. And those financial drivers I believe will drive adoption substantially of population health solutions.

Allen Kamer: (37:31)
That's great. So here's a question that came in from one of our participants, and it's for each of the companies, and Maya, we'll start with you. The participant wants to know, what are specific milestones that you're aiming to achieve, either in terms of revenue or clinical milestones, or even AI milestones, that need to be reached for a sustainable success over the next year or two?

Maya Orlicky: (38:00)
Sure. So I think I can respond to each of those sort of fields, right? So I think from a clinical perspective, that's where we've started, right? We've really started with validating our predictions clinically. However, there's always this sort of a specific milestone on a per-modal basis to really prove that we have better results, right? And I can share an example in the population health space, which is we started with the risk stratification score, and then from there we really saw that in order to make an impact, we need to also look at the type of intervention provided by the care management teams, right? In order to really impact the bottom lines. And so what we're doing now is we're also incorporating interventions matching for specific populations. So that's just one example, to show how we keep on adding sort of more specific detailed milestones, in order to show that we're improving clinically.

Maya Orlicky: (39:00)
With respect to the other components, I think there's always the matter of adoption which is really key I think in our field, right? And there we have sort of metrics in order to make sure that we're working both with payers and providers, with the care management teams, and with the users themselves, just to make sure that we're increasing adoption.

Allen Kamer: (39:22)
Great. Yotam?

Yotam Drechsler: (39:24)
Right. So if I have to summarize it to one key milestone in the coming year, then it is launching our [inaudible 00:39:33] study, the equivalent for phase three for stroke in the US. Most likely Europe as well with some of the top sites out there. This is a very unique study. So it comprises this, our therapy that has been already evaluated in previous studies, but it blends in the remote therapeutics, a very unique setup that I don't think anyone has ever tried before us on a large scale study for an unmet need. So making it right, making sure that we launch it with the right technology on our end, with the right design, with the right doctors, it's kind of a once in a lifetime opportunity to really make a dramatic change into this world. So kicking it off in the right way is the number one milestone for us in the coming year.

Allen Kamer: (40:32)
Right. Ohad?

Ohad Arazi: (40:38)
Allen, for us it's really scale. Our company was founded in 2014, we've been in this business for a while. We're I think really we're the trendsetters, and kind of pave the way for much of the imaging AI industry. And now as we continue to mature, our focus is scale. I think I shared with you upfront that we're on a mission to transform patient care by teaching computers to automatically read and diagnose medical imaging studies at scale. And to us that scale, today we have to the order of hundreds of thousands of patients that go through our system every month, and our goal is by 2022 to have millions of patients go through our systems per month. And so we're really looking to build that scale by first, continuing to sell directly to providers.

Ohad Arazi: (41:20)
We've also substantially increased our resale network, and have really been working on OEMs, meaning embedding our software into assets that are being used by radiologists or by imaging users, like the imaging modalities or the pack systems, the systems that are used to interpret the exams. Because we know that that will drive adoption, that will drive scale. So really for our mission to be meaningful, we need to touch millions of patient lives every month, and that's really what our team is working towards. We measure that metric, we talk about it all the time. We have a dashboard that shows how many lives we're touching on a daily basis, and so we're continuing to galvanize the team around that. And that's really our biggest goal in 2021, is to continue to really scale up this company, increase our presence in North America and globally, and touch more and more patient lives every day.

Allen Kamer: (42:06)
That's terrific. So last question for everyone as we're pushing up against time, it's a general question, but as we talked at the outset, this is about AI as being digital health's secret weapon. I'd like to hear from each of you what needs to happen overall for AI not to be so secret, for patients to feel comfortable, for physicians to feel comfortable, for overall AI to become widely adopted and understood as being beneficial in the delivery of healthcare. And we'll start with you, Maya.

Maya Orlicky: (42:46)
So I think one of the things is really around, and we've touched on it briefly before right? But around market education. So I think we're working with a very traditional market, and I think it's a gradual process to really understand first of all the impact, and sort of the goal of AI within [inaudible 00:43:05], I think Ohad said it as well, right? We're not trying to replace the physicians, we're trying to supplement them, optimize whatever we can in order to support them, so they can really focus on the essence of their job. So I think that's sort of one thing which, it's a gradual process to really get the entire healthcare community to really understand that.

Maya Orlicky: (43:29)
And then there is just the area of just AI explainability, right? Which is really sharing as much of the results as we can in order to have the physicians and the healthcare staff informed, and to be able to make the right decisions based on AI, but really have the data that they need in order to make the right treatment decision.

Allen Kamer: (43:54)
Great. Yotam?

Yotam Drechsler: (43:56)
Right. So as Maya said, and I think the overall notion is all about trust. And when there are [inaudible 00:44:07] partners, you don't want to go too fast. You want to take it kind of step by step, and build up this trust. For me, the partners are, just to make sure our technology companies that penetrate healthcare system, and there is the healthcare stakeholders, whether it is doctors, whether it is the medical centers and so forth. I do believe that this is where you build trust. AI, in essence it's also a buzzword. To some extent, I often believe that we kind of use it too much. I mean, AI is a tool to achieve a goal, and it's a way to use data science in order to interpret something that you maybe could not have been doing, could not done differently.

Yotam Drechsler: (44:57)
So when you go in AI and you use it for your pitch to investors, I think it's very important to realize the differentiations of what you have. And by the way, AI has been democratized by its tools, so almost everybody can do an AI today, so this is not really the differentiation today. It's really something that we use in order to help technology solve problems in a more traditional system.

Yotam Drechsler: (45:29)
So for us, I'm seeing two things. A, create this trust between startups, and I would say entrepreneurs with this medical system, and do it with communication and transparency in the most profound way. Second, maybe consider not to use too much of the word AI. Rather focus on the value you can bring and the kind of tools that you use, because some of it is just about... this is the downside of a buzzword. And thirdly, I think that time is often the most critical factor, and time, between when AI was introduced several years ago, I think a lot of time has passed. A lot of these values that we are talking about right now are almost taken for granted. I mean, our radiologists today know what AI is. There is no more... it's not scary anymore, okay? It used to be scary, a few years ago. And the boundaries can just extend and extend, so this is why we kind of use it these days for explanatory tools for therapeutic insight, but this is just the very beginning of the journey.

Allen Kamer: (46:48)
Thank you. Ohad?

Ohad Arazi: (46:52)
I'd really like to echo what Yotam and Maya talked about. To me, AI is still kind of going through its cycle of moving from hype to reality. And our role collectively as innovators in this space is to move from being experts to being partners. We have to be partners to the health system, AI is a partnership tool. And again, to me, the ultimate partner is about also changing our view on AI from the inside out to the outside in. I think historically when it started, it was driven by innovators that had a vision, and they were telling the market that vision, and it felt a little bit like a solution looking for a problem. And now when you hear about each of our companies, we're very, very focused on finding solutions that are valuable, and pain points that the health system has, and real needs that when users leverage AI to solve them, they can't live without them.

Ohad Arazi: (47:40)
And I think that's our role, is to continue to evolve as partners, build that trust like Yotam said, and really switch our focus from thinking about kind of the solution, the glitter of AI and what it can do, to really getting into the trenches and understanding, where is pain in the system? Where are needs that are unmet by existing technologies, existing workflows, and making sure that we tailor our AI solutions to solve those problems. That is really what creates stickiness, that's what creates adoption, and that's what will allow our broader sector I think to mature, and unlock the promise that it has, and the value that each of these companies can bring to the world.

Allen Kamer: (48:18)
Well thanks Ohad. So Ohad Arazi, CEO of Zebra Medical, Yotam Drechsler, CEO of BrainQ, and Maya Orlicky, VP of strategy and operations at Diagnostic Robotics. I'd like to thank all of you for your insights and comments, and educating us about the market, about AI, what you do and how you're impacting patients and patient care. I'd like to thank all of you for joining us, and remind everyone that the recording and more information is available at the SALT website, and hope to see you again sometime soon. Thank you for your time, and thank you for participating to our panelists.

Julia Collins: Combating Climate Change | SALT Talks #121

“Regenerative farming has the capability not only to create healthy soil, healthy plants, and healthy people, but also to sequester carbon and address the legacy load, which is part of the solution to climate change.”

Julia Collins is CEO of Planet FWD, a company on a mission to tackle climate change by expanding regenerative agriculture adoption. The company is building a software platform for regenerative agriculture alongside a climate-smart snack brand.

Climate change is the most important and pressing issue facing our planet and the food we eat plays a significant role. Regenerative agriculture represents an environmentally thoughtful approach central to combatting climate change. Between the 1940s and 1970s, the Green revolution introduced new nitrogen-based farming practices that helped boost crop yields, but simultaneously destroyed soil. “Regenerative farming has the capability not only to create healthy soil, healthy plants, healthy people, but also to sequester carbon and address the legacy load, which is part of the solution to climate change.”

Moonshot snack brand is the first explicitly climate-friendly snack brand. On top of launching crackers as its first snack product, Moonshot helps other companies shift their operations towards a more planet-forward approach. This includes offering data and tactical recommendations other companies can use and implement in their production.

LISTEN AND SUBSCRIBE

SPEAKER

Julia Collins.jpeg

Julia Collins

Founder & Chief Executive Officer

Planet FWD

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello, everyone, and welcome back to SALT Talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy. SALT Talks are a digital interview series that we launched during this work from home period with leading investors, creators, and thinkers. And what we're trying to do on these SALT Talks is replicate the experience that we provide at our global SALT conferences, which we host annually in the United States and abroad. What we're trying to do on the talks and at our conferences is provide a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future.

John Darsie: (00:51)
And we're very excited today to welcome Julia Collins to SALT Talks. Julia is a serial entrepreneur who realized that food was her calling as a young girl in San Francisco, where it was the epicenter of her community. She spent her career building food companies, having launched brands such as Mexicue, Murray's Cheese Bar, love Murray's Harlem Jazz Enterprises, which is the company responsible for the award-winning restaurant The Cecil. She later went on to co-found Zume Pizza, where she became the first black woman to co-found a unicorn company. When she became a mother, she knew she needed to find a way to bring delicious food to people in a way that helped heal the planet for everyone, including her son.

John Darsie: (01:35)
Today, Julia leads Planet Forward, which is a company on a mission to tackle climate change by expanding regenerative agriculture adoption. The company is building a software platform for regenerative agriculture, alongside a climate smart snack brand that will be bringing its first product, a cracker, to market later this year. I look forward to feeding that cracker ... We were talking before we went live. I have young children as well, Julia, so looking forward to that. In addition, Julia serves on the board of Black Girls Code and sits on the advisory council for Launch With GS, serves on the all-rays operating committee, and is an EIR for Cleo Capital, which our host Sarah Koontz founded today. She's an active angel investor focused on funding female entrepreneurs and BIPOC founders.

John Darsie: (02:25)
A reminder, if you have any questions for Julia during today's SALT Talk, you can enter them in the Q and a box at the bottom of your video screen on Zoom. And hosting today's talk, as I mentioned, is Sarah Koontz, the managing director and founder of Cleo Capital. And with that, I'll turn it over to Sarah for the interview.

Sarah Koontz: (02:42)
Thank you. Awesome. I'm so excited to have you here today, Julia. And I know you well, but as we jump in, I'm going to start with having me tell everybody who doesn't know you as well, how'd you get here? How did you discover regenerative agriculture? How did you discover food as a career? Tell us everything.

Julia Collins: (03:04)
Yeah. Well, it's also nice to see you, Sarah. So my journey here really begins with my grandparents. They migrated from the Deep South to the Bay area during the Great Migration to create a dental practice, actually, serving the black community during segregation. But the thing about my grandpa is he was so good as a dentist, and frankly, he was such a sweetheart, that everybody came to the practice, everybody from every race and every walk of life. And so I really grew up in this context in this family where we believe that not only was everyone equal, but everyone was worth serving.

Julia Collins: (03:43)
And as you could imagine, this kind of vibe, we were really a come one, come all kind of a family. And so say if you came to my house after high school, you would just walk right in the door. We didn't lock the door. And before you could get two feet, someone would offer you something to eat. So food has always been central to me as a medium for connecting with other people, as a medium for talking about important things, understanding of other cultures, I've always been obsessed with food. So it was very clear as a kid that I would be here, but the journey in between Korean was a bit circuitous. And I at one point thought that I would be a scientist, went off to study biomedical engineering.

Julia Collins: (04:22)
When it all actually came to a really perfect point for me in terms of clarity was, post business school, having a chance to be an intern for Danny Meyer when he was just building Shake Shack and understanding that I could actually merge my love of food with my love of technology to create a career for myself.

Sarah Koontz: (04:41)
That's amazing. That's amazing. So tell us a little bit about kind of what is regenerative agriculture, right? We'll start there just to sort of set the scene for a lot of the fun stuff we're going to get to talk about today.

Julia Collins: (04:56)
Yeah. So, so I'm going to get there, but I'm going to frame this really within the context of climate change, because I think it's such an important connection. And so I would argue, and I think many would agree, that climate change is the most pressing issue facing humanity. Social justice, racial justice, economic justice, everything is mixed into this idea that we have to take action on climate change. And so the reason why I got really excited about this field that we now call regenerative agriculture is that there's actually a relationship between the kinds of farming practices that we can use under this regenerative system and our ability to decarbonize and also draw down carbon.

Julia Collins: (05:41)
So what is regenerative agriculture? This is the term that we use for an approach to farming that helps to rebuild the health of soil, soil that's been degraded because of decades of dependence on heavy machinery and nitrogen-based inputs. And these were some of the technologies that were put forth during what we call the Green Revolution, this period between the forties and seventies, when we attempted to significantly boost yields, crop yields, and we did, to feed the planet, but we did so at the cost of our soil. So this approach to farming helps to rebuild the health of the soil, and as it does so, it helps to rebuild soil organic matter, which means that in the process of making the soil healthier, we're also drawing down carbon.

Julia Collins: (06:26)
And this is why folks get so excited about this kind of farming, this regenerative farming, because it has the capability not only to create healthy soil, healthy plants, healthy people, but also to sequester carbon and address the legacy load, which is part of the solution to climate change.

Sarah Koontz: (06:44)
And talk a little bit about .... really kind of geek out with me for a second and talk a little bit about carbon draw down, what is this? What does this mean and why does that matter?

Julia Collins: (06:56)
Yeah. So when we think about sort of the magnitude of the problem, 25 to 30% of global greenhouse gas emissions are coming from our food system; we've talked a little bit about why: heavy machinery, over-reliance on nitrogen-based inputs. Nitrogen is-

Sarah Koontz: (07:14)
Is it because the cows fart? I heard that. I read it on the internet.

Julia Collins: (07:19)
Yeah, absolutely. Livestock is absolutely part of it, but soil-based agriculture actually emits twice as much greenhouse gases as even livestock, the way we're currently farming, nitrogen as a soil amendment, fertilizer, pesticide, herbicide, fungicide. This nitrogen, when it's overused, starts to create nitrous oxide, and nitrous oxide is actually almost 300 times more potent than carbon dioxide. And so we absolutely have to address the issue with livestock through regenerative grazing or lessening our dependence on meat as a source of calories. But we also absolutely have to make huge changes to the way that we approach soil-based agriculture so that we can decarbonize.

Julia Collins: (08:07)
So the idea behind this is so powerful because not only does it create a framework where we can use our food systems to actually be agents for positive climate impact, but in rebuilding the health of the soil, we're also making the soil more resilient. So it isn't the case that we can completely stop climate change, nor can we undo everything that's happened. We will have to adjust. We will have to adapt as a society. But healthy soil, for every 1% increase in soil organic matter, you actually increase the holding capacity of the soil by 20 gallons per acre. So the soil becomes more spongy and resilient to the kind of extreme weather that we're seeing as a result of climate change.

Sarah Koontz: (08:53)
That's amazing.

Julia Collins: (08:54)
Was that nerdy enough?

Sarah Koontz: (08:56)
I love it. I love it. No, this is so helpful. And it's interesting because regenerative agriculture is something that we can't really see necessarily in our food, but Whole Foods last year said that one of their top trends for 2020, they did not weirdly have pandemics in there, but they said that one of their top trends was going to be regenerative agriculture. So talk a little bit about kind of how and why the broader sort of food world has gotten on board with this. Like, this isn't just a fringe idea of like crazy farmers.

Julia Collins: (09:34)
No, it absolutely isn't. I mean, when you ... I've looked at some recent surveys, including one that was co-sponsored with the Nature Conservancy, and when executives of top food companies are surveyed, they cite climate change as the single biggest threat, not only to their own health and their customers' health, but to their supply chains. And so most of the large food companies understand that they need to take action. What's exciting about what I see happening in the market, for example, General Mills making a million acre commitment to regenerative agriculture, Whole Foods naming regenerative agriculture is one of their top trends for 2020. And the examples go on. What's so exciting about this is we actually need the power of these very large companies modifying their supply chains to accelerate the kind of work that we're doing at Planet Forward, which is to also help smaller companies be able to create climate friendly products.

Sarah Koontz: (10:30)
I love that. So one more question about regenerative agriculture, and then we're going to talk about Planet Forward. So what do people do at home? Obviously this is an issue that primarily is about huge farmers and food companies. But if you have a backyard garden and you are like, "Oh no, I use fertilizer, that's bad," what do you do instead?

Julia Collins: (10:54)
Yeah. The mindset or the way to think about this is really to ... or if one wanted to do some research, really researching indigenous principles of land management, the kind of farming practices that have been used by indigenous populations around the world for centuries, that's a really good place to start. If one wanted to take a more academic approach, and in my world, we actually do soil testing in our backyards to see what's the best thing to grow. Growing food at home is really important. Another super important thing to do at home is to reduce food waste. Food waste, a friend of mine, Christine Mosley at Full Harvest, says food waste is the stupidest problem that we have on the planet, right?

Sarah Koontz: (11:37)
It's so American.

Julia Collins: (11:37)
It's wild. And something like 40% of all the food that's grown gets wasted. And you can imagine the carbon impact of all of that wasted food. So trying to reduce your food waste, growing a little garden at home, and really making plants the foundation of your diet, those are some of my best sort of climatarian tips.

Sarah Koontz: (11:58)
Yeah. I love that word. Wait, tell us about climatarian. The first time you told me that I died laughing, but I love it.

Julia Collins: (12:04)
Yeah. Well, when I gave birth to my son, I wanted to update my relationship to food and think about how food could be not only healthy for my body, but actually create a healthy climate. And I used to think of myself as a plant-forward eater. I started to think of myself as a Planet Forward eater, and that's where the name Planet Forward came from. But a climatarian is a lifestyle choice. It's someone who makes their consumption choices in alignment with the kind of climate that they want to live in.

Sarah Koontz: (12:31)
I love it. Climatarian. That's awesome. So, so Planet Forward, you kind of, walk us through ... Like, when did you start learning all of these things and how did ... Tell us about what Planet Forward is and how all of the stuff that you were learning in your journey there kind of led you to say, "Hey, this is a solution"?

Julia Collins: (12:53)
Yeah, there was something ... And I know a lot of people have experienced this, not just as a result of becoming a parent, but any major inflection point in your life where you just decide I actually really need to rethink my relationship to just about everything. Like, why am I on the planet? What am I doing? Why am I here? And for me-

Sarah Koontz: (13:14)
The small questions.

Julia Collins: (13:14)
The small questions, right? And for me, it became very clear that I needed to take action on climate change in order to be even just a moderately responsible parent. How could I leave a world to my son that was not as healthy as the one that I grew up in? That seemed crazy. So the first thing is I just became obsessed with climate change. The second thing is my obsession led to a tremendous amount of research and listening. And then I started to actually design action maps to climate action. That seemed like a good idea. So it was first that, Sarah. I just thought, yeah, I'll create a climate-friendly food movement. And then as I researched the problem, I realized that there were big opportunities around engaging consumers and then creating reliable data. And so that's where the company has begun to build from.

Sarah Koontz: (14:02)
I love it. So tell us about the snacks.

Julia Collins: (14:05)
Oh yeah. So we're launching a brand called Moonshot. This is a snack brand. It is the first explicitly climate-friendly snack brand, meaning on the front of the pack it says climate-friendly crackers. And the reason why we're hitting it so squarely on the nose is we really want to get consumers excited about this idea that they can be climatarians, that their food choices can help tackle climate change. So we're beginning with the line of crackers that are just delicious, but they're all sourced. They're sourced from ingredients that are grown using these regenerative practices that we've been chatting about.

Julia Collins: (14:43)
We also measure the scope one, two, and three emissions associated with producing the product, offset anything that we couldn't sequester, and the product is carbon neutral. So this is a carbon-neutral food product. And what's nice for the consumer is they now get to enjoy something that's delightful and delicious while also taking action on climate change and beginning to awaken into this more climatarian kind of living.

Sarah Koontz: (15:07)
That's awesome. And I mean, I think that's so important. It's awesome. We're both investors in a company called Zero that does something similar around sort of zero waste and grocery shopping, and by something similar, I mean, it makes it easy, right? We can all ... I was road tripping the other week across some of the US and I was struck by ... It's impossible to drink water on a road trip and not buy plastic bottles of water. You can buy glass bottles, but usually they're the wrong size to actually fit in your car, right? And a car accident, seems like it's probably not great for the climate either.

Sarah Koontz: (15:47)
And so it's just crazy how hard it is to make some of these better decisions. And the thing I love about Planet Forward's crackers is that it's going to make it easy. I can buy crackers and snacks literally all day long. And if that is fighting climate change and it is now my sacred duty to snack all day long, and I'm happy to do that. So that's what I love about it is most people want to help reverse climate change, but we need the support of companies to sell us products that do that because most of us, we don't have a green thumb. We can't go back to an agrarian society where we grow our own wheat with regenerative agriculture methods and then mill ourselves, and then turn it into crackers. Maybe we'll do that during season two of COVID this winter, but most of us don't have the time.

Julia Collins: (16:44)
Yeah, no, it does need to be easy and it does need to be accessible. And that's why we started with snacks. Snacks are a $605 billion global market. Something like 94% of consumers in the United States report snacking every single day and snacks often make up the bulk of our calories. So we started with something that was so accessible. But this idea of making it easy is so important. And this is why we actually decided to create software. So the initial idea was something very simple that I would have funded myself, which is let's create a climate-friendly snack brand. But I realized it was so hard, Sarah. It was so hard even for an entrepreneur who was very focused on it. And I thought, if it's this hard for me, how is anybody going to create climate-friendly food? And what was missing was this data. And so that's why we decided to actually create a tool that makes it easy for other brands to create climate-friendly products by giving them access to data and by giving them recommendations and tactical recommendations, actionable recommendations for how to improve.

Sarah Koontz: (17:47)
So if you're watching this and you are building a food brand you're distributed in a few different ... your local sort of Whole Foods or your local specialty grocers, what does this mean for you? Right? Where our food brands are vegan, we try to be climate friendly, but hey, we don't actually know. Right? What will the platform mean for those people in terms of actually being able to figure this out?

Julia Collins: (18:17)
Yeah. I mean, the question that you asked is really important, which is how am I doing in the first place? What's my baseline. And so the first tool that we're launching with the platform is this carbon assessment tool where you can actually get, at the menu item level or the product level, a very clear understanding of your current greenhouse gas impact and some other sustainability metrics. And then the next step is to say, okay, here's how I'm doing. How do I improve? And that's where we actually connect brands to ingredients that are lower carbon to packaging materials that are lower carbon to ingredients that are also grown using better sustainability practices and just really creating a playbook so that folks can move the ball forward.

Sarah Koontz: (18:59)
That's amazing. So we had a great question come in that my might refer to farming practices that predate even indigenous, and they mentioned, are some of these practices sort of on the micro scale, especially let's say similar to sort of some of the kind of biblical edicts around plant a field every seven years. Like, was Jesus the original climatarian?

Julia Collins: (19:25)
I mean, all of this wisdom is the wisdom that existed on the planet before the Anthropocene, you know? And much of the damage that's been done from the perspective of agriculture has really been done between 1940 and today. It isn't that since the beginning of time, humans didn't know how to farm. We did and we forgot, and now we need to relearn it. So whoever answered that [crosstalk 00:19:54]-

Sarah Koontz: (19:52)
... between that and plastic, maybe World War II should have just ended the planet because we have just ... like, the innovations that followed, while totally understandable in the moment, right? Because when you think about it, and I forget, and I'm sure you know, there was for a long time, a very real fear that by this point in time, there would be mass deaths from starvation because there just wasn't enough food. And so now I think sometimes it's easy to sort of go to a big box retailer and say all these big brands are what's wrong with the world, but your GMO's, they were created because there was a real fear that we were all going to starve to death.

Julia Collins: (20:36)
That is true. The wisdom of the day said that we needed to boost yields in order to feed the world, and that if we didn't, we would have massive, massive, massive extinction from starvation. That is absolutely the wisdom of the day. But now we have new wisdom and we have to act on it. Just as swiftly and decisively as we acted during the green revolution, we need to act now. And we absolutely can.

Sarah Koontz: (20:59)
So talk about that a little bit. Like, are we all going to starve to death if we start doing regenerative agriculture?

Julia Collins: (21:06)
Absolutely not. Even with a billion more people on the planet by 2030, absolutely not. The thing that we all worry about is that if we don't implement these kinds of agricultural practices, that we will starve because of desertification. If we continue to deplete the soils beyond the point that they're farmable, then where will the food come from? And vertical farming is a solution for some segment of some populations, but will not feed the entire world in the time that we need to get it done.

Julia Collins: (21:37)
What is so beautiful about this method of farming is that healthier soil is often more productive. And the reason why I say that is a healthy soil system creates a healthy crop, which is more nutrient-dense. What's the names we see these GMO, nitrogen-riddled crops that are huge and they look beautiful and they're very big, but they're nutrient-poor and so they're actually not giving as much nutrition to the humans that are eating them.

Sarah Koontz: (22:02)
It's like the giant strawberries and the giant blue ... I am a sucker for a giant piece of produce, and then you taste them and you're like, this kind of tastes like literally nothing. But it looks good on Instagram.

Julia Collins: (22:16)
Yeah. And sometimes you might even have the experience that you're still hungry after eating something that should have been so nutritious and filling. And it's because it's nutrient-poor and it's not grown in healthy soil. So all these things are solvable. I think they're sometimes so obviously solvable that people wonder, why hasn't this already been done yet? Yeah.

Sarah Koontz: (22:36)
I love that. I'm also going to use that as an opportunity to switch gears a little bit. So you're building an amazing company, an amazing space, but you're building it also in the tech industry with venture capital. And so let's start talking a little bit about that. So what was it like to raise money for a company like this? Were you spending a lot of time ... Some investors like me tracked you down at breakfast and said, "I don't care what you're doing next, take my money." But was everyone that smart? Or how did you explain regenerative agriculture to Silicon Valley?

Julia Collins: (23:17)
Yeah, it is very much the case that most of the folks that I talked to during my seed raise, and this is back in October, really this time last year, were not as aware of regenerative agriculture as a term or the field of climate tech that was related to agriculture. A lot of folks were focused on impossible foods and some direct air carbon capture and even some aforestation and reforestation companies, but not ...

Sarah Koontz: (23:46)
Yeah. We're going to colonize Mars. We don't even need this planet anymore. It's fine.

Julia Collins: (23:50)
Right. I actually just finished raising again, and this time almost everyone that I spoke to had heard of this. And so I think there's been a huge increase in awareness around the field. For many of us, that it is often the case that when you're pitching an investor, their evaluation or their framework might not include some things that are really important to you. So if someone doesn't have a pattern to match or a framework to work with to say it makes sense to make a bet on climate tech, then that often is a pretty tough pitch.

Sarah Koontz: (24:31)
There were a lot of kind of memes that went around earlier this year during COVID season one about all these people who were like, "Oh, I buy guns to protect my country." And it's like, "No, just wear a mask. We don't actually need your guns. You just need a mask." Sometimes the most impactful thing doesn't feel as dramatic, right? Like, asteroid mining to save climate feels really important. Bombing the ecosystem to create more range feels like very, wow, Iron Man. And then you're like, "Great. I just need you to eat these crackers." So is there sometimes a cognitive dissonance for people when you're like, "No, it actually just is as simple as this?"

Julia Collins: (25:09)
Yeah. It is wild. And one of the framings that I sometimes use in meetings is to imagine that the plants are robots. You say that carbon sequestration is related to plant photosynthesis, people just sometimes fall asleep. But if you say, imagine that there's a robot, that's commercially scalable, low cost, can adapt to any environment, that can actually suck carbon out of the air and bury it in the ground. They're like, "Really? What's that robot?" And you're like, "It's a plant."

Sarah Koontz: (25:40)
I love it. It's like the memes of like, "There's a miracle drug to fight COVID. Just kidding. It's a mask. Wear it." Right. I mean, it's Ockham's razor or whatever, right? Sometimes the best solution does not necessarily involve bombing the atmosphere to cause thunderstorms.

Julia Collins: (26:01)
It is sometimes the case that an investor invests based on your idea. In my experience, it's often the case that there are so many other factors that lead to the investment decision. And so even if somebody has to come along with you on the journey toward more climate awareness, if they believe that you're a founder that can get the job done, attract capital, build a team, that your timing's right, that your solution makes sense, then sometimes you can still get those deals. And I often still get those deals.

Sarah Koontz: (26:26)
Yes, you do. That's amazing. And so somebody else asked a really interesting question. How do we get multi-billion dollar corporations, who ... I'm a Baked Wheat Thins and Cheez-It person. This isn't sponsored content, I just have trash tastes in food. How do we get those big snack companies to pay attention to this? Are they paying attention to this? Because Planet Forward, Moonshot, your snack brand is going to be amazing, but it won't be the only crackers people eat. So how do we get other people to pay attention? How do we get big pretzel to care?

Julia Collins: (27:01)
Absolutely. So the consumer piece is really huge in this area and getting consumers just as excited about climate-friendly food as they are about organic food. So that's one. The other huge forcing factor or ... If I could wave a magic wand, I'd love for every major retailer in the country, from Target, to Walmart, to Kroger, to Amazon, and everyone in between to make commitments to a certain percentage of all of their inventory being certified climate-friendly or a climate-friendly buy. When we see those two kinds of things happening in the market, then I absolutely believe that even the legacy food companies will catch up. We do see [inaudible 00:27:42] at General Mills and Known and Unilever, so I don't mean to say that there isn't already a groundswell happening, but we need for everyone to get on board.

Sarah Koontz: (27:51)
Yeah. Yeah. I mean, if you've looked at the variety, the mind-blowing variety of Doritos lately, it is clear that if consumers will buy it, they will make it for us. So I agree. That's awesome. So talk to me a little bit about fundraising in general. You are a black woman who's raised more money than any other black woman almost combined for your last company, and then now you're doing it again with this company. And so obviously the fundraising landscape for women, for people of color in our industry is not what it should be. But what are you seeing? How has this year kind of made you more hopeful, less hopeful? Is it all the same? What's going on?

Julia Collins: (28:46)
So when I put my investor hat on, I'm much more hopeful. I have the privilege of being a scout for Cleo Capital, as you know. Before I joined your program, I did a little bit of angel investing on my side. When I look at the incredible founders that are coming up right now, the deals that come across my desk ... my laptop, I don't have a desk. The ecosystem of BIPOC founders, female founders, intersectional founders is I think stronger than it has ever been. There's so many more venture-backable, highly scalable companies coming up right now. So with my investor hat on, I'm highly optimistic.

Julia Collins: (29:32)
Then I put my founder hat on and I heard so much talk around funds making big commitment commitments to wiring and hiring, but I'm not sure as we close the end of 2020 that many funds have made that commitment. I think there are many that have, but many more still that need to catch up or should catch up, or I hope will catch up. I haven't seen the data from this year, but coming into the year, it was something like less than 0.2% of all venture activity was related to founders who identify as black and female. 0.2, so almost zero. And so I just continue to beat the drum of asking the venture community to do the same thing that you're doing with your fund and so many of my investors are doing, which is to actually support BIPOC and female founders by investing in them, not create [inaudible 00:30:33] for them, but by actually investing in them.

Sarah Koontz: (30:34)
Yeah. Yeah. I was sitting with a very well-known female billionaire once who does stuff in this space. And she was like, "Do you need mentorship?" I was like, "No, I need money." And she's like, "Do you need education?" I was like, "No, I need money. I need money." You'd be shocked at how hard it is to pay your rent with mentorship. It's that? So make the wires, then the hire is our friend, Tiffany Bell says. That's awesome. So tell me a little bit about some of the companies you've invested in. I mean, I know, but tell everybody else.

Julia Collins: (31:03)
Well, we talked a little bit about Zero, this incredible online plastic-free grocery store. Just imagine as a result of the success of this company what impact will be able to have if everyone in the world had access to their groceries with zero plastic. [Asaleka Strazia 00:31:24], the founder, she is an absolute force of nature and just incredibly gifted. And so that is one of the companies that I'm tremendously excited about.

Julia Collins: (31:37)
There's another incredible company called Hamama, which is all about growing food at home. And the novel approach that Hamama took was actually to create technology and IP around a home garden. This is this genius team coming out of MIT led by Camille Richmond, who actually created a patented technology for a seed quilt, something that you could put in your house and you water it once, and all of the sudden, micro greens pop up and now they're expanding into scallions. And I love ... I mean, first of all, the business is growing like crazy and it's so well run, but the idea that we could engage consumers in this idea of growing food, health food at home, I think is incredibly powerful.

Sarah Koontz: (32:18)
Yeah, I am so bad at growing my own things, even though I'm obsessed with the idea. My mom's an amazing gardener and Hamama sent me some of their seed quilts and even I managed to do it. And the joke I always make about that is it really is kind of like a Chia Pet. You just put the seeds on and water it and it grows. And so if you had a Chia Pet growing up, you've already practiced in-home gardening.

Julia Collins: (32:48)
Yeah. I think it's actually impossible to not grow food using their system. So-

Sarah Koontz: (32:56)
One time it didn't grow, but it was because I didn't follow the directions and I didn't add the right amount of water. Another time I let it grow too long and it just kept growing and growing because I was traveling. But those are user errors because I'm really, really bad at it, but I still got some great micro greens to go on my salads. And it was so easy, and it's sort of a gateway drug where now I'm moving outside of the city of San Francisco, and I'm looking at my little backyard and I'm like on Next Door trying to find a gardener who can grow me kale. We'll see how it goes. Yeah.

Julia Collins: (33:30)
Well, let me know if you need help.

Sarah Koontz: (33:32)
Regeneratively. Thank you so much for joining us today with Julia Collins for our SALT Talk. We're here pretty frequently, and we're super excited to have you come hear from some of the top thinkers, investors, and people around the world. Special thank you to John, Anthony, and the team at SkyBridge. And we'll see you soon.

Women's Wellness | SALT Talks #119

“Our mission and vision is to build a brand that makes women's health a lot less lonely and a lot less confusing.”

Jordan Gaspar is the Managing Partner of AF Ventures, a venture capital firm investing in high-growth consumer product companies. Jordana Kier is the co-founder of LOLA, the first lifelong brand for her body. Created for women, by women who have been there too, LOLA aims to address every reproductive life stage with a commitment to product transparency and a community built on candid dialogue about all of the things we don’t openly talk about.

The female monthly reproductive cycle has been very reactive and left women vulnerable. There simply was not a space for women to talk and engage with one another around this major part of their lives. This led to a holistic company that provided not only a supportive and open community, but a full suite of products to service those needs. This has sparked greater engagement among women who are becoming more conscious about their consumer choices when it comes to their body. “You're talking about products that a woman may use for up to 40 years of her life, why aren't there long-term studies about the different ingredients that might go into these products?”

LISTEN AND SUBSCRIBE

SPEAKER

Jordan Gaspar.jpeg

Jordana Kier

Co-Founder

LOLA

MODERATOR

Jordan Gaspar2.jpeg

Jordan Gaspar

President & Managing Partner

AF Ventures

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello everyone and welcome back to SALT Talks. My name is John Darsie, I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy. SALT Talks are a digital interview series that we started during this work from home period with leading investors, creators, and thinkers. What we're trying to do on SALT Talks is replicate the experience that we provide at our global conferences, the SALT Conference, which we host twice annually, one in the United States and one internationally, most recently in Abu Dhabi in 2019.

John Darsie: (00:43)
What we're trying to do at those conferences and on these talks is provide a window into the mind of subject matter experts as well as provide a platform for what we think are big ideas that are shaping the future. We're very excited today to welcome Jordan Gaspar and Jordana Kier to SALT Talks.

John Darsie: (01:01)
Jordan Gaspar is the managing partner of AF Ventures, which is a venture capital firm investing in high growth consumer product companies. Launched in 2014, AF Ventures manages 35 plus portfolio brands across a wide array of consumer brands in food and beverage, beauty and personal care, health and wellness, and pets. Hopefully we don't have any pets interrupting our broadcast here today, but if they do we'll embrace it and keep rolling. Prior to founding AF Ventures, Jordan was an attorney at Morrison Cohen LLP, where she advised venture and private equity firms and their portfolio companies on acquisitions, sales, mergers, and financings. Jordan graduated from Columbia College and received her JD from Fordham Law School in New York.

John Darsie: (01:49)
Jordana Kier is the co-founder of LOLA, which is the first lifelong brand for her body. Before co-founding LOLA, Jordana received her MBA from Columbia Business School, during which she worked at Rent The Runway and Quidsi, not to be confused with Quibi, which is the media company that failed miserably. She graduated from Dartmouth College in 2008 and was named to Forbes 30 Under 30 in 2016 and Crain's 40 Under 40 in 2019. Jordana also serves on the Dartmouth Entrepreneurial Network advisory board.

John Darsie: (02:24)
Just a reminder, if you have any questions during today's talk for Jordan or Jordana you can enter them in the Q&A box at the bottom of your video screen on Zoom, and now I'm going to turn it over to Jordan to host the interview.

Jordan Gaspar: (02:37)
Thank you, John. Really appreciate you and SALT having us today. I'm looking forward to speaking with everyone.

John Darsie: (02:43)
Great to have you. Absolutely.

Jordan Gaspar: (02:44)
So hi everybody. Excuse me in advance if I have any kids kind of bump into the picture. We'll do our best in this sort of new medium. I'm Jordan Gaspar, a managing partner of AF Ventures. As John explained, we're a venture fund that invests in high growth consumer brands. We see ourselves as having a unique model in that we offer a proprietary set of resources and a real hands-on approach to working with our teams across domain experience, in financial construction, marketing techniques, distribution and supply chain. Within that we, unlike your typical venture fund where it's a wide model, we do have a wide portfolio but it does involve taking an active approach to offer change and help support our founders and advocate for them in particular in ways such as this.

Jordan Gaspar: (03:36)
With over 100 million under management we've got over 35 brands in the portfolio that really do span primarily food and beverage, which was our bread and butter, no pun intended. Of the 39 active portfolio companies, 36 of them are food and beverage, but we recently expanded right before COVID in February into the new verticals of personal care, pet, beauty and wellness, and we are super excited because Jordana and LOLA are our pilot investment in personal care.

Jordan Gaspar: (04:06)
So with that, I'll have Jordana introduce herself and tell you a little bit about LOLA, which we're really excited to support.

Jordana Kier: (04:13)
Thank you Jordan, and thank you John and SALT for having us here. It's wonderful to share our stories. As Jordan mentioned and John too, LOLA is the first lifelong brand for a woman's body for reproductive health. Our aim is to provide the transparent products, the transparent content and a supportive community that we think women deserve for their entire reproductive life cycle. Initially when we launched the business it was really about changing the way women thought about, purchased, and received, and also talked about their feminine care products.

Jordana Kier: (04:54)
So the first three years of the business it was really about reinventing that experience, finding a lot of opportunity to improve this very reactive, very vulnerable journey that many women go through on a monthly basis. That let us to eventually developing our own IP, building our own manufacturing machine, developing our own content conversation as well as a platform for women to really engage and feel very informed as they go through their reproductive journeys.

Jordana Kier: (05:27)
We then set our sites on category expansion into sexual wellness to continue to deliver this very holistic approach to the resources that we believe women deserve for their reproductive journey. So obviously products but also expert advice, and eventually also expanded into brick-and-mortar retail with our launch into Walmart, full chain, in March of this year. So sort of tapping into that, the offerings that we provide, also making sure that this omnichannel access is something that she knows she can rely on LOLA for.

Jordana Kier: (06:06)
Our mission and vision is really just to build a brand that makes women's health a lot less lonely and a lot less confusing. We just continued a plan to expand our product portfolio, both physical and digital, with women's needs in mind, made by women, and ensuring that again, these products are available, however she wants to shop. So whether that's online, whether that's on shelf, especially in this moment in time when a lot of our purchasing behaviors are changing by the day. Really also in addition to that, and well, I think we'll get into this a little later, but wanting to make sure that we are sparking conversation that drives also policy change and really systemic change to ensure that we are improving women's lives for the better.

Jordan Gaspar: (07:01)
Thank you for that introduction. As longstanding investors in food and beverage, we see COVID as a big marker of change in the consumer landscape across the board. I'd say that we've seen the common notion that we've been investing in, that food is health, where we were investing in functional products, functional beverages, grain free foods, natural stress relievers like adaptogens. That's really evolved into more broadly products as health, and so with a blurring of the categories between food and personal care, and beauty, and the emergence of categories like ingestible beauty for the first time. There really is almost this convergence of multiple categories that used to operate in their silos that are really focused on general wellbeing, and people taking care of their bodies from within.

Jordan Gaspar: (07:53)
So I'd love if you wouldn't mind sharing a little bit about your perspective on how the natural personal care space is evolving and the rapid category growth that's been undergoing in the past couple of years, but even particularly this past year.

Jordana Kier: (08:05)
Yeah, I mean, even when we started the business in 2015 we, myself, my co-founder, we never thought about feminine care, personal care as part of an overall wellness routine, right? You think of wellness, you think of beauty, you think of pampering, right? But there's also these categories, food, personal care, that are sort of almost the foundations upon which we build great habits, and good hygiene, and yet these are things that are typically or historically have been very reactive categories.

Jordana Kier: (08:43)
When you think about the fact that a woman uses over 11,000 tampons in her lifetime but the FDA doesn't require companies to provide a comprehensive list of ingredients on the back of the box, and then sort of layer on top of that the historical stigma around these topics in general and how they're not really spoken about. That gave us an enormous opportunity to drive a conversation and to marry these categories with proactive wellness care, because I mean, even for myself it felt kind of almost like an awakening, where I was like, "Why aren't I thinking about these things?" I know I'm going to get my period every month, I know I'm going to need these products. I've been relying on my historical knowledge or my mom, my sister, my older cousin who I trust, so I just use what is put in front of me because as a 12, 13-year-old girl you're very impressionable and it's a vulnerable moment. To step back from that and say, "Wait a minute, we actually think it's important to know what we're putting in and around our bodies, particularly in this category." That was a really important moment for us and for every one of our customers.

Jordana Kier: (10:07)
The way we see it, there's really three main issues in our space. Is one, this lack of consumer awareness. It's a lack of incentive by brands to be fully transparent. Then a lack of public support to study these categories and keep companies accountable. I mean, when you're talking about products that a woman may use for up to 40 years of her life, why aren't there long-term studies about the different ingredients that might go into these products? So luckily, and especially in this year, all of the trends are pointing to a really positive change in all of these three issues that we've identified. We're seeing that in the naturals category. It's significantly outpacing synthetics in the feminine care space and significantly outpacing the options.

Jordana Kier: (11:04)
So you have kind of both a real growth of emerging brands, which is wonderful, it drives a broader conversation and helps to validate our hypothesis back in 2015, but then you also have the actual interest from consumers really putting their money where their mouth is. So we're just super excited and thrilled that the conversation is really changing at all angles, whether it's consumer behavior or it's policy, or even just the way that big businesses are thinking about changing their models.

Jordana Kier: (11:47)
When we launched in Walmart in March we have over time done a lot of really wonderful surveys to understand the changing in behaviors, particularly in this year when all of our lives have sort of been thrown upside down. A really interesting nugget is that 29% of Walmart feminine care shoppers told us that they're more likely to use natural feminine care products than they were pre-COVID, and 51% of women wish retailers would offer a better selection of natural feminine care. So we're not just seeing this in, again, the new brands that are coming online, but also the fact that purchasers and shoppers are actively looking for a change in this category.

Jordan Gaspar: (12:35)
We couldn't agree more, and I think that COVID itself is going to be a big marker for what the consumer's expectations are going to be of the brands that they start to consume. When we look at scaling consumer brands, we've always said that part of the rise of them is about money, manufacturing, and manpower. Through COVID I'd say that it's definitely been exacerbated by what our supply chain challenges, and financial challenges. So we see a post-COVID world that really does prioritize first and foremost supply chain, right? It's been something that the consumer has become extremely aware of, is where are the products coming from, how do they get to my door, what are they made of, and sort of this widespread technology adoption is going to be something that really does improve our industry. But beyond that, I think a lot of consumers are now becoming even more open-minded to sustainable practices, because you think about how much garbage we're all consuming in our homes that we weren't as aware of before. So sustainability, transparency, these are things that people are now living with on a day-to-day basis.

Jordan Gaspar: (13:40)
Then obviously making sure that there's just basic organization on the supply chain. I think that the consumer has become aware that a supply chain does exist that brings their products to their home. From a venture perspective we did see a shift in the space through COVID in terms of the financial construction of growth stage companies. Whereas there were certainly a lot of unprofitable businesses going into COVID. COVID definitely raised the awareness of founders in our space of profitability and how important it was to be self-sustaining and not relying on capital markets, and not expect that there's going to be the next raise ahead of them.

Jordan Gaspar: (14:18)
Early on in COVID I'd say almost our entire portfolio recut their budgets in March and April and really thought through what are our union economics, how can we optimize our partnerships, our supplier relationships, but how also can we build a more scalable, profitable business. So we've been saying that for the past eight, nine months that we're going to see a lot more profitable businesses come through COVID, and I think that that's certainly come to fruition.

Jordan Gaspar: (14:44)
Then beyond that, LOLA is also a perfect example of what is now an increasing prioritization of the omnichannel distribution strategy. As historical food and beverage investors, I'd say that we've seen that D2C and sort of digitally native brands were something that was really difficult and challenging for refrigerated and frozen foods and something that would probably be much easier in the personal care space, but it's now all of a sudden the food and beverage space has realized that it's really important to be omni and to offer an ability for consumers to be able to acquire products at their doorstep. So a lot of the concepts that the digitally native brands have thinking through their super fans, and marketing online and through social media channels are something that a lot of food businesses are rethinking, and vice versa, a lot of digitally native brands like LOLA have now had the ability to launch into brick-and-mortar retail. So there's a convergence really of the construction of a lot of consumer companies.

Jordan Gaspar: (15:45)
So, I'd love to hear a little bit, if you wouldn't mind telling us, about your D2C business and then of course the amazing expansion into Walmart this year.

Jordana Kier: (15:54)
I think for us, I mean, D2C can be such an important channel for a brand to build and grow business, but we see D2C as a channel, it's not a business. It is one way that you can reach our customers. For us it's been a vital channel because we've been able to allow her to feel seen and heard, particularly in these categories because reproductive care can be such an isolating and vulnerable journey, and allowing women the opportunity to connect with a brand directly and share what they're thinking, what they're feeling, what they think is missing in these categories. That's new, that's empowering in a way that we haven't seen historically in this category. But again, it's channel, it's not a business, and that's where I think this sort of cutting out the middle man type of approach and just sort of having that be the foundation upon which your business is built, that's a harder message I think to continue to have ... It's a harder message to have staying power as you expand into new channels because what we want to do, what we want to build is a household brand. If we want to be there for her every step of the way however she needs us, we can't just be available in one place. We have to be available in any place she wants to shop.

Jordana Kier: (17:28)
It's definitely been exciting to see this wave of brands really challenging the old guard and bringing new innovative products and services to light, to market, but I think some will be grappling with the challenges of building a brand that can last for the next 50 to 100 years. We feel very confident that by starting with D2C and by enabling that one-to-one connection and building that trust and authenticity, that just gives us a real leg up on some of these big incumbents who say they may know exactly what women want, but I think when you actually are connecting and having these very intimate one-to-one conversations, whether it's through email, whether it's through phone, whether it's through direct messages on social platforms, that's really how you get to the crux of what it is that's missing in these categories, whether it's product, whether it's experience.

Jordana Kier: (18:32)
I think COVID obviously has changed a lot of the way that we thought about our business and building it. Certainly thinking a lot more about growth in the right ways, and really being prudent about that. As a basically subscription business, because your period is basically the one thing you can't cancel every month, we're in a fairly inelastic category. So we're not one that would see a real major impact as a result of a pandemic. We're high growth, we're healthy in this environment, and frankly in any environment because we're providing customers with a long-term solution in a product category where they previously just didn't have that option. I think that goes for so many of your portfolio companies as well, where people aren't necessarily making a temporal change because they're home, they're making these structural changes to their lives and what they want to consume because they're sort of more awakened to the elements around them.

Jordana Kier: (19:42)
Obviously our customers' routines have dramatically shifted, so our focus has really been on maintaining that high touch customer experience and adapting to needs in real time. So whether that's flexibility around shipping, whether that's also partnering with Walmart to drive more digital resources. If they're shopping in the aisle we have QR codes in our fixtures in the aisle where you can actually obviously be interacting with the product in the store but also then get access to content on your phone. We're pivoting a lot of our community engagement strategy to be fully digital, including posting a weekly parent support group at home and then providing also a lot of really wonderful digital resources via our online hub, The Spot.

Jordana Kier: (20:30)
We've also introduced the LOLA Collective, which is a new hub for women's health and really bringing together a forward-thinking group of trusted reproductive health experts, advocates, educators, really making sure that people can find answers even easier than ever. I think we all I think are in this moment in time where the casual conversations that you may have in passing, whether with a friend, whether at the office, that's lacking now. So those moments where it might be an opportune time to ask or share a personal story, it's harder now, it's more difficult. So we are living more isolating, more vulnerable lives. Again, reproductive health is already an isolating or can already be an isolating journey. So our mission is to continue to build on what we had been building pre-COVID to ensure that she just continues to feel really supported.

Jordana Kier: (21:37)
As I mentioned, this March we launched full chain with Walmart, which was just really thrilling. I mean, we had been working on the launch for over a year at that point, and just have felt so supported and thrilled to find a retail partner who really shares in our mission, and making periods better through tested products, through reliable resources, with a really convenient and innovative shopping experience. I mean, when you think about kind of the footprint of Walmart maybe feminine care is not the first thing that comes to mind, but the fact is that the majority of US women shop at Walmart and half of whom are shopping exclusively for their feminine care products at the retailer. So that was really such an important data point for us because if we want to be driving transparent products, candid content, and also omnichannel access, what better initial retailer partner to launch with to really ensure that, especially in this moment in time, we're there for her when she needs us.

Jordana Kier: (22:46)
I also think it's important to look back at our D2C heritage and say there really is value in that channel and there's insight that we could bring to the retailer. That is something that Walmart has been so wonderful in terms of just being receptive to hearing us out and hearing the types of insights that we have on her behavior in this category. So a really exciting data point that we brought to them was 72% of our customers on our D2C channel don't just buy a single absorbency of product, and there's really no common, there's not a most common pack. In fact, most women are kind of going off of the default on our site. So we really worked with them to come up with an innovative solution to ensure that what we brought to the shelf still had some of that customization, that convenience magic. We were the first brand to cross merchandise tampons, pads, and liners, which with a partner like Walmart is really no small feat when it comes to execution.

Jordana Kier: (23:56)
As we look ahead too we're obviously prioritizing multiple shopping channels, being very ... What's the word? Sorry. Really making sure that we're looking into the data and understanding how her shopping behaviors are changing, what she's looking for on the shelf. So whether that's through our collaboration with Walmart, whether that's through maintaining and innovating on our D2C channel among others, we just want to continue to drive better solutions across the entire reproductive health category.

Jordana Kier: (24:30)
We did actually also launch family planning, which is what Walmart calls our sexual and intimate wellness business in September, so it's been kind of an incredible year for us as far as really trying to solidify our presence on the shelf in not just one but now two categories. Really through our omnichannel approach the goal is again just to provide customers with that accessibility so they're never caught unprepared, or we're there for her wherever she is, again, regardless of the channel. We're really laser focused on making sure that especially in this moment in time too where, again, shopping behaviors are changing, we're showing up where she needs us and where she's most comfortable.

Jordan Gaspar: (25:16)
It's been an unbelievable year watching not one, but two line extension launches for you guys. So a congratulations on that. I think that it's important for people to also understand how unprecedented this past year was in terms of for founders to even navigate this climate.

Jordan Gaspar: (25:32)
We ourselves are, we joke we're a startup fund for startups, and so we launched our business in January 2014 and really grew from what was a $4 million fund into where we are now. I look at this past eight or nine months, and we felt a lot of conviction around getting back to our own roots with our COVID response. So in this period of time, launching into retail is in itself always challenging on the scale that you did, but to do it during the surge is something that people have to really give you guys credit for. To give everyone context for that, back in March the retailers, as you guys all remember from a consumer perspective, got wiped out. All the products got pulled off the shelves. So all of these businesses that are coming to the market had to very quickly adapt.

Jordan Gaspar: (26:20)
So, if you look at we always want to invest in founders who are resilient and resourceful and relentless. We also now want them to be adaptive, and nimble, and be able to make very strong executional changes every quickly. That's something that was a big part of a hallmark of sort of launching in Walmart, is how did LOLA have to quickly pivot and respond to what was basically a complete overhaul of how consumers were shopping and all the expectations they had going in. So you guys did an amazing job with that.

Jordan Gaspar: (26:50)
For us, we had the privilege of seeing 39 companies navigate that, and that's been an amazing thing to see all the founders across categories, different verticals, different areas in the consumer space, some that are digitally native, some that are in brick-and-mortar, almost all nationwide, for the exception the ones that are just sort of D2C. What we did during COVID was starting in early March. We started having programming, where every day we would have town halls across the different areas that we could support our brands. If you think about things like, obviously I've spoken about the supply chain, but also what's happening real time at Walmart. Can we get the distributors in our spaces to host a seminar? Having prominent redistributors kind of post a seminar of logistics challenges and how to navigate working with organizations like Tag Logistics or with Dot Foods. Beyond that, the founders in our portfolio all had such an amazing community in that they got to work together. So on these daily town halls we'd have over 30 of our founders sharing notes and swapping ideas and discussing very real time distribution challenges and opportunities.

Jordan Gaspar: (28:04)
So one thing that we did encourage our brands to do is to work with the retail buyers in the way that LOLA does, and say, "Hey, you have product that just got wiped off your shelf, well, we have plenty of inventory for you. Please come to us as a first opportunity when you're thinking about how to fill your shelf space." There really was an amazing amount of distribution that came out of kind of generating that conviction and confidence from the buyers that a brand was able to deliver. To deliver on 4,600 Walmart stores during a pandemic as a launch was pretty impressive. So a big credit to the team and all the work they did.

Jordan Gaspar: (28:41)
I think that beyond that, there were a couple of other things that during COVID people have spoken a lot about but that behind the scenes we were all working very closely, how to navigate PPP, and that's obviously something that there's been a lot of emphasis on with everybody but in the sort of venture community in particular.

Jordan Gaspar: (29:02)
Then we've started to really see on the other side of kind of what is now eight or nine sustained months of people working from home. What is the EQ side of this? How can we support our teams differently than what we used to? So if the boardrooms were historically primarily going through the numbers, going through the manufacturing, going through marketing opportunities. We're actually starting to spend a lot of time with the boards that we work with our companies, talking to our founders about how can we support our entrepreneurs and how can they support their teams. It's not just about products as wellness, but it's also about taking care of the people who are building the companies.

Jordan Gaspar: (29:39)
So I think it's become a very comfortable place that a lot of natural products companies are starting to feel very comfortable saying what are the practices we're going to do to support our team during this time? What are the conversations we're going to have? How is it that we can be mindful of being a good employer? Because I think that coming out of this beyond just the products that we're ingesting and putting in our bodies is going to be a focus on people as a whole, and thinking through how can we be more human, how can we have more intention, how can we be thinking not just about sort of business fundamentals, but that if we have teams that are operating and working well together, how we can support them to grow and ultimately become better quality businesses to invest in.

Jordan Gaspar: (30:22)
So I'd love to hear you talk a little bit about kind of being ... We're a women-owned fund, so we share that, and I think that obviously as a women-owned company, a women run company, there's sort of specific challenges. I think that LOLA has such a unique culture in terms of how you encourage your team and how you work with your team, but even how you think about family planning and things like that. So I'd love to hear a little bit more about kind of how you guys view building your internal community.

Jordana Kier: (30:49)
Yeah. It's such a good question. I mean, when we started the business and through today, I mean, it continues to be an incredibly mission-driven organization. So when you have a year like we've had, that commitment to that mission doesn't waiver, but I think it's just so much more important to reinforce, and particularly too when you're not in the office, when you're not sort of having those casual conversations again and sort of consistently reinforcing kind of why we're all here and what we're all doing, and why it's important to continue to work incredibly hard. You lose some of that when you're home and all separated.

Jordana Kier: (31:40)
I think my co-founder Alex and I have both now got through our own reproductive journeys, had kids, et cetera. So, I think sort of to set that example as two founders and really sort of having women at the forefront of companies, and having them be the decision makers that address our reproductive and sexual health, leading the product innovation for such incredibly personal and intimate products. That is something that I think we're very proud of in terms of infusing our own stories, our own happy stories, painful stories. Just ensuring that our customers and our team see us as openly and authentically as we see ourselves and sort of just two women who found a problem that they wanted to solve. We both shared our own first period stories with the world it seems to spark a very candid dialogue. I think it starts from the top and then it sort of goes through the entire organization. It's infused in our values in terms of speaking up, and showing up, and being the voice for ourselves, for our company, for our peers, for our customers, and really never kind of settling on an answer that doesn't get to the root of a problem. I think that goes for both the subject matters that we work with, and work on, and work to improve, as well as just how we operate our business on a daily basis.

Jordana Kier: (33:23)
I think raising money has obviously been a really interesting journey for us. I think it's mostly been pitching to male investors, and I think that really opened our eyes to this information gap that truly does exist around women's reproductive health. We found ourselves kind of walking male investors through I think it was called a vagina's 101, like [inaudible 00:33:49] of just you get your period and then you're thinking about becoming sexually active, and maybe you run into the drugstore and you don't really know what you need, or you're embarrassed and you text your partner because they're going to be on their way home and you need something that they can pick up, and what is that conversation like. Just sort of [crosstalk 00:34:10].

Jordan Gaspar: (34:09)
They don't know where to buy tampons.

Jordana Kier: (34:11)
Exactly, right.

Jordan Gaspar: (34:14)
I mean, I like that-

Jordana Kier: (34:14)
[inaudible 00:34:14] is really where it, it's where it's at.

Jordan Gaspar: (34:17)
Where are consumers even buying these products?

Jordana Kier: (34:20)
Exactly. But I think it really started with telling kind of that whole story and doing it in a way that also invited conversation again. Our brand has never been about being scare tactiquy or sort of pointing fingers and saying, "You're putting poison in your body." Because that doesn't drive a productive and positive relationship, and that's something that we want to have with each of our customers, each of our teammates, et cetera. So really shaping that story and also finding opportunities too to where are there analogies where men could understand sort of what using a tampon might translate for them. So food is actually a really great analogy that we consistently used to tell the story and really present ourselves as domain experts. We were so encouraged to find that a real diverse group of investors were extremely receptive to the business, to the opportunity at hand. They understood the market potential, they understood the need for greater transparency because whether they were close with their sister growing up, whether they had a daughter, or whether the food analogy and story stuck with them. It really just took kind of every single approach to ensure that the story could really resonate.

Jordana Kier: (35:53)
We're just very proud to have a group of people around us who actively want to play a role in destigmatizing these aspects of reproductive health and educating women, educating men, having those open conversations and all of the things we don't openly talk about because these are not topics that should be only talked about with one subset of a population. That's not where we will get to the root of driving change.

Jordana Kier: (36:24)
I think there has been a real sort of exposing of kind of taking a step back and saying, "How are women's topics and how are women sort of playing a role in the purchasing decisions for their household, and are those brands actually speaking to that consumer?" I think globally to see that women were making up 80% of purchasing decisions in the household.

Jordan Gaspar: (37:01)
Trillions of dollars.

Jordana Kier: (37:03)
Trillions of dollars, right? Last I saw it was like somewhere almost in $32 trillion in consumer spending per year, right? The idea that it may not be women either behind those brands or helping to shape the strategy of those brands, or helping to fund those brands, that's a real opportunity to ensure that when I go into a store or when somebody else goes into a store I'm looking at a shelf and I'm feeling like I'm being heard. I think there's really, this again goes back to our D2C roots, I think because we were able to foster this really candid conversation with a grassroots community and really sourcing that honest feedback from customers, sourcing honest feedback from our team about the pain points that they experience in the category, infusing our own personal stories. It really helps to deliver on that competitive advantage and delivering that product improvement, that innovation that we want, that customers want, and really also offering that peace of mind too with sort of ensuring that we'll always be transparent with ingredients, we're always going to make sure we're kind of going above and beyond in terms of quality testing.

Jordana Kier: (38:22)
Not just saying like, "Our in-house people did it." But actually putting it to the test with third parties. It's not cheap, but it's really important that we do that and we go the extra mile and we put the ingredients on our box because we know that as our own consumers we would expect the same thing. So that has really been I think a really proud moment for us to just continue to know that they way that we developed our brand and our ethos five years ago still remains really strong and really resonant with our growing community.

Jordana Kier: (39:00)
I think specifically too with COVID, making sure that we can continue to provide access to resources and support across our digital platforms, support in store remains more crucial than ever. Over half of women surveyed by us said they turn to Google first to find answers to their questions, but only 4% felt supported and only 8% felt informed when reflecting on their menstrual cycle. So to me it's where can we play a role and continue to play a role and really step in as that expert, as that ally as she is going through her whole journey at whatever point she might be in, right? Whether it's a young girl figuring out kind of what's happening to her body, which we developed a first period kit, which we're very proud of, or a sexual wellness kit.

Jordan Gaspar: (39:55)
You guys have us the opportunity in our house to talk about periods for the first time, right?

Jordana Kier: (40:00)
Exactly, I mean.

Jordan Gaspar: (40:00)
So I say all the time, and I've said this to you, that being a venture investors one of the things that I really do love is as a working mother, and you're one as well, we unfortunately travel a lot, or we did before the pandemic, and you don't always get to have this sort of direct experience that you want to in terms of ... Just it's harder. It's a balancing act that we all are doing. So for me, investing in young brands gives me the opportunity to talk about things in my home that I normally wouldn't. So I joke that we invested in a sustainable water business, and so it gave my household many, many months to talk about sustainability and packaging. So with you, I don't know if you remember, but it was the first time that I actually had conversations with my daughter about her period, and I really thought and relived the experience of when we were young your whole education came through your mother of through books, and then you became a consumer of a brand of Tampax, or tampons I should say, or sanitary napkins because somebody handed you the box and you became a lifelong consumer. So you were really the first person who encouraged and taught me about how you can build community and really evolve the conversation.

Jordan Gaspar: (41:16)
So I've been so impressed with how you guys have done that more broadly, and I'm sure during COVID in a time when access to information has been really challenged, your community has definitely benefited from all of those I'd say educational resources that you guys really had instilled in the brand from day one.

Jordana Kier: (41:33)
Thank you. I think when we first started the brand we did a lot of focus groups. The first five minutes, I've told you this story probably millions of times, but the first five minutes people showed up and they're like, "Why am I here? What am I doing at this weird thing where I'm going to talk about something that I've never talked about openly with a bunch of strangers?" And cut to like three, four hours later when we're trying to kick everybody out, but if somebody wants to tell that one other story about this really embarrassing moment that they couldn't imagine anybody else having gone through, but three other people in the room, they're like, "Of course I've gone through that same thing." And to be able to be that conduit to connection and being able to say like, "These are topics that we should be talking about." We shouldn't feel embarrassed. We shouldn't feel like we have to shove a tampon up our sleeve when we walk to the bathroom in an office, and when 50% of the people there are probably either on their period in that moment or get their period more generally.

Jordana Kier: (42:41)
How can we start to break some of these barriers? I think it does start at home, it starts with an open conversation. It starts with not just a mother having a conversation with her daughter, but including her son, or having the father figure there, right? So really making sure that it does continue to grow and remain kind of more as inclusive as we possibly can be, because that's the only way we'll actually kind of chip away at some of the stigma that does exist in these categories.

Jordan Gaspar: (43:13)
100%. Yeah, I'm looking at the Q&A, and so I want to encourage anybody that if you guys have questions, definitely feel free to jump in them. I see one though that's asking about how men can be more supportive in general periods, and I can't speak for you, but I would say that first and foremost it's about not weaponizing your period. It's about understanding that there is a culture where there was to be an open discussion, as Jordana just spoke about in terms of educating not just our daughters but our sons, and reprogramming in some cases generations of men that there is no shame in taking care of your body as a woman. This is a reality that's every month part of our lives. So I think that where historical brands have definitely been made available to the female consumer, what LOLA's done, which has been to normalize the experience for young women. It's now going to carry through beyond period care but into sexual wellness.

Jordan Gaspar: (44:11)
We've seen a huge I say surge in companies that are launching and in platforms in the sexual wellness space, and we spoke to Jordana and said, "You guys have an amazing platform already, we're excited to see you continue to get behind that as an extension of period care." Just because there is so much opportunity in also having conversations about sexual education for young women, right? And that this isn't something that women should be ashamed about protecting themselves. So I'd love to hear a little bit also your perception of how your brand is extending beyond period care and kind of how you see advocacy across the board in terms of all the various sort of experiences that a woman can have.

Jordana Kier: (44:53)
Yeah. I think again, the real insight that we tapped into was that we were all going through individually these journeys when there's so much power and so much positivity and potential for change if you're talking about these things openly and inviting new folks in for their perspective, and that's how you get to innovation. That's how you get to improvement, that's how you get to policy change, institutional change.

Jordana Kier: (45:31)
I think sex is ... I mean, periods I think is definitely we want to invite kind of everybody into the conversation. Sex is generally already kind of where there are more folks in the conversation, and when we decided we wanted to continue to expand and extend the brand into building for this reproductive journey from what we say from her first period to her last hot flash and beyond. Sex is really that category where you're not just talking to one person, you're talking to more than one person. From a packaging perspective, from a information and content perspective, from even a kind of overall umbrella branding perspective it was really that moment when we said, "We have to change, we have to grow up."

Jordana Kier: (46:25)
We have to change a little bit of the way that we've been talking about these topics, even the palette should become a little more mature in terms of how we want to present ourselves to the world because we're no longer talking to just the subset of people who get their periods, but actually we're talking of the whole population and we want to be a brand that is not just a sexual wellness brand for women, but also for men. So that was really an exciting moment for us, and I think particularly too with content. There's so much, there's misinformation out there, there's not a lot of kind of empowerment toward women. There's just a lot of assumptions I think that these particularly young people have around sexual wellness, kind of intimate wellness. So we see it as an amazing opportunity to start to change that tone of the conversation again but through very similar tactics that we've always employed, which is inviting that conversation, inviting questions that you may have about sex and making it a totally non-judgemental supportive atmosphere. Only then when you are kind of really opening up and listening to sort of anybody who's coming into the room can you actually start to change the way that people may think about these categories and approach conversations with their partners as well.

Jordan Gaspar: (48:06)
This was a pretty interesting week that you and I were texting about a big policy change overseas in terms of period care and women's health. Do you want to maybe ... We talk about policy as part of this whole community, it would be an interesting thing to kind of maybe raise awareness about it here if people hadn't seen the news.

Jordana Kier: (48:27)
Yeah. I mean, Scotland just became, for those not up to date on their period news, Scotland became the first country to make period products free for all, particularly for people who can't afford them, which is such a promising step forward for menstrual equity and a practice we really do hope to see adopted more widely. Fighting for menstrual equity, increasing access to period products are issues that are at the center of our mission and are so critical to lifting that very detrimental stigma against women's health that still exists in this country.

Jordana Kier: (49:02)
I mean, we've been very fortunate to work with a number of amazing nonprofits. One of our kind of longest standing partnerships has been with an organization called I Support the Girls, which has seen a enormous surge in requests for period products starting in March of this year. I mean, with many homeless shelters, with many domestic violence shelters, tampons, pads, bras are often the most request items but the least often donated.

Jordana Kier: (49:38)
So back in 2016 when we launched our LOLA Gives Back program we were very lucky and fortunate to partner with I Support the Girls and have expanded our charitable partnerships over time and have been able to donate upwards of five, six million tampons, period products to women in need across the country.

Jordana Kier: (50:00)
The Scotland news has been incredible. I think, again, for us it really starts with let's change the conversation, let's open it up. Even myself, right? I hadn't even thought about the fact that these products may be in desperate need right here at home. So really again, raising awareness to the ingredients that you're putting in your body. The fact that for many of us it's a sad privilege that we have that we can afford this products every single month. What can we do about it? So again, just continuing to engage and raise these issues, raise these opportunities because at least for myself, and I know for so many of our customers, when they're made aware of things like that you can't buy tampons with food stamps, they want to help.

Jordan Gaspar: (50:58)
We only have a couple more minutes, so I think we should kind of think through some parting thoughts. I'd say that on our side it's going to be kind of, for our founders when we talked to them a lot about kind of navigating COVID, there was a couple different areas of the frame, right? There was the first sort of immediate response of reforecasting your plan, resetting your marketing strategies, resetting your team, thinking through financially how you're going to come out at the other side stable and sound. Entering into 2021 that's evolved, because what we've all learned through this period is that it's going to take a lot longer than we thought. So we've all been thinking as an industry creatively about how is marketing going to change, right? And how are we going to market to people now from their couches is what we've been saying for the past couple of months, and how will you continue to foster this community when people leave their couches again, and then they get out. So as we go into sort of a new climate for 2021 and we have more profitable companies that have learned to navigate marketing very different, we've seen adoption of our conventional and our mass retailers to really sort of think through wellness more broadly and to embrace it through the pandemic. On the other side of this, where would we be?

Jordan Gaspar: (52:20)
So for 2021, not predicting kind of when things end and the impact of that, if you could answer for me where do you want to see LOLA at the end of next year? What would be an amazing marker of not just kind of getting through this, but kind of how LOLA has ascended as an omni brand and gone into retail successfully, and built out their community, what would be sort of the goalpost there?

Jordana Kier: (52:47)
It's a great question. Would say that a few things. I think first from a business and brand perspective just continuing to invest and build in the areas in which we know have the most staying power. So whether that's brand building, whether that's community building, whether that's retail expansion, whether that's continuing to hone and refine our D2C channel and building up more digital products, whether that's things that are more virtual, or different ways that we can support customers to feel very supported by our products as they go through their reproductive journeys.

Jordana Kier: (53:40)
I would say ensuring that our team feels supported. I think yes, my hope, right? All of our hope is that next year at some point there is going to be a moment when we can go back to the office, or go back to be working in person. And sort of what does that look like, how do we ensure that we're building an environment where we're taking into account the last let's call it 12 to 16 months where things have really changed? People have moved, things have changed at home, right? So how do we ensure that we're sort of listening to our team and building the right infrastructure operationally where it's going to work for people who want to come back to the office versus people who sort of have made life changes but still care very much and want to work with the company and feel very passionate about the mission still?

Jordana Kier: (54:41)
Again, our biggest asset, best asset is our people. We feel really so proud of the team that we've built over the last five years and this year has been incredibly challenging and certainly nothing that any of us could've seen coming. How do you ensure that you're building an environment where you still can maintain through all of this different change and transitional moments an environment where people are still kind of feeling really inspired and motivated on a day-to-day basis?

Jordana Kier: (55:21)
So, a lot of growth from a business perspective, bottom line health as well as really making sure that the team is feeling like every day they're waking up and they're really excited to show up for the company.

Jordan Gaspar: (55:39)
Well, we're very excited to be part of the journey, so. I'm trying to think of if there's anything we didn't cover on. It's funny, we said during this that there were sort of topics that I feel like we had an opportunity to cover most of them. I'd say from our perspective, obviously it's going to see you guys continue to succeed, building your community, building brand awareness, building your distribution, but also launching innovative products that really meet a need in the market.

Jordan Gaspar: (56:08)
So we've seen a lot of commitment from Walmart through this, which has been amazing, and it's exciting to see them commit again to now the sexual wellness platform. But I think what our hope for you is to continue to see sort of the work and the building blocks you've put in place during this period, right? Because I feel like if you were able to navigate a launch like this and during this time, I suspect next year will feel like a breeze.

Jordana Kier: (56:35)
I mean, that's the hope, right? My [inaudible 00:56:38] too that, I mean, Jordan, it's been such a pleasure partnering with you. I mean, I think it's obviously been a very challenging year on so many fronts for so many businesses, and to have the network sort of being opened up to us, the connecting with the other portfolio brands, having just kind of those very spur-of-the-moment calls on how can I help. I mean, that's really where it's not in the good times obviously when you really want to base a relationship on, it's really about kind of the challenging times. I would say we've just been so lucky to obviously have an existing investor base that's very supportive but also now working even more closely with you and the AF team.

Jordan Gaspar: (57:32)
Thank you.

Jordana Kier: (57:34)
This is this moment too, where companies who are looking for active investors who say they want to support, right? And say they have value add platforms, it really did come to life working with the AF team this year, and I know it'll continue to be a really fruitful relationship. So just really grateful for the partnership. Thank you.

Jordan Gaspar: (57:58)
Thank you. You made our pilot investment into personal care easy. So as you know, we were excited about the transition, but I think our conviction around you guys made it feel like an easy adjustment, so thank you for that. We've loved working with you guys.

Jordan Gaspar: (58:15)
So with that, no kids interrupted us, no dogs. We made it.

Jordana Kier: (58:22)
I know.

John Darsie: (58:22)
Well, that was fantastic. Thank you both for joining us. I come from a place of ignorance. I'm one of four brothers, and probably when I started dating and all that stuff I probably thought you got tampons at Lululemon, but I've become a little bit more educated now.

Jordan Gaspar: (58:35)
That's actually a good idea.

John Darsie: (58:36)
And I have a four-year-old daughter and I'm thankful-

Jordan Gaspar: (58:39)
[crosstalk 00:58:39].

Jordana Kier: (58:39)
Really great idea.

John Darsie: (58:39)
... that we have women like Jordan and Jordana in the world that will help her along with her mother through the journey of health throughout her entire life. So thank you guys for doing this, and we're very proud to host conversations like this on the SALT platform.

Jordan Gaspar: (58:54)
Thank you for having us.

Jordana Kier: (58:56)
Thanks, John.

Pandemic Venture Investment Series - Episode 3 | SALT Talks #114

“Never in the history of medicine has a vaccine been developed so fast and so quickly.”

In the third episode of SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, hear from company leaders developing a COVID-19 vaccine (Eyal Desheh of MigVax), early virus intervention via nasal spray (Dr. Gilly Regev of SaNOtize), and AI technology that catches human error in helping prevent unnecessary patient deaths (Dr. Gidi Stein of Medaware). Moderated by Matthew Kalman, OurCrowd, Chief Content Officer.

MigVax’s potential vaccine offers an added benefit as it can be taken orally and can be stored in a normal commercial refrigerator. Schools could store the vaccine and nurses could easily administer. SaNOtize is tackling COVID from another angle through the development of a nasal spray. This can act as an early intervention in eliminating the virus if exposed and can work on many other types of viruses as well. “The idea is a little bit like a hand sanitizer... You go outside, and then you just come back and you spray [the SaNOtize nasal spray] in your nose and you can get rid of the virus.”

Typos when writing prescriptions is not an uncommon problem that can arise from overworked, tired doctors. These can and have resulted in unnecessary patient deaths. We see the introduction of technology across different areas of medicine to assist and improve medical professionals.

LISTEN AND SUBSCRIBE

SPEAKERS

Eyal Desheh.jpeg

Eyal Desheh

Chairman

MigVax

Dr. Gidi Stein.jpeg

Gidi Stein

Co-Founder & Chief Executive Officer

Medaware

Dr. Gilly Regev.jpg

Gilly Regev

Chief Executive Officer

SaNOtize

EPISODE TRANSCRIPT

John Darsie: (00:09)
Hello everyone, and welcome back to SALT Talks. What we're trying to do on these SALT Talks and our conferences is provide a window into the minds of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. And we are thrilled today to welcome you to the third installment of our pandemic venture investment series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arising from the pandemic crisis, and discuss breakthrough technologies that address issues from the coronavirus prevention and cure to social distancing and food supply.

John Darsie: (00:46)
The series is presented in partnership with OurCrowd, which is a leading global venture investment platform, and today's episode is titled, "Startups Tackling COVID and Other Global Health Challenges," and it features Eyal Desheh, a chairman of MigVax, Dr. Gilly Regev, chief executive of SaNOtize, and Dr. Gidi Stein, the co founder and chief executive officer of MedAware. Today's episode will be moderated by OurCrowd chief content officer Matthew Kalman. Just a reminder, if you have any questions during today's talk, you can enter them in the Q&A box at the bottom of your video screen on Zoom. Now I'll kick it over to Matthew to host today's talk.

Matthew Kalman: (01:24)
Thank you John, and welcome to this, the third episode in the pandemic venture investment series of SALT Talks presented with OurCrowd, where we showcase the latest advances in startup technology that's helping to address this worldwide crisis. I'm Mathew Kalman, the chief content officer at OurCrowd, which is a global venture investing platform based here in Jerusalem. Today, we're going straight to the heart of the crisis to talk to three CEOs of medical startups at the cutting edge of the battle against COVID-19, helping us to overcome the challenges of safer and more efficient healthcare.

Matthew Kalman: (02:04)
Joining us today is Dr. Gilly Regev, the CEO of SaNOtize. They're based in Canada, and they've been conducting clinical trials of what I think is the world's first and only proven therapy against the coronavirus. We also have Eyal Desheh, the chairman of the board of MigVax, an Israeli company developing what will be an oral vaccine against COVID-19. And we have Dr. Gidi Stein, the CEO of MedAware, which uses artificial intelligence to prevent errors in medication that are a leading cause of unnecessary deaths among patients. So we have lots to discuss. Let's start with the search for a vaccine against the coronavirus.

Matthew Kalman: (02:46)
There's been big news this past week about the success of trials of a vaccine being developed by Pfizer. And let's begin with the chairman of MigVax, Eyal Desheh. Now Eyal, you have many years of experience of drug and therapy development in your previous role as executive vice president and chief financial officer of Tether Pharmaceuticals. So from your experience, does the news from Pfizer this week mean that it's game over, they have the solution, and you and your team at MigVax can just pack your bags and shut up shop? Do we still need an oral vaccine.

Eyal Desheh: (03:25)
First of all, good morning and good afternoon everyone that is listening to us. Happy to be here and share some of my thoughts and our thoughts at MigVax, how we address this challenging pandemic and what's our approach and the view from our window, how it looks like. First of all, I think the announcement by Pfizer that they believe that their vaccine is safe and effective is great news. I am convinced that there will be others that will follow. Different mechanism of actions, there will be vaccine for COVID-19. It is challenging, but it seems to be possible. And by the way, let's not forget it was developed in record time. Never in the history of medicine a vaccine was developed so fast and so quickly. But nobody really started from zero.

Eyal Desheh: (04:40)
That said, I would cautious from declaring victory. I think that if we learn something important and major about the coronavirus since it was introduced early this year, the beginning of this year, is that we don't know what we don't know and we don't know enough. There are so many researchers and studies conducted all over the world. Think I read somewhere that there's an article or a paper on the subject which is issued every three seconds. So a lot of people are really diving very deeply into how to solve this virus and possible other viruses that might follow. We might be at the beginning of an era that's not a race for the vaccine, it's a race after the virus. But I think to start with, it's great news. For me, and you mentioned I spent 17 years in Teva. I didn't do drug development myself, but I did fund it and looked at results and how the process works.

Eyal Desheh: (06:05)
The idea that a vaccine for such a major disease or virus is approved based on a sample of a hundred people that were diagnosed, especially those people that were not diagnosed and were in the trial, it's a little difficult for me to digest. I think that over time we'll have more data. There'll be more people, and I think we need much, much more data and experience in order to be convinced that this is it. There'll be other vaccines no question. Let's say something about what we do at MigVax. We're developing oral vaccine, which is simple to use, easy to administer, doesn't need -70 degrees freezing, can be kept in the refrigerator of the school, and the school nurse can give a small [inaudible 00:07:06] to the students to drink and then come again three weeks later, give them the second dose and hopefully they are immune, they are vaccinated.

Eyal Desheh: (07:22)
So it's very very simple to operate. It's also simple to produce once we cracked, and we believe we cracked, the construct of the materials, which was not easy to develop. That's why it's taking us time. But as I said before, nobody really started from zero or from scratch. We're based on many many many years of our research in chicken, and vaccine that was developed in [inaudible 00:07:57] Academic Institute in the north part of Israel by very experienced and capable scientists. It's a construct of three proteins and [inaudible 00:08:11] that leads them to the right immune system antibiotic. It's [inaudible 00:08:16], go through the throat and then through our digestion system where it activates the immune systems in the body. And it has experience in millions and millions of chickens that were vaccinated successfully with this technology.

Eyal Desheh: (08:36)
Now we validated this with mice, and we're ready to for the final trial with animals before we move into our phase one to humans. And we hope that everything works right. A little less than a year from now, we'll have an oral, a safe, easy to use vaccine that will be available. So let's keep our fingers crossed, because it still is extremely challenging, and as I said, there will be room for a number of vaccines around the world, and at the end of the day, there should be enough to really vaccinate everybody if we want to get rid of this thing.

Matthew Kalman: (09:20)
So you're looking maybe at by the end of next year, this might be ready to be on the market.

Eyal Desheh: (09:28)
Yeah, with the disclaimer that we need to go through the phases successfully, and everybody that was involved in development of vaccines or drugs knows how many things might go wrong. But we're hopeful because we look at the success of this technology with hundreds of millions of birds, of chickens that were vaccinated against a virus from the same SARS family. Very very similar in its structure to the COVID-19. So we know it works. We absolutely know it works, but development is a process with many hurdles.

Matthew Kalman: (10:19)
Let's bring in some other people from our panel, because until we have a vaccine, we need protection from the coronavirus. We have masks, we have sanitizer, we have social distancing, but a Canadian company called SaNOtize believes it can go one step further, and with a simple nasal spray, it can actually kill the virus after we've inhaled it, but before it spreads to the lungs. And Dr. Gilly Regev who's the CEO of SaNOtize is with us. Dr. Regev, so what's the difference between a therapy and a vaccine?

Gilly Regev: (10:56)
Thank you Matthew. Thank you all for being here. First of all, I would like to say I agree with Eyal. There won't be one treatment. It will be a combination of a few different treatment, and vaccines will be some of them, but it's not necessarily just a vaccine. I think the big difference that they're both were talking about prevention. The vaccine will prevent you from getting sick from the disease. It's not that far from what SaNOtize is doing. SaNOtize has, I think we were the first company that actually came out with a nasal spray back in April with the idea that the virus multiply in the nose. And if the virus multiply in the nose and we can kill the virus at that point before it becomes a full blown infection, then we cured the disease.

Gilly Regev: (11:52)
The big advantage of what SaNOtize has I think is it's not specific to this specific virus, or if the virus mutates or change, then this will still work. So our treatment or nasal spray is based on the delivery of nitric oxide. Nitric oxide is a natural molecule that we all produce in our body. It is our body's first line of defense against infection. So it's not something new to the body, and when we deliver it, we deliver it topically through a liquid that delivers the nitric oxide. Nitric oxide, there was a publication that came out last month that was from a university from [inaudible 00:12:42] Sweden that the researcher actually said that nitric oxide is the only compound so far that have shown a direct effect on the SARS-CoV-2 virus. So we know nitric oxide kill the virus. We know that if you get the right dose to the right place, you will get rid of the virus.

Gilly Regev: (13:03)
What we have done so far, we have already done [inaudible 00:13:08], so we took our liquid formulation, we show that it can get rid of the virus very quickly in the lab, and then we've done recently, I don't think I even updated you Matthew, but recently we have done some animal testing in hamsters and have shown that the day post infection, we got a few log reductions of the virus in the nose of hamsters, which is a very strong model because they have receptors similar to human. So we know that this has a huge efficacy potential. We have completed over a hundred people in a phase two clinical trial in Canada. We've shown very strong safety of this nasal spray, and all that's left for us is to complete a phase two of efficacy trial showing that this is actually working in human and can prevent you from getting infected.

Gilly Regev: (14:06)
The idea is a little bit like a hand sanitizer, where you use a hand sanitizer when you go outside and you need to clean your hands. It's the same thing. You go outside, and then you just come back and you spray it in your nose and you can get rid of the virus. So it could be prevention. It could also be an early treatment, so early on in the disease, and this is the trial we're doing right now.

Matthew Kalman: (14:32)
What are the kind of challenges that you're facing actually doing clinical trials for an anti-COVID therapy? Because in order to test this, you have to find people who might have been exposed to the virus, they might be sick. There's been polls taken in the last week about whether people are going to be prepared to actually take the vaccine if the Pfizer vaccine is proven to be successful. Are you finding people are willing to join the trials?

Gilly Regev: (14:59)
There are lots of challenges. I think there are always challenges with doing clinical trials. We've been in this field for many years and we've done clinical trials and other indications, and there are always challenges in clinical trials. But with COVID, it is so much more. First of all, because as Eyal said, we still don't know more than we know. This is changing all the time, and if you design a clinical trial two months ago, the design may be different today. The endpoints, what you're looking for is different. The outbreak centers are shifting. So our biggest internal joke is all we have is to start a clinical trial in one location and we cure COVID, because then the cases come down and then it's hard to recruit. So you have to shift into a decentralized clinical trial, which is a new term coming out now with doing trials that are not in one location, one center, so you can recruit in different places.

Gilly Regev: (16:02)
As for prevention, I think the big challenge is prevention needs very large numbers to show prevention. It's even a little bit more challenging for us than for the vaccines because we need a control arm, and we need to show that people in the control arm got infected versus people in the treatment arm that do not get infected. So you need a really large sample size. And in the treatment, if you want to look at people very early on in the disease, then first of all, it's hard to find them and you need to identify the people right when they're tested positive. And a lot of people when they're tested positive, they're already sick for a week. So it's not necessarily early. Finding those people early on in the disease is challenging, and looking at what's your endpoint.

Gilly Regev: (16:50)
Most of these studies are done in treatment later in the disease, when people are at hospital, very sick. If we want to show it early, then one of the endpoint could be, okay, let's look at hospitalization and how many people get eventually to the hospital, and we want to reduce this. But hospitalization is coming down because there are more young people getting sick. So this shifts as well. So all the shift during this disease and the progression and everything we learn makes it very very challenging in a clinical trial world. And we keep learning all the time.

Matthew Kalman: (17:28)
So Eyal said with all the caveats and all the challenges that need to be overcome, they might have the MigVax vaccine by the end of next year. Are you prepared to tell us when we might have SaNOtize to protect us in the meantime?

Gilly Regev: (17:46)
We just had a good meeting with Health Canada. We believe from what we heard from them that once we show an efficacy in a phase two, they will consider releasing this to the market. So they will not require phase three due to the very strong safety profile of our treatment. So I would hope that by Q2 2021 this will have an approval. That's the goal.

Matthew Kalman: (18:14)
Okay. I'll be speaking to you in about six month's time to check that out. As we know, this crisis has thrown the world's health systems into turmoil. But even before the current crisis, the normal pressures of patient care were contributing to mistakes involving giving patients the wrong drugs and leading to unnecessary deaths. And that's exactly the purpose of MedAware, which is a company that was founded by Dr. Gidi Stein to address that issue. So Dr. Stein, before we come on to talk about your particular technology, I wonder how, as someone who knows the healthcare world well and up close, how much would you say has the COVID crisis changed the way that we deliver healthcare?

Gidi Stein: (19:07)
So hi, and really thank you for giving me the opportunity to talk with you. COVID is a terrible disease. Millions of patients are dying, but it also presents an opportunity, because it takes the extreme trends that were already brewing in the recent years. And today, we understand that being in the hospital could be one of the worst things that could happen to a patient. Hospitals are not safe. If patients get infected, physicians, nurses also get infected. So we have to change the paradigm by which we provide health and not hurting our patients in the meantime. And there's a lot of turmoil around that, and I think the trend is going into a distributed hospital, decentralized hospital.

Gidi Stein: (20:04)
So think of the possibility that an elderly person can be hospitalized at home. They don't have to go to the ER, they don't have to go through all the crowded spaces, all the nursing facilities. You can just stay at home and get your care at home. Now certainly, healthcare is not bounded by walls and by buildings. The same staff can provide health to a much wider audience and much safer health. Now obviously, there are a lot of workflow issues and technological issues that prevent us from doing so, but today, more and more emphasis is going on on telehealth, on remote monitoring, and I think COVID brings us a wonderful opportunity to really change the paradigms of which we provide health to our patients by really treating them at home and shifting the center from the hospital to the patient home.

Matthew Kalman: (21:07)
So Gidi, if we take that to its logical conclusion, and we've heard similar thoughts from Johns Hopkins and from Sheba Hospital here in Israel on previous OurCrowd events dealing with healthcare, so it does seem to be a move in this direction away from centralized hospitals, but MedAware deals with mistakes in prescribing and the giving of drugs and medications. Don't you think that those kinds of mistakes and problems will be multiplied even more if you decentralize the care so people are taking things in their own homes?

Gidi Stein: (21:51)
So last week, there was a new article published in the Journal of [inaudible 00:21:57] Medical Informatics Association in which MedAware did, in partnership with Sheba, in which we have shown that overworked, tired, sleep deprived physicians [inaudible 00:22:11] have a two to eight times likelihood of erroneous prescribing. Obviously even taking those hospitals and driving them to the extreme, and even in normal circumstances, the likelihood of erroneous prescribing and medication risk is quite substantial, especially in the middle of the night after a too long shift. And I agree that taking the distribution of patients to the home [inaudible 00:22:43] obviously a lot of room for mistakes and error, and this is where I think a technology similar to ours can be of benefit.

Gidi Stein: (22:54)
We can provide the real time monitoring of the sensor data, of the clinical data, and merging them and extracting only those rare events that can actually harm the patient and surfacing them to the providers or the nurses or to the care coordinators. Because one of the challenges in treating patients today, and especially in a distributed manner, is that there is so much information. We are flooded with information as clinicians. [inaudible 00:23:25] to know our left from our right, and within five minutes that we have to see the patient, really understand the the longitudinal patient record. So if there is a sophisticated AI system that can really pick up the specific risk in the mean time and send them directly to the right providers and caregivers, this could facilitate a reducing of the overall patient risk, and drive to more distributed healthcare and patients treated at home.

Matthew Kalman: (23:56)
So just talk us through the MedAware system. How exactly does it intervene in the process in order to try and stop these mistakes occurring?

Gidi Stein: (24:07)
So what we do is basically listen to all the data that comes from the electronic medical record and from the sensors and the [inaudible 00:24:15] data on a continuous, and using our AI technology, we "understand" and learn the behavior patterns of clinicians, and identify outlier situations as potential errors and flag them in the right time. So if a physician will prescribe a medication that is a complete anomaly to the patient characteristics or if suddenly a patient has a new lab test or vital sign which usually is an outlier to the patient medication list, then we would provide the right alert and say hey, we may have a mismatch here. If a patient is bleeding and he's [inaudible 00:24:57], doesn't make sense. And this is where AI platforms identify these risks and alert the clinicians at the right time.

Matthew Kalman: (25:07)
Right. Let's go back to Eyal Desheh, because I wanted to talk to you about the question that Gidi has raised about the fact that this pandemic is not just a terrible disaster, but it also presents a kind of business challenge and maybe even a business opportunity. How do you see the whole business model here has changed because of the pandemic? Because you say these vaccines are being produced in record time, you think you might be able to get your vaccine out by next year. This is not the way that you were used to doing things at Teva I'm sure.

Eyal Desheh: (25:49)
First of all, we learned that options are not just something that high tech companies grant to their employees, but a tool that government use to try to secure the healthcare of their population and willing to spend hundreds of millions of dollars on buying those options. Many of them are going to be thrown away to the garbage. So yeah, there are significant financial implication and business implication behind this. We don't know the prices. We don't know the prices. We know that if we take the analogy from the price of a regular vaccines, they range between a handful of dollars to hundreds depending on what kind of disease. So the price has yet to be determined, and I think companies are pretty silent about how much they're going to charge.

Eyal Desheh: (27:10)
I want to talk about the other half of this equation. No question that the wealthy world is going to be vaccinated once the vaccine is approved, FDA approved or EMA approved. Any regulatory authority, the Minister of Health here in Israel and so on. But I think it opens a series of moral questions regarding who can afford it, who's going to get it free of charge, or are we going to pay, who's going to fund it, and who's going to finance it. No question, Pfizer is a reputable, respected pharmaceutical company with a high level of ethics, and I'm happy that they were the first to announce success, because they will set the moral tone. But they're not a charitable organization, and they spend money, they got money from the US government, a lot of it. We don't know what kind of agreements they had behind the scenes on that.

Eyal Desheh: (28:35)
But hey, there's seven billion people on this planet. If we want to get rid of this disease and make sure that we can try and prevent other mutations and other viruses that might develop, we will have to really vaccinate the majority of the population on the planet. And at least 65% of the people that live here can't afford it. So I think the question is not financial. I think the question is of morals and ethics.

Matthew Kalman: (29:18)
Let me throw that to Gilly Regev at SaNOtize. You are a small company. You're developing a therapy that could help to save the lives of millions, if not billions of people until we have a vaccine. How can you scale from testing a hundred or 200 or 300 people in Canada to providing billions of doses of your SaNOtize spray overnight?

Gilly Regev: (29:48)
This is definitely a challenge. What we have started from the beginning, and in parallel, started to develop a new device for example that can help easily administer the drug. The drug in our case is very inexpensive, which helps to be able to eventually allow this to reach regions in the world that could afford it as well. I think what we are working in parallel is identifying manufacturing facilities, identifying drug production and distribution and partners that have the capabilities and can help us move this forward once we get the approval. So we want everything to be ready.

Gilly Regev: (30:41)
As you know, before you release a drug to the market, there's lots of testing and there's stability data that you need, and there is a lot of safety data that you have to collect before. So making sure that once we get to this point of approval, we're ready to give this to distributors and have the right partners at that point to help us reach as many people as possible. I think the biggest thing in our case may be that even if COVID is solved, I don't know if it will ever be, but in some way, and even if there is a vaccine, our treatment could be a flu preventation. So it's not just specific to COVID or the next pandemic that we're going to see at some point. So I think that everything we do is not just going to get lost if this is not needed in this amount, but at least we'll go into a flu prevention development further.

Matthew Kalman: (31:43)
And Gidi Stein, I want to come back to you. Eyal just raised this question that when it comes to the vaccine and who's going to get it, that's kind of a moral question. But we also see with the application of different medical solutions that you have to take the human factor into account. The whole basis of MedAware is that doctors have been making mistakes. And I just wonder, that's not just a moral question, that's a human question as well. What kind of take up are you getting from practitioners who are prepared to admit to their mistakes and want to use your technology?

Gidi Stein: (32:29)
When we tried to frame our technology, we try to be modest. We're not trying to teach physicians their work, we're not trying to teach their medicine, but you can do an analogy of spell checker. You can be the best poet in the world, write the most wonderful songs, but still have typos. We have a spellchecker. It doesn't make you less of a poet. And we look at our system as a spellchecker for clinicians. You can be the best doctor in the world, but you're human. You make typos in prescribing and not looking up in the right time, all kinds of slip ups. So we can just catch that and surface that. So it doesn't make you less of a doctor. Just shows that we're all human.

Gidi Stein: (33:11)
We have shown that taking this strategy, there's a huge uptake of our system by the clinicians because they are aware of their own mistakes. Although patients are the first to be influenced by the mistakes, but there is a second wave. The second wave is the clinicians, nurses, physicians, and others, and pharmacies suddenly understand that due to their mistakes, some life was taken or a patient was harmed, and this causes depression and even post traumatic stress disorder. Nobody wants to be there. It's not bad judgment. It's a typo. Who wants to kill someone just because of a typo? We're just making sure this doesn't happen. So framing it that way, physicians are accepting our system quite nicely.

Matthew Kalman: (34:02)
Let's go back to Eyal Desheh, because you mentioned something very interesting. Before, you mentioned the funding that various governments have given for the research into this vaccine. There's been a lot of national pride from different governments. I'm British. We heard day after day about the Oxford vaccine and how that was going. I know in different countries, different people want to be first in the race. Do you think that that politicization, if it's occurred, of the funding of this vaccine, has that been helpful? Has it been detrimental? Is it something that you've been able to latch onto, or are you ignoring that nationalistic side of things?

Eyal Desheh: (34:50)
Yeah, there is a new terminology about the nationalization of the vaccine. We're going to hear a lot about this argument in the next few months. If you ask me, I think if the world will learn to be a little less competitive and a little more humble and collaborative, we will all live in a better world. But a few leaders will have to be replaced before that happens. But this is not the political discussion. This is discussion about our health, about the world health.

Matthew Kalman: (35:30)
I just wondered how the politics, if its impacted the business at all [crosstalk 00:35:35]

Eyal Desheh: (35:35)
I'll tell you what I think. I think that the politics of the vaccine is bad politics. Throughout the past 10 or 11 months, we've seen a lot of money poured... And yeah, I can understand. I am an economist by education. I can understand that it's cheaper to throw money to the hands of pharmaceutical companies and research institutes to come up with the vaccine than to throw it on economy and fund the employed. It's much [inaudible 00:36:15], more economically efficient and effective. I can understand that. But what I haven't seen is global collaboration. I've seen China doing their own and Russia doing their own and the US doing their own and Israel is trying to do their own with our limited resources. And you're British, so the UK takes a lot of pride at the Oxford development, which is brought to market by AstraZeneca with all the complications. It's British pride.

Eyal Desheh: (36:53)
We'll have to forget about it. We're talking about a global pandemic, which has been delivered from country to country by iron birds that were invented a hundred years ago. There's no way to stop it. And anybody that believes that they will or make sure that their country's immune and the problem will be solved, it will not be solved because there will be other diseases. I think that calls for some global collaboration. Unfortunately we haven't seen that. We have seen that in wars that countries create treaties in order to fight a joint enemy. This is an enemy which is now worse than some of the worse enemies of mankind in history, and there's no collaboration between countries. So if you ask me, the vaccine politics is bad politics. I hope it will change. Excuse me, and apologize for being a bit blunt.

Matthew Kalman: (38:02)
That's what we're here for. Gilly Regev, I want to ask you a slightly different question. Here we are in something that's become known as impact investing. We're looking at commercial companies, but we're also trying to do good and help people. When you approach your science and your business, are you looking at this in a straightforward business manner, or are you also thinking, yes, I'm also helping to do good here?

Gilly Regev: (38:37)
I'm personally in this to do good. That's why I'm doing this. I don't think anyone would be able to work the way we work these days if there wasn't anything besides just to be successful. This is to change the world. This is to do good. We started this to help people with diabetic ulcers, to help people that are suffering from chronic sinusitis and from pain all their lives and trying to do good here. So I think part of our... And a bunch of our investors are impact investors because part of the reason we're doing this is because nitric oxide can kill drug resistant bacteria, and I think this is the big problem that we started the company from, is the reality that antibiotic is not going to work forever.

Gilly Regev: (39:30)
Who knows, the next pandemic could be due to antibiotic resistance and not due to a virus. The options are getting lower and lower. Large countries do not develop new antibiotic because it isn't worth it for them because they get resistance very quickly. So there must be a way to address the problem, and the only way is to get this impact investors and people that really care about what they put their money in and trying to not just make a successful business, but also a business that would change the world, that would help people. And I think that's a very important point.

Matthew Kalman: (40:11)
Gidi Stein from MedAware, what was your motivation for founding the company? Was it because it looked like a good business, or was it because you saw this problem up close?

Gidi Stein: (40:26)
Before I started this company, I was a full time physician on the way to professorship in Tel Aviv University. I teach students and residents, and I thought this would be the trajectory of my life, and I definitely never thought I would do startups. I thought a completely crazy idea. But then I was encountered with a case of a nine year old boy that here in Israel died simply because his physicians clicked on the wrong entry on the medication list and gave him the wrong drug by mistake. The ease by which physicians can kill a patient just by clicking on the wrong button without any really safety mechanism was haunting. I thought it could happen to me as a prescriber, it could happen to one of my kids, god forbid, if they go to the doctor. And I thought we should do something about that. And here we are today.

Matthew Kalman: (41:22)
Okay. Well we've reached the end of our time. Today, we've heard from just three of the 200 companies in the OurCrowd portfolio, and you can see more technology and startups and investment opportunities in both med tech and many other sectors on the OurCrowd platform. That's all we have time for. I want to thank our speakers, Dr. Gilly Regev from SaNOtize, Eyal Desheh from MigVax, and Dr. Gidi Stein from MedAware. Make sure to join us for the next installment next Thursday. Thank you to John Darsie and our partners at SALT, and we'll see you next time. Thank you very much.

Pandemic Venture Investment Series - Episode 4 | SALT Talks #113

“Your endpoint workstation is a major door for every cyber-attack. That's the main door for any sophisticated attack.”

In the fourth episode of SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, Ron Moritz, serial cybersecurity entrepreneur and sector expert, discusses with top CEOs from start-ups Morphisec, ITsMine and ThetaRay some of the consequences of COVID in the cybersecurity world.

The pandemic has seen a rapid transition to work-from-home setups for entire companies and their employees. With it has come the transition of company data and workflows to the cloud, creating a whole new set of cybersecurity vulnerabilities. A company’s IT team could more easily monitor and protect the company’s endpoints when they’re centrally located in an office, and now each individual employee at home must assume a certain level of awareness of their own cybersecurity. “The attack vector is becoming larger… from external attackers that now can attack the employee's router at home because they haven't changed the password.”

Companies have had to suddenly set up remote work operations for their employees. We’ve seen virtual private networks (VPNs) and virtual desktop infrastructure (VDIs) increase in popularity. As a result, we are likely to see the long-term adoption of more hybrid work environments, even after the pandemic, where employees regularly work part of the week from home.

LISTEN AND SUBSCRIBE

SPEAKERS

Ronen Yehoshua.jpeg

Ronen Yehoshua

Chief Executive Officer

Morphisec

Kfir Kimhi.jpeg

Kfir Kimhi

Chief Executive Officer

ItsMine

Mark Gazit.jpeg

Mark Gazit

Chief Executive Officer

ThetaRay

EPISODE TRANSCRIPT

John Darsie: (00:12)
Hello everyone. And welcome back to Salt Talks. My name is John Darsie. I'm the Managing Director of Salt, which is a global thought leadership forum at the intersection of finance, technology, and public policy. Salt Talks are digital interview series with leading investors, creators, and thinkers. And what we're trying to do during the Salt Talks is replicate the experience that we provide at our global conferences, which we host twice a year in the United States and internationally, and what we do at those conferences. And what we're trying to do on these talks is provide a window into the mind of subject matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. And we are thrilled today to welcome you to the fourth installment of our pandemic venture investment series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arising from the pandemic crisis and discuss breakthrough technologies to address issues from Coronavirus prevention and cure to social distancing and food supply.

John Darsie: (01:15)
This series is presented in partnership with OurCrowd, which is a leading global venture investment platform. Today's episode is titled Cybersecurity and Pandemic Accelerated Digital Transformations. It features Ronen Yehoshua, the Chief Executive Officer of Morphisec, Mark Gazit, the Chief Executive Officer of ThetaRay, and Kfir Kimhi, the Chief Executive Officer of ITsMine. Today's episode will be moderated by OurCrowd, a venture partner for cybersecurity, Ron Moritz.

John Darsie: (01:45)
Just a reminder, if you have any questions today for any of our panelists or our moderator, please enter them in the Q&A box at the bottom of your video screen on Zoom. And now I'll turn it over to Ron to conduct the interview.

Ron Moritz: (01:58)
Thank you, John, and welcome everybody to the fourth episode of the pandemic venture investment series, where we will dig into business challenges and technology solutions in the shadow of COVID-19. As John said, I'm Ron Moritz, I'm the cybersecurity venture partner with equity crowdfunding from OurCrowd, and I'm thrilled to be moderating today's panel discussion with a focus on cybersecurity. OurCrowd is a global venture investing platform that provides both institutions and individuals with an opportunity to invest in and engage in emerging technology companies. In fact, with over $1.4 billion in committed funds and 200 portfolio companies, three of which are joining us today, OurCrowd is the most active venture firm in Israel.

Ron Moritz: (02:45)
I'm joined today by the founding CEOs of three important cybersecurity companies whose solutions are being used by organizations to prevent and defend against always evolving innovative attacks that challenge our business operations and service delivery. Like nearly every company, each of our guests has been forced to adjust strategies, plans, and forecast this year. And each CEO has had to navigate through this disruptive economic cycle with little to no academic or business press compass. I've been looking forward to this opportunity to talk to my colleagues here all week and dig into their own experiences, observations with respect to the cybersecurity market, and leadership response. So let's get this panel started.

Ron Moritz: (03:29)
Kfir Kimhi is the founder and CEO of ITsMine, whose mission is enabling organizations to meet their responsibility as caretakers of sensitive information by preventing data leaks. Even before COVID-19 organizations have been pushing through yet another technology refresh cycle with cloud migration being a leading driver. And at the center of many of these digital transformation efforts is, of course, data. Data protection is a requirement for every organization and daily challenges range from ransomware where data is locked through breaches where sensitive data is released. There's been much written and said about how this year's pandemic has changed so many aspects of what was previously thought to be the normal in both our personal work lives. Kfir, what are some of the challenges you've observed the impact data protection?

Kfir Kimhi: (04:21)
Thank you very much for having me and it's great to be here. I think one of the things that we see is companies, first of all, needed to move to the cloud faster as they wanted. We see companies that their employees didn't have a computer at home or internet connection. And now because 100% of employees working from home, they first of all, needed to give them the equipment, they needed to connect them to the internet. And they also needed to move to the cloud in much fast away. So we have one of the customers, a healthcare in the U.S. that needed to move to the cloud in less than three weeks. They were expecting to have one year of movement to the cloud and just doing it in three weeks was first of all, making our employees capable to do the same works that they did at the office now to do it at home. What happened with our company data, where it is living, what people are doing with it? That's one of the major challenges that they see where data is scattered everywhere.

Ron Moritz: (05:34)
I think it's actually remarkable the changes we have seen. In some cases you mentioned acceleration beyond what was planned. And I think many of us actually do connect on a personal level to many of these changes, whether it's having children at home on Zoom or having our interaction with our colleagues over Zoom. It seems like the whole world is around Zoom these days, but what about the attacker? Are they also getting together over Zoom [crosstalk 00:06:01] these changes and adjusted their strategies and response? Have they discovered and pursued new ways to overcome the data protection defenses? What have you seen?

Kfir Kimhi: (06:12)
So first of all, of course, the attack vector is becoming larger, both from external attackers that now can attack the employee's router at home that they haven't changed the password, and even don't know how to do it, or to use other devices or even other people, the people that are not necessarily the traditional hackers that have long history in IT. It could be kids that are playing around with Darknet solutions that can provide them capabilities to encrypt data and taking ransomware for companies. And we see that in numbers of ransomware attacks that are not very sophisticated running all over the world. So, yes, the ways to attack companies are becoming, I don't know if saying it's easier, I'm not sure is it easier, but it's definitely more widespread and creating much more vectors of attack that when we sat in the office and have control on each and every device that we had, it looked completely different from the cybersecurity people.

Kfir Kimhi: (07:28)
I think that not only that is expectation from the company not to create downtime. To allow the people to work, to be careful with how much blocking the companies are doing. That balance become even more critical when we have 100% of employees working from home.

Ron Moritz: (07:53)
And I think you're right. I'm going to shift over to Ronen Yehoshua. Ronen, of course, the founder CEO of Morphisec. I've actually known Ronen for many years. And I know what gets him fired up. All you have to do is ask him who prevents the most dangerous cyberattacks, and he'll jump up and down and tell you that he does. So we'll start off a little bit more slowly with Ronen today and continue talking about this remote employee issue that Kfir actually raised. Working remotely, of course, is not new. And my own personal motto has been for many years, a good day is one where I don't see the inside of my car. Anybody who's talked to me over the last decade or so has heard me say that. Ronen with fast network connections and more workers, contractors, customers, partners, all of them leveraging personal computers to access the company's applications from anywhere from everywhere. How are organizations reacting and what are they doing? What have they done to ensure controls are in place to prevent these attacks?

Ronen Yehoshua: (08:53)
So, of course, everyone, I think what we've seen all over the place is that in the early days, everyone got actually into a big shock. Why shock? Because imagine your endpoint workstation is a major door for every cyber attack. That's the main door for any sophisticated attack. And for years, customer where used to build a certain architecture of defense over those endpoints. Actually, assuming that those endpoints are within a certain perimeter. So imagine that you are building ... you have a medical camp and you need all kinds of fences and other fence and other fence and other fence, and you're feeling safe and great. And suddenly one day everything goes out of this camp, outside of fences, everyone is out of the property [inaudible 00:09:49] for many years. How do you cope with that? It's a nightmare, just a nightmare.

Ronen Yehoshua: (09:56)
So at first, we've seen everyone trying to understand actually how to allow them to work? How do you think the PCs is the workstation out of the office into the home? And for some, how you allow them to work from their home PCs and then moving to cloud application Kfir mentioned, a huge movement there. But still, there's an endpoint, there's a station. Someone work on that, he gets emails, he browses, he is connected to the network at the end of the day of the organization, and he's totally exposed. So that was a big shock for everyone.

Ronen Yehoshua: (10:37)
So what you've seen, that some is taking immediate actions like VPN, the old known VPN which was almost neglected through the recent years has become a hero again. And everyone jumped on that. But VPN has its own issues from operation perspective and from a security perspective. It's not perfect. It's there but it's not perfect.

Ronen Yehoshua: (11:03)
We've seen customers which used to be VDI, Virtual Desktop enhance the usage of it, hoping it would give you more security we're able to manage centrally the virtual endpoint now inside the pyramid kind of. And understand whether the endpoint protection tools they had are manageable? [inaudible 00:11:33] really manage them when they're outside of the perimeter because those tools are so complex. And there are so many operational complexities that they got to use to manage them when they were in the perimeter, but now on the outside, it's a hassle, for example, updates. Every security tool needs continuous updates of knowledge about new attacks, new variation of attack. So when you are in the perimeter, it's easier to push them into endpoint. But what do you do when everyone are outside, you have less control on the endpoint. You don't know what's going on there? Maybe it's a home computer, what do you do with that?

Ronen Yehoshua: (12:12)
So a big mess. Until today only partial solutions, nothing is perfect and people are coping with that. But I think the interesting point though that everyone understand that this situation will be with us from now on post-COVID, and that's the big change. That's what's so fascinating because it's not that the situation changed for a short duration of one year, two year duration. It's probably going to be with us onwards not because of necessity, just because we all understood that a hybrid work for home office is the right way probably to do.

Ron Moritz: (12:54)
Right. I think this is a kind of a consistent feeling that I have when I'm moving around the cybersecurity industry as well. We kind of look back at the last 40 years and there's some who believe and they may be right that cybercrime and cyber terrorism, cyber warfare all originated with the technology cycle that began 40 years ago when we introduced personal computers and that the root of all evil stems from allowing people to have personalized computing experiences. So you can imagine what that means. It means that we're living in a world of stupid human errors. And I think cybersecurity recognizes that. Kfir in fact, suggested there's a relationship between the growth in such errors of working from home and creating more errors and more problems and stupid things that we do, whether it's allowing our children to use the same equipment that we use, and then introducing a certain malware or certain problems because of that.

Ron Moritz: (13:54)
There's been a lot of talk that in order to stem this growth and control such problems, organizations should embrace this idea of Virtual Desktop Infrastructure or VDI and some of the metrics actually suggest that more organizations are doing so in response to COVID-19 in fact. Do you have any insights around this VDI move as a cybersecurity strategy and maybe some of the things you've seen in the market? And what is, in fact, the security impact of VDI on a positive or negative and challenges you've seen from those who've already adopted it?

Ronen Yehoshua: (14:32)
VDI is, of course, a known infrastructure that was introduced ago with the two main targets. One is to simplify operations, manage everything centrally and all that, updates and things like that. And also from security perspective, the notion that if you have a more centralized control over your endpoints, you can secure them better. And that within the perimeter, the user can connect them from the outside and all that. So we had that in the past, and now it was to an extent a market that was slowly growing, but many used it partially. Now when Corona came and everyone went [inaudible 00:15:19], it was obvious that VDI is one of those elements that dramatically improve coping with the situation, both from operational perspective and also security perspective.

Ronen Yehoshua: (15:30)
So we've seen a customer who already used VDI expanded dramatically the usage of that. And we've seen customers who did not use VDI rushing to implement it, but it's not easy. Implementing VDI in organization it's a whole project. It can take a year to do that. But they had to do it fast. One of the elements we've seen is that recent years and the last two years, I think we've seen a new way of delivery of VDI through the cloud. We've seen VMware, we've seen Citrix, we've seen Microsoft investing a lot in delivering VDI system through the cloud for the public cloud. So if you do that, you can implement it in a quite fast way. So we've seen a lot of movement into VDI and people thought, yeah, that's going to secure us. But that is obviously not enough.

Ronen Yehoshua: (16:33)
In using VDI helps you that much and a lot of exposure for the VDI use case itself. And also for the person who is working with the VDI on the edge, on the other side. For example, if you're using your laptop to connect into a VDI system, you may think that nothing can happen on the endpoint because everything you do is done on there, the machine in the organization. But guess what? If for some reason someone was able to put a key logger on your machine, he can think everything, everything that you type that goes into the organization, including passwords. So what do you do then? You still need a protection on the edge machine. And again, the VDI itself it's a data [inaudible 00:17:30] and endpoint. It needs to be protected like any other endpoints. And not only that, it has a certain operational complexities that regular security system dramatically reduce the productivity.

Ronen Yehoshua: (17:45)
So VDI to summarize was heavily used during Corona. And I believe that it will continue to be used, but it represent new kind of needs in terms of security to make sure that it's a secure infrastructure.

Ron Moritz: (18:05)
Sounds good. I want to shift a little bit and in a way talk about some ideas that we just talk about seemingly every day, this concept of AI, and of course, Mark Gazit is the founder and CEO of ThetaRay which is a AI deep tech company that is very actively helping expose a variety of financial cyber risks that include money laundering, fraud, and bad loans. Which of course, I think we all understand what those issues are. Those are serious crimes. Everybody knows that the bad guys are attracted to money, and it's kind of like flies to manure, which means that Mark and his team are either cybercrime action junkies, or they love playing with manure. It's not unusual to find a correlation between economic down cycles and increased criminal activity.

Ron Moritz: (18:55)
And in fact, when times are tough, a criminal inner self is empowered to sprout what we might call chutzpah, which seems like inappropriate word to use given that I have three Israeli cybersecurity companies here. But even before COVID, neobanks, digital banking, all of that was attracting criminally motivated innovation and real innovation. We're not talking about lightweight attacks. We're talking about sophisticated innovative attackers that challenge our best cyber defenses, crawling through the action on the front lines between the good guys and the bad guys. Mark, can you tell us a little bit about some of the things that you've seen, the new changes, the challenges in this COVID year in this pandemic year?

Mark Gazit: (19:40)
Absolutely. And you're absolutely right. Even before COVID-19 the bad guys what attracted to money naturally. And you also mentioned the fact that the original sin was given everybody ability to have computer on the desk and then connecting those computers. So everything is connected and probably banks was the last type of organizations that try to keep their branches and try to ask people to come to branches of banks and field forms, etc. And, of course, even before COVID-19 digital banking became available, bad guys definitely wanted to use it. The sums are huge, we're talking about billions if not trillions of dollars. So it's attracted not under the most chutzpah out of the bad guys, as you said, but also, it created a hunt after the talents. So the most talented criminals today will do what they call financial cybercrime because the payoff is very high and the risk is very low.

Mark Gazit: (20:52)
The days of people trying to come to a branch of a bank and threaten the clerks or shoot them up are over, it still happens in Hollywood movies. It's okay. But in reality, it's so much easier to put a server in some remote country. And the server will save 25 cents from your bank account, but will use AI and do it hundreds of millions of times. And then they will disconnect the link, still maybe 20 or $30 million. And if you want to catch those guys, be my guest. Governments do it. We know that North Korea they stole $1 million from Bank of Bangladesh using cyberattack on Swift network. It's happening all the time. You would like to launder money. Again, it's so easy these days to open accounts. Now COVID-19 definitely accelerated this process. Because if historically bank had an opportunity to tell you maybe to come to the branch of a bank to identify yourself, today it's much more difficult if not impossible. You can be in Israel, but you have a bank account in the United States. What do you do? You cannot travel. So banks have to create some level of trust.

Mark Gazit: (22:05)
By the way, "poor bad guys", also suffer from the same phenomenon. Historically, you could put some cash in your suitcase and travel if you wanted to finance terrorist activities or human trafficking. If you're not a big fan of cash, you could put some diamonds in a suitcase, travel. Again, today it's impossible. So we have this huge problem of fantastic amounts of money moving between countries. It's a $20 trillion in 2020, it will be $35 trillion in 2022. And the ability of banks to analyze this data, to understand what's going on based on existing technologies that they used before, which were created for the traditional banking systems, whether it's rules, threshold, or signatures becomes almost impossible.

Mark Gazit: (22:58)
So the only way we see that now it's possible to deal with these type of attacks is by using artificial intelligence that mimics human intuition. And basically makes computers to think more or less like human beings, because we all know that through the real attacks comes from the places that you least expect them to come. And because everything now is connected. And as you said, everybody has access to computers. It's so easy today to conduct cybersecurity attacks and steal real money. And the last but not least on that regard, if you mentioned AI, one thing that people don't appreciate is the bad guys have access to artificial intelligence. They're amazing scientists. They don't follow any rules. "Sometimes they take professors and give them proposals they can't refuse." And so they have access to technology. And we assume we as good guys have to use the best technology possible to protect ourselves.

Ron Moritz: (23:56)
You mentioned some numbers that are simply just too big to put my head around. When you talk about market opportunities that are in the trillions, certainly that is an incentive to build a corporation. So the bad guys are certainly building some of these corporations, but you yourself are working with some of the most technologically advanced global banks, some of the biggest banks in the world, and they're counting on you to help them stay ahead of these financial losses, the embarrassment that comes from the financial and cybercrime that they experience. You must have a lot of sleepless nights, but also probably some tremendous highs from the work that you and your team have done stopping the bad guys. I'm wondering if you could actually get into a story or two and share that with us because I think that'll be fascinating.

Mark Gazit: (24:49)
Well, absolutely. These bad guys become bolder and because it's cybersecurity and because it's all remote, they also know that the price of failure is much lower. They can be physically arrested. And it's this specific work to work with those banks. Some of them went public about the work they do with us, like [Santander 00:25:09], but some of them, of course, keep it more confidential. So we're not mentioning names. But yeah, sometimes we work very hard. And then for example, we identify networks of tens of thousands of people financing ISIS. Now, when you look at those transactions that were different accounts, every transactions were very small. $10, 15 Swiss Francs, €8. And they all look different. They're all coming from different places, but when you take artificial intelligence that combines all those transactions, suddenly you see tens of millions of dollars flowing to finance terrorist organizations.

Mark Gazit: (25:49)
And obviously our system help banks to identify it and then law enforcement agencies went in and luckily for us totally stopped this type of activity. And I think each and every one of us especially Israelis, but all around the world could be influenced by this ability to finance financial organizations. And it was almost impossible to identify those transactions because they were really different.

Mark Gazit: (26:22)
Another one is a human trafficking. One of the banks that we worked, we found very, when I say we, artificial intuition system found different set of transactions again in the hundreds. And we found that actually all were about human trafficking, poor girls that were sold from one of the Eastern European countries. So yeah, it's true. We catch bad guys, by the way, in this case, Interpol went in and that took care of it. And we know for sure that we did it before the girls were transported. I know there's a better way to describe it. So definitely there's a huge excitement and the understanding that we make a world a much better place. And you're absolutely right, when there's a downtown, there are more people that join those bad guys when everything is connected, the way to transfer money is easier. And we just need to remember that behind those scientific worlds, cybersecurity, financial cybercrime, etc. sometimes there are real lives that are being affected. And it's great to make those lives better.

Ron Moritz: (27:40)
Absolutely. Sounds truly fascinating. And this talk of cybercrime makes me think about the different roles that are played by both police and military. In both organizations we find the offensive and defensive activities, and they range from protect and serve, which of course is the logo of the police and peacekeeping and active defense and proactive strikes. And these are terms that we sometimes hear in the cybersecurity industry as well. There's probably a fine line sometimes not so fine line between many of the roles played by police, a civilian service, military national security service. Different times we've talked about having offensive cybersecurity. As a pandemic has played out this year, we saw many different ways in which the political leadership, in fact, attempted to leverage these services in our international battle against Coronavirus. Some have been more successful than others.

Ron Moritz: (28:31)
I'm going to start with Kfir. I want to understand this role that police and military have, the metaphors that we've using over the many years to explain cybersecurity. Maybe you can help us understand the differences between these approaches? And looking backwards, which approach do you think was more successful in response to this year's pandemic related cybersecurity threats?

Kfir Kimhi: (28:55)
I think again, that it all depends about the attack factors. So if we are talking about the necessarily to protect our boundaries from extended attackers? Naturally, we need to wear the hat to of a military person. We need to be able to use tools that will allow us to put the attackers as far as we can. When we are looking about the insider threat, when we are talking about the attackers that is already inside the network and might harm one of our major systems or file storages where we keep all our crown jewels. Or if we are talking about one of our employees that is using the data, either in not a careful way or even about to leave the company, doesn't know what's going to happen with him because of COVID-19, maybe he's confused because about something that happened in his house and he's deciding to take massive amount of data before he leaves the company, needs a completely different approach. And military tools will not help. You cannot shoot with a tank on a school even though there might be some big exposure happening inside.

Kfir Kimhi: (30:26)
So the approach need to be different when we are talking about different attack factors. And when we are talking about insiders, we need to wear a policemen hat. We need to explain, we need to present what would be the punishment. We need to train and give also some good sign or a warning if it's needed. But it need to be with education, with bringing the people in and understand what is our expectation of them? And the capability to put the security cameras as well, to understand that if something bad is happening, that we need to be involved, we need to explain, we need to warn. And sometimes we need to take action.

Ron Moritz: (31:18)
So, Ronen and Mark, same questions. Are you aligned with Kfir, or do you see things differently?

Mark Gazit: (31:25)
So shall I jump first? Just because I'm not muted and Ronen is. It's always a challenge in those [inaudible 00:31:34]. So I am very much aligned with Kfir. I think that the role of law enforcement agencies is changing. Ron, of course, you know about my history and past with those agencies. I think again, before COVID-19 they all understood that the world is changing. They all understood that one of my good friends who is head of one of the European top security agencies told me, "We have dedicated people that come 7:00 AM, they drink coffee all day, and then maybe they will work till 7:00, 8:00, maybe 9:00 PM. And then they go to sleep. And he said that our clients would wake up at 3:00, 4:00 PM, will go to the closest internet cafe. They will take Vodka Red Bull and they would start their work. That was before COVID-19. Now, they're doing it from home and everything is connected, and that technology is there. The encryption is there and the know-how is there.

Mark Gazit: (32:38)
So I think the government agencies understand more and more they should be able to build tools and legislation that would allow them to identify this type of activities. They should count more on technology. And more and more people are becoming computer savvy in law enforcement agencies. I have to say there is a caveat here though, and that will give you again, an example, you asked me to give real examples. So I gave you an example, we found that our system in use [inaudible 00:33:14] artificial intelligence, in many cases, identifies a money laundering 70 days before the actual attempt to withdraw money from a bank and conduct the crime happens.

Mark Gazit: (33:23)
Now, on the other hand, we don't want to be in a world that is the minority report for those of you have seen the movie. So Police departments and security agencies, they can't just count on computers to indict people. No, none of us would like to be in a situation that suddenly some algorithm decided that somebody is guilty and then this person goes to jail. So I think that it creates a challenge for law enforcement agencies and we see with many regulators, how to use technology, but make technology full explainable and transparent. For example, AI is an area where you don't necessarily know how decisions been made. For example, you say, Alexa, turn on the lights. You don't care why Alexa understood you? You just knew they use was what they called neural networks and deep learning, etc. But when it comes to law enforcement agencies, you have to be able to explain each and every step. And usually when we start this type of discussion and with regulators, with government agencies, first, we say, "Look, we understand that black box is not good for you. Let's talk about glass boxes, let's talk about transparency.

Mark Gazit: (34:37)
And so to summarize what I said, I very much agree with Kfir that, like anybody else, law enforcement agencies are going through transformation. That's been extremely accelerated by COVID-19. And I think that there will be more and more scrutiny to see that those technologies that we use in day-to-day life will be explainable. We'll be transparent. We'll be able to also withhold the scrutiny of judges and courts, which I think is the right direction.

Ron Moritz: (35:13)
Yeah. In fact, just to add a quick comment there, I've been excited to see that in the area that you serve, the financial services, the regulators are finally coming up to speed when it comes to some of the deep tech technology that innovative companies like ThetaRay are introducing. Ronen, did you have anything you wanted to add to that thought?

Ronen Yehoshua: (35:35)
Yeah, I would add from a bit different direction. Even before COVID we always discuss that one of the major challenges defenders in cybersecurity have is that ... if you think about military? It's how to be on a defense posture. We've been taught in the army that the best defense you have to quickly move to attack. You cannot stay on the defense side because you always lose. But the challenge in the business world is how can you attack? You cannot attack, even if you knew, who would you attack? We don't know who to attack. So it got to the discussion, a different term, which is a reactive and proactive. So if you cannot attack, then the best you can do, you should be proactive rather than reactive. You cannot allow ourselves just sitting like a duck waiting for the attack coming onto you and build the defenses and wait for something to happen and react. You need to be proactive, but the challenge is how can you be ... what's the meaning of being proactive in cyber security?

Ronen Yehoshua: (36:49)
That's one of the things that Morphisec, actually was built upon on the idea of being proactive with moving down defense technologies and all that. So and I think now with COVID that even become even worse because we all understood that, again, with all this parameters, those defenses being reactive all the time, and suddenly, poof everyone is outside. There is no perimeter anymore. You don't know what to protect. Your employees are at home and moving around with the computers and your other applications are moving to the cloud. We had that before, but now everything is very intensive. So that brought many to think that we have to change a mindset from a defensive reactive to a more proactive approach.

Ronen Yehoshua: (37:40)
And I think one of the interesting subject that came up, or became more intensive is the zero trust architecture discussion which is a kind of a method, I would say that can cope with this new environment, new reality, where everything is dispersed. Everything is outside. You cannot think about any parameters. You don't have this military camp that you're protecting. Everyone is outside. And now you have to think differently how you protect. So zero trust is an interesting architecture, lots of vendors moving there. And I think that's something that we'll see evolving strongly because of that.

Ron Moritz: (38:27)
So that's interesting. You're starting to touch on some of these direct and long-term changes in cybersecurity that COVID-19 has brought about. And you've been engaged in the industry across many verticals for a long time. I'm just wondering, on the basis of this direct changes that you've talked about, has COVID driven other changes in cybersecurity consistently across all verticals, or if not, which sectors are actually experiencing the greatest impact and why do you think that's the case?

Ronen Yehoshua: (39:02)
Yeah. I think that we've seen two interesting segments which we didn't think about before that they become highly attacked. One of them is healthcare. Healthcare always was a target but I think it's tripped now, very, very intensive. And we see lots of successful attacks coming there and we get a lot of calls from customers that are in panic. We've been in a never-ending sales cycles with them and suddenly, "Hey, we buy now? Because shit we heard about the other hospital in the other County that was just hit." And so that segment is dramatically raising interest in the area of cyber attack. I don't have an exact answer why? I think those organization traditionally were not sophisticated, very exposed and suddenly have become a very easy attack and especially they're in turmoil, why? They're working so hard, there's so much load on those organization today. And I can assume that their IT and systems and security's collapsing, just collapsing from the load, from the diversity they have to deal with. So that's become an interesting a segment.

Ronen Yehoshua: (40:27)
And the second one, again, very surprising especially the U.S. is the education system, the K-12 and all that, attack tripped. And most probably the reason is the remote learning. All student now are connecting into the schools, organizations remotely and no one is prepared. This movement outside opens many, many doors and are just jumping on that. And this organization they're not sophisticated, it would take them time. And if you ask them for ransom, well, they would probably give you the ransom.

Ron Moritz: (41:09)
There's certain irony to hear you call out the healthcare industry in a pandemic year. Do you think that the response in the healthcare industry and maybe education as well has been adequate, or is there a lot left to do? I'm a healthcare CISO, Chief Information Security Officer, what do I need to include in my 2021 resolutions, where at the end of the year, we're all making resolutions. What are those guys going to be thinking about?

Ronen Yehoshua: (41:37)
Of course, they have to stress in what they have, and they have to do that not in the traditional way. They first action someone will do when he's under stress, he will try to build the defenses he knew in the past or he heard in the past, but as we just spoke, they are less relevant today. And they need to think about more innovative ways and approaches again, being proactive, applying prevention methods and things like that. And the challenge is also ... Again, many of those, such as healthcare security is not a business. Financial and bank and insurance. This is part of the day-to-day. They have lots of teams heavily invested. They have SOC analyst and all that. Healthcare will never have that, education will never have that. So they have the challenge of finding effective systems which are easy to operate. And as you know in security, it's a magic formula.

Ron Moritz: (42:47)
Sounds like making security simple is a way forward for all the cybersecurity companies.

Ronen Yehoshua: (42:55)
Exactly.

Ron Moritz: (42:55)
I want to get a little bit more personal before we begin wrapping up. All of you are of course, are responsible for important category, leading cybersecurity companies. MBA101 teaches us that you all have responsibilities to your employees, your investors, and of course your customers. That's the first thing you learn in business school. But there's no MBA course, or at least there hasn't been in the past. There might be in the future which, of course, we'll have to do over Zoom, but there's no MBA course to really prepare anybody for a pandemic and let alone CEO.

Ron Moritz: (43:26)
So I'm really interested in hearing your own experiences, how each of you might've read the economic signals, the business tea leaves in the first quarter of 2020, and then how you actually led your companies through the pandemic, and did COVID-19 effect your business models? Where you're forced to scramble to create new business plans? Did they impact some of your product roadmaps? And did COVID-19 provide new opportunities that you wouldn't have had had the pandemic not happen? So I'm really interested in hearing from all of you guys. So round robin it, whoever wants to go first, feel free.

Ronen Yehoshua: (44:06)
I can jump in. [crosstalk 00:44:07]-

Kfir Kimhi: (44:07)
Yeah, go ahead.

Ronen Yehoshua: (44:09)
No, Kfir, I was just speaking. Please.

Kfir Kimhi: (44:12)
Okay. I think that it's related to three things. First of all, when it's coming to customers, we look at the opportunity. And luckily for us, we are creating the next generation of the DLP, and traditional DLP was so hard and so complex and so expensive. So companies that even started a DLP project, and just in the beginning stages of the classification and look how bad and how long it's going to happen? As they're coming to us and know that they couldn't do it in a much faster way with a much lower budget, make it much more appealing to them to work with a startup company. And that's created a very big opportunity for us. And we see 600% in the last quarter coming because of that.

Kfir Kimhi: (45:16)
From the other perspective, we are talking about investment. And luckily for us, we did a short investment right before COVID started, but we are definitely looking now to do another round, to make sure that we are safe for the next 24 months and can grow faster. So we are definitely looking at that if weren't expecting to do finance year-round during 2021. Now we are working on that intensively to start doing it in Q1, 2021. And for the third parties, of course, our employees, which brings two different things to the stage. First of all, the workforce. We see a lot of opportunities in bringing more people in, very good people that can join in both from the technical perspective and also from the sales perspective. We see an increase in the amount of potential employees and employees that would like also to work on success fee, which we haven't seen in the past in such large numbers.

Kfir Kimhi: (46:36)
So I think that those are the three major changes that we see that we are trying to work with. And we hope that we build something that is strong enough to keep growing in this Covid time.

Ron Moritz: (46:53)
Mark or Ronen, any thought?

Ronen Yehoshua: (46:58)
[inaudible 00:46:58].

Mark Gazit: (46:59)
Okay. Thanks, Ronen. So definitely when COVID-19 started, and as you said, they don't teach you in Harvard Business School about COVID-19, but you always have this sort of two tendencies. And as CIO, I found that the always need to deal with the short-term, long-term growth versus profitability, etc. And here, a new crisis comes. So first, we braced for impact, we reduced cost significantly. We said, let's make sure that we have enough financing. Started financing round immediately. And evaluated all our current customers. And then when the fog went down a little bit, and we understood that COVID-19 is with us to stay. It's not something that will disappear in a month or two. It was back in April. I actually took another quote by Winston Churchill that said, "Never waste a good crisis."

Mark Gazit: (48:06)
So we said, "This is a crisis, so let's see what we can do?" And then we just started to listen to our customers and ask them and look at them and to see what's going on there? And we found something very interesting. On the other hand, their business model is changing. For example, when we install our system, it is usually a big project, long deployment cycle, a lot of integration with internal systems, they just cannot do it anymore because people are at home. And banking system is not something that you can do and replace remotely. So it was a surprise for them. On the other hand, we found that although some of the projects going slower, actually everything that comes to international transactions is growing. And in some cases, banks told us, "Look, let's slow down the project a little bit." But when it came to correspondent banking, they told us, "Look, we want it yesterday. We need it now."

Mark Gazit: (49:01)
And we said, "Look, if something good is happening to them, then let's focus on that particular area." I can tell you that we did more deployments during the COVID time than we did for the entire 2019, because they really needed solutions that are working, deployed and active. And, of course, we also had to change our sales model. We love meeting people. We sell trust. So building trust relationship is extremely important, but how can you do it when you can't even travel and meet with people? So we definitely created more events, virtual dinners, and we can talk a lot about it. Also, ability to take the company, to build the company, to keep it together every week. We always had what we call, [foreign language 00:49:57], it's religious. We do it, and people connecting from all around the world...

Mark Gazit: (50:06)
So in a nutshell, I would say that we do look at it as an opportunity. It's not a secret. Again, I mentioned something there because they made it public that their digital banking business grew by 40% during COVID-19 and we are lucky to be in heart of it. So we look what's working, we try to invest more in those areas. We try to find constantly things that are not working and try to not invest in those areas. And the most important is to keep in touch, to keep in touch with our customers, without shareholders, with other stakeholders. And of course, to make sure that all the employees keep in touch constantly.

Ronen Yehoshua: (50:50)
Yeah. So from an operational perspective more of the same as Mark as just mentioned, can add do that, that with all those actions that you mentioned internally, we also ... How you use [inaudible 00:51:07] every crisis is an opportunity. What do we take out of it post-COVID? Because we quickly understood that the way we work will change. So let's start now or get organized for the day after.

Ronen Yehoshua: (51:23)
For example, R&D, everyone they're using a desktop, we moved everyone to a laptop. It's a big project that gave a lot of flexibility about how we work with them. And we started planning how the office will look like, how we do the shifts with new people the day after, and start implementing it now. So looking from an operational perspective, look at the opportunities that Covid brings in. From a customer perspective, of course, every crisis is an opportunity as well. So we try seeing where the opportunities there? Work from home, of course, is an opportunity, we understood quickly that going out is a major issue. So we came out, of course, quickly, like everyone does, by the way, in our now market. Quickly with all kinds of offerings around that, all kinds of promotion around that. And of course, we were happy to see that works.

Ronen Yehoshua: (52:18)
And we also, from a product perspective, we, for example, that was the trigger for us to move to cloud delivery. Our product traditionally it's an architecture of a management system that is hosted usually on the on-premise because customer wasn't worried about security and all that, but now everyone wants to move to the cloud. So that was an opportunity for us to do that. We want to do that before, but they needed the trigger. And that was the trigger, and guess what? Now, almost every deal that we do is cloud-delivered.

Ronen Yehoshua: (52:52)
So that was also all kinds of issues around the product that we leveraged because of COVID. And of course there was a lot of challenges. Lead-Generation, very, very hard. People disappear. The phone number when the office is not working anymore. People are listening to webinars because they're bored and they have time, not necessarily because they want to buy. So you have a lot of a garbage in your lead generation. So a lot of challenges around that.

Ron Moritz: (53:30)
Hopefully, the people who registered for this Salt Talk are here to learn [crosstalk 00:53:33], at The top of the hour. And I really did want to ask one final question, because I know that two of you Ronen and Mark, you were already out in Abu Dhabi earlier this year following the signing of the Abraham Accords at the White House last summer. I'm aware and I have been aware for many years that there's significant demand for cybersecurity solutions throughout the Gulf Cooperation Council, especially in the financial, healthcare, and government sectors which we've talked about throughout this past hour.

Ron Moritz: (54:08)
Given Israel's place as a global cybersecurity powerhouse by most reports, second to the United States, I'd be remiss if I failed to ask about the opportunities these new relationships with the Gulf States and other States in that region offered to your companies and what impact that's had on your sales and marketing strategies or will have on your sales and marketing strategies? This seems like, maybe you have a different perspective, but it seems like the Abraham Accords are counterpoint to this very challenging pandemic here. So really quickly 30 to 60 seconds round robin, let's get your thoughts on that.

Ronen Yehoshua: (54:58)
I think all of us were very proud to be there. We're highly excited. Now, from a business perspective, in terms of security, again from a very initial look, it's a highly developed economic environment. Highly, amazing, but it seems that in the early days of digital transformation, I would say maybe one step behind the U.S. or Europe or something like that. That's what's my feeling. And they definitely understand that the transition the digital transformation brings with that the risk of cyber and they have to deal with that in the early days of the implementations. And of course, they are looking for best of breed. They're looking for the best technologies and the only used to work with Israel, I think before on the agriculture and all that. And I understand there's a great opportunity here because the [inaudible 00:55:54] cyber. So obviously cyber will be a hot topic, nice business to do there. And I definitely foresee things will happen. Looking forward to that.

Mark Gazit: (56:09)
Yeah. Ronen, I think it's a very nice finish to the discussion. Because absolutely Israeli technologies and the growth of the market in the UAE in the Middle East and the corporation thanks to Abraham Accords creates an enormous opportunity. It's not that there were no commercial ties. Again, you know about my past. But now at least for me to make it formal, to make it public, to be there, not only as a business person that loves doing business in the Gulf, but to be there as an Israeli, having Jonathan Medved come in there. And of course, being part of Margalits high-tech delegation, it's a totally different feeling, a combination of pride, but also understanding that it's a huge and developing market. UAE looking at themselves as the next financial hub of the world in par with United States in par with London and with Singapore and Hong Kong.

Mark Gazit: (57:15)
I think that's also a gateway to additional countries in the Middle East and also to Africa as well. And it's only three and a half hours flight from Israel, and it's almost the same time zone. So I think that not all the people appreciate the huge opportunity that it created. I think we Israelis really need to make sure that we provide them the best solutions. I totally agree with everybody who said, "It's a very, very developed economy." They know exactly what they're looking for. They're looking for the best solutions, very advanced economy. And I definitely think that the combination of their access to market and the enormous growth. And Israeli innovation creates something that far beyond what we really expect. In my eyes, this is the new Middle East that where economy drives peace.

Ron Moritz: (58:10)
I'm thrilled that we've been able to end on a high note like this. I think we've just got some really interesting and nuance points today. I want to thank Kfir, Ronen, and Mark for joining us. I know the demands of company building are many and more, and I really appreciate the time that each of you is carved out to share your insights. Today, we've heard from 3 of OurCrowd's 200 portfolio companies. You can see more technology and startups and investment opportunities in both cybersecurity and many other sectors at ourcrowd.com. Thank you to our partner, Salt. And make sure you join us for the next installment on December 3rd.

Ronen Yehoshua: (58:48)
And thank you, Ron, for hosting us.

Mark Gazit: (58:50)
Thank you very much. [crosstalk 00:58:52].

Kfir Kimhi: (58:51)
Thank you.

Marlon Nichols: Cultural Investing | SALT Talks #108

“The more fund managers of color that we allocate, or that LPs allocate capital to, means the more people that look like them and have shared experiences with them, will receive funding dollars, as well.”

Marlon Nichols is a founding managing partner at MaC Venture Capital (formerly known as Cross Culture Ventures), which finds the entrepreneurs who are building the future for the rest of America.

A career started in consulting eventually led to venture because as a VC, one has skin in the game for the length of that investment. It offers the ability to directly shape the nature of the companies, support more diverse entrepreneurs and identify opportunities to address traditionally underserved communities through entrepreneurialism. Slowly, there are signs of increased focus on diversity in the venture capital space with many groups reporting on their diversity numbers. “A nerve has been struck, and people are digging in and seeing the value; not only the social value, but the economic value of diversity.”

Coining the term, “cultural investing,” it seeks to identify global behavioral shifts with potential staying power. Pop culture is the driving force, so it is used as a key indicator is predicting where major cultural movements are heading.

LISTEN AND SUBSCRIBE

SPEAKER

Marlon Nichols.jpeg

Marlon Nichols

Managing Partner

MaC Venture Capital

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

Joe Eletto: (00:07)
Hello everyone, welcome back to SALT talks. My name is Joe Eletto and I'm the production manager of SALT, a global thought leadership forum, and networking platform encompassing finance, technology, and geopolitics.

Joe Eletto: (00:19)
SALT Talks is a series of digital interviews with the world's foremost investors, creators, and thinkers, and just as we do at our global SALT conferences, we aim to both empower big, important ideas, and provide our audience a window into the minds of subject matter experts.

Joe Eletto: (00:34)
And today, we are thrilled to welcome, Marlon Nichols at SALT Talks. Marlon is a founding managing partner at MaC Venture Capital which finds the entrepreneurs building the future for the rest of America.

Joe Eletto: (00:46)
He's a former Kauffman fellow, and investment director at Intel Capital, with an extensive background in technology, private equity, media, and entertainment. Marlon's unique eye for global trends and shifts in consumer behavior has helped him capture many high potential investments which include Gimlet Media, MongoDB, Thrive Market, Fair, LSNR, Mayvenn, Blavity, Pipe, WonderSchool, and other companies that reflect overlooked markets.

Joe Eletto: (01:16)
He serves on the board of directors for Ajua, Blavity, Finesse, Kauffman Fellow's program LSNR, Riff, Sote, and WonderSchool. Marlon is the recipient of MVMT50 South by Southwest 2018 Innovator of the Year Award. A 2018 nominee of the ADCOLOR in Tech Award, Digital Diversity's Innovation & Inclusion Change Agent Award.

Joe Eletto: (01:41)
Was named PitchBook's 25 Black Founders and VC's to Watch in 2018 and 2019. Was the Techweek100 winner, and was named one of Silicon Republic's 26 VC professionals spearheading change.

Joe Eletto: (01:55)
He's been featured on TechCrunch, Fortune, Blavity, and NBC, and is adjunct faculty in entrepreneurship and venture capital at the SC Johnson College of Business at Cornell University.

Joe Eletto: (02:07)
If you have any questions for Marlon during today's talk, please enter them in the Q and A box at the bottom of your video screen, and now I am thrilled to turn it over to Sarah Kunst, a friend of the firm, and managing director of Cleo Capital to conduct today's interview.

Sarah Kunst: (02:22)
Thanks, Joe, and thank you, Marlon for coming, we're super excited to have you today, and we have a lot to talk about.

Sarah Kunst: (02:30)
We have been friends for a long time Marlon, and we've been in tech for a long time, but for everybody who has not known you for years, and years, tell us how you got here?

Marlon Nichols: (02:41)
Well, first of all, thanks for having me. It was great to get the email, or the call, and it's a pleasure to be here.

Marlon Nichols: (02:49)
I am the product of an immigrant entrepreneur; my mother. We're from Jamaica, and we moved here when I was about seven years old, and I watched her move from a housekeeper, and nanny, to a beautician, to then owning her own salon, and building that salon for about over 20 years. That salon essentially raised me.

Marlon Nichols: (03:17)
With that, I did my undergrad at Northeastern University and studied Management Information Systems, I was always interested in technology, and I thought that if I had a business degree, I could be helpful with my mom's entrepreneurial ventures.

Marlon Nichols: (03:30)
And so, graduated, and jumped right into the enterprise software world. I joined a seed stage enterprise software company right out of undergrad, and within a year, was asked to move to the U.K. to help launch that company in the U.K. to serve the U.K. and Europe.

Marlon Nichols: (03:52)
Three years later, that company was acquired by SAP, and I decided that I didn't want to be an operator and so, I shifted to the other side of the spectrum, and pursued a career in consulting. And so, I first worked with the Blackstone Group doing post M&A integration work. And then that shifted to more strategy consulting, focus on media and entertainment.

Marlon Nichols: (04:16)
And so, that was about a five year career for me in consulting and it went pretty well, I learned something about myself again, similar to the goldilocks story, right? Too small, too big, need something right in the middle. And so, what was right in the middle for me, was venture capital.

Marlon Nichols: (04:35)
I decided to go back to business school to pursue a career in venture. I chose Cornell University, I became the CEO of the school's MBA lead Pre-Seed Fund for the two years that I was there, and that enabled me to network into the venture community.

Marlon Nichols: (04:52)
I graduated with a job at Intel Capital. Quickly became an investment director, they sponsored me to be a Kauffman Fellow, which towards the end of that five year period, opened my eyes to the fact that I had wanted to also be an entrepreneur, but within venture.

Marlon Nichols: (05:12)
Set out create my first fund, which was called Cross Culture, we invested in 43 companies there, it's a very high performing fund to this day, and now we're on to our second fund, which we rebranded as MaC Venture Capital.

Sarah Kunst: (05:28)
Awesome, good and so, tell us about MaC. Tell us about Charles, and Adrian, your partners there. I've known all three of you separately, and you have three of the most accomplished prior careers before coming together to start a fund.

Sarah Kunst: (05:48)
Give us their bios in their absence.

Marlon Nichols: (05:50)
Yeah, and so, I am probably, the least interesting of all of the partners. You heard my background, I mean, Charles King was a Hollywood super agent when he was with WME. I mean, he managed the careers of folks like Oprah Winfrey, and Tyler Perry, Michael B. Jordan, Ryan Coogler, et cetera.

Marlon Nichols: (06:14)
And then branched out to create his own media company with a focus of making sure that black and brown folks had more representation... Better representation on the big screen, and on the major streaming platforms, and that company is called Macro.

Marlon Nichols: (06:30)
And then Adrian, Adrian was the fifth mayor of Washington, D.C., right? I mean, D.C., some could consider it a state, so he might as well be a governor. After leaving office, got tapped by Marc Andreessen to help create their regulatory practice, working with companies like AirBnb, and Lyft, et cetera. Helping them figure out how to navigate government, and regulatory agencies to build amazing companies.

Marlon Nichols: (06:59)
And then our other partner, Mike Palank who's also a WME agent, and worked with Charles at Macro for a while, also took the helm as acting CFO and CEO of a couple of startups himself. We just have a... It's an interesting DNA, because we have such varied experiences, but we get along so well, and see the world in such a similar way, that it just works.

Marlon Nichols: (07:29)
But those varied experiences helped us to create some really valuable relationships across a number of industries, that we can then leverage to help our portfolio companies grow.

Sarah Kunst: (07:46)
Yeah, absolutely. That's amazing. You've been an operator, and an investor, and have had a close-up look at entrepreneurship from your mom your whole life, do you love VC? I know that some of us are in it to maybe, change it a little bit.

Sarah Kunst: (08:03)
Tell us, what do you see as the pluses and minuses of our industry?

Marlon Nichols: (08:08)
Yeah. I like what I do, honestly, and it took me a while to get here, right? Just the mindset that I wanted to be in VC. The things that attracted me to it, or what I was looking for in my daily professional life was, one, I wanted to be around cutting edge technology all the time. I wanted to interact with super smart people that are very creative. You find that in most entrepreneurs.

Marlon Nichols: (08:38)
I also wanted to engage with companies at the strategy level, and I wanted to have some real skin in the game, right? With consulting, you can get a lot of that stuff, but you have no skin in the game. With venture, you're tied to this company for five to ten years, maybe sometimes longer, right?

Marlon Nichols: (08:59)
I did find those things, I find those things every day. I meet interesting people every day, I'm introduced to just provocative technology, and interesting solutions to real problems. I absolutely love what I do. Can the industry change? Absolutely. One, there's not enough diversity in the industry, not only racial, gender, and thought, we can get better on all fronts, and I think we need to in order to really realize the financial benefits that we all want to see.

Marlon Nichols: (09:41)
As an example, you think about underserved communities, and some of the challenges that those communities have seen over years, decades. And the fact that, if you apply technology to some of those challenges, we can solve them. And those represent billion dollar opportunities. We've invested in some.

Marlon Nichols: (10:04)
Unless you have a diverse team, investment team, to identify those opportunities and then to screen for the right founders to solve those opportunities, you're going to be sitting on the sideline, while these remarkable things are done, or created.

Sarah Kunst: (10:23)
Can you tell us a little bit about Kauffman Fellows; what it is, all of that?

Marlon Nichols: (10:27)
Sure. It's a two year fellowship in venture capital... Global fellowship. And it started out as wanting to basically, introduce talented people to venture capital and get them started in this space. It has evolved over the years to an organization that can help existing venture professionals become better venture professionals.

Marlon Nichols: (10:55)
And we do that through connecting to a pretty significant global network of the who's who, and the who is emerging, in venture capital. As well as, teaching some of the key traits that I think, make for a great leaders. How do you... Diversity, as I mentioned, right? Why is that important? Why should you embrace it, right?

Marlon Nichols: (11:25)
Part of why I was so excited about joining a board is, because now I have an opportunity to really shape what the venture capital community looks like going forward.

Sarah Kunst: (11:38)
Yeah, and that's so important, and we're very glad you're there. You and I talk about this a lot, and we're in conversations a lot about this, but what does the funding landscape look like for Black and Hispanic fund managers, and then also for Black and Hispanic founders, right?

Sarah Kunst: (11:56)
Especially, this year, of reliving the 1960s when it comes to the Civil Rights Movement, it feels like. Have there been changes? What are you seeing right now?

Marlon Nichols: (12:08)
Yeah. It's tough, right? It continues to be tough, however, I think, I'm seeing some chinks in the armor, there are some folks coming around and starting to realize that you're missing out on some possible exponential return opportunities as LPs, as you call it.

Marlon Nichols: (12:34)
I guess, the CIO was at Yale, just made a statement recently advocating for the need for diversity. Years past that never would've happened. We're starting to see a lot of endowments reporting their diversity number et cetera. Diversity has always been an interesting thing, because it ebbs and flows.

Marlon Nichols: (13:02)
At times, it's very top of mind, and then it goes away, and then rinse and repeat over the years. And what I'm finding this time around, is it seems to be sticking. A nerve has been struck, and people are digging in and seeing the value. Not only the social value, but the economic value of diversity.

Marlon Nichols: (13:33)
That's going to lead directly... The more capital that goes to diverse fund managers, will directly affect the number of diverse... And when I say diverse I mean, black and brown... Founders, that receive capital.

Marlon Nichols: (13:48)
Because it's human nature... We can try to game it all we want, but human nature is to work with, to be friends with, to spend time with people that resemble you in several ways, right? Whether that be, you just look alike, or you went to the same schools, or you grew up in the same communities, or you summered in the same towns. Whatever those things are that make you feel similar, and comfortable... That's what you're going to gravitate to.

Marlon Nichols: (14:22)
The more fund managers of color that we allocate, or that LPs allocate capital to, that means the more people that look like them, and have shared experiences with them will receive funding dollars, as well.

Sarah Kunst: (14:39)
Yeah, I totally agree. Awesome, well, be sure to drop your questions in the Q and A. Also, a great opportunity to pitch Marlon, he's a captive audience.

Sarah Kunst: (14:50)
Marlon, tell me, what can allocators and investors do? Right... You just said, it's super important to back more diverse fund managers, and diverse investors, so that more diverse people get funded. But what can allocators, and investors do to be better at both attracting to hire, as well as funding diverse talent?

Sarah Kunst: (15:12)
You worked inside of Intel Capital... And I've done the same thing, I've worked inside of large funds that aren't particularly diverse until we show up. What's the key to attracting that talent, and then what's the key to funding it?

Marlon Nichols: (15:30)
Yeah. I don't think it's any different from any other industry, right? If you put the word out that you are for recruiting diverse talent, then you'll get the applications, and you have to be open to receiving them, and truly vetting them, right?

Marlon Nichols: (15:50)
But then, it's about creating a community, a culture where they feel comfortable. There's been a lot of talk about the tech industry, and the woeful diversity numbers, and FANG does not have a hard time recruiting people of diverse talent in, they have a hard time retaining them, right?

Marlon Nichols: (16:19)
And that's because you're asking them to assimilate to a culture that doesn't quite fit all their needs, or considers their needs. And so, a big part of it is retention. If you let folks know that... If you're a venture firm, or you're a fund-to-funds, or whatever, and you are recruiting, you are going to get diverse candidates to apply.

Marlon Nichols: (16:46)
You got to pick the great ones, and then you have to create an environment where they can actually, feel comfortable, at home in, and thrive in.

Sarah Kunst: (16:56)
Yeah, I totally agree, I couldn't agree more. Amazing. So, what do you invest in? Tell us about the fund, and especially your areas of interest, and focus, and thesis, and what you're excited about right now, especially in this crazy COVID time... Stage, sector, all of it.

Marlon Nichols: (17:17)
Sure. That's a big question. I'll start with our thesis. We coined it, cultural investing. And for us, culture is the proxy for human behavior. Essentially, what we're doing is, we're trying to identify emerging behavioral shifts that are global in nature, and then doing a lot of research to figure out whether those shifts have stay power. Or put another way, can become a part of social norm or pop culture.

Marlon Nichols: (17:52)
And the belief is that, pop culture drives everything in our society. It's like the equivalent of having a crystal ball, right? If I can see where people are spending their time and money today, and I could see where people are going to spend their time and money in the future and invest there, then essentially, I'm investing in tomorrow's next great companies.

Marlon Nichols: (18:15)
That's the crux of our thesis, there's a lot technical stuff that goes into that, but I won't bore everyone with that here. And then, in terms of the areas we invest in... Well, the stage is seed stage, right?

Marlon Nichols: (18:32)
It's usually, we're a part of the first institutional round of capital that a startup is taking in, and we typically write initial checks up to 1.5 million seeking to get about 10% of a company at that stage.

Marlon Nichols: (18:50)
There are six areas that we've traditionally invested in. Commerce, which is leveraging the internet and mobile to sell products and services, and marketplaces are a subset of that. I love investing in very differentiated marketplaces. Fintech is another area, and the focus here is really about, the under and unbanked, and how do you move them or bring them on to the digital economy.

Marlon Nichols: (19:19)
And then health, or digital health, which is the convergence of telemedicine and traditional medicine, with the intention of fixing healthcare in the U.S. Driving down cost, driving up efficiencies, by leveraging technology.

Marlon Nichols: (19:36)
Immersive reality, and this is AR/VR et cetera, but for now, the focus is as intently on enterprises and how that technology can work, and solve real problems there for businesses.

Marlon Nichols: (19:51)
Media and entertainment, we have a lot of media and entertainment DNA, but what we're doing there is less around content, more around finding new and differentiated distribution channels, and platforms that can aid with the efficient creation of new content.

Marlon Nichols: (20:08)
And then regulatory, which really plays into Adrian's background. Where we're looking for companies that are building terrific, game-changing solutions, but that will bump up against the status quo, and will need help from our government allies, et cetera, to make it work.

Marlon Nichols: (20:34)
Those are the six areas that we typically invest in, and we lean heavy on the software side. We never say never in terms of hardware, but software is definitely our bread and butter.

Sarah Kunst: (20:47)
Awesome, that's so cool in so many things. What are some of the companies that you've invested in that you're super excited about in this moment, or just in general? I hate when people ask me this question, so I'm going to ask it to you.

Marlon Nichols: (21:01)
Which baby is your favorite baby?

Sarah Kunst: (21:06)
Classic. The one that pays you that's the answer.

Marlon Nichols: (21:08)
Yeah. There are a number of them. Probably, the hottest company in our most recent portfolio, is a company called, Pipe.

Marlon Nichols: (21:16)
Pipe is solving the friction between enterprise SaaS companies and their customers, in terms of, when you get paid, do you need to do subscriptions, etc. And it's also created a new exchange that allows these companies with recurring revenue to basically, fund their growth based on those recurring... Those contracts, essentially.

Marlon Nichols: (21:50)
It's a company that's growing very, very, very fast. It represents already, in less than a year, a 10X markup in our portfolio so, we're excited about that one.

Marlon Nichols: (22:03)
Another company in the media and entertainment space called Riff. They're basically, using three dimensional AI technology, to do dynamic and contextual product placement into film.

Sarah Kunst: (22:22)
That's amazing. And I know that your partner Adrian is very excited about one of your probably, most well-known on Instagram ad companies, NUGGS.

Sarah Kunst: (22:33)
And I won't lie, I'm not a big chicken nugget eater, and I'm not a big meat replacement eater, so I haven't yet had them, but so many of my friends are obsessed with them, it's like Supreme, if Supreme made chicken nuggets.

Sarah Kunst: (22:48)
Tell us a little bit about that one, just in case people have not yet heard.

Marlon Nichols: (22:51)
Yeah. That deal, unfortunately, was done before we got together. That was one of our legacy portfolio companies so, I don't know a ton about it, but you're right, every chance Adrian gets, he's posting about NUGGS.

Marlon Nichols: (23:07)
And their social media marketing game is just unmatched. But yeah, I think you gave the highlights of it.

Sarah Kunst: (23:15)
Yes. If you're looking for meatless chicken nuggets, NUGGS is your food.

Sarah Kunst: (23:21)
Tell us... How can founders make themselves more investible and easier for investors to back. I'm sure you're like me, and look at hundreds and thousands of companies every year, and there are probably, tons that... If they just were 10% better at the pitch, or the email, or the whatever, right... We might be able to dig in and find a gem.

Sarah Kunst: (23:47)
But I know for me, and maybe for you, I know I missed stuff, because the founders just... What they're building might be amazing, but the way that they're telling me the story, I just missed it.

Marlon Nichols: (24:02)
Yeah. One of things... Going back to the diversity conversation, right? One of the challenges is, how do you get in front of these investors? And it's not always fair, right? Because you may come from a place, or your network is very different from that of the folks you're trying... Whose attention you're trying to get.

Marlon Nichols: (24:25)
We have a channel on our website where any entrepreneur can reach out and fill out a quick form, give us their deck, et cetera. We commit to reading every single one of those as a team, and following up with the ones that make sense for us, right?

Marlon Nichols: (24:40)
That's just something that we're doing to make it easier for all founders to get access to us. Not everyone's going to get a favorable email back, but everyone's going to get a review, and a response.

Marlon Nichols: (24:56)
In terms of what founders can do, I think, it's two things. One, it's research, right? Introspection, and research as a pair. Really understand what type of company you're building, the scale and scope of it, right? And then, doing the research to find out which venture funds, or investors fit with that.

Marlon Nichols: (25:25)
It doesn't make a whole lot of sense if someone's focused on enterprise companies only, and you're a consumer company, for you to be reaching out, that's probably, not going to be a good fit, right? Square hole, round peg... Whatever.

Marlon Nichols: (25:40)
Do the research, there's so many investors out there, and be deliberate about who you're reaching out to and when. And then, the other thing I'd say is, follow their process. A lot of folks will tell you how they want to be reached out to, or how they prefer to connect.

Marlon Nichols: (26:02)
Some folks like just connecting on social media, and doing it that way. Some folks like to receive emails, some folks like for you to just submit your stuff on their... Whatever channel they have for you to submit it. Some folks like LinkedIn, right?

Marlon Nichols: (26:19)
You figure that out through your research, and just follow that direction.

Sarah Kunst: (26:25)
Yeah, I actually, say on my LinkedIn, instead of my bio blurb at the top... Do not reach out to me on LinkedIn to pitch me, please go to cleocap.com, and multiple times a day... And it's funny, because, the reason I say it is just because LinkedIn isn't a great tool for it, but then, I'm like, oh, God, I'm thinking about entering into a decade long relationship with this founder, that's harder to get out of than a marriage, and they couldn't read my only single, simple request.

Sarah Kunst: (26:54)
Candidly, never say never, but it makes me nervous about investee... About those founders, because I'm like, it's so hard to run a company, and there's so many things that are so hard to get right, that if you can't get those early, basic, obvious, I am telling you, in all caps, please, this is how to reach out to me right... What am I in for?

Marlon Nichols: (27:16)
Yeah, I mean we all have our little tests to see who should get the time, et cetera. But yeah, I'm less annoyed by it, and think of it less as a signal, it's more so, you probably just won't get my attention.

Sarah Kunst: (27:33)
Yeah, that's a great way to reframe it, look at you, that's what my therapist would say. Exactly, why give these people your attention? That's a good point so, if you're listening, you're wondering how to get in front of investors, they're preferred method is usually, not a bad place to start.

Sarah Kunst: (27:51)
If anyone has questions, drop them in the Q and A, Joe if you have a question, feel free to jump in, as well. But otherwise, let's just keep chatting.

Sarah Kunst: (28:03)
One thing that's come up a lot this year is, people are asking how the pandemic is impacting investing. As a really early stage investor, I've generally said, I don't think about it a ton, because there's an acceleration in trends, but the companies I invest in are pre-seed so, they're still going to be getting started years from now, when we're hopefully far past COVID.

Sarah Kunst: (28:25)
But has it changed how you invest? Or how has it made you think about investing?

Marlon Nichols: (28:31)
It hasn't changed how we invest. Because we have the fortune of being a little bit downstream from you, right? So, our sweet spot is, they have a viable product, and they're starting to get some feedback from the marketplace, right? We have some data that we can look at.

Marlon Nichols: (28:49)
In terms of COVID, I guess, the only additional thing that... Or the thing that, it puts a little bit more emphasis on is, can this company perform in down turns, as well as up turns, right?

Marlon Nichols: (29:06)
If it can't really, perform in a down turn, how much risk does that add to the equation, right? We're looking at that, but we've found in general, a lot of people have said this, COVID has proven to be an accelerant of trends.

Marlon Nichols: (29:27)
We talked about our thesis, which is all about behavioral trends, right? A lot of this stuff that folks are learning about now, we've already studied and have been investing along those lines, right?

Marlon Nichols: (29:43)
We have a pretty significant digital health portfolio already in place that's already appreciating, right? And rinse and repeat, right? It hasn't had an adverse effect on our portfolio today. In terms of meeting companies, that's a little bit different, right? Because you do the... Oh, let's go grab a drink, and let's get dinner, or lunch... You can catch folks in a moment where they're letting their hair down, and it's a relaxed environment, you have less of that now, right?

Marlon Nichols: (30:27)
One thing that I've been doing with the companies that we've invested in is, you'll get a random phone call, and text message from me, and we'll just jump on a FaceTime on... I don't know, 11 AM on a Saturday, just because, right? And not talk about the deal, or anything, just talk, right? So, I can get a sense of who you are, and are you someone that I want to spend time with for the next 10 years.

Marlon Nichols: (30:57)
You do things like that, and way more reference checks now, and blind reference checks, because you have less FaceTime.

Sarah Kunst: (31:04)
Well, more FaceTime, the app, less face time IRL.

Marlon Nichols: (31:06)
Yeah.

Sarah Kunst: (31:15)
How has that changed on your side, when you guys go out and fundraise, right? Because we'd go out and raise money from a lot of other people so, we have money to invest. What has that changed during COVID? Has it changed it during COVID?

Marlon Nichols: (31:30)
Yeah. We're able to have a lot more meetings, right? Because in the past, you'd have to schedule the in-person's in Boston, and Chicago, New York, and I live in LA, and now I can have all those meetings in one day, right? It condenses the process for us a bit.

Marlon Nichols: (31:52)
But then, on the flip side, we have seen one or two endowments and pension funds that are like, we absolutely need to meet in person, that's a part of our process. And so then, you'd have to... Difficult decision. Do I fly to Boston and have this conversation, or do we just take a pause on this one, and see how things pan out?

Marlon Nichols: (32:21)
Fortunately, I have a partner in Adrian that's not afraid of getting on planes.

Sarah Kunst: (32:25)
Nice.

Sarah Kunst: (32:29)
Actually, talk about that a little bit. Adrian splits his time bicoastally, you're in LA, he spent some time in San Francisco, a lot of the team is in LA... What do you think the future of work, both for VCs but also for startups looks like? Are we just going to be disembodied heads in different Zoom rooms forever? What happens post-COVID?

Marlon Nichols: (32:52)
I'll start with us, we're definitely going to keep our office, and all that stuff, right? We actually, share space with Macro, the media company, which creates a really interesting vibe, when you're blending startup founders, entrepreneurs, with creatives in the entertainment industry, right?

Marlon Nichols: (33:14)
Some really cool, and unique things happen that way.

Sarah Kunst: (33:17)
[inaudible 00:33:17] office?

Marlon Nichols: (33:18)
Yeah, wait till you see the new one.

Sarah Kunst: (33:21)
I need to come hang out, I just want to meet up, bro. I love it.

Marlon Nichols: (33:26)
Yeah. That's cool so, we're definitely going to maintain that, but because our team has been split between LA, and the Bay Area, and as you said, Adrian's back and forth to the east coast, we've always had the remote procedures in place, right?

Marlon Nichols: (33:44)
Our partner meetings have always been virtual, or partially virtual, some of us in one office space, and others wherever they are. We're set up for this, essentially. What I've been hearing from portfolio companies is that, for the foreseeable future, they're probably going to be fully remote. But longer term, there's probably going to be a satellite office wherever they consider their main hub to be. Where people can go to at different points throughout a year, or whatever.

Marlon Nichols: (34:22)
But for the most part, I think people are comfortable with being remote, and gaining access to great talent from wherever. Don't have to worry about convincing them to move, or dealing with that stuff. And I think, everyone is getting more and more comfortable with remote work, right? And being able to build a corporate culture remotely.

Sarah Kunst: (34:48)
Yeah so, if Oprah's not likely to show up at your office, you probably don't need one, I got it.

Sarah Kunst: (34:55)
We have a great question from [TJ 00:34:58]... What kind of international investment footprint would make you consider investing? Will you invest outside the U.S.? How do you think about that? What goes into that conversation?

Marlon Nichols: (35:11)
Yeah. When Joe was reading my bio, he called out two companies that are Kenya-based, Ajua, and Sote, both are Delaware domicile door, or incorporated, but they operate in Africa, essentially.

Marlon Nichols: (35:39)
What we're looking for in offshore investments is, one, who's a local investment partner that can be in the journey with us, because that's a long plane ride. And also, I don't know everything that I probably need to know about the local environment there, the culture, the economy, et cetera.

Marlon Nichols: (36:05)
So, you need a co-traveler that understands that so, we tend to get in with very strong local investors. The other thing is, can this be a product that is not solely for that part of the world? Can that product come to the U.S. or go to Europe, or wherever, and still be successful? Is it global in nature?

Marlon Nichols: (36:33)
And then obviously, the founders, right? Do you trust these founders, are they the right people to build this company, wherever it is in the world, essentially.

Sarah Kunst: (36:46)
Yeah, awesome. And do you invest in companies? I think you covered this, but... Do you invest in companies that don't have a U.S. presence? That don't have a Delaware Seed Corp? Because I know for me, I don't care where you're building, I just have to wire money to a U.S. bank account.

Marlon Nichols: (37:00)
Yeah, I just need to be comfortable with how the company will be... Which laws the company's going to be governed by.

Sarah Kunst: (37:10)
Exactly. As long as we can settle it in California court, game on. Yes.

Sarah Kunst: (37:16)
Awesome. And then [Steven 00:37:18] had a great question... What's the biggest difference between Intel Capital and being on your own?

Marlon Nichols: (37:25)
Yeah. My five years at Intel Capital were amazing. I learned a lot, and worked with some phenomenal people. The greatest difference though, is that it's a corporate VC and so, inherent in that, is that the investments have to be strategic to the company, right?

Marlon Nichols: (37:50)
And Intel was great, because it's an ingredients company so, strategic meant a lot of things, right? But there was still a universe of products and companies that I couldn't invest in, because they just didn't fit with the road map for Intel Corporation.

Marlon Nichols: (38:08)
I think, that's the biggest difference with being a financial VC, versus a corporate VC, it's a strategic mandate.

Sarah Kunst: (38:16)
Yes, yes. Awesome, and I think, we're almost out of time so, I just have one last question for you. It's far too rare I think, that conversations between two VC investors are two black people, right? And even more so, a woman. How do we make this less rare, right? You talked a lot about the tactics, but is there any... One piece of advice, or one thing to leave of... How do we make this the status quo, instead of a lot less common than it should be?

Marlon Nichols: (38:56)
I think just being more... We talked about the funding part of it, and what LPs need to do, but us as GPs, we just need to help each other, right?

Marlon Nichols: (39:09)
Whether that be around fundraising, sharing information about LPs that invested or didn't invest, and why that was the case? Making those introductions... If you get a speaking opportunity that you can't attend... Who can go instead of you, right? That is also black, that is also... That is a woman? Not also... That is a woman, right?

Marlon Nichols: (39:33)
It's just about putting each other on, and truly being co-travelers and allies.

Sarah Kunst: (39:41)
I love it, and I also love allies like SALT who have done an amazing job with bringing me on to have some of these conversations, and I think that, that's a huge part of it, as well. Because as they say in Africa, it takes a village. With that, thank you so much, Marlon, for coming on today, and thank you Joe, and SALT for having us.

Sarah Kunst: (40:04)
Marlon, if people here want to pitch you, where do they go to do it?

Marlon Nichols: (40:10)
macventurecapital.com/contact

Sarah Kunst: (40:13)
Amazing, amazing. Go find him there, and leave his LinkedIn alone. Awesome, thank you so much, Marlon, and thanks, SALT.

Marlon Nichols: (40:19)
Thank you, this was great.

Joe Eletto: (40:21)
Well, thank you both. I mean, it's truly a privilege to bring conversations like these to the SALT platform. I have a personal stake in bringing diverse conversations here as a member of the LGBTQ community. I don't see myself in these conversations, usually. I don't see myself in finance, I'm one of two people at SkyBridge, a very welcoming firm, who are out.

Joe Eletto: (40:43)
Thank you all so much.

Marlon Nichols: (40:45)
Thanks.

Pandemic Venture Investment Series - Episode 2 | SALT Talks #105

“This crisis has presented an opportunity because it gives the power back to policy makers to change the status quo for their city streets, specifically around transportation.”

This second installment of the SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, includes a look at the mobility sector in the current COVID-climate, how top entrepreneurs and their mobility start-ups are navigating the unprecedented business challenges and opportunities in our era, and what we can expect for the future mobility revolution. Moderated by Yakir Machluf, Mobility Lead, OurCrowd.

The pandemic has brought to light many of the unrealistic timelines associated with the adoption and rollout of autonomous vehicles. We’re seeing more companies readjust their business plans to reflect this reality and implement more incremental technologies like advanced driver-assistance (ADA) systems. Growth has instead been seen around other sectors like micro-mobility. Open-air intra-city movement patterns have increased as a result of the pandemic with bikes and scooters seeing a particular jump. “A lot of the usage we see on our vehicles, specifically e-scooters are a mile-and-a-half to two miles. This is a 50 to 100% increase from pre-pandemic.”

With the increased implementation of technology within vehicles, the need for vehicle cybersecurity has become essential. It’s an industry that has long relied on in-person demonstrations and onboarding. The pandemic has increased the adoption of remote training and virtual demonstrations that work in tandem with clients’ on-site systems, a more digital approach that will drive down costs long-term.

LISTEN AND SUBSCRIBE

SPEAKERS

Michael Dick.jpeg

Michael Dick

Chief Executive Officer

C2A

Graham Gullans.jpeg

Graham Gullans

Vice President, Business & Corporate Development

Superpedestrian

Adi Pinhas.jpeg

Adi Pinhas

Chief Executive Officer

Brodmann17

EPISODE TRANSCRIPT

Joe Eletto: (00:13)
Hello everyone, welcome back to SALT Talks. My name is Joe Elleto, and I'm the production manager of SALT, which is a global thought leadership program and networking platform encompassing finance, technology, and geopolitics. SALT Talk is a series of digital interviews with the world's foremost investors, creators and thinkers, and just as we do at our global SALT conferences, we aim to both empower big important ideas, and provide our audience into a window into the minds of subject matter experts. And thank you for joining us if you're in joining us in the United States, a day after the election which is still ongoing.

Joe Eletto: (00:49)
This will be obviously something that continues throughout the week, but we appreciate you waking up early and joining us. We're thrilled to welcome you to the second installment of our pandemic venture investment series, where top entrepreneurs, investors, and business leaders dive deep into the challenges and opportunities arising from the pandemic crisis, and discuss breakthrough technologies, address issues from the coronavirus prevention and cure, to social distancing and food supply. This series is presented in partnership with OurCrowd, which is a leading global venture investment platform.

Joe Eletto: (01:24)
Today's episode, Next-Generation Mobility in a Post-Pandemic World features Michael Dick, chief executive officer of C2A, Graham Gullans, vice president of Business and Corporate Development of Superpedestrian, and Adi Pinhas, chief executive officer of Brodmann17. Moderated by OurCrowds mobility lead Yakir Machluf. If you have any questions during today's talk, please enter them at the Q&A box at the bottom of your video screen. And now I will turn it over to Yakir to conduct today's interview.

Yakir Machluf: (01:55)
Thank you, Joe. And thank you for that kind intro, and I of course, thankfull for the opportunity to be part of SALT Talks. To our audience today, just reiterating what Joe mentioned, welcome to our discussion today about Next-Generation Mobility in a Post-Pandemic World. This is of course a part of a complete series of SALT, in partnership with OurCrowd. So the mobility sector is among the hardest hit due to COVID-19, with automotive manufacturing ground to a halt, ride hailing down 75%, and public transportation usage rates down, sorry, seeing one of the greatest declines in history with a very slow recovery rate.

Yakir Machluf: (02:37)
We have three great speakers joining us today to discuss the challenges and opportunities that the pandemic brought to the mobility sectors. Our first speaker as Joe mentioned, is Adi Pinhas, co-founder and CEO of Brodmann17. Brodmann17 is actually Adi's third company founded by him, in the computer vision space. Preceded by Vigilant Technologies in '98, JustVisual in 2006, and Brodmann17 founded in 2016. Adi, thank you for joining us today. Can you share a few words to our audience about Brodmann17?

Adi Pinhas: (03:10)
All right. Thank you very much for inviting us today. In Brodmann17, we're developing advanced driving assistance systems for vehicles. So features like automatic emergency brake, adaptive cruise control, self-parking vehicles, and so on. This is the functions and technology that we're developing with the mission of taking these advanced technologies from the premium vehicles, from the premium models to the mass market, in order to improve safety, comfort, and so on.

Yakir Machluf: (03:47)
Thank you Adi. Our second speaker is Graham Gullans. Graham is the VP of business and corporate development at Superpedestrian. Graham has built and invested in multimodal transportation companies for the past five years, and he sits on the board at Zoomcar, India's largest shared car rental company. Previously, he was also the co-founder and COO of LiftMetrix that was sold to Hootsuite. Graham, great having you on board with us today. Maybe a few words about Superpedestrian to our audience.

Graham Gullans: (04:15)
Sure. Thanks, Yakir. Nice to meet everyone. Superpedestrian is first and foremost, a technology and engineering company. The company got its start having spun out of MIT seven years ago, and we're based in Boston. We focused on the core technology that we call vehicle intelligence, which is an autonomous maintenance system that lives inside micro-electric vehicles. So anything that touches the electronics or mechanical system of small vehicles, such as e-bikes and e-scooters, our technology allows the system to measure, detect, prevent the most common challenges from happening. In the context of mobility that improves the safety of these vehicles and lowers the costs operating. So specifically, we find ourself in the micromobility space where those are the two biggest challenges in the industry, addressing the core safety needs for cities and riders in micromobility, addressing the core cost side and challenges of making this business sustainable into the future.

Yakir Machluf: (05:17)
Sorry, thanks, Graham. We'll definitely touch upon some of those points later on in the discussion. Last but not least we have Michael Dick joining us. Michael is the co-founder and CEO of C2A. Michael has 25 years of senior level leadership experience, previously co-founding NDS, which was acquired by Cisco for $5 billion back at 2012. Michael served as the VP of service delivery for five years, and is regarded as a pioneer in embedded network and content security. He has global experience working on large scale systems that protected billions of dollars of content for customers including BSkyB, Foxtel, Star TV, Sky Italia, Direct TV and others. Michael, thanks for joining today. Can you briefly introduce our audience to C2A and what is it that you do?

Micheal Dick: (06:02)
Thanks Yakir. Nice to be here. So C2A does in-vehicle cyber security. And as the previous speakers have described, vehicles are becoming more and more connected, and are offering all types of autonomous services, whether it's a desk type systems or automatic parking, et cetera. So imagine on the one hand, you have computers in the vehicle that are controlling the safety systems like the steering wheel and the brakes. And on the other hand, you have these cars that are connected to the internet, offering all types of services, online services, vehicle-to-vehicle, vehicle-to-infrastructure, et cetera.

Micheal Dick: (06:47)
So you can imagine that the threat of outsider attack into these vehicles is very high. And that's what C2A is here to try and prevent. From the various different attack surfaces in the vehicle, we have developed products to be able to protect those vehicles against attack, and not only prevent attacks but also to monitor and to manage the in-vehicle cyber security lifecycle, over the 10 to 15 years that the car has to be on the road, on an ongoing basis. So that's basically in a nutshell what we do.

Yakir Machluf: (07:29)
Thanks for that, Michael. So with no further ado, let's get right into it and talk about mobility and COVID-19. Starting with when we're usually thinking about the future of mobility autonomous cars come to mind, and the past 12 to 16 months have really not been easy for AV development worldwide to say the least. We've seen AV timelines and launch dates being pushed back by several years, less capital directed towards the development of new AVs and an overall conservative tone sounded from Car manufacturers in regards to AV deployment. Adi, I'll start with you. As I know you had more than a few discussions about this topic with OEMs and Tier Ones. Can you take us through what goes on behind the scenes of AV development, and how did COVID-19 play a role in that?

Adi Pinhas: (08:15)
So I think in the case of the autonomous vehicles what happened is that, like in many other cases, COVID accelerated decisions that should have been made a lot before. For couple of years the industry understood that autonomous vehicle is going to be a huge challenge bigger than initially anticipated. It's going to be more expensive than originally budget. And we saw that even Waymo by Google raised a capital in order to make happen. They also realized that it's very complex and we saw for a long time, every other week, two companies announcing on a new alliance in order to work together and be able to do that, impossible alliances in some cases.

Adi Pinhas: (09:14)
But then COVID happened, and it forced everyone to look into reality and see that we need to push the timelines. We need to think about it again, and today what we see more, I think, solid plans. Even from a business plan perspective, you will see that most of the thinking in the work today is about trucks, where you have very clear ROI, less about robotaxi, definitely less about passenger vehicles. And so, everyone or many are regrouping, creating better more solid plans, and we'll continue with that work.

Yakir Machluf: (09:56)
Thanks for that Adi. Now I'm sure for a startup working in the space much like Brodmann17, that could prove challenging. Can you elaborate on some of the challenges from a startup perspective, and possibly share even some of the opportunities that you recognized during this period?

Adi Pinhas: (10:13)
Yeah. So earlier this year, of course, COVID created, the outbreak created a big confusion in the market, especially for some of the OEMs and the Tier One suppliers. They had bigger issues in front of them from a supply chains to sales, manufacturing challenges, and so on. But then exactly as we said, because of autonomous vehicle is going to be delayed, now they are focusing again on the ADA's, on the advanced driving-assistant systems. What we are frequently calling the level one to level three systems. So now that they are not going to be anytime soon autonomous vehicle, they realized that we need to take care of the driver. To create systems that are going to make the car more efficient, more comfortable, safer of course. And that's not only in the integrated solutions, this is beyond integrated solutions.

Adi Pinhas: (11:12)
What we see now is that a fleet management are looking to add these technologies as an aftermarket or after sale by adding these type of technologies to monitor professional drivers. Some insurance companies are talking about regular, a passenger, a driver, but definitely for the professional drivers, adding these systems to monitor the drivers, and to create better training plans, to create better safety scores for insurance purposes. So few of the OEMs and the Tier Ones, actually realized that they put aside for too long this ADA's technologies then now they have a gap to close. So they are working with us to start and deploying the level one to level three solutions, until the level four, level five will eventually reach perhaps in a decade or so.

Yakir Machluf: (12:13)
Got it. Thank you, Adi. Of course, not only autonomous cars have been affected by COVID-19 and as people were forced to either stay at home or follow strict social distancing limitations, the entire way in which people and goods move around has changed. Some would say that they changed for good. Graham, moving on to you, can you share some thoughts on these changes and how will urban mobility change in the coming years?

Graham Gullans: (12:43)
Sure, thanks Yakir. There's an adage that you never want to let a crisis go wasted. So with cities and public policy, things are typically difficult to change, they take time. But this crisis has presented an opportunity because it gives the power back to policy makers to change the status quo for their city streets, specifically around transportation. And that's starting to happen quite rapidly now. So there's really two major impacts from a city policy perspective that is been accelerated by COVID. Number one, the ability to change the policy, right? Typically, it's been hard to change policy, the time it takes to influence it can be years. But now, we're specifically seeing cities accelerate those timelines on how they allocate street space and manage traffic. So across the US and Europe, primarily there's a real willingness to change streets. Some examples are, there's a lot more open air dining and retailers moving into the streets.

Graham Gullans: (13:41)
New York is a good example of this, cities and retailers are given space now on the streets replacing either lanes or car parking. In the UK, there's been a huge appetite for infrastructure spending on bike lanes. They're committing to invest £250 million on bike lanes to support micro mobility. And then when there was temporary bike lanes put up in place for the pandemic, they're now becoming permanent. People are seeing the revalue, and cities are appreciating that long-term stability. And then one more soundbite is Paris actually is taking an aggressive stance. They're taking back half of the parking spaces from cars in the city, which is around 70,000 spaces. So it's an incredible amount of city land that's being dedicated back to better mobility options than the car and other transportation options. And this appears to be sticking because policy is pushing towards making those permanent changes, and that's the accelerating factor that COVID has had on mobility.

Graham Gullans: (14:43)
The second of the two major ways in which it's having impact is travel patterns has changed. You alluded to it in your introduction Yakir, but everyone knows public transit is down massively. And they're having to cut budgets because of the shortfalls even more so than they can. So cities need to promote other alternative options. Ride hailing is unfortunately not necessarily the solution because there's still that other person in the car with you, and we've seen that down as well.

Graham Gullans: (15:15)
The two best mobility options in a pandemic world are driving your own personal car because it's perceived to be safer. However, cars have been in a 10-year fight against personal cars because of the traffic and safety reasons. And so cities are really promoting more options for mobility, specifically micromobility because micromobility is preferable when you're in the open air environment and you don't face the public health challenges of public transit with people being close to each other, and then driving of course is pollution. So micromobility specifically, immobility has been accelerated by way of the... by COVID.

Yakir Machluf: (15:54)
So you just alluded to micro mobility and challenges. So I would like to ask you about specific challenges for micromobility due to COVID. What did you experience during that period?

Graham Gullans: (16:10)
Sure. Well, there's always short-term challenges, but also open opportunities. So I'll talk about kind of what immediately happened following COVID, and it presented, well, opportunities and challenges and then we'll look at kind of what challenges exist long-term. When COVID forced folks to a lockdown, it actually caused people who had not experienced bikes in a long time or scooters for the first time to try those new options. So specifically medical professionals were used to taking the bus, train or driving and carpooling, we're now experiencing the efficiencies and advantages of micromobility. But that same constituency now also saw the dangers of car dominated streets.

Graham Gullans: (16:53)
So what you're seeing is the pandemic has caused new people to experience it, promote it and then that's also suggesting a path away from car dominated streets. Within micro mobility in the short-term, there's a lot of positives and then I'll express the challenges as well. Positives, number one, there's longer trips. Meaning a lot of the usage we see on our vehicles specifically e-scooters are a mile and a half to two miles. This is a 50 to 100% increase than pre-pandemic. Number two is that people are using them for a broader array of purposes. It's not just recreation or tourism, they're using it in their day-to-day. Again, away from the public transportation. And there's a much more diverse set of demographics and trip purposes being used.

Graham Gullans: (17:41)
So that's the tailwinds that the pandemic has provided micromobility. The challenges for micromobility, specifically, are to making sure these changes stick. So building resiliency into transportation, so we don't go back to the monoculture of cars. So that's number one, cities do need to work on their public policy. But they're getting the support of businesses and restaurants who see the advantages of people riding bikes to a restaurant. So in New York, actually, restaurants used to not like bike racks in front of the restaurants, they'd prefer car spots.

Graham Gullans: (18:18)
Now they actually promote bike racks because it will bring more people in then [inaudible 00:18:22] parking spots. So we had to make sure these changes stick. Another challenge is that we need to make sure these transportation options serve a broader diversity of travelers. Scooters and e-bikes fit a large audience, but not all audiences. There will be transportation options into the future that I think will stick long-term, that we've not seen on the road today. And that's what we need to focus on.

Yakir Machluf: (18:45)
Thank you, Graham. Michael, moving on to you. Automotive cybersecurity and COVID-19, tell us what's the connection? Michael, oh, perfect.

Micheal Dick: (19:01)
Yeah. Sorry. Yeah. So even earlier on this year before COVID, February timeline. ISO published the 21434 specifications with regard to in-vehicle cybersecurity and also lifecycle management. And so, also the UNECE WP.29 was published and is going to become legislated at the end of the year for those countries that belong to that organization. Which means that if somebody wants type approval for a vehicle in the country, they're going to have to be compliant with the UNECE WP.29 specification. Now, this all happened before COVID, and the fact of the matter is that that's continuing. In other words, whatever happens after COVID, any car that is manufactured from 2020 to 2023 is going to have to be compliant with these specifications.

Micheal Dick: (20:04)
Which means that the car manufacturers and the Tier Ones all in the whole industry has to move towards cybersecurity and lifecycle management. So I think there was a bit of a panic in the beginning of COVID, how are we going to do this with COVID? But we found that especially with C2A seeing that most of our systems that supply solutions to cybersecurity and lifecycle management are cloud-based, we can offer it as a service to our customers. And they've learned now over time that they can be completely independent and they can implement whatever they need to implement on a remote basis. Whereas in the past, this used to use up a lot of manpower, you need a lot of services to do these investigations, et cetera.

Micheal Dick: (21:06)
We can now do it automatically on through a system that is cloud-based for them. So for us it's been interesting because it hasn't really affected the investigation of the Tier Ones and the OEMs into these new technologies and doing proof of concepts or something like that. We can continue doing that remotely. We don't have to be, yeah, and they don't have to be actually... They can do it remotely as well. So from that perspective it's been easier for us. It is difficult working without meeting people for the first time sometimes over Zoom, et cetera. But I think the world is getting used to it and-

Yakir Machluf: (21:54)
Yeah. I think we all need to get used to this new normal. Yeah. So I think actually, this was actually very insightful thought to think that most of us usually think that due to COVID the entire automotive industry stopped, but actually understanding that cybersecurity and the cyber threats are still eminent and are progressing although the majority of the industry kind of put to a halt, it's an interesting thought and just makes it that much more imminent in comparison to maybe autonomous cars and all of that. Now can you tell us more about the new regulation and what do they actually mean from an automotive manufacturer perspective?

Micheal Dick: (22:40)
... So it's actually quite interesting, if you speak to a car manufacturer today, and you say to them let's say, "There's been a vulnerability published." Does that vulnerability affect you in any of the models that you have on the road? And if it does affect you, what can you do about it and which models are affected, et cetera. All the OEMs, car manufacturers, they don't really know the answer to that question. When a vulnerability becomes available they have to go do research, they have to investigate. They have to try and find all the development teams around the world, all their suppliers. It's a very complicated supply chain, Tier Ones, Tier Twos, Tier Threes all supplying into the same vehicle.

Micheal Dick: (23:35)
And it takes them weeks actually, to know if they are affected or not. We actually... we had a market survey about six weeks ago that came up with this, that it takes them weeks. We spoke to many OEMs and Tier Ones. It takes them weeks to actually do that investigation, which is obviously not acceptable. Especially as you get more connected and there's more software in the vehicle. There's going to be dozens of vulnerabilities on an ongoing basis. And this is for the 10 to 15 years that the car is on the road. And it's now become compulsory for the car manufacturers to actually run that in-vehicle cybersecurity lifecycle management in an organized and automated way.

Micheal Dick: (24:23)
And because of the complication of the number of partners involved and how they all communicate with each other, et cetera. So this becomes a difficult thing to implement. And in our survey that we ran, our market research, one of the complaints was also that there're no tools available to allow them to be able to do this type of lifecycle management. And so that's what we... Luckily, we've been investing the last three years in trying to develop this product, that is now become compulsory for[inaudible 00:25:01]. So we're seeing a lot of traction and a lot of interest on an ongoing basis since we launched this a few weeks ago. And as I mentioned before, they won't able to get a car manufacturer from 2022 in some countries and 2023 in others. Will not be able to get type approval unless they can show that they're compliant with these regulations.

Yakir Machluf: (25:27)
So you've actually alluded to several interesting points here. And I think the most interesting one is your ability to actually cut the need for resources, cut times, actually make manufacturers and the suppliers more independent. So this actually brings me maybe to the next point, and I would love to open up the discussion at this point. And talk about more about cost efficiency and open up the discussion to Adi and Graham as well. Can you maybe kind of talk us a bit about cost effectiveness aspects in your verticals? Adi, how is Brodmman17 solution could address maybe cost effectiveness solution in fleets and Graham for micromobility. I would love to hear your thoughts on that.

Adi Pinhas: (26:16)
Yeah, cost is a big issue. Most of the features that I mentioned, they are not hard to sell. A self-parking vehicle, of course, everyone want's it. The big issue is the gap between how much it cost and how much people are willing to pay for it, same for the insights from the fleets. Cost is not only the amount of dollar, it's also the power consumption of these systems, the heat that they generate, the size, and so on. So we are trying to work on all these dimensions. Other forces are also important here. So regulation, for example, the moment that regulator decided in Europe and then in Japan, that all new models needs to have automatic emergency brake. So now the automakers once that is a regulation, they need to find a mass market pricing for that, it's no longer an advance, a premium feature.

Adi Pinhas: (27:27)
So we have the drivers that like the features very much, we have the regulations as another strong force that is driving the market forward. And the third one is ANCAP, ANCAP are publishing new safety standards every year. So if an automaker would like to maintain his four, five safety stars, and ANCAP are now stating that automatic emergency brake as a part of the reverse camera is a must. Then again, they need to find solutions, they need to find cost effective solutions in order to implement it. So here, in order to achieve that, we are taking a completely new approach into this system. Taking a softer approach, working with commodity hardware, creating [AJI 00:28:25] architectures in order to create a bottom line, a system that is complying with the regulation in ANCAP, but still has a fraction of the cost of what it is today.

Yakir Machluf: (28:43)
Thanks, Adi, Graham.

Graham Gullans: (28:45)
Sure. So micromobility, specifically costs is very important. But actually, there's two groups of micromobility, and it's more important in the shared case. So micromobility as a personal consumer vehicle type has been around for 100 plus years with the bike, and then Kick scooters, which you see a lot of kids on these days. So micromobility on the personal side has not been impacted by costs in the last decades, a couple decades, because the cost of owning a bike is relatively low, the cost of maintaining a bike is relatively low. And that has not been a challenge because the cost of keeping that vehicle on road is internalized by user and the consumer itself.

Graham Gullans: (29:27)
When shared mobility, specifically in micromobility became such a hot trend. With the introduction of bike sharing across the world, but also electrification of e-scooters and e-bikes costs became everything, right? And the industry is still at its infancy, where it could be a make or break for the industry. If you don't figure out the cost side of running a micromobility fleet, then micromobility is going to be more challenging to have long term sustainable life unless it's subsidized. Which is not the goal of Cities necessarily. And the reason why shared micromobility is so different than personal bike or scooter ownership is because those costs now borne by the shared fleet. And you now have significant costs for labor, you have higher use and abuse of vehicle, so the cost of the vehicle lifetime becomes challenged.

Graham Gullans: (30:20)
And so, when you can't internalize those costs to a single consumer, and they get spread out over fleet, it makes the business hard to run. And so that's what we focused on for the seven years that Superpedestrian has been in business, which is lowering the cost side of running fleets, specifically to micromobility. If you think about the two biggest costs, it's labor of keeping your fleets on road, service maintained and generating revenue, and two is vehicle lifetime. Those are the two things that have challenged the industry. So that's what our core system has been developed to address, which is to lower the cost of labor for keeping the vehicles on road, and safe, and repaired and maintained. You should address that through technology, right?

Graham Gullans: (31:02)
Technology is scalable, the technology is inside the vehicle as well. And so, the vehicle is able to do things that a human would otherwise do. Inspect whether or not the brakes are safe to ride on, make sure the core electronics in the system will overheat or fry, because they've been left out in the rain or been going up and down hills. If technology can do that. Now the costs of running your fleet get lowered because labor is now cut in half or more. So you don't need to staff up teams to go in and visually inspect. Plus technology can do a better job than a human can do, because they can look inside the hood without a human going in with a scope.

Graham Gullans: (31:39)
And so, technology addresses the labor costs of running micromobility fleets. And it also is able to extend the lifetime of vehicles because it's able to detect when failures can happen in the first place. It knows when... That you may run into the end of a life, or a battery pack, or a motor, it can autonomously, our autonomous maintenance layer can alert us to that before it happens in the first place. Again, going back to safety and cost side of things. So technology addresses the core costs of running micromobility. And we're at the forefront of that for a relatively new industry that's trying to navigate being a sustainable option for citizens in cities.

Yakir Machluf: (32:18)
Maybe you can expand on that because I think that we have a lot of investors or potential investors in micromobility and mobility as a whole tuning in. And they're probably all familiar with Bird and Lime. And since their inception, we've seen a lot of venture capital money flowing into those companies. Now they have initially maybe worked with off the shelf scooters, but they have since evolved to introducing new models, where would be... So they're also claiming for cost efficiency and of course, enhanced operational optimization. So maybe you could contribute your thoughts on that. In regards to Superpedestrian, where is the actual value coming from?

Graham Gullans: (33:02)
Sure. So the space is super exciting from an investment perspective, and from a city perspective, because of the demand for micromobility. When vehicles were electrified, specifically e-scooter and now we're seeing more e-bikes on the fleet side, the demand was a multiples higher than bike sharing schemes. Once you lost the dock, and once you powered these vehicles with electronics, the demand was much higher. So the shared scooter has been one of the vehicles of choice, you're seeing cities across the globe, there's two to five trips for that single vehicle type, which is pretty impressive in terms of demand and revenue generation relative to the asset value. The asset value is hundreds of dollars, not thousands of dollars, again, cheaper than e-bike, which also makes it more sustainable. That's why the venture investors poured money into the spaces because the demand was like this faster adoption than ride hailing. The revenue growth was off the charts. You put scooters on the road, you'll get rides that day. And you'll be at full demand within a couple of weeks.

Graham Gullans: (34:07)
So it was an incredible promise. But the cost side challenges of running the business lagged the revenue growth, and that's where we've been for the last year or year and a half, which is all micromobility operators need to focus on the cost side because you've proved that this business can be sustainable before you can keep growing top line. The land grab strategy doesn't necessarily work unless you're running a business model that's sustainable. Specific to Superpedestrian, while the industry was scaling, going to land grab as strategy, we spent our time focusing on a vehicle that could operate at 50% or lower costs than what all our other fleets. Is taking our core embedded patented technology and stick it into the vehicle type of this shared scooter. So we emerged as a second mover with better technology and the advantages are safety which you know helps us win city permits and partner with cities, but also lower costs of operations, right? And that is the fundamental difference.

Graham Gullans: (35:04)
When you can lower your costs by that amount or more, as we've done across our deployments, your market and the promise becomes so much bigger for micromobility. What it really started at was thousands of cities around the world down to even towns will have micromobility. Where it's been constrained to is only large cities can support micromobility because large cities have the demand, but small cities can't support it. We've now proven that our cost side of the fleet can operate in a much bigger [team 00:35:33] because you can go into markets with less demand and less density, you can go more distributed population. You're still serving the needs of micromobility, but you're now serving thousands of cities rather than the top 25 cities of the world which have that high demand. So that's the difference in lowering costs.

Yakir Machluf: (35:52)
Thank you, Graham. I want to again maybe kind of allude back to a point that we made before. So we have here three leaders of three different startups. Two of you based in Israel, one in Boston, how did COVID-19 and the outbreak and all the lockdowns and the ban on flights and all of that affect your ongoing and your relationships with clients abroad? Open style, everyone, as you went there, Michael, Adi, Graham, take it away.

Graham Gullans: (36:21)
I'll jump in real quick. I'll answer a slightly different like you Yakir, which is the biggest difference I've seen is that are hiring folks, so our company is doubled in size in terms of headcount. I think we're closer to 100 now, in the last six months. So the pandemic accelerated our ability to hire. The interesting point here is that we've not specifically required people to be located in Boston. And prior to COVID, we were much more focused on that finance teams, Ops teams, HQ, centralized in Boston. Now, when we've gone out and hired from the industry and other talent, we ask people where they live, but it's not necessarily a requirement. So it means the talent pool for us is much larger, right? We can go international, we can go East Coast, West Coast, Central. And so, it's now an afterthought, into the third conversation you have in hiring of where you're located. And we don't necessarily ask people to move into where we are. So I think that's been great because it opens up the talent pool.

Yakir Machluf: (37:22)
Amazing. Adi, if you want to tackle both, either relationship, or operational point of the effects of COVID.

Adi Pinhas: (37:30)
I think, was something that helped us very much to scale is the ability to do remote demos. So before COVID, it was unheard of that if the customer wants to see a demo, you need to go to the customer and show how it works. After all, it's a very large OEM, or Tier One. But now they can't meet us, even if you will go there a cooperate regulations are not allowing them. So what we worked back in March and April is to create a bulletproof DIY demos and showcases. So today, every other week, we are sending a demo kit to New Zealand, to Australia, to Korea, the customer on the other side is assembling it and it works. And so from that perspective, a lot easier to scale now.

Graham Gullans: (38:29)
Just to comment briefly on that, I think it's fascinating you use the word bulletproof because demos naturally go wrong, right? They go wrong, not when you're testing it in your office, but when it's in someone else's hands. So I think that's super important. I like that.

Adi Pinhas: (38:43)
It's a lot more convincing also to the customer, because it's not like a magic show. If he puts the assembly by himself driving, then it works, then it's creating even better confidence toward the demo.

Yakir Machluf: (38:57)
Michael, your thoughts on that?

Micheal Dick: (38:59)
Yeah. So with us, when we do a demo, for example, remote demo, it's not really a demo. It's not like a demo kit, it's the real thing. We are actually have an instance of AutoSec, which is the... in vehicle lifecycle management system. And the customer actually sees a live implementation of the system. This is what he's going to get. It's not a demo, it's the real thing. And we keep on updating that on an ongoing basis. So he sees the latest and greatest, and he can play with it, and he can see all the features by himself. And he can very soon... Until now, until COVID, it's been common in automotive industry, for many companies all over the world to offer services.

Micheal Dick: (39:53)
They said they'll put a whole lot of people on site and you'll be able to [inaudible 00:39:56] investigations, to do integration [inaudible 00:40:00], for example, in cybersecurity, the most two important things are visibility and traceability. So you know what you have and the [chief 00:40:09], if something is published, you can trace it to see where it affects you, where it doesn't affect you. This has been offered traditionally to the market by having lots of people doing this work for the car manufacturers, which is not relevant anymore. It's not practical anymore, because you can't be flying around the world anymore. And everyone's trying to save money, you can't have these loads of people trying to, do these investigations, et cetera.

Micheal Dick: (40:38)
So once you can have a real life system on remotely, or on cloud, or on premise that they can use. So they see, firstly, that they can be independent, and they don't have to be dependent on multiple companies to give them the visibility and traceability. So it's practical, and also saving them money. So let's say it's an interesting development.

Yakir Machluf: (41:05)
Thank you for that. So maybe as an ending note, before we move on to the Q&A questions, and I see that we have a few. What is the biggest trend that our audience and investors in the space generally should be aware of in regards to your vertical? Michael, let's start from you.

Micheal Dick: (41:22)
Yeah. So as I mentioned before, I think that 2020 is the year of cybersecurity for automotive. There's been a lot of talk for many years already, maybe 10 years, people have been talking about cybersecurity for automotive, from the hacking, there were hacks demonstrated, how important it is, and everyone said how important it is, et cetera. But there haven't been any implementations of advanced cyber security on the production lines. And the market was getting a little bit nervous. Everyone's talking about it, why is it not happening? So finally, we've arrived at the time where it started to happen, and that's the year of 2020. And that's because of legislation. Number one, because the timing is now with both ISO and the UNECE publications, which are now going to become compulsory for the OEMs, and Tier Ones for the industry to implement. So that's the first thing.

Micheal Dick: (42:24)
And the second thing is that issue of the way that we approached, the different approach that is going to be, that is different now, in the sense that, now it's more important to be able to work remotely, to be able to work independently, and to be able to save money. So I think that we start, we're actually starting to see it happen. Many of the OEMs that are putting out requests for quotes, for new systems, for new vehicles, with new production. Start of production in the next couple of years, are now including, large quantities of cyber security requirements as part of that RFQ. And we're seeing them coming out now one after another. RFQs that include all the cybersecurity requirements, and lifecycle management requirements. So there's a big change, 2020 is the going vehicle cybersecurity.

Yakir Machluf: (43:30)
Thank you for those insights. Adi, can you contribute a trend for our audience?

Adi Pinhas: (43:36)
I think, earlier this year, I met a few worried people that asked me if this is the end of [inaudible 00:43:43]. This is the end of software in vehicle and so on, and they couldn't be more wrong. There is no way back, vehicles are becoming a software platform. And especially the automakers, they are looking on the great product that Tesla are developing. And they're writing their own software. And in most of their cases, they are getting the software from companies like us for the Tier Ones, which means they get it in three years delay, and they understand the gap. They are starting to think about the vehicle as a software platform to see how they can work with companies like us that are developing AI and software and improve their products significantly from what they are today. So there is no way back, vehicles are going to become smarter and better.

Yakir Machluf: (44:33)
Thanks, Adi. Graham, a trend in micromobility?

Graham Gullans: (44:37)
Perfect transition because 2021 is all about the year of software for micromobility. So firmware on the vehicle, on the boards itself, and then cloud maintenance, right? The software that doesn't have to happen in real time on the vehicle but can be a little bit more persistent on the cloud. That's not something that has ever been part of micromobility. That's been... Micromobility is vehicles that are left on the street and need human maintenance and touch and care. The time to lower the cost is now, the land grab strategy was going away at the end of 2019. And the impact from COVID accelerated that transition away from scale at all costs down to lower cost of operations. And the way you do that is through software and connected smart vehicles.

Yakir Machluf: (45:26)
Thank you. So I do see here a question. And I do urge our audience, if you want to have your questions answered live, please do submit them in the QA box. But I'll address one of those. We have a question here. Will the cost of the pandemic make it harder for countries to fund major mobility project? And if yes, how will this affect VC mobility plays? Open mic.

Adi Pinhas: (45:57)
So I think what we see that especially the Big Five, Japan, Korea, China, the automakers countries, Germany, US, they consider the automotive industry to be a national treasure. And they protect them very much, there is a lot of knowledge, a lot of money over there. And they are going to protect it, they are going to find ways. They monitor very closely this industry, and they are going to make it work for them.

Micheal Dick: (46:30)
Yeah, that's true. It's also... We're getting into, as Adi mentioned, there is no way back. I mean, this is, in order to compete, the car manufacturers are going to have to put in their investment in the tier Ones are going to have to put in that investment in order to be able to compete, otherwise, someone else will eat their lunch. So I think from that perspective, it's going to become even more important for them in order to be able to compete and keep up their... They've been through a serious knock for last few months, in order to be able to recover, they need [inaudible 00:47:09] I know this is going to be their... this is the only way forward for them.

Graham Gullans: (47:13)
Lastly, I'll add that in my micromobility, it's much more set by the specific city rather than the country. So what you're seeing is the city's budgets for mobility is constrained. And typically, there's not an ability to fund projects such as micromobility. So from an investor's perspective, and from a micromobility operators perspective, it's again, allowing private companies to be sustainable so that it's... Can be on streets long term rather than necessarily tapping public funding.

Yakir Machluf: (47:47)
Great, thanks for those really insightful replies. And I think we've discussed some really interesting nuanced points today. And I want to thank again, our three speakers from Brodband17, Superpedestrian and C2A. Make sure to join us for the next installment of pandemic venture investment series by SALT, in partnership with OurCrowd, taking place next Thursday. Today, we heard from just three of over 200 companies in our portfolio. I welcome you all, to log on to ourcrowd.com, that's O-U-R-C-R-O-W-D .com, where you can see more technology startups and investment opportunities in both mobility and many other sectors. I want to thank again to our partners from SALT.

Pandemic Venture Investment Series - Episode 1 | SALT Talks #96

“Some of our best investments have come out of these periods of extreme stress in the markets.”

This first installment of the SALT Talks: Pandemic Venture Investment Series, presented in partnership with OurCrowd, includes a survey of general pandemic investment trends and disruptive approaches to funding start-ups from Jon Medved, CEO, OurCrowd; and a revealing interview with Steve Krausz, Managing Partner, U.S. Venture Partners, on key sectors, potential opportunities, and lessons learned from previous crises. Moderated by Alec Ellison, Chairman, OurCrowd U.S.

Having gone through multiple economic crises over several decades, Krausz sees an evolved investment landscape. We see more diverse investments that test the strength of companies in venture portfolios. “The difference here, and it's a dramatic difference, is that the venture community now is a very global community. It has a footprint that spans all of the continents.”

The pandemic has brought about a rapid acceleration in digital growth and integration. Companies and their management understand the need to transform their organizations to be more digitally-oriented, beyond just the needs created by an extended work-from-home period. “The digitization of the world economy is going to be enormous.”

LISTEN AND SUBSCRIBE

SPEAKERS

Steve Krausz.jpeg

Steve Krausz

Managing Partner

US Venture Partners

Jon Medved.jpeg

Jon Medved

Chief Executive Officer

OurCrowd

EPISODE TRANSCRIPT

John Darsie: (00:12)
Hello, everyone, and welcome back to SALT Talks. My name is John Darsie, I'm the Managing Director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology, and public policy.

John Darsie: (00:26)
SALT Talks are a digital interview series that we launched during this work from home period, with leading investors, creators, and thinkers. What we're really trying to do during these SALT Talks is replicate the type of experience that we provide at our global conferences, The SALT Conference. What we're trying to do is provide a window into the minds of subject matter experts, as well as to provide a platform for what we think are big ideas that are shaping the future.

John Darsie: (00:51)
Today, we're thrilled to welcome you to the first episode of our Pandemic Venture Investment Series, which is being presented in partnership with OurCrowd, a leading global venture investment platform. In this series, we're bringing top entrepreneurs, investors, business leaders together for deep dives into the challenges and opportunities arising from the pandemic crisis. Today's episode, Investing in the Pandemic and the New Normal, features Steve Krausz, Managing Partner of US Venture Partners, and Alec Ellison, the Chairman of OurCrowd US, with an introduction by John Medved, the Chief Executive Officer of OurCrowd, who joined Anthony yesterday for a SALT Talk as well.

John Darsie: (01:33)
Just a reminder, if you have any questions during today's talk, you can enter them in the Q&A box at the bottom of your video screen. Now I'm going to turn it over to Jon Medved again, to provide a more detailed introduction into this series and today's talk.

Jonathan Medved: (01:46)
Thank you, John. It's great to be here with The SALT Talks. This is a very, I think, important beginning of a new series called the Pandemic Venture Investment Series. We are attempting here to cover a broad range of topics about the investment opportunities represented by the crisis that we're all living through. It's both focused on medical issues and ways that we can combat the pandemic directly, but also what we call the new normal. So there will be sessions in the coming weeks, once a week, about mobility, about artificial intelligence, about ag tech, and about a variety of other great topics. So please come back and see us.

Jonathan Medved: (02:33)
Just a few words of introduction about OurCrowd. OurCrowd is the world's largest venture investment platform. We're managing close to a billion and a half of commitments. We've made over 220 individual company portfolio investments, where you as an accredited investors can actually choose which one you would like to join us with. Each of these investments are curated by the OurCrowd investment team, we invest our own capital, and then we set terms, sit on boards, and open these investments to our crowd. We also offer at the moment, 22 different venture funds.

Jonathan Medved: (03:14)
Today we're proud to start off this series by featuring one of our investments in the spectacular fund known as US Venture Partners, out of Silicon Valley. We were fortunate enough to be a limited partner in US VP number 12, and we're welcoming today my good friend, full disclosure. We went to high school together, Steve Krausz who is general partner, managing partner at US VP. Steve has been there literally, since I think four years after the fund started, 1985. So about 35 years of venture experience. The fund, US VP has invested primarily in Silicon Valley, but also very, very strongly in Israel. They include in their portfolio, great companies such as Check Point, Box, GoPro, Mellanox, Trusteer, and [inaudible 00:04:14]. You can go on and on. It's a great team of people who we're close to.

Jonathan Medved: (04:18)
I also, another full disclosure, I think my first big venture capital investment almost 30 years ago was done together with them in a company called Compugen, which became a billion dollar company in bioinformatics. We're big fans of US Venture Partners.

Jonathan Medved: (04:36)
To interview Steve Krausz and to get his unique perspective, we're joined today by my partner and also very good friend, Alec Ellison. Alec is the Chairman of OurCrowd in the United States. He has a very rich, decades long background where he was the President of Broadview International. Broadview was perhaps in the day the leading investment bank focusing on technology companies. That's where I met him the first time. He traveled to Israel, did more transactions in Israel, frankly, than any local Israeli investment banker. Broadview was later acquired by Jefferies, where Alec then became the Vice Chairman and the head of their technology investment banking group. Today, as I mentioned, he is the US Chairman of OurCrowd, and a big part of our recent success.

Jonathan Medved: (05:28)
So I'm going to turn it over to you, Alec, to talk to my good friend Steve. I think the viewers are in for a treat today. Thank you.

Alec Ellison: (05:37)
Thanks very much, John and Steve, it's really a pleasure to be able to have this discussion with you this morning. Again, welcome to all of our participants.

Alec Ellison: (05:47)
So Steve, let's jump into it. We're approaching eight months into this pandemic. You've been around long enough, as John Says, to have lived through quite a few crises. Even before that, I guess crash of '87 was probably the first one you went through. What do you perceive as different about this crisis from the perspective of being a venture investor.

Steve Krausz: (06:09)
Well, thank you very much. I really appreciate the introduction and the kind words, Alec and John. The difference here, and it's a dramatic difference, is that the venture community now is a very global community. It has a footprint that spans all of the continents. At the time when I entered the venture industry, and it very much was a cottage industry then, you could probably fit all of the VC firms into one room. In '87, it was an industry that had a few tens of billions of dollars invested overall. What happened then and what happened again in 2000 and then again in 2008, were really a fundamental crisis of liquidity, in both our industry, as well as in the public markets.

Steve Krausz: (07:07)
So what is certainly different now is the industry spans all geographies, and it also has sources of capital that it didn't have in the past. It also has a group of individual that are highly diverse but what still remains true is that the crises like these really shake the industry to its core and prove to be a real test of the teams that we invest in.

Steve Krausz: (07:43)
What I would say is going to be different this time is that fundamentally, the structure of work and the structure of the kinds of industries, the supply chains, how people think about their investments in terms of the broad diversity, is going to be very, very different. In past crises, most of us burrowed down and tried to extend the life of the capital that we had invested, but we didn't change strategies dramatically. This time, I think the strategies are changing quite a bit.

Steve Krausz: (08:20)
But as you point out, some of our best investments have come out of these periods of extreme stress in the markets. As a matter of fact, one of my very first public companies, a search company called Verity, we invested in it just after the '87 crash. Then after the 2000 crash, we invested in [inaudible 00:08:46] and Guidewire, which became two public companies. During the 2000 and 2009 period, we invested in Trusteer and Box. So those were really opportunities coming out of those kinds of crises, but this one, this one will be different because of the importance of the venture capital [crosstalk 00:09:10].

Alec Ellison: (09:10)
So picking up some of the opportunities you had in the past. Largely, those were financial crises, crises of liquidity, as you said. We almost had a financial crisis here in March, which was very scary, very, very rapid. Seems to have been, at least for now, put on hold. Frankly, the recovering I think has surprised many, in terms of the public equity markets, but it feels like this time we're dealing with a shift with the economy. Much has been made of the acceleration, digital transformation. I think it was back six months ago, at end of April, [inaudible 00:09:47] said that we've seen two years of digital acceleration or digital transformation in two months. A quarter later he talked about technology resilience or technology transformation being the key to business resilience. It didn't have anything quite quotable on his earnings call earlier this week.

Alec Ellison: (10:07)
Do you think we've seen seven months or eights months, in the eight months, eight years of digital transformation or do you think it was more of a quick acceleration and now we're back on the old trajectory just a few years forward?

Steve Krausz: (10:24)
Well, I think what's changed is the attitude of company management about how quickly they have to make the transformation to a more digital footprint across the globe. So management teams are wrestling, and I was listening to the JP Morgan technology conference yesterday, where Jamie Dimon was talking about how his organization has thought about how many people have to come to the office, how it has to reach out its customers, what consumers are going to be doing differently, so that's a fundamental shift. I think though for the most part, at least to date, has been playing on trends other than the work from home that were already underway. That has to do with cloud, the transition to cloud, the transition to a digital economy, as far as financial services, the change in logistic systems, and some of the changes that were already starting to happen in healthcare. We can talk about that a little bit more later.

Steve Krausz: (11:35)
But I think that the impact of this transition, because venture and technology plays a much more important role across the globe, this time will be fundamentally different from past changes. The digitization of the world economy is going to be enormous.

Steve Krausz: (11:57)
Now, I think what remains yet to play out, quite frankly, and I don't think anyone appreciates this, is we were on a longterm path of improving economics for many people across the globe, bringing many people out of poverty, many people in the middle class in China and elsewhere in Asia, Africa was improving. I think we have seen a fundamental jolt to those economies, and I don't think yet we have a prediction of how that's going to play out. I think whatever trends we started will be accelerated, though, that I know.

Alec Ellison: (12:38)
I mean, what you're getting at is a lot of the so-called COVID casualties, hospitality, travel, some of these are very people-intensive types of businesses, these are in many cases whether it's in developed economies or developing economies, more able to lift up masses than the so-called pandemic plays, which tend to be highly knowledge intensive. Everything from Zoom that we're on now to Nvidia to the mega caps of Apple and others.

Alec Ellison: (13:11)
So as you think about your own portfolio, are you seeing any bifurcation yourselves, in terms of COVID casualties and pandemic plays?

Steve Krausz: (13:22)
We have, I think that's if you were to look at it and make some broad statements, anything that was related to accelerating the digitization of healthcare. We've been participants in healthcare IT for quite a while, but we have seen those companies do quite well as the pandemic had reached us. Companies like Omada, which deals with dealing with diabetes and the management of treatment of diabetes from the technology point of view. We've seen anything related to online E-commerce, Primary, which allows young parents to buy clothing for their children in a fashion is quite predictable, that's exploded because people have left stores and moved towards E-commerce for practically everything that they buy.

Steve Krausz: (14:28)
Some of our enterprise software companies, quite frankly, those are the ones, a few of them actually have struggled. Things in the ad tech space, companies that are dealing more with traditional marketing, automation kinds of plays and even sales, since the entire sales industry has [crosstalk 00:14:47]-

Alec Ellison: (14:47)
Do you think that's because retailers or consumer companies have had less budget or more of a fundamental shift beyond that?

Steve Krausz: (14:56)
Well, I think it's part of it is because retailers have had less budget. I think another part of it is that the way in which companies and enterprises have reached out to their customers or manage their sales forces has changed. You don't have a lot of sales people in the field anymore. You don't have the same workflows that you once had where people had to travel or the channels that you did marketing in or advertising in have changed dramatically. So while digitization will allow you to make those shifts quickly, the near term hit in terms of how these budgets are spent and how these tools are used has changed quite a bit. So those have really seen a dramatic effect.

Steve Krausz: (15:39)
Now fortunately, we haven't played in areas that have been particularly hit by large capital budgets going into travel or into hospitality, so we've managed to avoid-

Alec Ellison: (15:56)
Do you think you avoided... was that more luck or was an area you didn't really like that much beforehand for whatever reason?

Steve Krausz: (16:03)
It was more of an area that we didn't feel matched up with our skillset. As a firm, we've always believed that the partners and general partners at the firm should understand the industries that they're investing in very well, where they have deep and networks that they can pull experience, executives out of and people out of. So that wasn't an area that we understood well.

Steve Krausz: (16:29)
Having said that, years ago, just to show you how venture firms change over time, we did a lot of physical retail stores. I mean we were starters of Ross stores and [crosstalk 00:16:39].

Alec Ellison: (16:38)
Of course, yeah.

Steve Krausz: (16:39)
Yeah, we had [inaudible 00:16:41] running shoes, we had a terrific franchise. We moved that to E-commerce but it really has changed over time. I think every venture firm has to have that kind of transition as the world around it changes.

Alec Ellison: (16:58)
Good, speaking with enterprise software for a minute, where you said there has been occasionally some struggling. Now, enterprise software is about as sticky as things can be. In fact, the pandemic is showing that enterprise software, whether it's a maintenance or a SAS model, is probably stickier than your rent. You're going to pay that fee to keep your company up and you were glad to not have to pay the rent. We've all learned that now.

Alec Ellison: (17:26)
So a little surprised to hear that the enterprise software companies are struggling. Is it more than they're struggling to grow as opposed to maintain their customers and that growth requires some face-to-face selling and that's what's slowing the growth, or is there something different at work?

Steve Krausz: (17:44)
Now let me be clear, it's only in specific areas. What I said is it's the ones that had served channels that directly went after sales as traditionally done or the distribution of marketing dollars as traditionally done. I think that also what is happening there is what's happening throughout technology, is the winners are really winning. Whereas it used to be where you would have three or four... it used to be that the top company, people would say the top company got 50% of the business, number two would get 30%, and if you were three or four you might be able to survive and everybody else was gone. It much more is winner take all and it's I think the winners are going to take 70% or 80% of the market, and that's the challenge because I think that there's less opportunity sometimes. That's a challenge in the industry because there are so many companies being started.

Steve Krausz: (18:44)
So it is a winner take all economy right now, but it's also one in which innovation is happening all the time so you can knock down the big dogs in any sector. I don't say easily, but you can do it with great technology and great people.

Alec Ellison: (19:01)
Let me stay with that for a minute. You can knock down the big dogs. A lot's happening concurrently politically, questioning the dominance of the big five that now have half of the NASDAQ 100 market cap. All companies founded, '70s or later, Apple being the youngest, I guess. Apple, Microsoft in the mid '70s, so Apple, Microsoft, Amazon, et cetera. Do you really believe that you've got companies in the valley that can challenge the Goliaths?

Steve Krausz: (19:36)
Well, there are a few names where their size matters and brand matters to such extent that I think that they're going to last for a very long time. IBM had a run of about 100 years, I am not making any predictions about Microsoft or Amazon or some of the really big Goliaths, as to how long that'll happen but I really do believe that innovation has just made tremendous ability to challenge some of the big Goliaths. I'm not... however, we are right now in a period where capital matters a lot and brand does matter a lot, but and these companies are still very young and the teams that are running them are still teams that started them to a large degree. You look at Amazon, look at Salesforce. There's a lot to be said about having that kind of managerial expertise that's used to dramatic change.

Steve Krausz: (20:46)
However, having said that, look at Snowflake. We're not investors in that company, unfortunately. I know some of the board members well, terrific company. They have really changed and are challenging some of the big dogs. I mean, look at SAP, their recent earnings report was very disappointing. I would never-

Alec Ellison: (21:11)
[inaudible 00:21:11] rushed out to say it's a different model. Don't hate us.

Steve Krausz: (21:15)
They are a different model but they were recently a very dominant players and I think if anybody had looked back 10 years ago, they wouldn't have seen or predicted that there might be changes like that. Now again, a lot of it does go to leadership. I think when McDermot left there, it made a big difference.

Alec Ellison: (21:36)
Just to go back to healthcare for a minute. Have you changed your allocation to that sector over the last 10 months?

Steve Krausz: (21:46)
This is interesting. We have, and we have always been unlike many venture firms, we have always been a participant in healthcare. We have always been a participant about pharmaceuticals, as well as devices, and the ratio in the past was roughly 80-20. Over the last few years because of the expertise of my partner John Root and Casey Tansey. John is an MD and neurologist, he understands the changes going on the pharmaceutical industry quite well. Casey, former CEO, but also what's going on in the economy with regard to digital health and the ever increasing change in the entire way the US healthcare system is both paid and delivering healthcare. So we're probably more like a 70-30, 65-35, depends on how you describe the healthcare [crosstalk 00:22:49]-

Alec Ellison: (22:48)
The healthcare [crosstalk 00:22:49] being the 30 to 35?

Steve Krausz: (22:51)
Yes, yes. I'm sorry for not being clear on that. With the healthcare and the healthcare IT side of it, increasing quite a bit. So I think it's going to be an area since it's in the upper 20s as a percentage of the US GDP predicted over time with the aging of the population, but also with the farther involvement of people in their own health management. We're invested in that area quite successfully, and we've made a few investments there.

Alec Ellison: (23:31)
Any specific ones you've made in the last six, eight months that you want to flag?

Steve Krausz: (23:36)
Yeah, I mean I think that if you... one of my partners, [inaudible 00:23:41] invest in a company called Optimize, which does remote patient monitoring. We think that that's going to be an area because of all the devices that we're wearing, excuse me, because of the automation of healthcare records, and also because of the involvement of people in their own health management, remotely managing healthcare I think is going to be a major trend I the healthcare industry. So that's one that we invested in recently and feel real excited about. That was during the pandemic.

Steve Krausz: (24:20)
We've done a couple of others during the pandemic also. We've long been a player in cyber security, and we've been very successful as John kindly mentioned. We were investors in Check Point at its very beginning.

Alec Ellison: (24:34)
Right, I remember well from another side of it.

Steve Krausz: (24:37)
[crosstalk 00:24:37] alongside Shlomo Kramer and his most recent company Cato, which also plays to the pandemic, is a company that it really addresses the fact that the way that the networks around the world were built in the past, heavy on equipment, networking equipment, heavy on networking protocols that have changed over time. Cato allows you to do all of what we're doing today around the world very inexpensively and yet be very secure at the same time.

Alec Ellison: (25:09)
Was this at a seed or A round stage or a little later, or?

Steve Krausz: (25:12)
We were the first institutional investor alongside Aspect, which is now [inaudible 00:25:21], so that was a series A, and have been joined since then by great luck and light speed. Couple of great partners with us and people we like to work with.

Steve Krausz: (25:31)
The investment that we did just recently was in Cyber Hunters, where my partner Jacques Benkoski sits on the board. Cyber Hunters is a company that is, or cyber AI as many know it as, is a company that does extended threat detection and response. What I mean by this is it allows you to do threat detection in a dynamic way, in an autonomous way. You don't have to have all these scripts. It figures out for itself what kind of threats you're seeing. Believe me, that's been an explosion since the pandemic hit.

Steve Krausz: (26:13)
Another healthcare-

Alec Ellison: (26:14)
It was also exploding because of 5G rollout, which just creates so many more devices on the edge too.

Steve Krausz: (26:20)
Absolutely.

Alec Ellison: (26:21)
Correct?

Steve Krausz: (26:21)
Absolutely, and the 5G really hasn't hit yet, it's been talked about quite a bit. I know that certainly Apple's depending on it quite a bit. It's going to dramatically change everyone's experience on the internet and the way that they work with technology. What it's also going to mean though is that again, back to our earlier point, that some of the real big dogs are going to have an opportunity to see some exciting new startup companies go after them. Even though much of infrastructure, as it relates to equipment and semiconductors, has not been a sweet spot for a while for us because of the capital intensity, but for many there is so much capital now that's available, both in venture from the seed stage to the series A to the later stage venture funds, but also private equity firms are getting involved. You're now seeing the rise of SPACs, which is really just a way for large pools of capital to invest in startup industries.

Alec Ellison: (27:36)
So your interest rates do pretty interesting things don't then?

Steve Krausz: (27:40)
Then zero interest rates help quite bit, yep.

Alec Ellison: (27:42)
Yeah, yeah, or they expect working [crosstalk 00:27:46]-

Steve Krausz: (27:46)
Just the flood of liquidity that's coming from all of the central banks around the world. It's hard to see that changing at least over the next couple of years and we could have a different discussion about what it means.

Alec Ellison: (27:58)
So floods of liquidity typically impact valuation? We're certainly seeing valuation, bifurcation in the public market. Are you seeing major changes in valuation in your markets since March? If so, is it altering the stage at which you're focusing?

Steve Krausz: (28:18)
Well, we have seen valuations increasing now for the last few years. I mean if you go and US Venture Partners is primarily a series A. We're not a seed investor but we're primarily a series A, which means from our definition, once there's a little bit of product market fit shown. So valuations have about doubled during the last two years, and from where they were before in the later rounds. In the series A, they have gone up maybe about 50% or so. In the seed stage, it's been flatter, which historically actually has been a pattern we've seen in other periods of crisis where the very, very early stage was hit the hardest. The later stages didn't see the kind of valuation increase but this time they are. I think that that'll probably adjust. I can't quite honestly, it follows public markets, all the [crosstalk 00:29:23]-

Alec Ellison: (29:23)
Yeah, doubling sounds like a lot until you look at Amazon and Apple, or with Apple in particular, triple is flat.

Steve Krausz: (29:30)
Again, going back to the JP Morgan conference yesterday, Mike Millman put up a couple of slides in which he was showing that the market cap if you're talking about for early, for fast growing companies, was now 20 times revenue on the recent IPOs and also on some of the recent public companies for companies that were growing well over 30%. About 13 times revenue for companies that were growing between 20% and 30%. That's astronomic, that used to be PEs.

Alec Ellison: (30:02)
Well again, it's what happens with zero interest rates. That terminal value in the future doesn't get discounted so badly.

Steve Krausz: (30:08)
Right, exactly, exactly, right. So it does have echoes of what we've seen before but I think the firms that have been around for a while and the partners that have been around for a while know how to manage through that.

Steve Krausz: (30:22)
So what we've done is during this period we've raised a lot of capital for all of our early stage companies. When the money is available, we take it. We tell our companies, rather than the traditional one year to 18 months, they better have money for two years plus. [crosstalk 00:30:44].

Alec Ellison: (30:44)
The worse thing to do is run out of money. What would you-

Steve Krausz: (30:45)
You never want to run out of money.

Alec Ellison: (30:48)
Anything you're doing or your firm is doing that you would characterize as contrarian to your [crosstalk 00:30:54]-

Steve Krausz: (30:54)
That's a... I would say thing. I would say that if you look historically at venture capital, what has been contrarian has been our commitment to some of the healthcare areas that venture capital have historically pulled back from a little bit. That was particularly medical devices because medical devices were seen as firms that had to go through the-

Alec Ellison: (31:22)
FDA?

Steve Krausz: (31:24)
... FDA cycle, also had to have phase one, phase two, phase three clinicals, and were very expensive and very capital intensive with modest sized markets. But we've remained active investors in that space and continue to make investments in that. In fact, we made an investment in that space recently, that was one called CARLSMED, which my partners have done, which is a patient specific, a design for a vertebrae implant to solve for ruptured discs and the like, but it's patient specific. So you're putting together all the technology that allows you to build essentially a disc for a particular patient and put it in their bodies. That's the kind of thing that many firms wouldn't have even touched in the past. [crosstalk 00:32:16].

Alec Ellison: (32:17)
So yeah, I tend to agree. A lot of firms have avoided the area because of the regulatory clearance, but devices tends to be easier to clear the FDA on than therapeutics.

Steve Krausz: (32:30)
[crosstalk 00:32:30].

Alec Ellison: (32:33)
It would appear to many that [crosstalk 00:32:36]-

Steve Krausz: (32:36)
[crosstalk 00:32:36] gross margin attached to them and distribution attached to them that's a lot more difficult than therapeutics and training.

Alec Ellison: (32:42)
Oh yeah, absolutely. The therapeutic companies can be worth billions before they even have their clearance or their approval, rather, and aren't being sold at all but the pandemic is clearly accelerating elements or the speed of approval. Do you think that is a secular trend or that it is likely to just be pandemic specific and we'll see a reversion back to a little more of a slow paced regulatory clearance environment? On both the devices and on therapeutics.

Steve Krausz: (33:12)
I would say that what we have learned from past disruptions like this is there's no going back. Once there really is a change and a change that is merited because you have some reasons and in this case the reasons are you have a lot better analytics. The hard part is still the onboarding for trials. I mean we're seeing it today, but look at how fast in COVID-19, we've been able to onboard 30,000, 40,000 people or more for some of these trials. So I think because of the digitization, we're learning how to identify, how to track those people, how to contact them, and how to enroll them. There's so much pressure to improve that cycle that I don't think we're going to go back.

Steve Krausz: (34:03)
Now, it doesn't mean though that we're going to give up protecting patients by doing it properly, but I think that the way in which we process it and the way in which the FDA reviews and makes their approvals will accelerate. Plus, you have more involvement now from competition from China, competition from Europe, and I think that will only make things better from the point of view of putting some pressure and fire under people's seats here to get stuff done.

Alec Ellison: (34:33)
You made a reference to capital intensity, I want to turn to a segment that I don't think your firm has been active in because of its capital intensity, which is space commercialization.

Steve Krausz: (34:43)
Yes.

Alec Ellison: (34:44)
I think I explained to our viewers, your own personal background early in your career.

Steve Krausz: (34:48)
So yeah, early in my career, I was a double E out of Stanford back in my passion, I had a lot of interest in space because my father actually started a company that made deep space antennas for tracking the early Apollo programs and Mercury programs before that. Also, for intercontinental ballistic missiles coming down [inaudible 00:35:14].

Steve Krausz: (35:14)
Then I worked at NASA and at NASA in the '70s, that was the time when Viking was first landing on Mars and that was very exciting to watch. So I've always watched the space area well and I have personally gotten involved with a group called B612 Foundation, which is run by a former astronaut, Ed Lu and Rusty Schweickart helped to start it. That tries to look for large life-ending events from asteroids. So they do some terrific work now, originally were going to put a burden to space that would be solar orbiting, but now they're managing a lot of the data that's coming from smaller satellites. So again, there was an idea that changed too. They originally felt that they had to put something up in space and now they can use all these micro satellites being put up by many venture backed companies and some of the really, the best entrepreneurs we're seeing who share my passion for all things space.

Alec Ellison: (36:19)
So you do believe this actually will be an area where we'll see more venture because capital intensity is declining?

Steve Krausz: (36:26)
I do believe it's going to be an area because the need for capital to do some of these things, especially when it comes to lower with orbit and things around our planet are becoming reachable from a venture pool of capital that's available, but. There's a lot more money that is available in some of these areas that can take it all the way and again, private equity firms, large defense contractors who are looking for other ways to add to their business, and public, private partnership, but you do need a big fund. Our funds tend to be in the $350, $400 million range, series A focused because that's where we really think the best bang for the buck and our expertise is. We like that space, but if you have a billion dollar fund or a multi billion dollar fund, heck, go for it. My hat's always off to my good friend, Ira Ehrenpreis, who invested in Tesla, and then he followed up in SpaceX. So I'll give a tip of the hat to Ira. He just has the conviction and the vision that I'm a little reluctant to step out my partners who'd probably whack me down [crosstalk 00:37:39] strategy Steve, but [inaudible 00:37:42].

Alec Ellison: (37:43)
Well, I know we have about five, six minutes left. We're going to a lightening round of question. I want to ask, we'll pick up on what you just made about your firm. Your firm has stuck to it's knitting, you're on fund number... what number is it now?

Steve Krausz: (37:53)
12.

Alec Ellison: (37:54)
12, right, as John said at the outset.

Steve Krausz: (37:56)
Hold on, my lights just went off on me.

Alec Ellison: (37:57)
Okay.

Steve Krausz: (38:03)
That's because my wife has put in these timers that if nobody is moving around and it's still nighttime out there, she wants to see, anyway.

Alec Ellison: (38:12)
So you stuck to your knitting?

Steve Krausz: (38:14)
Yes.

Alec Ellison: (38:14)
Many of your colleagues, firms, in the valley have not, they're got bigger firms, they have set up all different size firms, stage firms. Why is that? It's obviously served you well, but that's been a bit of a contrarian play in it of itself, correct?

Steve Krausz: (38:29)
That's true. I think that comes from a couple of things. One is, we do have a, from a strategy point of view, we think that good venture investing comes from investors who have been in the industry, who know the industries well, that they're investing in, and choosing opportunities that have a multi-decade capability to do well. So I think we've been fortunate enough to pick areas in IT and in healthcare that really are multi-generational actually, in their appeal.

Steve Krausz: (39:07)
But we also, we did have larger funds back in the 2000 period, in both in terms of personnel and also in size. We were investing basically in the same areas but we realized that it's very hard to do three, four times your money on very large firms unless you have a very fortunate capital cycle and market cycle playing with you. So when we know how to do what we do, and we do it well. We've very selective and very careful in bringing on new partners and developing them. We think that it works for us.

Steve Krausz: (39:48)
Other people have done a wonderful job building large platforms and work for them well. I mean, look at what the guys at Andreessen Horowitz, who I respect a lot, and Light Speed and NEA have done. NEA started the same time that were more or less, and they've really developed a much more multi-asset category. But I think that for us and for our LPs, they know what they're getting when they invest with us and they've had good returns for 40 years now, so. We're [crosstalk 00:40:21]-

Alec Ellison: (40:21)
So being early stage makes you particularly... well, all firms are dependent on the management teams, but early stage maybe even more dependent. So how is your valuation of management teams and CEOs in particular, had to change in our more virtual environment now with Zoom and otherwise?

Steve Krausz: (40:40)
Yeah, I would say that that is an area that we feel very strongly about, in terms of sticking to our knitting, as you would put it, in terms of really wanting to sit down and get to know our teams and their ability to hire teams. So what that has meant in terms of what has changed, is we're leveraging even more some of the teams that we know personally or have close relationships with because despite the fact that this means of communication works okay, hiring a full management team over Zoom, people are still people. It's tough to really get to know what's at the heart of a person's core and identity. How their value system, how they think about people, how they think about hiring. Also, management teams, we rely on them to hire the teams below them. So we're relying more on people that we've seen that have done it successfully in the past than perhaps some others who are willing to do the entire... we've done a few things entirely over Zoom, but it's mostly through relationships that we've already had or people that have relationships with those people. So that's changed a bit. I think that it's probably going to remain the same for at least this investment cycle.

Alec Ellison: (42:15)
So speaking in the last minute or two of getting to know someone better. For our viewers to get you to know you better, just some quick lightening round questions, quick answers. Last book you read for fun?

Steve Krausz: (42:27)
The last... actually, there were two that I just finished. One was Just Mercy, which is Bryan Stevenson, and during this period, what's going on in this country and around the world, I thought it was just a terrific book. He is with the Equal Justice Initiative and it's well worth reading. Then one of my partner, Irwin Federman and I both share a love of history. Years ago I shared a book on The War to End all Wars. He followed up with a book called The Bridge on Drina, that's probably one you've never heard of before.

Alec Ellison: (43:02)
No, no.

Steve Krausz: (43:03)
That was by a... it was written right based on by Ivo Andric, who was a former Yugoslavian ambassador to Germany, and it was about the decline of the Ottoman Empire and the Baltics. I am a real fan of the Balkan states, rather. I have a real interest in history. So it was written about the end of the Ottoman Empire and what happened in the Balkans.

Alec Ellison: (43:27)
So speaking of history, most historical figure alive or deceased, you most want to have dinner with?

Steve Krausz: (43:36)
Boy, the alive or deceased that I most want to have dinner with? I would say that really, especially at this moment in time, it would probably be Jefferson. The reason is, I want to know what the hell he was thinking when he wrote the Constitution of the United States the way he did. There's a whole bunch of things he could've cleaned up, but I think he's a perfect example of an individual who you admire an incredible amount of what he did, and yet on the other side in this personal life and some of his thoughts, you think, how did those two ideas exist in the same brain?

Alec Ellison: (44:17)
Right.

Steve Krausz: (44:17)
That's-

Alec Ellison: (44:18)
Real quick one for you. What kind of smartphone do you use?

Steve Krausz: (44:21)
I have an iPhone 11.

Alec Ellison: (44:24)
Okay, 11 all right. Reasonably [inaudible 00:44:26].

Steve Krausz: (44:25)
Yeah.

Alec Ellison: (44:27)
Then finally, company in your portfolio most likely to become a household name?

Steve Krausz: (44:34)
A household name?

Alec Ellison: (44:37)
I know you love... yeah, so it's not like you don't love all your children but a company that's most likely for [crosstalk 00:44:47]-

Steve Krausz: (44:47)
Well I would change it, a little differently. [inaudible 00:44:49] become a household name in the world in which I travel because again, I'm on the tech side. That would be probably Cato, I think has a chance to be a real leader and ring the bell [crosstalk 00:45:00]-

Alec Ellison: (45:00)
Just for our viewers again, describe Cato again. You mentioned earlier.

Steve Krausz: (45:03)
Cato Networks, founded by Shlomo Kramer, who I've invested with a number of times and an Israeli entrepreneur who's probably been the best security entrepreneur that I've known and watched, although and there have been quite a few that we've invested in. What they do is they really manage the change in the network that you run over. So the entire software stack is going to run in their environment and they're going to allow you to connect all of your devices, keep them secure, keep them well managed, at a much lower price than you have done in the past. So I think that they have the ability to be the software and the backbone that runs all of what we think in the past of telecommunication systems, whether it be the AT&T's of the world or the Comcast's of the world. I think that the software and the architecture, they could be the heartbeat of that.

Alec Ellison: (45:59)
Terrific, thanks so much, Steve. So you heard it here first, Cato. To all of our viewers, thanks so much for joining us. Steve, you're really a great, far ranging discussion this morning. I think back to you, John, to wrap it up.

John Darsie: (46:14)
Thank you, everybody, for tuning into today's SALT Talk. This is the first episode in our Pandemic Venture Innovation Series. We're very excited about this partnership with OurCrowd, one of the leaders in the crowd funding space for venture investments, so we're excited. So thank, also Steve, for joining us. We'll look forward to hopefully meeting you at one of our in-person conferences here in the near future.

Steve Krausz: (46:37)
I appreciate that, John. Again, I apologize for the coloration here because I am sitting here in the dark in California. This room just happens to have a very yellow light. My son is just going to gag when he sees me with the complexion that I have today, especially considering where we are right now in the election cycle, but I've really enjoyed it. We're USVP.com, it's very easy to find us. Please reach out if you have any questions and thanks for the followup. I very much enjoyed the partnership with OurCrowd. I thank Alec for leading me through this conversation, and my good friend Jon Medved, for all of the support that he has given us and the exciting companies that he's started. I think it's a great idea, so.

Alec Ellison: (47:26)
Yeah, no, ourcrowd.com, we currently probably have a dozen individual companies on the platform and all these several funds as well. So please join if you haven't already. Thank you again, Steve, and John.

John Darsie: (47:37)
Yep, thank you, Alec.

Steve Krausz: (47:38)
Thank you. Good night, have a great day, everyone. I can go back to sleep now?

John Darsie: (47:42)
Absolutely.

Steve Krausz: (47:43)
Thank you.

John Darsie: (47:43)
Thank you, all right.

Jon Medved: Equity Crowdfunding, Venture Capital & Angel Investing | SALT Talks #92

“[The Abraham Accords] are not just about business, it's about basically taking away the sand equivalent of the Berlin Wall. There was this artificial divider in the heart of the world.”

Jonathan Medved is a serial entrepreneur and according to the Washington Post “one of Israel’s leading high tech venture capitalists”. Medved currently is the founder and CEO of OurCrowd, the leading global equity crowdfunding platform for accredited investors and angels. OurCrowd has $1.2B in commitments and has made investments in 200 companies and funds, and 30 exits since its launch in February 2013.

Venture capital has long been inaccessible to the majority of investors who don’t have $5-$10m available for a limited partnership. A crowdfunded platform gives individuals and institutions an opportunity to invest in venture portfolios. “Today, these private companies stay private much longer. When they finally go public, most of the money has been made by smart investors in the private markets and those are venture capitalists.”

The Abraham Accords represent a major moment in the relationship between Israel and the UAE and Bahrain. While Israel was not at war, the normalization has already created massive business opportunities with governments of the US, UAE and Israel announcing a $3 billion fund. There are now 112 direct flights between Israel and the Emirates where there were none before.

LISTEN AND SUBSCRIBE

SPEAKER

Jon Medved.jpeg

Jon Medved

Founder & Chief Executive Officer

OurCrowd

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello, everyone. Welcome back to SALT Talks. My name is John D'Arcy. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology and public policy. SALT Talks are a digital interview series that we launched during this work from home period with leading investors, creators and thinkers and what we're really trying to do during these SALT Talks is replicate the experience that we provide at our global SALT conferences and that's to provide a window into the mind of subject matter experts as well as to provide a platform for what we think are big ideas that are shaping the future and we're very excited today to welcome a speaker from our last SALT conference in SALT Abu Dhabi in 2019 and a leading Israeli entrepreneur, Jonathan Medved of SALT Talks.

John Darsie: (00:56)
Jonathan, welcome, thanks for joining us. Jon is a serial entrepreneur and according to the Washington Post, he's one of Israel's leading high tech venture capitalists. In 2008, the New York Times supplement, Israel at 60, named Medved as one of the top 10 most influential Americans who have impacted Israel. Medved is the founder and CEO of Our Crowd, which is a leading global equity crowdfunding platform for accredited investors and angel investors. Our Crowd has 1.4 billion in commitments and has made investments in 200 companies and funds and made 30 exits since its launch in February of 2013.

John Darsie: (01:36)
Our Crowd exits have included JUMP Bikes, which was sold to Uber; Breathe Cam, which was sold to Canon; Argus, which was sold to Continental; Crosswise, which was sold to Oracle; and Replay, which was sold to Intel. Bloomberg Business Week said on May 7, 2015, that Our Crowd is hands down the most successful equity crowdfunding platform in the world right now. TheStreet.com described Our Crowd as crowdfunding for real investors. Prior to starting Our Crowd, Jonathan was the co-founder and CEO of Vringo and the co-founder and general partner of Israel Seed Partners with $262 million under management. And I know it's a great source of pride for us, I referred to the fact that Jonathan spoke at our SALT Abu Dhabi conference in December of 2019.

John Darsie: (02:26)
That was well before the Abraham Accords were announced, the peace deal if you will between Israel and Bahrain and the UAE, and we were very proud to have brought Jonathan into the UAE to speak at our conference and start building those bilateral commercial relations which have resulted in now diplomatic relations and we're very excited to help Jonathan and Our Crowd build on that success and given his open mindedness and his commercial instincts, he has already been one of the first Israelis to build business ties into the UAE. So, again, we're very proud of helping facilitate that and we're also very proud to have Jonathan on to talk more about that.

John Darsie: (03:03)
A reminder, if you have any questions for Jon during today's SALT Talk, you can enter them in the Q&A box at the bottom of your video screen on Zoom and hosting today's talk is Anthony Scaramucci, who's the founder and managing partner of SkyBridge Capital, which is a global alternative investment firm. Anthony is also the chairman of SALT and with that, I'll turn it over to Anthony for the interview.

Anthony Scaramucci: (03:23)
John, thank you and Jonathan, it's a great pleasure to have you on SALT Talk. The only bad thing about all this, I was hoping to see you in Abu Dhabi in December but unfortunately, we've got that on hold. Obviously, we want everyone to be safe and healthy and we promise everybody we will be back in the region once we're all very confident that those two things can be achieved but before we get into the Abraham Accords and your amazing business, I want to go into your background. I ask every one of our guests sort of the same question. Tell us something about yourself that led you to the journey of starting Our Crowd and where you are today.

Jonathan Medved: (04:03)
Thank you, Anthony and it's great to be back with you and hopefully, it'll be in-person with you, either SALT in the US or back in Abu Dhabi, maybe someday Israel. You never know.

Anthony Scaramucci: (04:18)
I tried to get to Israel twice a year until this whole thing happened and so we'll definitely take you up on that as well.

Jonathan Medved: (04:24)
Cool. I grew up in California in a pretty typical American Jewish family, went to public school, grew up as a product of the 60s and 70s, went up to Berkeley and things sort of changed a bit when I finished my freshman year at Cal and I wanted to go abroad and I asked my parents, like any normal Jewish kid, "Where will you pay for me to go get some seasoning?" And they said, "Israel." So, off I went. I fell in love with the place, ended up learning Hebrew, visiting several times and have been living in Israel for over 40 years.

Jonathan Medved: (05:07)
Now, I was really lucky to get involved in technology from a very early date through another Jewish tradition called nepotism. My late father, Dr. David Medved, was a pioneer in fiber optic communications and I joined the family business. Turns out that I had a liking for tech and helped him raise money and we ultimately sold that company to the Amoco Corporation and that was my first exit. Then three or four companies later, all of them either successfully sold or taken public in New York either on NASDAQ or on the New York Stock Exchange, built a venture capital fund and in 2013, started Our Crowd.

Jonathan Medved: (05:55)
The idea behind Our Crowd was to open up access to the venture capital asset class to the broad range of investors who sort of watch venture capital from afar and say wow, that's great but may or may not have had the $5 or $10 million available for a limited partner's check or didn't understand the sort of esoteric nature of the VC term sheet and we started it and now seven years later, we're about a billion and a half in assets as you spoke about, 60,000 investors worldwide and an increasing number of institutions who are investing in our large and successful portfolio. So, that's my story.

Anthony Scaramucci: (06:40)
Well, listen, I love the story. I want to jump right over ... We're going to talk about venture capital in a second but I want to jump right over to the Abraham Accords. So for people who don't know what that actually means and some of us are super focused on the news like you and me and some of us are focused on finance. What are the Abraham Accords and what does it mean to the State of Israel, what does it mean to the Emiratis, the Bahrainis, what does it mean for the region and what does it mean for your business, Our Crowd?

Jonathan Medved: (07:13)
So, first of all, it's mistakenly called a peace deal and it's not a peace deal because we never were at war with the Emiratis and the Bahrainis. We never had a normal relationship, so it's really a normalization set of deals that now establish full relationships. To give you an idea, I was just in Dubai last week and it took me 20 hours to travel there each way. I had to fly from Tel Aviv to Zurich, hang out at the airport for five or six hours, then Zurich back to Dubai. It's a nightmare and on the way back, I had to go via Frankfurt.

Jonathan Medved: (07:56)
As of January, there will be 112 direct flights between Israel and the Emirates, 112 weekly. It's a three-hour flight. What it changes is-

Anthony Scaramucci: (08:13)
Sounds like some pent-up demand, though, huh, Jonathan? It sounds like long lost brothers and sisters trying to get reconnected, right?

Jonathan Medved: (08:20)
Big time. I was talking today to an Emirati and I said, "Do you think we can use these 112 flights?" And he said, "Are you kidding? We're going to need more," because everybody he knows wants to come to Israel and everybody I know wants to go that way. So it's not just about business, it's about basically taking away the sand equivalent of the Berlin Wall. There was this artificial divider between ... In the heart of the world, in other words, if you look at the map, you'll see that Israel and the gulf are connected by a land bridge which really is the middle of the world and there was a division there which was artificial, was because of politics or mistrust. It's now open and this is going to cause huge business.

Jonathan Medved: (09:11)
I was on CNBC last week. I described it as a $10 billion near-term opportunity. That was before the three governments, US, UAE and Israel just announced a $3 billion fund. So somebody smart, who I know, said, "Medved, you missed it, you missed a zero. It's more like $100 million opportunity." What's interest is the rest of the world is playing a role and I was on a call last week with a group of Japanese businessmen. All they wanted to talk about were these accords and what do they mean for world trade. So it really is one of these things which is much needed good news in today's difficult environment and really going to change things in a big way.

Anthony Scaramucci: (09:59)
The decision to come to the SALT conference, so I mean you sort of made history coming to the SALT conference in Abu Dhabi. Correct me if I'm wrong, but I think you were the first Israeli business person to speak at a large event in the United Arab Emirates. Is that true?

Jonathan Medved: (10:16)
That is completely true and thanks to you.

Anthony Scaramucci: (10:20)
I appreciate that. I'm not looking for the credit for it but I appreciate you accepting our invitation but what went into that for you?

Jonathan Medved: (10:31)
Look, it was a dream come true. I've been doing business in the gulf sort of under the radar for 12 years already. In 2008, I had a startup called Vringo, which was in the mobile content video sharing business and our first big customer was a UAE operator called Etisalat and we established really great business with them. So good, that we took our company public in 2010 and then as we were filing our S1, the SEC said, "Why are you leaving out the stuff about Etisalat in your prospectus." And I said, "Well, for obvious reasons, I don't want to get them in trouble. We're from Israel. These connections are sort of quiet." I think the New York Times called it the worst kept secret in the Middle East, the connections between Israel and the UAE before the normalization, but the SEC said, "Sorry, buddy, you got to disclose it." And what was amazing was how cool our partners were in the gulf.

Jonathan Medved: (11:36)
So, I've seen this going on below the surface and I just felt back in 2019 when you invited me that things were right for a change. It was not just that your conference was being sponsored by Mubadala and serious people down there but they were ready to hear about Israel. They were ready to talk openly and this was already, I think, a signaling of the winds of change afoot back a year ago.

Anthony Scaramucci: (12:07)
All right, so let's segue. I mean all that is fantastic and obviously one of the goals of the SALT conference was to create those types of synergies and I always tell people, I want people to have opportunities to meet people that can help them with their business. Hopefully, we can learn something from each other and lastly, and this was something I said to all the guys at Mubadala and ADGM, I'm there to have fun. Other people want to be boring and dry, I'm sorry. I grew up on Long Island, that's not what we're about, okay? So I'm there to have fun and so hopefully it was a combination of those things.

Anthony Scaramucci: (12:45)
Let's talk about Our Crowd for a second. What are we doing at Our Crowd? Why is it called Our Crowd? I think that's a fascinating connection into your business plan. Explain your business plan to people. Explain where you want to go directionally with the business.

Jonathan Medved: (13:00)
So, look, the idea is that venture capital should be in everybody's portfolio. The problem is it's not only not present in 99% of accredited investors in America, they estimate about 14 million accredited households in America and less than 1% have a venture capital commitment, which means a lot of people are simply sitting on the sidelines. Now, that didn't really matter 30 and 40 years ago when people went public early. Companies like Microsoft and Amazon and others went public at sub-billion dollar valuations. You held onto these things for 20, 30 years like the way that people like Warren Buffet recommend, you made 500, 1000 times your money. That's great.

Jonathan Medved: (13:49)
Today, these private companies stay private much longer. When they finally go public, most of the money has been made by smart investors in the private markets and those are venture capitalists and private equity people who are doing growth and the reality is that it's a shame, and it's really hard to watch this sort of inequality, this lack of democratization. Jay Clayton at the SEC has been talking about this quite insistently that given the fact that we've reduced the number of public listings by half. In other words, companies simply are not now ... We have the [inaudible 00:14:29] phenomenon and whatnot but still companies are not going public the way they used to.

Jonathan Medved: (14:34)
You've got to give some kind of a chance for everybody else to get in but it's not just, by the way, the individual high net worth and investor of the family office, it's the institution. I mean most institutions look at Yale University with envy. The Yale endowment now is targeting, I think, it's 23% of their endowment in VC this year. That's extraordinary. So I don't know how many of our listeners now are institutions, do a gut check, guys. Ask yourselves how much of your corpus is committed to VC and I'll be shocked if a bunch of them can get to 2% or 3%. It's simply too hard.

Jonathan Medved: (15:17)
The venture funds are too small. It's too esoteric. You've got to be sort of a known guy out in the valley and so that's why we set up Our Crowd. The first way we solved the problem was to provide access to the world's second Silicon Valley, which is Israel. So, a big part of our growth story has been the growth in Israel over the last decade. When we started back in 2013, there was about $2 billion being invested annually in Israeli venture capital backed companies. This year, it'll be over $10 billion. So there's been a four-fold growth, which is extraordinary for an ecosystem over this period of time and we've got now 60,000 accredited investors and close to 500 institutions and family offices who are now on our platform and accessing our investments every week. We're doing about 100 deals a year where you can pick your own deal or you can pick a fund and we have a family of 22 funds at the moment.

Anthony Scaramucci: (16:23)
So, first of all, congratulations on all that. It's fantastic. We'll talk about your pandemic fund in a second but I want to ask you something that is about 10 years ago, Dan Senor, who's a friend of mine, he wrote a book called Start-up Nation. When I visited Tel Aviv, I think, in 2015, I had an opportunity to visit some of the incubation venture capital laboratories, some of the things that Israelis were working on related to cyber security, cyber theft, protection of people's digital assets, et cetera. For people on this Zoom call that don't know a lot about Israel and a lot about what's going on in venture capital there, I was told, and I'm assuming it's still true, that there are more venture capital investments being made in Israel or from Israel than all of Western Europe. I'm assuming that's still true and if it is, tell us about the progress that the Israelis are making in the world of venture capital.

Jonathan Medved: (17:26)
So, it's roughly true. It depends on whether you're counting the UK or not or if you stop in Germany and go farther east but the reality is that there are about 7000 Israeli venture backed companies. There are hundreds of venture funds. All of the major venture investors from Silicon Valley put money into the Israeli ecosystem and what makes it unique is that $10 billion I referred to, about 90% comes from overseas. So while there are significant capital pools in Israel, most of this is people literally in the past coming physically to make those investments, today doing it all on Zoom. We're up, by the way, this year in Israel from $8 billion to $10 billion in the time of the COVID pandemic, which is unreal.

Jonathan Medved: (18:15)
What makes Israel so interesting is a couple of things. Number one, the big source of this technology other than sort of a mindset and a culture which asks a lot of questions, which breaks a lot of rules, which dreams a lot, I've got a good friend [inaudible 00:18:32] from Intel, says the way to motivate an Israeli R&D team is tell them that what they're trying to do is that it's impossible. I mean that's probably the most important part of this phenomenon but on top of it, you have about 400 multinational corporations who are located in Israel, doing R&D and increasingly providing exit to our companies.

Jonathan Medved: (18:54)
You have three trade agreements with Europe, increasing ties with Asia and this unbelievably core relationship with the US and a very strong sort of cultural and technology affinity with Silicon Valley where there are probably about 100,000 Israeli expats so deeply embedded in the American tech ecosystem that some of these M&A transactions where a big American tech company buying an Israeli company, they're negotiating in Hebrew because the guy working for Google, Facebook, whatever in the valley is speaking Hebrew to his cousin or his own brother-in-law or whatever it is back in Tel Aviv.

Jonathan Medved: (19:37)
The ecosystem in Israel is very broadly distributed according to sectors and you'll see everything from cyber security to food tech, Ag tech, the cloud, ecommerce, mobility now, drones, you name it and what's really interesting is we're starting to scale companies up. It used to be that we would sell them, I think, on the cheap and for a couple of hundred million dollars and call it a day. Today, if you're not selling your company as a billion dollar plus exit, you're not making the press and it turns out that Israel now has between 40 and 50 unicorns, that is private companies that are now worth a billion dollars. The big exits were Mobileye in the mobility area to Intel for 15 billion and a bunch of great stuff going on including in our platform.

Jonathan Medved: (20:32)
We have several that ... We just go a company called Lemonade, [inaudible 00:20:38] company went public with probably the best debut of an IPO this year in New York and that's an Israeli company that went three years to $3 billion in value very, very quickly.

Anthony Scaramucci: (20:54)
And a friend of mine, who you may know, Michael Oren, who obviously is a similar guy-

Jonathan Medved: (21:01)
I went to college with his ex-wife and by the way, Dan Senor and I go way, way back.

Anthony Scaramucci: (21:07)
We don't have to bring up ex-wives on the Zoom call. I mean come on. I mean Jon hit the ... You have to have a five-minute ... You have a five-second delay when [inaudible 00:21:15] can't bring up the ex-wives on the Zoom call, okay? One of the stage lights is going to come down and hit you in the head.

Jonathan Medved: (21:22)
I love Micheal. Michael's a regular guest of mine.

Anthony Scaramucci: (21:27)
But I'm just saying, Jesus. I was coming up with a really good question and then you bring up the ex-wife, the poor guy, right? All right, and the poor woman. All right, but anyway, he wrote a book a few years back, maybe 10 or 12 years ago called Power, Faith and Fantasy. I don't know if you've read the book-

Jonathan Medved: (21:42)
Yes.

Anthony Scaramucci: (21:42)
... but it talked about where things are in the Middle East, where they are for Israel, what America's relationship is like for Israel. Where do you see America's relationship with Israel today and where would you like it to be over the next 5 or 10 years?

Jonathan Medved: (21:59)
Well, I think that the American/Israel relationship has never been better and yet, it's not a question of one party or one administration, it's always been that way and really from the time of Harry Truman, who, god bless him, recognized Israel at a moment when it wasn't even sure that we would survive, that we were being attacked on all sides. It was an experiment and Harry Truman said this is the right thing to do and recognized the new Jewish state.

Jonathan Medved: (22:31)
Since then, our relationship with the US has been sort of bedrock and it's not just based on defense needs or common intelligence sharing but it's about values, about the fact that we're both democracies, the fact that we're both about a liberal outlook on life, about capitalism, about creativity and it really runs the gamut with culture and religion and families and the American/Israel relationship is unbelievable. Where it's going to go is continue to be driving shared economic benefit and what's remarkable is how many big American corporations are now taking advantage of Israel a sort of their idea factory.

Jonathan Medved: (23:19)
Israel is really good at ideation, creating new ideas out of nothing and whether it's the tech companies or even companies like John Deer or big automotive companies, they all realize that they need to be in Israel. So that's why there're 400 multinations, mostly American companies, who are there. But what makes Israel so interesting today is that these set of special relationships are really now spreading around the world. So, Israel is trying to dance at two weddings at the same time, increasing relationship with Asia, in particular with Japan and Korea and China, Singapore has been a longterm friend. Israel's biggest trading partner continues to be Europe which is in our backyard and despite some political ups and downs in that relationship, the trade business is very significant.

Jonathan Medved: (24:15)
But what Israel and America share is this entrepreneurship sort of leadership in the world and there really is nowhere else for startup investing in companies like Silicon Valley and like Israel. They are both unique in terms of the way the world works.

Anthony Scaramucci: (24:35)
Excuse me, before I turn it over to John, Jonathan, let me ask you about your pandemic fund. You just started it. It's a pandemic ... It's called the Pandemic Innovation Fund. It's a slightly different business idea from your other aspects of your business model. Tell us about that. Tell us how it's going. Tell us what you'd like to see for it over the next three to five years.

Jonathan Medved: (24:59)
So, look, I think that what's remarkable about this very special and challenging time we're living in is sort of the tale of two cities aspect to it because there are a lot of people who are suffering. There's a lot of terrible unemployment. Many traditional businesses have been belly punched and are reeling but on the other hand, the digital economy is booming and you can see it in the price of the FANG stocks. You can see it in what's going on with startups but if you are empowering everything from work from home or if you're empowering telemedicine, if you're empowering diagnostic testing or remote education, your business is on fire, doing really, really well.

Jonathan Medved: (25:47)
So, we decided to set up a fund that would focus on both the medical aspects of the pandemic that frankly had been under invested, whether it's diagnostic testing or tracking and tracing or vaccines or prevention. We were committed to that but also investing what we call the new normal. So we put together this relatively modest $100 million fund and we're still early days in putting it together and raising it but we're investing in a bunch of really interesting companies including one of the leading candidates in Israel for the vaccine. This one happens to be an oral vaccine which is very important given some of the issues in storage and logistics to get some of the more esoteric vaccines out to the world.

Jonathan Medved: (26:38)
If you look at what happened with polio, the first vaccine was a shot and then the Sabin vaccine, which was oral, was the one that really took the day. So we're hoping that that'll be ... That company's called MigVax. We're hoping that will be a winner and a whole bunch of other companies that are doing everything from robotic process automation to distance learning, cyber security which is becoming a huge part of the work from home conundrum [inaudible 00:27:11].

Anthony Scaramucci: (27:12)
All right, well, with that, I'm going to turn it over to John D'Arcy. We've got a ton of audience participation here, Jonathan. Congratulations on everything that you're doing and it's an awesome story and I hope that SkyBridge and SALT and all of us can be together soon and help grow that story.

Jonathan Medved: (27:30)
Thank you, Anthony.

John Darsie: (27:32)
Yeah, Jonathan, we have a lot of audience questions, so looking forward to getting into these. The first one, going back to the Our Crowd platform, you talk about how your goal is really to democratize access to the type of venture capital opportunities that typically are only available to large investors with high minimums. What is the minimum for an investor on Our Crowd and what's the process like for them to be onboarded, to verify their accreditation, for them to ultimately invest in deals on your platform.

Jonathan Medved: (27:59)
It's great. So, first of all, it's an accredited investor platform. So you've got to meet those criteria. In the US, where I imagine most of your listeners are, this is a million dollar net worth test outside of your primary dwelling or a $200,000 annual income test and again, there are about 14 million households that meet that. We have a pretty frictionless onboarding process where we use a third party vendor who qualifies that. We use something called 506(c) which is a new part of the Reg D regulations that allow us to actually do public solicitation. So, in order to do that, we do have to get more than just a self attestation to your credited status. We do that pretty quickly but it's pretty much about a one-day process and you're up and running and you're on the platform. And again, we have about 60,000 registered investors at the moment. Like it to be 600 or 6 million someday or 60 million but we'll get there.

Jonathan Medved: (29:06)
But once you're on, then every week, you're going to see several opportunities and you're going to get this information by email and be invited to go to our website either through your mobile phone or through your desktop. We actually post a lot of information about the company and the investment opportunity including the company's debt as well as an analysis written by our team because we put our own money in as any GP does. I mean we're not a crowdfunding platform in the traditional sense where companies are paying us to slot them and then we're getting a commission from the companies. We're principle investors. We're venture capitalists. So we're putting GP money in. Each of the investments is approved by our investment committee. It's been fully diligenced and then once we do that, we share that information with the crowd.

Jonathan Medved: (30:02)
We actually lead the majority of our investments. We sit on company boards and then we open these investments up to the crowd. The minimum investment in a single company deal is $10,000 per deal and the minimum investment in a venture fund is 50,000. So it's quite accessible and quite democratic. I mean let's face it, most of the venture funds you want to be in, their minimums are like $5 million. So to bring it down to 50,000, we think is going to change the way that access is done and I noticed there was another question that someone had asked about benchmarking. We're very, very obsessed with performance and we are benchmarking ourselves against Cambridge and all the other metrics that are watching people's performance.

Jonathan Medved: (30:53)
We have good performance for some of our portfolio funds. We have a fund called OC50, which actually takes your $50,000 investment and then divides it into 50 individual bite sizes of approximately $1000 and so you get a very hyper diversified portfolio of venture companies. Very, very interesting in it's construction. All of these companies that we're doing diligence on on the platform, in any event. And we're now getting ready to launch series four of that fund. It's an evergreen fund that we continually make available on our platform and performance has been running, depending upon which iteration, in the healthy double digit IRR net after fees. So we're quite happy with that.

John Darsie: (31:45)
In terms of companies that are on your platform, in terms of the deal pipeline, is there a geographic focus? Are you focused on Israeli or Jewish entrepreneurs or is it a global fund? What is the makeup geographically of the types of companies you have on the platform?

Jonathan Medved: (31:59)
There's absolutely no religious or ethnic focus at all. There is a slight geographic preference simply because we live in Israel, we're headquartered there. We now have 13 offices around the world ranging from Sydney, Australia to Hong Kong to Singapore to London to Madrid, down in Sao Paulo, Brazil and our newest, of course, is in Abu Dhabi. So thanks to you guys. And the reality is that we ... Today, about 54% of our deal flow is in Israel and about 46% outside of Israel. So we're approaching parity between Israeli deals and external deals, which I think is a good thing.

Jonathan Medved: (32:51)
So, on the one hand, if you're seeking a great source of Israeli deals, please come to Our Crowd but we're offering deals elsewhere. So, as you mentioned in your very kind introductory comments, we were investors in JUMP Bikes, people who have seen those red bikes, bought by Uber. We were investors in Beyond Meat, which was one of the best IPOs, really, of the last decade before it went public. And these are ... We were investors up in a Canadian company called Wave. It was bought by H&R Block for 440 million, and we're continuing to make ... We just led a big round at a very nother interesting food tech company. I can't say it actually now because they're about to announce it soon, so I've got to watch my tongue but the reality is we're about half/half in terms of deals in Israel and outside of Israel.

Jonathan Medved: (33:43)
Those outside of Israel are by and large US deals, although we have some deals in China and Europe and we're really seeking to be a global platform and as we get bigger, we'll do more and more outside of Israel.

John Darsie: (33:56)
So, you talked about how you've been quietly doing business a little bit in the gulf even prior to the normalization of relations in Israel but you were one of the first, I think you were the first Israeli businessman to sign an MOU with an Emirate firm after the Abraham Accords. What has surprised you about the opportunities and the entrepreneurial spirit that exists in the gulf and what type of opportunities do you see for commercial collaboration between Israel and the UAE going forward and Bahrain for that matter?

Jonathan Medved: (34:25)
I think the opportunities are great. First of all, there was a question there of Bahrain as well as the UAE, because the UAE's got a GDP of about more than 10x that of Bahrain, they get lost sometimes, but I think there's great opportunity in Bahrain. There are a whole series, I think, there's now 12 weekly flights going to go into Bahrain from Israel. So we don't want to leave them out of the equation and we're very committed to that. Our regional office for the GCC, if you will, will be in Abu Dhabi but we'll probably be building in long run, sort of satellites in other cities and other regions there as we grow it.

Jonathan Medved: (35:09)
Look, the opportunity is essentially for three different things. It's for investment whereby both Israelis are going to be investing there and we're getting ready to announce our first investment in a UAE company, which we're very excited about. People from the region are going to be investing in Israel and we've got ... We just announced $100 million framework investment deal with the Al Naboodah Group. That's number one is a tremendous sort of bilateral investment.

Jonathan Medved: (35:42)
Number two is going to be creating joint ventures whereby it's not just about taking Israeli products and moving them into the gulf or gulf products and moving them to Israel, but it's going to be about creating new things together. I was sitting on a porch outdoors last week with a group of 20 and 30-something sort of next gen Emirati business people who were the sons of ... And one of them pointed to this huge building in the distance and said, "That's my dad's building," and he said, "I want to build something bigger." And I said, "Well, where is the building going to be?" He goes, "I don't want to build the building. I want to build the startup." And these guys were all interested in AI and food tech and mobility and logistics and they were completely up-to-speed with what's going on in both Israel and in Silicon Valley and I think that when you put these two together, it's going to be fireworks.

Jonathan Medved: (36:45)
The third area which we're looking at is actually doing research and development over there because there are generous government benefits and it's easier, in some cases, to actually recruit people from abroad to come live in the Emirates as expats because today, let's face it, in Israel, we're growing our ecosystem but we're short, at the moment, about 20,000 engineers for our companies and that gap is growing. So we really need to do R&D everywhere. We've got teams working in the Ukraine and Hong Kong. People are working for Israeli companies. They are becoming sort of like baby multinationals and I am certain that there's going to be a lot of really interesting R&D done in that area too.

Jonathan Medved: (37:37)
So, the opportunities are huge. It's going to be broad. It's going to be everything from property technology to clean energy to logistics to Ag tech, to food tech because they're really into food security, cyber security, oil and gas, you name it. There's going to be a lot going on and I think we haven't even seen the beginning of this.

John Darsie: (38:03)
Yeah, just to echo that, we obviously have some clients in the region on the SkyBridge side and we have friends in the region in Saudi and the UAE and Bahrain but we were blown away as we dove deeper into that ecosystem as a result of SALT about the entrepreneurial vigor that exists among the next generation, especially in the UAE and in the region as a whole. So it's a very exciting time.

John Darsie: (38:25)
So, we have another audience question about how do you source deals for the platform, especially ones that are highly competitive? How do you get into those deals and how do you source them?

Jonathan Medved: (38:35)
So, first of all, we source them, by and large, through our network of investors because once people are investors on the platform, they trust us, they see how we work and they want to bring us into the deals they're looking at. They want our opinion and we're quite happy to share that. That's probably our biggest source. Perhaps our best source of deal flow is from our entrepreneurial core, the CEOs of our companies, the 200-plus, they bring their friends because they work with us because let's face it, today, the way you get into a highly competitive deal is not to outbid somebody. That's so last century. Today, the way you get into a good deal is by outbidding somebody on the value that you can add.

Jonathan Medved: (39:22)
In other words, you've got to be able to convince the smart entrepreneur, the smart CEO that you're not just going to write them a check and be there in the future to write more checks, which is a big part of this job, to continue to sustain these companies going forward, but that you can provide strategic introductions to partners, that you can help recruit key members of his management team, that you can get them in the media, that you can introduce them to other investors. I mean this is really what this is about.

Jonathan Medved: (39:54)
It's not like about picking a public stock. We're not deal pickers. We are company builders and we bring to this a remarkable amount of added value because of the crowd. Because we have 60,000 people on our platform and hundreds of family offices and multinationals and whatnot, we're able to go to an entrepreneur whether it's in Abu Dhabi or in Israel or even in Silicon Valley and say how would you like this international network to come work with you and that becomes, usually, a very compelling part of the value proposition. We urge them to call our other CEOs and ask what's it like working with these guys? Do they really deliver? And smart entrepreneurs do their diligence on the investor the way that investors do their diligence on the company and that's how you get into the good deals.

John Darsie: (40:48)
So, before we let you go, I want to finish on another followup question about your Pandemic Innovation Fund and about the pandemic in general. So as some of you may have seen, we put out a press release yesterday. We're going to be doing a series of SALT Talks, partnering with Our Crowd, which we're very excited about, talking about all the innovation that's taking place as a result of the pandemic whether it be new trends that are emerging or the acceleration of existing trends. One of the interesting things, I think, about your Pandemic Innovation Fund, and it's not just first derivative effects of the pandemic. It's not just okay, we're going to have remote work, so we're going to invest in Zoom and Skype and Microsoft Teams. There's a lot of second and third derivative investments in that fund that I think are fascinating. Could you talk about some of those second or third derivative effects and the investments that you're making as a result of those effects?

Jonathan Medved: (41:36)
Sure. So look, I think that when you start looking at, for example, food tech, which you might not think that food tech has much to do with the whole pandemic story but as you know, by the way, during the pandemic, there were terrible breakouts that happened in ... Yeah, there's a dog-

John Darsie: (42:01)
That's part of the Pandemic Innovation Series. [inaudible 00:42:04] dogs barking in the background.

Jonathan Medved: (42:06)
Yeah, a bark suppression algorithm which we can sell to ...

John Darsie: (42:12)
I need a bark suppression algorithm and don't worry about it. People appreciate the dog barking in the background.

Jonathan Medved: (42:19)
It's actually the most effective security system known to man were dogs.

John Darsie: (42:24)
Absolutely.

Jonathan Medved: (42:25)
But in any event, there were a lot of meat packing companies that really got terribly whacked and there were all kinds of issues about food security as a result of the pandemic. People went attacking these food shelves and so there are companies where we have money invested like Ripple, which is not the cryptocurrency but the plant based milk, where all of a sudden, their sales started to take off because of the fact that they have a long shelf life and people didn't want to have to go keep running back to the market and they said wait, this stuff lasts for a month or even longer in my refrigerator? I'm going to get that.

Jonathan Medved: (43:10)
We have another company called Tovala, which basically makes a smart oven that takes a pre-packaged piece of food which is shipped to you. It's, by the way, fresh and it cooks it for you. Their sales went through the roof as a result of the pandemic. We have a company called Trellis which helps big food companies do optimization of their supply chain so that they can save 15% and so I'm just drilling down here at various ... I'll give you another one. We have a company called Tevel, which used drones to pick fruits and it turns out that there's been tremendous shortages of farm hands and for foreign workers during the pandemic to get ... So just fruits rotting on the trees. So these drones do that.

Jonathan Medved: (44:04)
So there's four examples in just one narrow segment of companies that most people would not think of as having been impacted by the pandemic. So this new normal we're living in, we haven't even begun to understand how deeply reality is changing and we all think ... We all understand Zoom now and we're amazed that Zoom's market cap keeps on seesawing with IBM but there's a lot more beyond Zoom. I'll give you one more example in the medical area which is that we had a pandemic innovation conference online where we had the head of Johns Hopkins Health on and he predicted that 30% of hospital visits are simply going to move to telemedicine and then we had another webinar with the head of one of Israel's leading hospitals, Sheba Innovation Group. I asked him what he thought of that prediction, because it's pretty astounding when you think about it, 30% of hospital procedures are now ... Or visits are now going to go online?

Jonathan Medved: (45:10)
That's a huge market opportunity and he said, "Way underestimated. Try 70%." So, you look and you start thinking, has the smart investor realized how big this shift, disruption is going to be in the delivery of medical services and digital health, of telemedicine, and I don't think most people have really thought this through yet and that's why you need things like our Pandemic Innovation Fund, which are focusing on that.

John Darsie: (45:42)
Well, John, thanks so much for joining us. Again, we are so excited to do the SALT Talk series in partnership with Our Crowd. It's a fascinating platform and we share so many of the same values in terms of democratizing access to alternative investments and also plenty of other values as well but thanks so much for joining us this morning. Anthony, you have a final word for Jonathan?

Anthony Scaramucci: (46:03)
Listen, we got to get back together. That's what I'm looking for, okay? I'm looking for some one-on-ones, face-to-face, that's what I'm looking for.

Jonathan Medved: (46:12)
And some hugs.

Anthony Scaramucci: (46:14)
Yeah, yeah. I got to tell you, there's a guy in his basement, he's beating up on the guy that's not in his basement and I'm in my basement too, Jon. So we're sitting there right now. But I mean, maybe the basement is after all ... Maybe the basement is the best strategy after all, I don't know. We'll have to see.

John Darsie: (46:32)
It's been a long day.

Anthony Scaramucci: (46:33)
All right, you do well.

Jonathan Medved: (46:33)
A lot of great companies set up in basements and garages, that's for sure.

Anthony Scaramucci: (46:37)
Amen. All right, well, you be well, Jonathan.

Jonathan Medved: (46:40)
Thank you, guys. See you soon.

Marty Chavez: How Tech is Transforming the Financial Industry | SALT Talks #88

“The software has so much knowledge of markets, and data, and models, and risk, and positions, and trades that anything you could want to know about the markets and about our risk, you can just ask the software.”

R. Martin (“Marty”) Chavez is widely renowned as a trailblazer and leader who revolutionized the way that capital moves and works on Wall Street. Most recently, Marty served in a variety of senior roles at Goldman Sachs, including Chief Information Officer, Chief Financial Officer, and global co-head of the firm’s Securities Division. Chavez began his long and illustrious career breaking from tradition as an openly gay Latino working on Wall Street, an industry that had not yet earned a reputation as widely accepting.

In the 1980s, Goldman Sachs made one of its most important decisions in its company’s history when Lloyd Blankfein helped develop a computer-generated risk management system by integrating computer scientists and IT professionals with the trading desk. Chavez was the 12th member of this new age team, named SecDB, developing software that revolutionized Goldman’s ability to process data and inform risk management. “You can ask the software to run trillions of ‘what if's, hypothetical's, what if dollar-yen moves here, what if the fed does this to interest rates?’ And then you can start to ask, ‘Well, how much money would we make or lose?’"

Chavez is now applying the AI technology and ideas he helped develop in finance to the life sciences, his original passion. This includes a company that has created a digital microscope designed to outline cells and their tissue specimen to identify potentially cancerous properties.

LISTEN AND SUBSCRIBE

SPEAKER

Marty Chavez.jpeg

Marty Chavez

Chief Information Officer

Goldman Sachs (2014-2017)

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello everyone. And welcome back to SALT Talks. My name is John Darsie, I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance technology and public policy. SALT Talks are a digital interview series that we launched during the pandemic with leading investors, creators, and thinkers. And what we're trying to do during these SALT Talks is replicate the type of experience that we provide at our global conference series, the SALT Conference, which we unfortunately had to postpone in the wake of the pandemic, but are looking forward to resuming in 2021. And what we're really trying to do at the conferences and on the SALT Talks is to provide a window into the mind of subject matter experts, as well as to provide a platform for what we think are big ideas that are shaping the future.

John Darsie: (00:51)
And we're very excited today to welcome Marty Chavez to SALT Talks. Marty is widely renowned as a trailblazer and a leader who turned the Wall Street trading business into a software business, revolutionizing the way that capital moves and the way that capital works. Most recently Marty served in a variety of senior roles at Goldman Sachs, including Chief Information Officer, Chief Financial Officer, and the global co-head of the firm's securities division. Marty was also a partner and a member of the Goldman Sachs management committee. Marty has achieved singular acclaim in the financial services industry for his work on SecDB, an early platform that transformed the trading business into a software business. He's also known for bringing the front and back offices together.

John Darsie: (01:35)
Far from the stereotype of a banker, Marty is a disruptor at heart, and he was among the most senior Latinos on Wall Street during his time at Goldman, as well as the most senior openly gay executive at Goldman Sachs. In 2016 a New York Times profile describe Marty and his departure in sensibility from the button-down partners of Goldman LOR. Prior to joining Goldman Sachs, Marty was the CEO and the co-founder of Kiodex, which was acquired by SunGard in 2004. And he was also the Chief Technology Officer and co-founder of Quorum Software Systems. He holds an A.B magna cum laude in biochemical sciences and an S.M in computer science from Harvard and a PhD in medical information sciences from Stanford, specializing in architectures and algorithms for probabilistic expert systems.

John Darsie: (02:26)
So Anthony, our moderator today, Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, he overlaps a little bit in terms of Harvard and Goldman Sachs with Marty. But I would say they took slightly different paths. I don't know if Anthony has his degree in biochemical sciences or that long architecture is algorithms and probabilistic expert systems, but he's a pretty smart guy and we're looking forward to a conversation between Anthony and Marty. And reminder, Anthony is also the chairman of SALT, Anthony with that, I'm going to turn it over to you for the interview.

Anthony Scaramucci: (02:57)
Marty, after he blasted me with H.R. McMaster, reminded everybody that I got fired after 11 days and McMaster threw me a farewell party just right at the Adam's apple with the karate chap, he's bringing up the fact that you are way smarter than me, right? And the reason he's doing this is because I threatened to fire him last time. And of course it was a hollow and very shallow threat, Marty. And so now here we are again, we're stuck with him [crosstalk 00:03:24] the next 45 minutes. So I'm sorry about that, Marty, but you know what, what can we do? We got to get millennial traffic on SALT Talk and so John is our millennial magnet.

Marty Chavez: (03:35)
Okay. Seems to be working.

Anthony Scaramucci: (03:37)
It's great to have you on. And in all seriousness, you are a true pioneer and you've done many things for our industry. But also, the way you've lived your life and your openness is to me, it's a very gratifying thing. And so I'm usually appreciative of you joining us, but I want to talk about your personal and professional background because, why did you go into investment banking, how did you lead there? And when you were a kid, did you think you were going to go in that direction? And if you didn't think you were going to go in that direction, what direction did you think you were going to go in?

Marty Chavez: (04:12)
Well, actually, paradoxically, the only reason I ended up on Wall Street is because it was not part of my plan. And what I mean by that is as college class of 85, and I remember in my graduating class, it seemed like almost everybody was going to Wall Street, if they weren't going into consulting. And well, something happened in October of 1987, and there are so few people from the class of 85 on Wall Street as a result. And so I took a different path. I'm a computer scientist, and I'm really just a computer geek and always interested in applying computer math software modeling analytics to real-world problems and I've been interested in a lot of different real-world problems. And my first job was actually assigned at the times, it was when I was in prep school and it was a summer job at the Air Force Weapons Laboratory. And I was writing Fortran programs to simulate explosions of neutron bombs. That was sort of a thing you could do in New Mexico at that time.

Marty Chavez: (05:23)
Turns out the math is pretty much the same math used all over the place, including on Wall Street for modelings, [inaudible 00:05:30] partial differential equations. So who knew that would eventually be useful, but I went off in a different direction. I studied biochem in college simply because one of my professors said, "The future of life sciences is computational," which seems obvious today. It was not obvious in 1981. So I was at Stanford Medical School, and I was doing this MD-PhD program and doing some work on machine learning, early work, early groups of people saying, "Hey, can we get machines to figure out how to do diagnosis of sick people just like doctors do?"

Marty Chavez: (06:10)
The problem though, the scope and the complexity of problems in medicine are so much greater than what the computers were able to do at that time. So my PhD research was, well, can we get approximate answers really fast with the low compute power we've got, but it honestly, wasn't really working. And that time, the early nineties is now we look back and we say, "That was a nuclear winter of AI and machine learning." We stopped using the term AI because what we were able to do was so far away from the aspirations of artificial intelligence, it was almost an embarrassment. So in the middle of that, a Wall Street firm that I had never heard of, told the head hunter, "Go to Silicon Valley and give us a list of entrepreneurs in Silicon Valley with PhDs from Stanford in computer science and ship them in for an interview."

Marty Chavez: (07:11)
And so I thought it was a joke. I thought it was taking this bank really scamming them for a free trip to New York, hanging out with my college roommates, see shows, have a good time go to an interview. And so I went to the interview and one thing led to another, and a week later I moved to New York and that's how I got on Wall Street, entirely serendipitous. I had the background they were looking for but I had no idea what my background was going to lead to, it just happened.

Anthony Scaramucci: (07:43)
That was a fascinating story, and you started in J. Aron and if I remember correctly from your bio, and so you know Lloyd and Gary who are personal friends of mine.

Marty Chavez: (07:54)
Since I was a kid.

Anthony Scaramucci: (07:54)
Like Tim O'Neill, who moved on [crosstalk 00:07:56] Goldman geography, but I want to take you back to those days. I joined Goldman in 1989, and I can't remember the Chief Technology Officer, I think his first name was Rick, but I can't remember his last name.

Marty Chavez: (08:08)
Taking me back. I wouldn't be even remembered back then.

Anthony Scaramucci: (08:11)
Okay. But there was something that happened in the mid eighties at Goldman, where they made a mainframe decision that they felt was the incorrect one.

Marty Chavez: (08:21)
Yes.

Anthony Scaramucci: (08:21)
Do you remember this part of the story?

Marty Chavez: (08:23)
Yeah, I do remember.

Anthony Scaramucci: (08:24)
And so I think they chose digital when they probably should have chosen IBM and gone with the more robust and so there was a big technology commotion. And the reason I'm bringing this up is that I still feel it's 30 years later or 35 years later from that decision and C-suite people still have a problem in technology in terms of understanding where to go, why to go where to go. And so what would you say to those people that are listening in to us right now about what you've learned in your career and how to guide people that are not as technologically proficient as you are, but have to make these really big macro decisions for their companies?

Marty Chavez: (09:06)
Well, I think that everyone can learn a lot from [inaudible 00:09:11]. So what happened in response to the episode you described is that Lloyd and the other J. Aron partners effectively began seceding from the IT decisions of the firm. And you'll know, Anthony, that J. Aron had just become a part of Goldman Sachs a few years earlier. So it always had this independent streak and Lloyd would go to the IT division of Goldman Sachs and he'd say, "I want a risk management system." And they go and do a bunch of work for a year and then they'd be very excited. And they'd presents what they had done to Lloyd and you know Lloyd so I'll paraphrase. He said, "This is not at all what I had in mind." Though he might've said it more vigorously and they kept going back and forth.

Marty Chavez: (10:04)
And so Lloyd had what today I think is one of the most brilliant brainwaves that any leader has ever had and he is not a computer scientist or mathematician. He said, "The problem is we have this far away IT division, and they do their thing and they know a lot about computers. But over here on the trading floor, I got a different reality and different problems. I know a lot about trading and I don't know about computers. We're talking past each other, we're speaking different languages, we are not communicating. So when I say, I want a risk management system, I know what I have in mind, but they're not hearing me and they're looking for functional specification, but I don't know how to write functional specifications. And so this is going to go on forever, it's nobody's fault.

Marty Chavez: (10:53)
So Lloyd's thought was, once he had the awareness, he said, "Well, what am I going to do about it? I'm going to go across the river to where you find computer geeks." And in those days, you went to Bell Labs, close to New York, cross the river. And he said, "I'm going to get my very own computer geek and I'm going to put that person in the chair next to me. And I'm going to treat him really well, like a professional on the trading desk, even though he is not at all like the salespeople and the traders. And I'm going to order the salespeople and the traders to work with him and listen to him, and I'm going to run everything by him. And we're going to do that and see how it works."

Marty Chavez: (11:32)
Well, that's the guy, Armen Avanessians, he's still at Goldman, he hired me. He's the one who said, "Hey, what we need here is a piece of software that becomes the trading business. The software has so much knowledge of markets, and data, and models, and risk, and positions, and trades that anything you could want to know about the markets and about our risk, you can just ask the software. You can ask the software what it is right now, but with software, you can do something that you can't do anywhere else. You can ask the software to run trillions of what if's, hypothetical's, what if dollar-yen moves here, what if the fed does this to interest rates?" And then you can start to ask, "Well, how much money would we make or lose?"

Marty Chavez: (12:17)
So this was Armen's brainwaves in response to Lloyd's. And then Armen says, "Well, I got to go shopping for computer scientists and Stanford, Silicon Valley seems like a good place to get them." And then that is the SecDB project. So I just had the incredible fortune of being an early person in this group, which Armen called strategists are strat for short. I was maybe the 12th person and now it's several thousand. And having people like that and bringing them into your business and not treating them as tech support, "Can you help me turn my computer on and off?" But, "We've got some problems in this business on the scientific process. As partners, let's collaborate on solving them." When you invite computer scientists, data scientists, machine learning people, into your business, and you treat them as first-class citizens, you get an amazing result. And that would be my counsel to any leader, you do not need to be a computer scientist to run that playbook.

Anthony Scaramucci: (13:23)
Well, I think it's great advice and it's basically to be less intimidated and be more communicative, I think is the real thing. I mean, sometimes people do to their insecurities and the fact that they're intimidated, they overshoot, or they try to pretend that they know more than they do as well. So I think you're giving really good advice to C-suite people. Let's talk about AI for a second, because I'd like to get your thoughts on AI philosophically. The brain right now, the human brain is probably learning more quickly than a computer at this point. Is that fair to say, or not necessarily true at this point?

Marty Chavez: (14:01)
Anthony, there are some things that human brains do really, really fast, and the computers are making progress, but they're still not where human brains are. So let's say you're a human being evolving on the savanna, and you're looking for predators on the horizon.

Anthony Scaramucci: (14:24)
Pay attention Darsie. This is you by the way, that you're evolving on the savanna. So pay attention, Darsie, okay? I think we're going to get a few shots in, Chavez. I mean, after the way he started this thing. Okay. So we're back on the savanna, we're all evolving together. Go ahead.

Marty Chavez: (14:39)
And we're watching out for predators. Human beings and human brains are really, really fast at predator detection, do I stay here or do I run? And that's something that computers are getting very much better at very, very fast. But then here's something that human brains are actually pretty terrible at. So no matter how smart you are, if I asked you to multiply two, 10 digit numbers, any $10 calculator is going to be faster and more reliable than any human being by a really long shot. So human brains just work in very, very different ways and there's been a lot of research, right? We seem to have a cognitive system that makes very fast decisions using a lot of approximations and guesses and pattern matching based on experience that helped us avoid getting eaten by predators.

Marty Chavez: (15:34)
And we have a much more complex system that is mathematically based, where we can reason about how to make correct decisions under uncertainty and that system, however, is not instinctual. It gets amazing answers, but it's slow. And the answers will often be different from the answers our gut gives us and understanding the difference between those two is super important.

Anthony Scaramucci: (15:59)
So then the follow-up question is an obvious one. When does that sort of stuff converge between the human and the computer?

Marty Chavez: (16:08)
Yes. So we don't know, there's a lot of opinions. I I'll say a couple of things, first of all, there's something incredibly powerful about anything, you know this is from finance, anything that compounds, compounded growth over time is exponential. And it might seem really, really slow, 2%, 3% growth, but you look at it over 20 and 50 years and it starts being extraordinary, right? And so something like Moore's Law, which says compute power is increasing exponentially. Well, back in the fifties, it didn't seem so great, seemed to be going pretty slowly. But now we're onto the proverbial second half of the chess board where you've been doubling, and doubling, and doubling, and suddenly it's starting to be really meaningful. And so computers are getting so much faster and they've been doing it for a long time and we don't really see any end in sight.

Marty Chavez: (17:12)
And so it seems like at a certain point, they'll just be enough computing power that you could simulate a human brain. You could simulate all of those neurons spirally. And so that will be one way that you get automatic or artificial general intelligence, that seems like it's going to happen. Who knows when? But one thing is very important to say, is that there's been a breakthrough and we're really seeing the fruits of that breakthrough in these last 10 years. Here's the breakthrough. If you can take a problem and you can frame it in the following way, "Here are a billion examples of my problem." Let's say my problem is recognizing whether there's a cat in this picture, right? Here's a billion images and human beings for some reason, love talking about cats and posting pictures of their cats on the internet. So we got lots of pictures out there on the internet.

Anthony Scaramucci: (18:10)
Wasn't the internet invented for that thought, Marty? [crosstalk 00:18:16] and so forth, right?

Marty Chavez: (18:19)
Well, as silly as the example is, it's really powerful because there's billions of images out there on the internet. And people have said, "Hey, look at my cat." And so now a computer can look at all these images and say, "Oh, a human being has told us, 'These 500 million images contain a cat, these 500 million images do not.'" If you can frame a problem that way it's been labeled so that these ones are cats, these ones are not cats. Using techniques that are standard deep leaning, we can train up a deep learning network and we can give it a new image that it's never seen before and ask, "Is this a cat?" And it will give us a highly reliable answer.

Marty Chavez: (19:00)
But it's gone beyond that, Anthony in that now you can show it an image of a cat. It'll tell you how many cats there are, where they are, what breed of cat, how old the cat is like, it'll tell you an awful lot by looking at the image. Now, that is amazing because now think of some real problems like translating from one language to another. If we have out there on the internet, billions of documents that have been translated from English to all these other languages, we can shove them into a neural net and it can now translate between languages. So any problem that can be framed in that way, the techniques we have now are so amazing that they're going to be better than any human being at that problem.

Marty Chavez: (19:45)
But here's the punchline. A lot of things that we do, and our having general intelligence, we don't think can be framed in that way. There is no sample set of a billion cats and a billion not cats. And because that doesn't exist, these techniques don't work. And for us to really have artificial general intelligence, we're going to need another big breakthrough. And if that breakthrough has happened in some lab somewhere, I'm not aware of it.

Anthony Scaramucci: (20:16)
But it's a fascinating discussion. And so ultimately, and I'm sort of leading you, but I'd like to get your opinion. You're optimistic about future innovation and you're optimistic about the unleashing of the prosperity that that will afford human beings in civilization.

Marty Chavez: (20:34)
Absolutely. Yes, sir.

Anthony Scaramucci: (20:35)
And so then the secondary question is, well, we have to figure out a way to make sure that there's some level of equal distribution so that it just doesn't become some top heavy, would that be fair logic?

Marty Chavez: (20:44)
I agree 100%, I think with these exponential technologies, you see a power law behavior in the distribution of wealth, right? So we're all familiar with the bell curve, right? There's people certain height, that's the median, finding someone who's three feet above the median height is going to be surpassingly rare, essentially zero probability. But wealth to your point is not distributed that way, almost no matter who you are, there's someone who's 10 times richer, right? Eventually you get to Jeff Bezos, but the people who are just sort of unfathomably richer than everybody else. And it seems that these exponential technologies are increasing that winner takes all dynamic.

Marty Chavez: (21:33)
So I am a huge advocate. We have to do something about this because while these technologies will make the planet better and will make life better, they pose many problems. There's existential problems about work, what will we need human beings to do? And about retraining people whose jobs go away, not so much because they've gone to China or India, but because they've gone to computers and robots. And how do we retrain them for new things and how do we do that in a timeframe where society doesn't break down? And so I am a firm proponent that there will always be interesting things for human beings to do and human beings are always better than machines at doing. I don't see that changing, but during any 10 to 20 year period, you can have some huge dislocations. So I'm all in when it comes to universal basic income, what would that actually look like, how do we get it done? Those are the hard questions.

Anthony Scaramucci: (22:38)
Right. And also a package of, I think you and I probably share a similar faith you and I. I did Andrew Yang's podcast and I am a believer in UBI, but I would also say I am a believer in uneven outcomes, Marty, but I want there to be more equal opportunity. Because I was a product of the good public school system and two blue collar parents that didn't go to college. But without that good public school system, I couldn't have catapulted into Tufts and Harvard and ultimately to Goldman Sachs. And so we recognize some of our success in life is providential, but it would be nice if we could come up with the right policies, not necessarily left or right policies, but the right policies that could flatten that playing field.

Anthony Scaramucci: (23:21)
But one thing that human beings are not great at, Marty, and maybe machines can help us with this is that we have this narrative going between socialism and capitalism and there stark narratives. And perhaps there's something more subtle in between that we can synthesize and make people understand that you can have unlimited outcomes, but you need some base level of equal opportunity. But that's for day and another SALT Talk. I want to go back to what you're doing right now and how you have used all of this wonderful life experience that you have to do what you're doing today. Tell us what you're doing.

Marty Chavez: (23:59)
Well, if you wait long enough, all kinds of amazing things happen. So I took essentially a 25, maybe more, 25 year call it detour, away from the life sciences and computation and life sciences, the intersection of those two things. And with the progress of software and technology and chips getting faster, that 25 years has been amazing. And so problems that we couldn't begin to solve in 1990 now look like they might be solvable, maybe not today, but we can see a path. And so almost everything that I'm doing these days is at that intersection of computation and life sciences, can we take a scientific process that is often, for instance, in the case of discovering new medicines, also a business process. And can we do to that process, what I and many of us at Goldman worked on for the trading business?

Marty Chavez: (25:07)
Turns out that the trading business, as hard as it was, is actually a really easy problem to solve compared to say, simulating a human organism or a human population. How many things do you need to know about a foreign exchange forward trade, two currencies, the exchange rate, the delivery date, party A, party B, you've now fully specified it. Imagine what it would take to fully specify a human being or even a single cell inside a human being. Well, the computers have made so much progress that you can actually begin to tackle these problems. And so I'm advising working with an array of companies and they are doing fascinating things.

Marty Chavez: (25:52)
I'll give you a couple of examples, paige.ai, as the first board I joined after I retired from Goldman. And I had heard about it from my friend, Jim Pryor, a legendary investor who was their first investor. And here's what they're doing, think of it as creating a new microscope to give to pathologists, except this microscope is digital. And this microscope has the unbelievable property that it outlines cells that you're looking at in the tissue specimen and says, "I think these cells are cancerous and here's the cancer I think these cells represent. And here's the treatment protocol that I would recommend." Not replacing the pathologist, but a second set of eyes on the problem with amazing results.

Marty Chavez: (26:44)
Another company, I'll give you an example of, Recursion in Salt Lake City, doing amazing things where they are building up a library of images of cells, and we're talking vast numbers of images. And here's what the cell looks like by itself. And now if we perturbed the cell a little bit with some molecule there might be a drug candidate or a [inaudible 00:27:09] with a CRISPR mutation, change its genetic code a little bit. Here's what the cell looks like now. And we're capturing how the cells metabolism changes, and we're doing this over and over again, and then we're throwing machine learning at it. And so we're then using the models that come out of this process to guide drug discovery.

Marty Chavez: (27:31)
So drug discovery has mostly been throw a million molecules at a cell and see what they do. And then eventually scale it up to mice and eventually human clinical trials, very expensive, very high failure rate. If we can do anything in software to fail earlier say, "Stop, don't even run any more experiments here, that's not going to work." And to find more promising candidates earlier, this would transform drug discovery. So those are the kinds of things I'm working on.

Anthony Scaramucci: (28:01)
Well, it's fascinating. I'm thrilled that we have you and your mind working on these things for all of us. I want to switch the topic abruptly. John's going to come in here in a second and ask the questions. We've got lots of questions in the queue. I want to talk about digital currency for a second, because you have a view there, you have a philosophical opinion there. And just wondering what you think of crypto currency, the ongoing digitization trends that's impacting us, there's also an EOS coin. Some of us don't even know what that is, myself included. And I was wondering if you could talk a little bit about that and what your opinions are in crypto.

Marty Chavez: (28:40)
I love talking about crypto. I worked on some of the techniques, some of these cryptographic techniques when I was a grad student and they're powerful and they're fascinating. And when I first heard about Bitcoin, I got really excited because actually Bitcoin is a solution to an old problem in computer science. It's called the Byzantine Generals Problem, but it's really an old problem of, we've got a noisy world full of unreliable information and disloyal people. In the face of that, how do all the loyal people come to a decision, how do we all agree on something? Well, this is the core of what the Bitcoin protocol does, which is how do we all agree that this is a real transaction where party A sent this many Bitcoin to party B, that that is what the blockchain does.

Marty Chavez: (29:38)
And so when I first heard about Bitcoin, I thought, "Okay, is super incredibly interesting. I got to get really up to speed on this because I can see all kinds of applications." But immediately the skeptical part of me sets in. So I've got two huge skepticisms that remain, though I'm open of course, to changing my view with new data. Here's one part of skepticism, these techniques to achieve fault tolerance agreement, like agree in the face of 50% of the network being hacked, they're very expensive, right? I did an analysis for a class I taught at Stanford and I remember at the time I taught the class in February. The amount of electricity consumed by all the Bitcoin mining ratings was equal to the entire energy consumption of Switzerland, right?

Marty Chavez: (30:31)
So just running the Bitcoin protocol, that is very expensive. And so I wonder, do you really need that kind of super expensive computation for most applications or is this maybe a kind of overkill? That's one skepticism? The second skepticism is I have never believed for one split second that Bitcoin or Libra or any of these things is going to replace the US dollar. I think that is an absolutely preposterous idea. And the reason for that, is really when you think of what money is, right? Money fundamentally, especially fiat money and legal tender, all relate to something very deep and political philosophy.

Marty Chavez: (31:18)
Which is, if we are in the boundaries of the US and I owe you a dollar, and I give you a dollar bill which says, "This note is legal tender for all debts public and private." And you reject it. It doesn't matter whether you accept or reject my dollar bill. My debt is forgiven, it's extinguished. I tendered the bill to you, doesn't matter if you accept it, the debt is gone. And the US backs that extinguishment with its monopoly on the use of force within its boundaries. It can put people in jail for not paying its taxes, it can seize their property, right? That is something that's not going away anytime soon. And so the idea that Bitcoin and a bunch of people running computers would just replace the sovereign seems to me like something that's not happening in our short-term reality, or even the medium or long-term.

Marty Chavez: (32:08)
So those are my skepticisms. But can we take the US dollar and use the techniques being developed here in digital assets such as Bitcoin, and continue the dematerialization of the dollar. It's already mostly electronic, right? We've got these paper bills, but most dollars are not represented that way, they're in bank accounts. And we can talk about what bank accounts are, right? That digital journey of the US dollar has been going on since the 1950s, my view is it will continue and it will adopt all of these techniques. And you will have a digital US dollar. You would have heard about it during the pandemic. There were discussions in the Congress that were super exciting.

Marty Chavez: (32:54)
"Hey, we're going to order the Federal Reserve to create a digital US dollar. And then we're going to distribute the stimulus money directly to Americans with this new digital US dollar." It is a fantastic idea. But when I read that I thought, "Okay, I'll sit down and I'll code up a digital US dollar over the weekend. Yeah right, like that's going to happen." It's a vast project, you don't order the Federal Reserve to get on it this week, right? It's something that will evolve, my view, must evolve to stay competitive with the Yuan. The Chinese are very aggressively turning that into a digital asset. I think we absolutely have to, as a matter of sovereign might and wealth and diplomatic policy and maintaining the dollar as the global reserve currency, it must digitize, it must become a cryptocurrency itself.

Anthony Scaramucci: (33:45)
And what is EOS?

Marty Chavez: (33:46)
So EOS is a company I've known about. It's a coin [inaudible 00:33:52] associated with a company called Block.One. And I've known the founders of Block.One for a few years, one of their investors is a friend of mine for many years. And so I've always followed with interest what they're doing. And yes, they have this currency, but what they're most excited about is building distributed applications for finance, for social media that are based on this currency and also creating a new fabric for computing, where you can do very complicated, distributed calculations across millions of machines and do them reliably even if the computers are going up and down and the communication links are failing. I think that technology of a distributed global computer is super important and I'm happy to work on that with them as well.

Anthony Scaramucci: (34:45)
Well, fascinating stuff, Marty. I'm going to turn it over to John. He's got questions from our audience and we really appreciate you being on today.

Marty Chavez: (34:53)
Sure. Thank you, Anthony.

Anthony Scaramucci: (34:55)
[crosstalk 00:34:55] Don't be asking about the skateboard, okay? I know you're thinking of the skateboard Darsie. Just stick to the facts, okay?

John Darsie: (35:02)
We're going to have to do an entirely separate SALT Talk about the idea of a blockchain US dollar digital currency. Because, I think that's a fascinating topic. And like you mentioned, it's something that China has announced their intentions to aggressively digitize their currency. It's almost already digitized on an app like WeChat where people are exchanging currency in an app that is the dominant app in China, despite that currency not technically being the sovereign currency, so it's a fascinating topic. I want to switch gears a little bit. So there's a problem on Wall Street as there are in a lot of industries and it's a diversity problem.

John Darsie: (35:38)
And you are a Latino, you're an openly gay man, so you occupy a very rarefied space on Wall Street. How did that experience shape your time? You're working at Goldman and on Wall Street, is Wall Street a friendly place to work for someone who is openly gay and someone who might not fit the archetype of what the average worker at one of these banks look like, and how much did you fight yourself trying to blend in versus being yourself and being openly representing your identity within the firm?

Marty Chavez: (36:10)
So I had a bit of an unusual story, which is I came from Silicon Valley to Wall Street in 93. As I mentioned to Anthony, I really wasn't planning a career on Wall Street, I was looking for a free trip to New York. And I was out in Silicon Valley at the time and I remember going to venture capitalists meetings with my co-founder and he would actually tell me to kind of do it up a little bit, "Go ahead and wear that Queer Nation t-shirt to the meeting, I'll think that's cool." And so here I have a Wall Street and I didn't know anything about Wall Street. I'd only heard that it had a reputation for being homophobic. So they put the offer in front of me instead of saying, "Yeah, this is great." I was just silent and I was silent because I'm thinking, "Wow, am I going to go back into the closet just for a different job, I don't really need or want this job, particularly I'm happy in Silicon Valley."

Marty Chavez: (37:11)
And so as I sat there, I just blurted it out to the gentlemen who was hiring me, "I think I need to tell you that I'm gay." And this was 1993. Suffice it to say that that kind of experience had never happened to him and I'm not sure it had ever happened to anywhere in Wall Street back in 93. And so he didn't know what to say. And so all he could think of to say was, "Hey, do you have a boyfriend?" Which is, I think maybe not the response you would have in 2020, but I took that to mean, "Well, this must be a gay friendly place." I think it would have been more accurate for me to have concluded that this was a place that didn't care if I was straight or gay, it just cared that I was good at math and software. And for me, that has always been enough, for me personally.

Marty Chavez: (38:09)
I don't want anybody to do anything special for me, but neither do I want my being me to be a liability. And if it is a liability, I'll go somewhere else. Now that kind of open-mindedness over the years became more sophisticated at Goldman Sachs and elsewhere. And we began to understand that diversity of your workforce was like diversification of your portfolio. The only free lunch available, you get a different perspective. You avoid missing things by making it a place where lots of people want to come. So Wall Street has definitely made that evolution. I've always been almost always the only one or two of people like me in the room. And been super fortunate that I had a lot of straight white Jewish males who were my mentors and brought my career along at every step of the way.

Marty Chavez: (39:12)
If I had been waiting for a Latin mentor or an LGBT mentor, or God forbid, one who was both Latin and LGBT, I'd still be out there waiting. My philosophy from growing up, and this is something my mother drummed into our skulls, growing up in Albuquerque, New Mexico where Hispanics were the majority by numbers, but not the majority in any way by economic clout. And my mom would say, "You're Hispanic. You'll have to work twice as hard to get half as far. So no moping about that, you better get busy." And so that while it's rather brutal advice and wouldn't be for everybody, and it's unfortunate that someone has to give it, I'm grateful to her for that as well.

John Darsie: (40:03)
Well, it's a really inspiring story and I have to give Anthony credit too. He's made SkyBridge a place that is very much like that. We have several openly gay members of our workforce and he's worked very hard on LGBTQ issues. And I think he's part of the solution as well. And I think for you, you've now created that role model for people who, whether it's a non-traditional path or a traditional path to Wall Street that young Latinos, young-

Anthony Scaramucci: (40:29)
Nice speed you've got, Marty. See how he's buttering me up. [inaudible 00:40:31].

John Darsie: (40:31)
I do have to give Anthony credit.

Anthony Scaramucci: (40:35)
He took the ballpoint pen and stabbed it into my jugular as we started, but now he's foaming and... keep going Darsie.

John Darsie: (40:43)
I got to make sure I keep my job. We opened this in a very rocky fashion, right?

Marty Chavez: (40:48)
I understand that.

John Darsie: (40:49)
But it's just an inspirational story. And hopefully you've become that role model for a lot of young people who-

Anthony Scaramucci: (40:55)
But in all seriousness to Marty, it is truly inspirational. And so I've always believed that life, liberty and pursuit of happiness, maybe they thought it was supposed to be for just straight people, but it's not, it's for everybody. And you are a living example of that and a role model for that. And one of the things I worked on with vice president Biden a few years ago, actually was in Davos, expanding the human rights about sexual preference not just the United States, but around the world. So we're making progress, thank God. And it's because of people like you willing to be out there taking a stand.

Marty Chavez: (41:31)
Well, I'd like to say I was some kind of a hero, for me it was really more pragmatic than that. I just thought, I'm not going to go backwards in my life. I hated being in the closet and I'm not going to do that. So it was almost a kind of expedience, but I guess it doesn't matter however-

Anthony Scaramucci: (41:48)
No, I think you're not giving yourself enough credit because we're both contemporaries. And I know a lot of my friends, I'm born in 1964. A lot of my friends born in the sixties had great difficulty opening up, particularly if they grew up in a Latino community, or an Italian community where the parents are very Roman Catholic, okay, and there's a lot of blocking and block-headed thinking that goes on. So it took a lot of risks. You deserve the credit for being the role model that you are. Go ahead, John. I know you spoke-

Marty Chavez: (42:20)
And 64 was a good year. Anyway, I was born in 64 too.

Anthony Scaramucci: (42:23)
Were you? Yeah. So see, there you go. See that's a-

John Darsie: (42:25)
Now he's going to get into an astrology thing with you.

Anthony Scaramucci: (42:29)
It was a great year, okay? Go ahead, Darsie, continue.

John Darsie: (42:34)
All right. I want to talk about the pandemic for a moment. So you've now shifted back into maybe what was your original passion in life sciences, but you pay attention to tech trends across a wide spectrum of industries. What do you think the pandemic in terms of long-term consequences or results of the pandemic that are here to stay in terms of digital trends and the way we think about work, think about living. What trends do you think have been accelerated by the pandemic that are here and that people particularly investors, for example, should pay close attention to?

Marty Chavez: (43:07)
Sure. So I think my view would almost at this point, be the consensus view or the emerging consensus view, but maybe I got to it a bit ahead of time. But the idea is that the pandemic with all its terrible cataclysmic consequences has in the sense of a chemistry reaction, it's a catalyst. It isn't making things happen that it was just not sensible for them to happen, it's speeding up in a dramatic way, things that were already happening, but they might've been happening too slowly for us to really observe them, right? And there's some aphorism about 10 decades of progress in 10 months, right, and then you have other decades where it seems like nothing happens. Well, we've had one of those 10 months, 10 decade kind of periods. And so I don't know where all this is going to go to shake out, but there's a few things that I'm highly confident about.

Marty Chavez: (44:09)
First, the digitization of finance, right? The idea that we have these little pieces of paper that we still write things on, right, or little pieces of paper that say US Federal Reserve Note on them. It's so cute, it's so quaint. It's kind of ridiculous, right? And think of all the things that we write on little pieces of paper, here's a particularly horrible example. If you've ever bought an apartment, you know how many pieces of paper come together for that, right? So all of those things are going away. I had some experiences during the pandemic of people requiring notarized documents and everything that we had to go through to cause a document, a physical document to be notarized in the depths of a pandemic, right? So, that's changing.

Marty Chavez: (45:00)
And we're just going to look at all these cumbersome workflows that have lots of paper steps and lots of manual intervention and anything that doesn't need to be there like, why are you swiping a card? That is also kind of silly and quaint and signing some piece of paper even more so. So you can see all those things as gone. And it's just a matter of months. I think another thing that you're seeing iS some restrictions that no longer made any sense. So for instance, if you're a pathologist in a clinic or hospital, there's been a requirement you have to be in a clinic or a hospital. They're looking at your microscope, looking at those slides, but you know what? No, you don't like, who said that, right? There just weren't the tools.

Marty Chavez: (45:48)
So one of the interesting things that Paige, which I mentioned to you has been doing is, in the process of constructing this AI and machine learning enabled technology that spots cancer cells, you can make the entire workflow of a pathologist go digital. No need to be in a lab, no need to have a microscope, no need to be in any particular place. So this trend of telemedicine, maybe you could just have a Zoom with your doctor and stick out your tongue, that's happening and there's not going to be going back. There'll be some things that you still have to be present for but there's a ton of things that you don't, and those are not coming back.

Marty Chavez: (46:31)
And people are working really hard on making those kinds of unnecessary in-person interactions go away. The really big question, which we don't have the answer on is, what will happen to the office? Now I'm a computer scientist, I'm an engineer. I've been building virtual communities since I was 10. I do occasionally like being in a physical space with people, but actually I'm more productive at work if I'm not surrounded by people bugging me. And so going virtual for me, I've just told everybody who wants to do some kind of collaboration with me, "I'm all in. And think of me as a permanently virtual person." There will be times when we get together, but I'm in boards meetings and people say, "Oh, this would be so much better if it were in person, I can't wait to go back to the way things were."

Marty Chavez: (47:30)
And I will always say, "You know what? I am very interested to hear that it's, you think it would be better for you if it were in person, I'm totally fine. This is great for me. I didn't have to travel across the pond to be in this meeting and I'm loving that." Right? So I think we're going to see the same thing happening with the world of work. There's going to be a regular cadence where people want to get together in an office or something that maybe looks a little bit like an office. But I don't think it's going to be 9:00 to 5:00, Monday through Friday, that is a relic of the industrial revolution and that rigid construct is going away. It will be replaced by something much more flexible and will vary by role and will vary over time. And we don't know exactly what that's going to look like, but we're starting to see the outlines.

John Darsie: (48:21)
Well, I think that's a fascinating masterclass in where we're headed. And I think Anthony and I have experienced that. We have young kids at home, it's been nice to be able to spend time with your family. You go into the office a couple of days a week, and then you feel like I can be just as productive at home and so it becomes more of a blended life. But you have so many great answers to so many great questions. You're not just a nerdy computer scientist, you understand the social elements of all this. You talked about universal basic income. You worked on Wall Street, so you understand the money part of it and you're a civically engaged type of person.

John Darsie: (48:51)
Do you ever see yourself? And I'm hoping the answer is yes. But do you ever see yourself serving in an appointed position or an elective office down the road, if vice president Biden wins, Anthony's going to be calling his future Chief of Staff and telling him that, "You got to call Marty Chavez to digitize the dollar and fix a lot of other problems we have." But is that something that you've thought about and want to do?

Marty Chavez: (49:14)
If asked to do something that I could be effective at, given that constraint, that I'm a mostly virtual guy, right? Then-

John Darsie: (49:25)
The government should be the same way. It's like if they can't sit down in the same room, they can't pass the stimulus bill. They want to send everybody $1,200 checks. And that becomes a big ordeal when you could digitize the whole thing and it could happen in an instant.

Marty Chavez: (49:36)
I would be up for something that didn't require me to move and something where this combination sort of weird intersection of experiences and skills that I've had would be useful. I'd have to think hard about it.

John Darsie: (49:53)
I was trying to think of what job would be the best fit for you. And then one came to mind and it was president of the United States.

Marty Chavez: (50:01)
Yeah. I think you have to move to Washington for that one.

John Darsie: (50:04)
Yeah, maybe not. Maybe in five or eight years, whatever it may be, maybe that'll change and we can have more digital president Chavez.

Marty Chavez: (50:12)
Yeah. Well, you're very kind. And I do believe in giving back, I don't know exactly what forms that will take over time. For me, it's mostly been philanthropic I'm president of the Harvard Board of Overseers this year, and that's something I'm really passionate about. But you never know where where the path will take us.

John Darsie: (50:35)
So we say that we would like to have our guests back in the future on a lot of shows, but this is one, we actually mean it. I feel like we could talk about so many different topics for such greater length, but it was great to have you on, we even went into overtime a little bit here. But thank you so much for joining us. It was a pleasure, Anthony, you have any final words for Marty before we go.

Anthony Scaramucci: (50:52)
Yeah, because I mean, you just blew us up on every other guests that came on [inaudible 00:50:56].

John Darsie: (50:56)
I didn't say which ones I was lying about.

Anthony Scaramucci: (51:00)
Now we got to call every person that came on to SALT Talks, "No, we really did mean that we [inaudible 00:51:03]." It's okay, [inaudible 00:51:09], we're surviving the pandemic. Marty, great to have you on, it's a real pleasure. And I hope and we both really do mean this, hope we can get you at one of our live events at some point.

Marty Chavez: (51:20)
That would be fun. And like a cryptocurrency thing, that I'd definitely say yes to that if it ever makes sense [crosstalk 00:51:26].

Anthony Scaramucci: (51:26)
Well, we certainly want to do that as well. And wish you the best of luck with what you're doing and hopefully we can connect soon.

Marty Chavez: (51:33)
All right. Thank you.

Anthony Scaramucci: (51:34)
Thank you for joining SALT Talk.

Marty Chavez: (51:35)
Be well. My pleasure. Take care.

Dr. Finian Tan: The Future of Deep Tech | SALT Talks #85

“If you want to create a circle of life for venture capital, you need every single part of it, and you need the country to have the political will to do this, and the capital and the R&D spend, and they must be in the right R&D environment.”

Dr. Finian Tan founded Vickers Venture Partners in 2005 with four partners, and has grown Vickers into a top-performing, global deep-tech firm with $3B under management across six funds and co-investments. Vickers invests in early-stage companies with technical solutions to solve large, global problems. Finian was Deputy Secretary of Trade and Industry for the Singapore government.

Serving as Deputy Secretary of Trade and Industry at 34, a major project was turning Singapore into a Silicon Valley for Asia. Creating that ecosystem is difficult and similar to building a national park that develops a natural self-sustaining circle of life; it cannot be artificially maintained. This effort sought to use venture capital, work hubs and regulations to allow start-ups to thrive in Singapore. “If you want to create a circle of life for venture capital, you need every single part of it, and you need the country to have the political will to do this, and the capital and the R&D spend, and they must be in the right R&D environment.”

LISTEN AND SUBSCRIBE

SPEAKER

Dr. Finian Tan.jpg

Dr. Finian Tan

Founder & Chairman

Vickers Venture Partners

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

Rachel Pether: (00:08)
Hi everyone, and welcome back to SALT Talks. I'm Rachel Pether and I'm a senior advisor to SkyBridge Capital, a global alternative investments firm, as well as being the MC for SALT, a thought leadership forum and networking platform that encompasses business, technology, and politics.

Rachel Pether: (00:26)
SALT Talks is a series of digital interviews with some of the world's foremost investors, creators and thinkers. Actually, our guest today is really a combination of all three. Just as we do at our global SALT events, we aim to empower really big, important ideas and provide our audience a window into the mind of subject matter experts. Today I'm very excited to be welcoming Doctor Finian Tan to SALT Talks.

Rachel Pether: (00:54)
Finian founded Vickers Venture Partners in 2005 with four partners, and he's growing the company to become a three billion dollar, top performing, global deep tech firm. They invest in early stage companies with technical solutions to solve large global problems, and one of them happens to be, spoiler alert, a T-cell-based vaccination platform that can be designed for COVID-19. Before starting Vickers, Finian was a managing director at Draper Fisher Jurvetson as a founding partner of its Asian Pacific operations, he led the investment into Baidu and remained its largest backer until IPO. Prior to this. Finian was deputy secretary of trade and industry for the Singapore government. He received his doctor in philosophy and master of philosophy in engineering from Cambridge, and he received his BAC in engineering from the University of Glasgow. Finian, it's a real pleasure having you with us today.

Dr. Finian Tan: (01:57)
Thank you very much for having me, Rachel.

Rachel Pether: (02:01)
You're a difficult one because I just want to talk about so many things. I want to talk about your role with the Singapore government, your investment into Baidu, the work that you're doing with Vickers Financial Partners, and obviously, go into more detail about the COVID vaccine. But before we get into some of these in detail, tell me a little bit more about your personal story.

Dr. Finian Tan: (02:23)
I was with Goldman Sachs in 1996. I was based in Singapore and then London and New York. I was in charge of trading for Asia for a company called J. Aron, which was part of Goldman Sachs. Running Asia from New York wasn't good, so I decided to come back to Asia; I chose Singapore. I'm a Singaporean. In '96 I came back and as soon as I got back, I was approached and asked to serve in the administration as the deputy secretary in the ministry of trade and industry. It was a change to serve my country. I was then a young man of 34. Couldn't quite say no, so I became deputy secretary. Part of my role was to help make Singapore into a Silicon Valley for Asia.

Dr. Finian Tan: (03:11)
As some of you will know, Singapore's per capita income is pretty high. It's about the same as the US. The next stage of growth is entrepreneurship and innovation driven. It was natural for them to want to give me this task. I made three recommendations. One was the setting up of a billion dollar fund to jumpstart venture capital. The second was the setting up of a physical science hub, where people can live, work, play, study. The third was an interministry community to change rules and regulations to allow startups to thrive.

Dr. Finian Tan: (03:47)
With the government approved all three and made me the chairman of all three, and that started my life in venture. I kind of love adventure.

Rachel Pether: (03:57)
You have obviously been very successful as a venture capitalist as well, and we can touch on that shortly, but you mentioned that Singapore was aiming to become the next Silicon Valley, and I know many cities around the world have this aim and do you think that's a reasonable aim to have? Can you just create it using capital? I'd love to know your views on that.

Dr. Finian Tan: (04:31)
Well, many cities and countries have tried it with varying success. It's very difficult to do because you have to create an entire ecosystem and creating an ecosystem is never easy. For example, if you wanted to create a cougar national park, that's very hard to do because it's not like a zoo where you bring animals in and you feed them. In a cougar national park situation, you would have to allow them to feed on their own, so you have to have the grass, the earthworms, the rabbits, the deer, and then the predators, and the whole thing needs to go through the circle of life, and it needs to be self-sustaining. No matter what you do, there will be gaps. There will be gaps where you have to feed some groups in order to keep them alive for a while, and eventually, you reach a self-sustaining cycle of life.

Dr. Finian Tan: (05:30)
In most countries, it's just too difficult to do. You have to feed everyone, just like the zoo, where you have to feed all the animals and so you can import all the animals will eat. But if you want to create a circle of life for venture capital, you need every single part of it, and you need the country to have the political will to do this, and the capital and the R&D spend, and they must be in the right R&D environment. It must have the right stage of growth. I think if any country could do it, Singapore probably is in a good place, but it's not quite there yet.

Rachel Pether: (06:08)
That's great. I love that analogy of comparing it to a zoo or an actual ecosystem like the cougar national park. Is that really where your love of venture was born? Maybe you could tell me a little bit about that part of your journey as well and really getting this passion for venture capital and early stage companies.

Dr. Finian Tan: (06:34)
Venture is really a blend of financial and tech. I had a really good finance trade at Goldman and since I did my PhD in engineering at Cambridge, I am a tech guy. It was a nice combination of two skills. That's why I decided that what's I'm going to be. I joined a firm called Draper Fisher Jurvetson ePlant Ventures. They're pretty well known. DFJ is well known for Tesla, SpaceX, [inaudible 00:07:04], but at that time they were well known for Hotmail and Skype. I joined them as as founding partner for Asia and my first investment was a small company at that time called Baidu, which, as you know, become the Google of China. We took a very large stake in the company. We became the largest shareholder of the company in the IPO, so when Baidu listed in 2005, it was an extremely successful IPO. In fact, it still holds the record of the best performing IPO in [inaudible 00:07:38] history. That was very good. I had a lot of publicity. Appeared on front covers on magazines including Forbes. They called me the Baidu backer. With that behind me, I decided to start my own fund, and that's how Vickers was born.

Rachel Pether: (07:54)
What made you believe in Baidu at such an early stage? What was it about the company and its story and its prospects for growth?

Dr. Finian Tan: (08:06)
The year 2000 was a very difficult time because it was the first time that the internet came to the floor and there were thousands of companies. In fact, anything that had three Ws in front or had .com would shoot through the roof. They were worth billions on air. It was difficult to discern what would work and what wouldn't.

Dr. Finian Tan: (08:32)
I decided to, in my book, draw a line in the middle, put what I understood for sure would happen on the left, and on the right put things that I was still a little unsure about. The right side started filling up. [inaudible 00:08:48], InfoSpace, Yahoo, Amazon, eBay. I wasn't sure about the business models because they were all burning cash just for eyeballs.

Dr. Finian Tan: (09:01)
It started filling up, I stopped, and then I said, "What do I know for sure about the world?" Number one, I knew that China would grow. I was absolutely confident that that would happen. Number two, I knew that the internet would grow. That's it. I asked myself, "What could I invest in that will surely make money in these two things that I felt would happen for sure happen?" I concluded it would be the operating system of the internet in China. But what's the operating system of the internet? Is it Cisco? Is it the Explorer? I concluded that it was search because that's what everybody does. I asked the team, "What do we know about search?" Not very much.

Dr. Finian Tan: (09:56)
We went out, we spoke to all the incumbents, we spoke to all the customers of search, we spoke to all the companies that have come to the DFJ family. We spoke to those people that have gone outside of the DFJ family. After about a month or so, we huddled together and we decided that Baidu was the one that really stuck out, like a tall puppy. The reason was because search is very objective. It's speed and relevance, and you could measure. Baidu had a new architecture which was very related to how many people search for a particular item and click on it. It was linked to search results rather than using a directory. We felt that was the best. It was like a magnitude button, so we decided to invest in Baidu.

Rachel Pether: (10:53)
Fabulous. I think that appreciation and love of data has also carried into Vickers Venture Partners. I would love to know more about that because I think your offering is so unique here, even just we were talking before about the number of founding partners that are actually doctors. Tell me a bit more about Vickers Venture Partners and the focus on deep tech as well.

Dr. Finian Tan: (11:20)
We didn't start out that way. We started as more or less a general list VC, always drawing the line in the middle and asking ourselves what do we know and what we don't know, then trying to invest in core areas.

Dr. Finian Tan: (11:37)
But we were industry agnostic. We would invest in fintech, games, eCommerce, all sorts. After a while, we realized that we were very good at some parts of our business and not as good in some. We decided to split risk into three buckets. One is technology; does it work? IP, are you in the lead? Is there going to be a monopoly? And third, the market. Will people buy your product? We were not so good at guessing the market. I can't even guess what my wife likes, let alone my children, et cetera, let alone seven billion people. We only knew what we liked, personally, and sometimes we tend to extend that erroneously. But we were pretty good at intellectually guessing whether a tech would work, especially if it was our field of interest.

Dr. Finian Tan: (12:40)
We decided to take only one risk rather than three and we focused it only on the tech. Will it work? Market must be known and ready before we would look at it. We don't take IT risk. You have to own the IP. You have to be in the lad. After we did that, our performance really skyrocketed. Our home run pool increased from 28% to 50%. Our failure rate dropped from initially it was 34%, and then dropped to 20, and now, including core investments, is about 6%. That's when we started climbing up the ranks and today we have about three billion under management across seven offices globally.

Rachel Pether: (13:24)
Fantastic. Does this approach mean that you're more highly concentrated, like it's more of a high conviction approach, I guess, than some other venture capital firms?

Dr. Finian Tan: (13:37)
We're very different. Let me give you a few examples. When I talk about tech risk and I talk about not taking market risk, it requires some elaborations. People often wonder what kind of deals will not have market risk. Everybody has market risk. All companies have market risk. Not quite. I'll give you an example. Let's take a cure for cancer. If you actually had a cure for cancer, the number of patients per year is known, but incidence rate is known and mortality is known and morbidity is known, the prevalence is known. Everything is known. The only thing that's unknown is will the drug get FDA approval, how efficacious is it, how toxic will it be? That's a risk we are willing to take; it's a calculated risk. It's nicer when we reduce the risk to one bucket, and then we focus on building strengths in that bucket. That's why we have so many PhDs and doctors, because we double down on what we were good at, and cut out all the other noise.

Dr. Finian Tan: (14:42)
In most other venture capitalist investment committee meetings, the IC meetings would be very noisy. What do I mean by noise? One buy brings an eCommerce company, one guy brings a bike sharing, a ride hailing, game company, social network, and one tech company. For us, it's easy. Ride hailing out, eCommerce out, logistic out, game company out, social network out. Tech, okay, that's interesting. We would strip that future. We've decided we'll take the tech risk and we've decided that we will only do holy grail type breakthroughs. Breakthroughs that are so impactful that it will change the world and it will have a paradigm shift that will basically make everybody change the way they look at this particular problem. If it's a holy grail breakthrough that's still a dream, that's still risky. If it's a hold grail breakthrough that's already been made and everybody knows about it, it would be too expensive. We focus on a small goldilocks zone, where it's a holy grail breakthrough that has actually already been made, but requires the last push with data to convince everyone of this new paradigm shift. That's the only thing we do. As a result, out of the 5,000 views that we receive, in the past, maybe 4,000 would qualify. Today, less than 100.

Rachel Pether: (16:19)
That's a very easy filtering and screening mechanism, isn't it? I do want to talk, you mentioned cure for cancer, obviously, that's a very nice analogous to a vaccine for COVID, but I did just have an audience question come in, which is relevant to what you've just said. It was that if the market is ready for a company's products, i.e., if the market risk is known, does it often mean that your companies are in late stage when it comes to investments?

Dr. Finian Tan: (16:50)
Not necessarily, because if it's too late, then it's too expensive for us, so it would come under the second bucket. It's typically the third bucket, which is the goldilocks zone, where it's a breakthrough. Breakthrough in our view that has already been made. But people don't get belief. The reason why they don't get belief is because they haven't dug deep enough.

Dr. Finian Tan: (17:14)
Let me give you an example. We have a company called ROWDC. They have a biodegradable plastic alternative. In order to be an alternative to single use, disposable plastic, you need to meet three criteria. Number one, you need to be as cheap as plastic. Number two, it must feel like plastic and have all the material properties, waterproofness, high temperature, et cetera. Number three, it must be biodegradable. We had been hunting high and low forever and we found many, many companies that met two, but not three. Finally, we came across one company that could do all three. This was the only company that we could find, but they only had a small plant for 250 tons, so they had to scale from 250 tons to 25,000 tons. There was an apparent prototyping risk, and as a result, many VCs were holding back, unsure how risky this was. We rolled up our sleeves, went to the company, and in the midst of our due diligence, we found that the company had already tested their microbes in this big, full scale tank of 25,000 tons factory that we'll be using. They manually pull out all the microbes and the nutrients and they grew the material manually, which means the microbiology has already been tested.

Dr. Finian Tan: (18:50)
What's the rest? The rest are movement of oil through pumps, centrifuges and pipes. This is an old academic study. It's 100 year old subject. You learned it in flu dynamics. I've moved such oils in the refinery at Shell where I used to work before. Ten times larger. We could calculate it to the decimal. Actually, if you come to think of it, since it's a mixture of engineering and microbiology and both of them would work, one plus one would be two, so we felt that this is a breakthrough that had already been made. We invested, the company then started increasing its scale and talking to customers, and today it's almost a unicorn. They just closed a Series B round, it's a staple round with B1 and B2. After the milestones are hit in a few months, they will be a unicorn. We invested in the tens of millions just because we were I guess conscientious enough to immediately fly and dig deep instead of being affected by noise.

Dr. Finian Tan: (20:06)
If you had six companies to look at, one was a social network, one was ride hailing, one is going to be Twitter, one is going to be the next Angry Birds, and then you have a tech company that looks a bit risky, the priorities are different. For us, we drop everything, but the only thing we're looking at, we fly there tomorrow, and we roll up our sleeves and if it's the holy grail breakthrough that has already been achieved but just needs a little bit of push, that's the one we want.

Rachel Pether: (20:36)
Excellent. I guess that deep knowledge of the company really derisks the investment for you, doesn't it, because you have-

Dr. Finian Tan: (20:42)
Absolutely.

Rachel Pether: (20:45)
... so much. You mentioned you work on things or you look at investments where the market is known, the market is huge. Obviously, we would be remiss not to talk about the work that you're currently doing in the COVID vaccine development space. One of the companies that you're focused on within Vickers Venture Partners is Emergex. Let's please share with the audience the work that you're doing here, because it's really quite phenomenal.

Dr. Finian Tan: (21:15)
Yeah. This pandemic is affecting all of us, and everybody must be asking the question, "When will life return to normal?" Like, really normal. With parties and stadium events and rock concerts and going to clubs and not wearing a mask and not social distancing any more. That can only come from a vaccine that can eradicate the virus. When I saw "eradicate," I mean like smallpox or yellow fever or polio, where the virus disappears, or SARS-1. It cannot be the flu vaccine kind of efficacy because the flu is still with us, and COVID-19 is much more lethal than the flu. If all the protection you get is similar to the flu vaccine, which, by the way, is only 10% to 60% efficacious, life will not return to normal.

Dr. Finian Tan: (22:15)
Dr. Fauci was just interviewed recently and he said that if the vaccine is only 50% efficacious, we will still be wearing masks, we will still be social distancing, and unfortunately, the technology that's being employed by all the lead horses in the race, because there are, by the way, 177 companies to be racing to the vaccine finish line. 167 of them are working on antibody approaches, which are very similar to the flu vaccine. All of them working on the surface protein. The virus has a spike; everybody's trying to mimic the spike. I don't think that it's going to result in an eradicating vaccine. It will reduce mortality, it will reduce morbidity, it will reduce transmission, but life ain't going to return to normal until we have an eradicating vaccine.

Dr. Finian Tan: (23:11)
I mentioned yellow fever, smallpox, polio, et cetera. They were eradicated because they induce T-cell responses, not just antibody responses. Thankfully, there are 10 of us working on T-cell vaccines and I think Emergex has a very good shot at it, maybe the best shot at coming up with an eradicating vaccine, maybe seven, eight months from today.

Rachel Pether: (23:41)
Wow, that's a timeline we can all look to with some optimism. You mentioned 167 out of 177 are working on the antibody vaccines. What are some of the disadvantages of this? Do you think it will create a false sense of security almost, or do you see this more as a stop gap until we have something that can actually eradicate the virus?

Dr. Finian Tan: (24:15)
Let me explain the difference between antibodies and T-cells. When the virus enters the human body, it starts with moving in the fluids, through the lymphatic and the blood. Viruses are a small little bugger with little spikes. They will encounter antibodies in the human blood, in the human lymphatic system. Antibodies are little Y-shaped things that exist in the human body and we have all types of antibodies for every single virus that we have ever encountered and will probably ever encounter. We have antibodies for them, but not very much of each type.

Dr. Finian Tan: (24:55)
Let's say we get virus X. Virus X enters the human body and through the blood it will encounter some antibodies, which don't fit. One of them will fit, and that's called the antibody X. It will fit virus X like a lock and a key. Once it fits the surface of the virus, it will then say, "Oh, I need to neutralize this and I need to build memory for this." They will then start to build the army, which will take seven or 10 days, so that you have an army of antibodies that will neutralize these virus X. What the vaccine tries to do is the vaccine tries to look like virus X, but without the toxicity. They would copy the surface and typically, since it binds to the spike, they just have to copy the spike; they don't have to copy the whole virus. The Y only joins with the spike. It binds with the spike. That's what everybody's doing, 166 of them, designing vaccines that look like the spike of the virus.

Dr. Finian Tan: (26:01)
Using different technology, some of them, they take an adenovirus and then they use peptides to make the spike, and then they build it with carbohydrates. Some other people use inactivated coronaviruses, which already has a spike. Some of them are using MRNA, messenger RNA, which basically hijacks the manufacturing part of the cell to produce the vaccine, trying to mimic the spike again.

Dr. Finian Tan: (26:29)
Antibodies really focus on the surface of the virus and try to mimic the surface of the virus. What happens if a virus escapes an antibody and enters a cell? That's disaster, because if it escapes the shield of antibodies and enters the cell, it will then do two things. It will start to multiply frantically and build thousands of itself using the manufacturing capacity of our cell. The other thing that happens is the cell will try to kill the virus, and it will chop up the virus into little bits of viruses. These bits are then displayed outside the cell and become an antigen-presenting cell, and you have these little bits of virus outside of the cell. That says that I'm foreign. Our T-cells will then come and destroy them based on recognizing the little bits of the virus. Only a few T-cells, actually one type of T-cell, will recognize one type of bits of virus, and that T-cell will then clone itself and make armies, just like the antibodies did, so that when they see infected cell, then they recognize all these little bits, they will kill it.

Dr. Finian Tan: (27:49)
Killing infected cells is so crucial because infected cells are a factory that produces more and more of the virus, and it is the infected cells that cause the symptoms. Imagine if the lung cell was infected, then you can't breathe. If other parts of your body gets infected, that part of the body will not work very well, and you get puss, you get liquids, and you get pneumonia, et cetera. So you have to destroy infected cells to prevent the factory. You have to destroy the factory from making clones.

Dr. Finian Tan: (28:24)
If you wanted to induce T-cells, you have to mimic an infected cell. You don't mimic the virus. I just said, what does an infected cell look like? An infected cell has little bits of virus parts stuck to it. You don't have to copy the whole cell; you just need to copy the viral parts. This viral parts, they don't really come primarily from the surface of the virus. They come from the insides of the virus, because there's more volume than surface area. I'll give you an example. When you eat meat, not many pieces of meat have skin because it doesn't have the surface. It's the insides. The intestines don't have skin, the liver, the heart, the stomach, and all the flesh does not have skin. You have to copy the steaks of the virus rather than the horn of the cow. The steaks of the virus does not look anything like the face of the cow or the horns of the cow. Antibody approach just copies the horn of the cow, and we are copying the steaks that a cut-up virus looks like.

Dr. Finian Tan: (29:38)
What are the 10 of us doing that is different? I think that most of the people doing T-cell vaccines today are kind of intelligently guessing what it will look like. They use AI, they us computers to predict how the virus will be cut up by an infected cell. Maybe you will have the nuclear capsid which is like the intestines of the virus, and some people say it comes from the flesh. It maybe is 30%, 20%, 10% of the three different parts because that's what happened to flu, that's what happened with SARS-1, et cetera, and they used computer prediction.

Dr. Finian Tan: (30:19)
Emergex has decided to do something different. They decided to do it from first principles. What we did was we infected all the human supertypes; there are six supertypes in the world that covers 98% of all blood types, and we see what happens when these supertypes infected cells, what sort of bits of virus are displayed. We collected all of them and we did a mass spectrometry. Today, we are the first in the world to announce that we now have the library of peptides that expresses all the supertypes in the world, 98% supertypes of the world, and what the viral parts will look like. We're now in a good position to produce a vaccine that looks exactly like an infected cell, so we're very optimistic that it's going to work, and work very well.

Rachel Pether: (31:27)
That's very refreshing to hear. I think it's fascinating what you're talking about, mimicking the infected cell. How would that work in terms of mutations or COVID-19 different strands, because those T-cell-

Dr. Finian Tan: (31:45)
Very good question. Because it's mostly internal proteins ... Generally when viruses mutate ... I'll give you an example. If somebody wants to disguise themself so the police doesn't recognize it, it doesn't change his liver. It just changes its face, wear a hat, shave. Generally, surface proteins mutate and internal proteins don't mutate so much. Since we are mostly internal proteins, we can cope with mutation, and because of that, the efficacy of T-cell vaccines last 30 years, the efficacy of the flu vaccine waned 16% per month, mainly because of the mutation of the surface protein. We are talking about a potential T-cell vaccine that will be a single shot and will last for 30 years, and can protect us from every serotype of this disease.

Rachel Pether: (32:51)
We have one question that's come in from the audience on this, and we actually have about a dozen other questions that have come in, but I do want to ask one final question on the vaccines. When you talk about efficacy and when you say 50% efficacy, does this mean you would reduce the symptoms, or does it just mean that in 50% of the cases it's actually effective at all?

Dr. Finian Tan: (33:19)
We don't know, but what we know is it would ... the thing that causes an infection to become a disease, two things: One, it's viral load, and two is viral diversity. That pushes it past the bottleneck and then becomes a serious disease. If the antibodies can reduce viral load and reduce diversity, that's good for that person, but it tends to encourage escape mutants. For example, if you have antibody X and virus X comes in, then it's docked and then it mutates into virus Y. That's the one that goes out and infects somebody else. Suddenly, it doesn't work anymore for the other person, but it worked for you because ... time is the most important.

Dr. Finian Tan: (34:22)
The human body will produce its own T-cells and it will also produce its own antibodies and it's the best defense. The trouble is time. Because it takes a while to build the army, sometimes a person gets overcome by the disease and dies. Sometimes he gets very sick before he recovers. Sometimes it's asymptomatic because viral load and diversity wasn't very great, and you had the time for the defense to be built. The key about our T-cell vaccine is we have the army of T-cells on day zero. It might not give you complete immunity, it will not stop the infection, but it stops the disease and converts the disease into something that's asymptomatic or clinically no disease, or very light disease. That gives you the time for your body's own defense to grow its antibodies and to grow other types of T-cells to defend against this virus.

Dr. Finian Tan: (35:30)
In fact, our vaccine is a combination of T-cell vaccine that builds T-cells on day zero, and then, when the infection comes, the infection becomes the boost. It's the prime plus boost strategy. It's like when you get a booster shot of a vaccine. You get the primed T-cell and then the infection is actually a boost that brings all the other defenses. Together, it gives you real complete immunity.

Rachel Pether: (36:03)
With Emergex and the work you're doing, that is obviously a company that has huge global impact. It could potentially touch every one of us. Is impact a particular focus area for you?

Dr. Finian Tan: (36:17)
Well, we don't go out to make an impact, but because our criteria is a holy grail type breakthrough, it naturally implies an impact, and generally would be a very impactful company if we achieve success. There's some risk, technological risk, and by the way, when I say our failure rate is 6%, that's measured by dollars and not number of companies. Number of companies is larger than that, but we don't put more money after that so if it doesn't work out, we don't put more money in as a result. In dollar terms, our failure rate is only 6%. In terms of numbers of companies, it's larger. We don't always succeed, we don't always spot them right. Sometimes we encounter risk that we didn't foresee, but generally, really, really good. I think more than two-thirds of the time we're correct.

Dr. Finian Tan: (37:15)
We're very excited about Emergex, not just because we believe we can potentially produce a neuritic aiding vaccine, but also because of how quickly we can manufacture it. Because of our delivery mechanism, we can one day put it on the microneedle patch that could potentially be put on your arm for a minute, self-administered, no coaching required because it's an inanimate material that we're using. Instead of using a live virus as the carrier, we are using a particle that's stable and room temperature. It's very exciting. It will take us months to produce for the world, and it's so easy because you don't need somebody to administer it. You don't need a syringe, you don't need refrigeration, et cetera.

Dr. Finian Tan: (38:12)
Our first clinical trials will be with a microneedle syringe, but as we improve this, we can theoretically put it on a micropatch or a bandaid.

Rachel Pether: (38:24)
That's incredible. I think that lack of cold chain is also, just that speed for getting it to market, not requiring cold chain, and takes off that logistical burden as well, so that's pretty exciting.

Dr. Finian Tan: (38:37)
Some of the vaccines that are currently going to clinical trials require minus 80 degrees Centigrade to store, and that's a logistical nightmare.

Rachel Pether: (38:52)
Yep. That's very cold. As someone who lives in Abu Dhabi, I can only appreciate how cold that is. We just have a couple of minutes left, and we do still have so many questions that have come in. For any audience questions that we haven't had time to get to, please do just let one of the SALT team know and I'm sure Dr. Finian would be happy to answer them. I would like to end on maybe a softer question for you, Dr. Finian. Maybe you could share with the audience what is one of the early lessons that you learned when you ventured out on your own.

Dr. Finian Tan: (39:34)
The biggest lesson was, because of success sometimes you think that you're pretty good at this, and then realize that you're actually not so good at this part of it, but you were good on the other side. That took a while. We had some tough times. Companies fail. Later, looking to data, we realized and managed to pinpoint why we were making mistakes. We were going into a territory that we were not necessarily the best at: trying to guess the market. We're not good at crystal ball gazing. Some people are pretty good at that, but not us. We're boring tech guys and we like to take our time and go through the nitty gritty of tech, almost like doing a PhD itself, trying to figure out and learning about a particular topic. For example, we had to dig in very deep into immunology to understand the difference between antibodies and T-cells, and the difference between using computers to predict and using prospects for us. Why do RNA viruses mutate? How do they mutate? How do you solve the problem? Why is the flu vaccine a wrong approach? They took a lot of time and a lot of rolling up of the sleeves.

Dr. Finian Tan: (41:01)
We continue to make mistakes and we continue to miss good ones. That's the nature of the game. The beauty of venture capitalists, you don't need to be right all the time, but when you're right, you're really right. Is today worth maybe 1,500 times more than when I first invested. We're listing a company now in China that's 110x from where we invested it. In seven months, we could get an approval for Emergex, and if we do, this will be another 150, 200x type return, so even more. The bioplastic is another very, very interesting company.

Dr. Finian Tan: (41:43)
Recently, about a year now, we invested in a company in Calgary that has a geothermal solution to green energy. As you know, geothermal is the greenest of all green energy. That's super exciting. It's called Eavor and they have found a way to reduce geothermal prices by a factor of 10. Geothermal, the earth is always hot, and I don't know if you know this but the center of the earth is as hot as the surface of the sun.

Rachel Pether: (42:19)
I did not know that.

Dr. Finian Tan: (42:24)
It's always hot, so it's not like solar, where it's hot in the day, cool at night. It's not like wind; sometimes windy, sometimes not windy. It's not like hydroelectric, which destroys the environment. This is always hot, so it can be baseload and you don't see anything because it's all underground. The surface can be a nice beach, it can be a property that you build houses on. It's like you're using the earth as a battery. In fact, it's an earth battery and it's nuclear powered because that's how the earth is kept warm, through nuclear.

Rachel Pether: (43:03)
The projects that you're working on, for lack of a better description, they really blow my mind. It's been such a pleasure speaking to you today, and I'd love to have you come on in maybe another six months or so to give us a progress report on how you're going with Emergex, but from my side, thank you so much for your time today, Dr. Finian.

Dr. Finian Tan: (43:23)
Thank you.

Rachel Pether: (43:23)
It's been a real pleasure talking to you.

Noah Kerner: Micro-Investing & Robo-Investing | SALT Talks #83

“I feel like, why spend your time on something that's not noble in pursuit if you have the opportunity to do that?”

Noah Kerner is CEO of Acorns, financial technology and financial services company specializing in micro-investing and robo-investing. Born in New York City, Kerner got involved with Acorns two months after launch as an adviser, investor, board director and then CEO. He is a 4X entrepreneur, Co-author of Chasing Cool with the former CEO of Barneys, and former DJ for Jennifer Lopez.

Acting on a lifelong mission to level the playing field in a world of haves and have-nots, Acorns was founded to bring tools of wealth creation to everyone. The goal is to make it easy to save and invest even small amounts of money, where typically investment tools are reserved for the financial elites. Acorns has an initiative focused on opening children’s investment accounts, highlighting the importance and value of early, compounding growth. It also seeks to offer investment education to prevent less experienced investors from overreacting to short-term market swings. “The market swings every day. It's in the red, the blue, black. It's impossible to stay calm and make rational decisions… great investors stay the course.”

Acorns Job Finder is the latest product launched by the company. Income is the most important aspect in people’s financial lives and serves as the basis of investment, so Acorns is now helping customers find a wide-range of job opportunities, made especially important during the pandemic.

LISTEN AND SUBSCRIBE

SPEAKER

Noah Kerner.jpeg

Noah Kerner

Chief Executive Officer

Acorns

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello everyone, and welcome back to SALT Talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum and networking platform at the intersection of finance, technology and public policy. SALT Talks, if you haven't tuned into any of our series yet, is a digital interview series that we launched during the pandemic with leading investors, creators and thinkers. Our guest today is another one that merges those three topics, and we're very excited to have a wide-ranging conversation with him.

John Darsie: (00:37)
SALT Talks, what we're really trying to do with this series is replicate the experience that we provide at our global conference series, the SALT Conference. That's to provide a window into the mind of subject-matter experts, as well as provide a platform for what we think are big ideas that are shaping the future. We're very excited today to welcome Noah Kerner to SALT Talks. Noah is the CEO of the micro-investing app, Acorns, and he's the co-founder of the shareholder rights startup, Say. His background is very colorful and diverse.

John Darsie: (01:08)
He's a four times entrepreneur. He's the co-author of Chasing Cool, and the former CEO of Barneys and also a former DJ. Noah built the leading creative agency for the young adult market, which was called Noise. Before being acquired by Engine, Noise developed hundreds of products and marketing campaigns for this generation. Including Facebook's first application, the first credit card to reward responsibility rather than spending for Chase, Vice's music website called Noisey, and the top-branded game in the app store.

John Darsie: (01:39)
Noah's been recognized as one of Billboard Magazine's Top 30 under 30, one of Adweek's Top 20 under 40, and Fast Company's one of their innovation agents and impact council members. Also, as a judge for the Webby Awards. He has also advised and invested in a variety of fast-growing startups, including WeWork, where he served as the chief strategy and marketing officer from 2013 to 2014. He's passionate about educating today's youth as well. He's lectured on entrepreneurism, FinTech and media at NYU, at UCLA, at Stanford and Columbia.

John Darsie: (02:16)
He currently serves on the board of VH1's Save The Music Foundation. Noah is a graduate of Cornell University, where he studied psychology and economics. I believe today he's coming to us from the beautiful Berkshires. Hosting today's talk is Anthony Scaramucci, who is the founder and managing partner of SkyBridge Capital, which is a global alternative investment firm. Anthony is also the chairman of SALT. With that, I'll turn it over to Anthony for the interview.

Anthony Scaramucci: (02:42)
John, thank you. Noah, it's great to have you on. Thanks so much for joining us and congratulations on everything thus far. The cool thing about you, Noah, is you're just getting started, so I have no doubt that the next decade and the next two or three decades, you're even going to be more sensational than the last few. Congratulations. Let's go back to what motivates Noah Kerner. Go ahead. Where did you get all of this great energy, passion, innovation?

Noah Kerner: (03:12)
Someone told me, not that long ago, to write down your purpose, which I thought was a ridiculous ask, but I did it anyway. I sat down and just wrote what came out of me. What came out was, level the playing field. Then it is like look back in your life through the lens of that. Because for me, it was this organic process of like, "Okay. Level the playing field." I went all the way back to my childhood. I grew up in the East Village in New York, much like you. I was a public school kid.

Noah Kerner: (03:41)
I grew up around kids that didn't have a lot, but I had this weird dichotomy in my life where in the day I was with all these kids who didn't have a lot and at night, I was playing tennis with the wealthiest kids in Manhattan. That was every day going back and forth, back and forth. Then for high school, switched. Private high school by the day. I got turntables at 14, slightly terrified my parents and became immersed in hip hop and started doing hip hop nightclubs at 16. It was like by the day wealthiest kids in Manhattan, at night, grittiest nightclubs in the city.

Noah Kerner: (04:12)
That was the beginning of my life going in between these worlds and understanding the haves, the have-nots. I got to travel the whole country as a young person touring as a DJ actually, so I saw what was happening and how people were living. I felt like, "Huh, maybe it's time to dedicate myself to helping to bridge that divide. If I have the opportunity to do that, that would be a good use of my time."

Anthony Scaramucci: (04:38)
Okay. That was sensational. You got a great book. You have a great memoir in you, but I want to go on this a little further before we get into Acorn. When you say level the playing field, the way I understand it is you want people who are in the have-not category to have an equal opportunity, or at least to get closer to the starting line that other people have. What private high school did you go to?

Noah Kerner: (05:01)
Fieldston.

Anthony Scaramucci: (05:02)
Okay. There are wealthy people at Fieldston. There were probably some less wealthy people, but mostly wealthy people, so there was a divide. We know there is a great divide in the country, but what is that impulse, Noah. Go a little deeper. I'm not your shrink, but trust me, I'm a lot cheaper than a shrink. Go a little deeper for me. Tell me why that impulse and why that purpose?

Noah Kerner: (05:28)
Well, I think it's painful to watch. I think as a person, if you have any sense of empathy to see the way that this divide exists, it's just painful to watch. I don't know if I can combine my professional life and that sense of purpose, that's really good. To give a little more context. My father worked in banking for many years, but he was actually in the philanthropic side of banking. He was technically the first corporate social responsibility officer. He used to give the bank's money away to community development projects, but at the time, it was not a core part of the DNA of the bank.

Noah Kerner: (06:05)
It was because of the Community Reinvestment Act that they had to give the money back. I also saw this, working for these big banks, doing philanthropic stuff, but that wasn't really part of the DNA so I just always saw these gaps. That's the best way I can say it. I feel like, why spend your time on something that's not noble in pursuit if you have the opportunity to do that?

Anthony Scaramucci: (06:33)
I've got to ask you a question because this is just curious. You've been on both sides of it. You've been with the haves and you've been with the have-nots, but the have-nots are just as smart as the haves. Am I right or wrong? I mean, in my neighborhood, I mean, I was sitting up at Harvard Law School. I'm like, "Okay. I know you guys think you're all great with the blue and Brooks Brothers outfit on, but there were kids in my neighborhood that are as smart as you guys, if not smarter. They just didn't have the advantages." Do you feel that way?

Noah Kerner: (07:02)
And happier actually. I felt that way a lot. Yeah. I-

Anthony Scaramucci: (07:06)
Yeah. Possibly happier. Yeah. Why happier, do you think?

Noah Kerner: (07:12)
That's a good question. Maybe more freedom somehow. I don't know. I always felt more comfortable on that side. You know?

Anthony Scaramucci: (07:24)
Yeah. Well, listen, I've been on both sides, so I'll give you my view of it. It's not necessarily more freedom, but it's less expectation. If your dad is a crane operator, like my dad was, my parents thought I was going to Hartford Law School. When they took the map out, they were like, "Okay. We're going to Connecticut?" I'm like, "No, we're going back up to Boston. It down the block from Tufts." My parents didn't know any better, so if you don't have the expectation then there's a little bit of a relaxation to that.

Anthony Scaramucci: (07:54)
I felt a lot of people that I went to law school with were so fearful of failing because of what they needed to 'live up to' that they were pressurized. There's dilemmas on all sides. I appreciate that. I appreciate where you're coming from. You built an amazing business. Let's talk about Acorns now because it fits into your life plan and it fits into who you are as a guy. It's a brilliant idea. For those of us that don't know a lot about Acorns ... I do, but there's lots of listeners that may not. Tell us about Acorns. Tell us why you initialized it. Tell us how's it going so far?

Noah Kerner: (08:30)
Yeah. To get back to the leveling the playing field, at the highest level it's really about putting the tools of wealth making in everyone else's hands. That's like you asked the question, why shouldn't everybody have access to these things that have been reserved for the rarefied? That doesn't make sense. At the most basic level, Acorns makes it really, really easy to save and invest small amounts of money for the future. Then we also layer on top financial literacy as an integrated function inside the product. We've opened up over 8 million accounts in the U.S..

Noah Kerner: (09:01)
The customer base is really that it's the everyday American almost exclusively, and the product is designed that way. Functionally, we have a bunch of products inside. Like we help you round up your spare change, automatically invest the spare change into a diversified portfolio. You can set up a retirement account. It's the easiest way to set up a retirement account. Automatically contribute by the day, the week, the month. We have a kid's investment account, so if you just started a family, you can easily set up a kid's investment account.

Noah Kerner: (09:32)
Then we built out a banking product that helps you. Well, our goal is to get people to spend less, save and invest more. It all comes back to us for how do we help people maximize their saving and investing potential?

Anthony Scaramucci: (09:49)
You've attracted a very interesting investor list. You've got Dwayne Johnson, The Rock, Dany Garcia, you've got Jennifer Lopez, you have Ashton Kutcher. How did you get these people?

Noah Kerner: (10:04)
Probably mostly from former lives. You know what I mean? Getting back to the beginning of the story, just navigating these different worlds, music, entertainment, hip hop, whatever. I think the common thread for all of them is that they connect to the storyline. Like Dwayne Johnson is perfect. His company, Seven Bucks Productions, he started because he had seven bucks in his pocket. His story is the acorns to oak story. Our brand is all about, how do we help people move from being tiny acorns to mighty oaks? All those people share that. Jenny from the block, that whole storyline is the same.

Anthony Scaramucci: (10:43)
Well, I mean, I want to emphasize this because we got a lot of young people that listen to these SALT Talks. You kept your relationships, you didn't transact with your relationships. You made them holistic and you made them symmetrical so these people wanted to come with you in your life. It's not like you were just operating as a DJ, that was over, hasta la vista. You kept in close touch with everybody. The point is, no matter what's going on in your life, you could, as an example, work in the White House for 11 days, get your ass fired after 11 days.

Anthony Scaramucci: (11:16)
That could be a bad thing, but it could also be elements of good where now you've bonded with General Kelly who fired you, become personal friends.

Noah Kerner: (11:22)
Right.

Anthony Scaramucci: (11:23)
You see what I'm saying? There's a big lesson to people that you got to keep your relationships because these people have clearly helped you, but you've also helped them because you've built this amazing company. Now, let's talk about the transaction. I go to the store. I'm a member of Acorn. I go to the store, I buy something, it's $4.15. What does your app enable me to do?

Noah Kerner: (11:47)
We round it up to $5. The 85 cents automatically gets invested into a diversified portfolio of ETFs, so like thousands of stocks and bonds.

Anthony Scaramucci: (11:55)
That hits my Credit Corp or how does it round up?

Noah Kerner: (11:59)
It pulls it from your bank account.

Anthony Scaramucci: (12:01)
I got it.

Noah Kerner: (12:02)
As part of registration, you link your bank account. That becomes your funding source. We see your spending, and then we pull the spare change and invest it for you from your bank account automatically.

Anthony Scaramucci: (12:12)
Okay. All right. It's a brilliant idea. You've got companies out there that are known as robo-advisors, companies like Betterment or Stash or Robinhood, so how do you differentiate from them?

Noah Kerner: (12:25)
Yeah. To be honest, we don't really think about competition. I like the idea of blazing a path and leaving a trail. We pioneered micro-investing. We pioneered bringing financial literacy and education together in the product. We pioneered getting brands to invest in you for shopping with them. We move in our own way and we move forward in our own way and don't really look right and left necessarily. I'd say from the customer vantage point, the key thing to understand about Acorns is the customer we serve, the simplicity of it, the way it helps you grow and grow wealth and the number of tools we provide to help you unlock your potential.

Anthony Scaramucci: (13:13)
Tell us about Acorns Early. What does that mean? What's Acorns Early?

Noah Kerner: (13:17)
It's a kid's investment account, so parents can automatically set up investment accounts for their kids, as many kids as you have. You set up a recurring contribution and it just automatically invests into the kids' future for you. If you're an Acorns customer, it's pretty much 30 to 60 seconds to set it up. It just works like magic. You can see that we have a graph called the potential graph so you can see what that money can become through compounding over time, which I'm sure everybody here knows, but that's when your money grows on top of itself.

Noah Kerner: (13:46)
We have financial literacy for families. Then we have brand partners that are family-oriented and invest in you when you participate with them.

Anthony Scaramucci: (13:57)
It's amazing and it's also a reminder to people the earlier that you start investing, the more value there is in the compounding. You can give small amounts of money at an early age, end up with way more money than if you start out with large amounts of money at a later age. I think you're taking advantage of that for people and you're also explaining that to them, so there's a lot of wisdom in what you're doing. The COVID-19 has complicated investing. What is Acorns Grow and how is Acorns helping its users understand the opportunities of long-term investing in the COVID-19 landscape, Noah?

Noah Kerner: (14:35)
Yeah. Grow is our education product, and it started out of this idea that when you're an investor and you read the news, you're going to make bad decisions. The difference in this space between news and education, I think is really critically important, right? News is the world's coming to an end. The market's crashing every day. The market swings every day. It's in the red, the blue, black. It's impossible to stay calm and make rational decisions when you watch this. Education for us is providing information to our customers that helps them.

Noah Kerner: (15:13)
When the market goes down, you know this, that's the worst time to pull your money out. If you're not super sophisticated about this, and you're paying attention to the news, you're going to pull your money out because you're going to panic. My parents did that two or three times and probably lost 200/300% on their money. Our messages to the customers are, great investors stick with it, great investors stay the course. If you look back in time throughout history, every downturn has ended in an upturn. That kind of information is much more useful than the market went down a thousand points today. The world's coming to a fucking end. You know?

Anthony Scaramucci: (15:47)
Yeah. Well, I mean, I agree with you. I mean, we had Morgan Housel, who wrote the book Psychology of Money. What ends up happening is people get so emotionally charged about their money they do the exact opposite thing that they should do. It's based on the fight or flight response and most people have a flight response when it's their money because it's their life savings. They get very, very worked up about it. Also, they lose some confidence in the system so they think, "Okay. That number that I'm looking at on CNBC for that stock is just a number. It's not reflective of an underlying business."

Anthony Scaramucci: (16:23)
It's super important for people to be aware of that. You have become a very well-known enterprise. I mean, everybody knows about Acorns. Millennials, generation X and Z up into the old fogies like me. How did you do that? How did you get the proliferation of your brand?

Noah Kerner: (16:45)
Starting with, and I think this gets lost a lot, but a real focus on product and product quality and making sure the product is good so people talk about it and refer it. I mean, the majority of our growth comes from organic and referral growth. We focus a lot on things like NPS, which is net promoter score. How likely are your customers to refer your product to a friend? Making the experience great. From a marketing perspective, we have partnerships with everybody from The Rock to brands. We do a lot of press. We do search engine optimization.

Noah Kerner: (17:14)
We have our content publication, Grow, that gets a couple million uniques a month. It's a pretty holistic approach, but at the most basic level is thinking about how to make a great product experience so people love it and talk about it.

Anthony Scaramucci: (17:28)
All right. You're doing something pretty gigantic today, right? You're launching Acorns Jobs Finder, is that correct?

Noah Kerner: (17:35)
Yeah.

Anthony Scaramucci: (17:35)
All right. That's pretty huge. Okay. Mazel tov. Congratulations. Okay. Now, what are we doing with Acorns Jobs Finder? Tell our delegates about it.

Noah Kerner: (17:44)
Yeah. It comes back to the leveling the playing field thing and also, I think trying to be timely. I can't sleep at night when I think about what's happening right now and how much unemployment there is and all the statistics around how much people are struggling. There are pre-COVID and COVID reasons for why we did it and why we did it now. If you think about the banking industry at large, and we do that, just what are the gaps, right? Ask questions. Why doesn't the banking industry help people with income when income is the most important part of your financial life? This just seems like a weird gap in financial services.

Noah Kerner: (18:24)
We said, "Look, we help people save and invest money. To do that, we have to help people earn more money. If you can earn more money, you have the potential to save and invest more money." That was pre-COVID logic. COVID logic for why we did it now is obviously you know the statistics around labor and unemployment. This is a really tough time so we wanted to deliver millions of job opportunities, remote jobs, side gigs, part-time, full-time to our customers and say, "Look, there's a lot of opportunities."

Noah Kerner: (18:54)
There's a lot of interesting statistics around side gigs for example when you see the huge uptake in side gig activity during COVID. It turns out a lot of people don't know what type of side gigs there are, how to find them and what to choose. We said, "Let's bring this to bear inside of our product and bring these opportunities in a really important time."

Anthony Scaramucci: (19:17)
Let's talk about the pandemic. You said that you're having some sleepless nights. Are you having some sleepless nights related to the pandemic?

Noah Kerner: (19:24)
I have sleepless nights because it's hard for me given what we do to digest what's happening to people in the country. I mean, I obviously have some sleepless nights because of some of the activity happening in the world and in the country. Mostly it's if you're as immersed in this problem as I am, and we are as a company, it's very hard to sleep when you see these statistics. 70% of Americans not having a thousand dollar emergency fund. Our statistics show that the average American wants 75,000 to feel financially comfortable.

Noah Kerner: (20:00)
That's a pretty big, enormous gap that is not going to magically get filled. Unless we're helping people earn more, unless we're helping people save and invest for the future, unless we're helping people spend less so they can save and invest more, it's going to be very, very difficult to move into the future.

Anthony Scaramucci: (20:19)
Well, listen, I join you in having the sleepless nights. The reason I'm asking you is there are a lot of nights in the last six months where I've lost sleep because of all the stuff going on. The political ramifications of what's going on, the healthcare ramifications, the fact that we have this dystopian information, disinformation out there, worries me, but you're talking about the income divide. Let's address that for a second. Why do you think that that has happened to the extent that it has happened? It seems you could really trace it back to the last 40 years, Noah. Why do you think that that's happened?

Noah Kerner: (20:56)
Well, pretty much flat middle-class wages, rising debts. It's really I think-

Anthony Scaramucci: (21:04)
Okay. Let's address that. Why are the middle-class wages flat?

Noah Kerner: (21:07)
Well, there's a lot of reasons for why middle-class wages are flat, but I think when you ... By the way, one of them is when you look at payroll inside companies, a lot of the wages are going to healthcare costs and things like this. There's a lot of reasons. Combine that with the rising debts, and looks like this, and the rise of personal loans and credit card, credit card debt, and the increase in that, you get into a really difficult cycle that we're in. Unless it starts to go like this, I think we're going to be in a very difficult-

Anthony Scaramucci: (21:38)
Okay. CEO wages are going like this though, right? No?

Noah Kerner: (21:42)
Absolutely.

Anthony Scaramucci: (21:43)
Okay. You get CEO wages going like this, everyone else's wages going like that, that's going to cause some tension and anxiety and possible anger in a society, right?

Noah Kerner: (21:52)
A hundred percent.

Anthony Scaramucci: (21:54)
What do you think has happened then? Have we lost our noblesse oblige in the society? Are we catch as catch can where just everybody's out for themselves in an Ayn Rand kind of a way? Or we don't have the fabric knitting and stitching or social contract tighter together? What do you think is happening?

Noah Kerner: (22:16)
That's a really deep subject and obviously there's a lot to say on this. When I think about what I do and back to what I view as purpose and the idea of trying to level the playing field, if you think about banking, as an example, just look at credit cards and how the credit card industry works. You and I get credit card points and rewards paid for by the debt of other people who don't have a lot of money. I don't like using hackneyed phrases, but the system in many ways is rigged to enable people who have money to make more money and people who don't have money to go deeper into debt.

Noah Kerner: (22:56)
I think if you think about investing, even right now there's this whole range of savings products that have been pushed over the last couple of years, with a 1.5% interest rate, saving, saving, saving, saving. Well, you can't save your way to wealth. You can't even save your way past inflation. I think it's information. I think it's education. I think there's not enough people working to level the playing field and actually giving a shit about that. I think when people start making money and they get here, you don't want to come down from that position. People seem to ... It's actually always been a surprising thing to me.

Noah Kerner: (23:33)
Any modicum of success for me is incredibly humbling, but I meet a lot of people who get more successful and seem to lose sight of ... So it's a strange phenomenon. I think there's a lot. I think there's psychology. There's socio-economic forces, macroeconomic forces. There's a whole series of range of forces.

Anthony Scaramucci: (23:57)
Yeah. Look, I tell my conservative friends, "I got it. I understand that the rich want to get richer and I'm all for unlimited outcomes, but you got to be very, very careful because if you break the society and we disassociate the super wealthy from regular people, you will have an upheaval." It's just, unfortunately, that happens. You got to study five or 6,000 years of history. You are way better off figuring out a way to help your neighbor. Otherwise, you're going to be ending up living in a bob-wired security compound, sitting in your McMansion with your family while your neighbors are suffering.

Anthony Scaramucci: (24:34)
I'm not exactly sure if there's a social good to that. I don't understand why having 10% less and your neighbor doing better, isn't better for you overall, holistically. That's a whole longer-term philosophical discussion. Where is it ... Before I turn it over to John Darsie who's dying to ask you questions, and we got tons of questions in the queue, where is Acorns five years from now, Noah?

Noah Kerner: (24:59)
Our vision is to build a financial wellness system that helps everyday Americans save and invest every day. That's our stated vision. I'm sorry. What that means is there are many things you do in your financial life that impact your ability to save and invest, spending, earning, borrowing, literacy, all those things. We want to help you maximize all of that around saving and investing so you have as much saving and investing potential as you possibly can. In the next five years, Acorns will be much more of a system of products that work together. That's one.

Noah Kerner: (25:31)
We're already the largest subscription service in U.S. consumer finance. By the way, the subscription pricing model is also really important to the concepts we've been talking about, which is when you think about the way people are charged fees in banking, most of it is surprise and most of it is variable. Overdraft fees, minimum balance fees, all these things that pop up out of nowhere. Our thought is let's bring a very predictable, simple, transparent pricing model to this category and say, "It's $1 a month, $3 a month, $5 a month, whatever, here's what you pay. Here's what you get."

Noah Kerner: (26:04)
We have an ambition of a hundred million everyday Americans saving and investing every day. It's a pretty lofty ambition and ideal, but I think if we could achieve that, that would help to make a dent in the fabric of society. Also, literacy levels. Really, really getting people more financially literate and focusing on getting our customers, learning about all the things they need to learn about with their money. I think it's a travesty that financial literacy is not part of the core education, because how do you get dropped off into the world not knowing how to do your taxes? That doesn't make any sense to me?

Anthony Scaramucci: (26:39)
Look, you preach to the converted. Have you read The Richest Man in Babylon by George Clason?

Noah Kerner: (26:44)
I haven't. Tell me about it.

Anthony Scaramucci: (26:46)
Yeah. I want to recommend it to you because your whole business model is basically based on that. I read the book when I was 14. It had a big impact on me, but the central thesis of the book is if you want to get to independent wealth, you have to pay yourself first. If you have a cable bill and you have an electric bill, that's all fine and dandy, but whether it's $5, $10, a hundred dollars every month, you have a bill to yourself which goes into a savings account, or goes into a stock market account.

Anthony Scaramucci: (27:16)
I've been doing this since I was 14 years old, and it did have a dramatic impact in terms of developing the good habits of savings, which you are trying to do for so many Americans as people around the world. I'm going to turn it over to John Darsie, but Noah, I've enjoyed the conversation. I was your therapist there for about 10 minutes so I will send you a side bill and we can round that up into my Acorn account, okay?

Noah Kerner: (27:40)
You got it.

Anthony Scaramucci: (27:41)
All right. Thank you. Go ahead, John.

John Darsie: (27:43)
All right. Now, for the normal part of the session where Anthony is not acting like your shrink. What's interesting to me, and Anthony talked about this earlier, is how you've differentiated yourself from other FinTech players in the space focusing on investing. To me, the power in Acorns, and comment on this, if you will, is reinforcing positive habits. He talked about, we did a SALT Talk several weeks ago with Morgan Housel who wrote The Psychology of Money and writes a lot about that exact topic on his blog regularly as well.

John Darsie: (28:15)
How much of the platform is about reinforcing the right habits in terms of when you spend money, you should also be saving money and investing money? How have you guys thought about the investor psychology piece of this business?

Noah Kerner: (28:27)
Yeah. It's a good question. I mean, a lot of our customers have not saved or invested before, so what we find there's this ... And we talk to a lot of our customers. We get this feedback. There's this sense of hope and confidence that happens with discovering the product, and more importantly, the fact that you can actually save and invest money. The way the product functions is that there are a lot of ways to contribute really regularly.

Noah Kerner: (28:49)
You come back to the product, you see it happening right in front of your eyes and that from a conditioning perspective is really important because as you know, the act of saving and investing is just complicated. It's out of reach. It's just hard to do, so if we can make it easy to do, but also show you that it's happening right in front of you, we like to say celebrating growth and milestones, that helps people begin and it helps people build the confidence to be able to continue doing it. It's very much a conditioning.

Noah Kerner: (29:21)
I like the idea of, and ask the question, can we make saving addictive? Because there's a lot of addictive shit out there. There's a lot of addictive platforms that aren't necessarily good for you. If you could take those mechanisms and apply them to something that's really good for you, that's wonderful.

John Darsie: (29:38)
Right. Yeah. There's a great book called Nudge about that exact thing. Is that the same way that big tech companies use all of their research and AI capabilities to nudge people into behaviors that benefit the company, what if we as a public good started creating nudges into the right behaviors that actually makes people healthier and wealthier and happier?

Noah Kerner: (29:59)
Yeah. Richard Thaler is an advisor to the company. Very familiar. I love that book, but that's exactly it. By the way, the other side of this, and the other side of money for most people, probably all of us in different moments and different times, not all of us, but a lot of us, there's a lot of shame and embarrassment tied up in it. It's hard to talk about if you're struggling, you don't want to talk about it. The fact that you can find this place where little by little, it adds up, it builds a sense of hope. I think that emotional component is important because there's a lack of hope. There's a desperation in struggling with money. A hundred percent.

John Darsie: (30:45)
Yeah. No. It's definitely something that people are very reticent to talk about even within their own families. Talk a little bit more about Acorns Grow. We have a couple of questions about what's your long-term vision and mission for educating today's youth and our population in general, about financial literacy? How can we use technology to further pepper people with just these small stories about how you pay your taxes, how you understand the different taxes that you eventually are going to have to pay?

John Darsie: (31:13)
You see people like athletes coming into college football programs and going to play professional sports that buy a $2 million house without understanding the basics around property taxes and income taxes and understanding personal budgets. How are you going to use technology the way you've done with Acorns, the core product, from a Grow perspective to educate people?

Noah Kerner: (31:34)
Yeah. The best thing to understand is that the core product involves education. We don't think of education as a side thing. There is a separate website we have called Grow, but the education is part of the product. The way we think about it ... And by the way, we have not delivered on this yet. We will. Educating at the moment of decision-making is the way to crack this. It's very hard to get people to read content. It's very hard to get people to remember. It's harder. Richard Thaler will tell you, you could get someone to read something, but forget about trying to get them to remember it.

Noah Kerner: (32:07)
You've got to educate at the moment of decision-making. What that means in our world is product and education come together in one experience. Education is not branded entertainment. It's not over here. It's here. There are things that we'll do for you. Like we automate investing, but there are things you need to know as an investor to make good decisions. We can't automate the act of you not taking your money out of the market when it goes down. You have to know that that's a bad decision.

Noah Kerner: (32:35)
We have to educate at the moment of decision-making so that you are constantly reminded of every downturn ends in an upturn, every downturn ends in an upturn, every downturn ... This kind of stuff. We don't make it hard to pull your money out because we don't believe in that. You should be able to withdraw. It's free. It should be easy, but it's not a good idea to withdraw unless you really, really need the money.

John Darsie: (32:57)
Have you guys done any studies around the behavior of Acorns' investors relative to the general public in terms about how they react to periods of market volatility?

Noah Kerner: (33:08)
We have actually. First of all, during the pandemic, and this is not the case, historically, we've seen really high retention rates. There's a bunch of factors, but we attribute that in part to the constant barrage of education and information, making sure these customers have this. We've also run test controls during market dips to see what happens when we don't educate people, versus when we do, and there's a much better behavior among people who get educated through those periods. I think we like to have our hand held during those moments.

Noah Kerner: (33:40)
I'm sure when you talk to your parents or anybody who's ... Even I go ... I mean, I have financial planners. I freak out too. When things are sideways, I'll get them on the phone and they'll be like, "Okay." It's kind of embarrassing because of what I do, but I'll get them on the phone and I'll be like, "I mean, this one, are you sure? This one's different." You have to hold people's hands. Everybody has anxiety. Even the people with the most experience doing this, you still have moments of anxiety.

John Darsie: (34:15)
Yeah. We've had plenty of financial advisors on SALT Talks talking about that exact thing, is that their job is part investment manager, but the larger part of it is psychologists for their clients and reassuring them during periods of volatility to stay the course.

Noah Kerner: (34:29)
Yeah. I wish I had my conversations with my guys recorded because it would be hysterical.

John Darsie: (34:33)
Book recommendations [inaudible 00:34:34].

Noah Kerner: (34:35)
What'd you say?

John Darsie: (34:35)
Sorry.

Noah Kerner: (34:36)
Yeah.

John Darsie: (34:36)
We have a question about book recommendations. Anthony mentioned The Richest Man in Babylon, which is a great book. Do you have any authors, whether it's books or bloggers or anyone that you read frequently that help shape your worldview or any book recommendations that you're reading right now?

Noah Kerner: (34:53)
Well, as it relates to this stuff and behavioral economics and money, I actually am a huge Thaler fan not, so Nudge and Misbehaving and those books, I think are great.

John Darsie: (35:01)
All right.

Noah Kerner: (35:01)
As it relates to life, I'm a Churchill fan. I like to read biographies and I think The Last Lion, that series is one of the great series from an inspiration perspective. Like you said, this is as much about courage to move through difficult times as it is about technical knowledge. Man, nobody had more cards to move through a difficult time than Churchill. His great lines run through my head all the time, never, ever, ever, ever, ever give up. We'll fight in the hills, we'll fight in the streets.

Noah Kerner: (35:33)
Just that mentality, the optimist sees the opportunity in every challenge, the pessimist sees the challenge in every opportunity. Just all those reminders of stay courageous.

John Darsie: (35:46)
Well, our director of sales at SkyBridge is a massive Churchill fan. He's also British so he fashions himself as a modern-day Churchill, so I get to hear a lot of Churchillian quotes and everything every morning. In the middle of the pandemic was no different as we confronted all the issues that everyone in the world and in our country and in our industry faced during that time period.

Noah Kerner: (36:06)
Here's a good pandemic joke.

John Darsie: (36:08)
All right. Leave us with a nice Churchill quote to get everybody inspired as they leave today.

Noah Kerner: (36:13)
When you're going through hell, keep going.

John Darsie: (36:15)
There you go. Keep investing in your Acorns account because the compounding won't stop. Noah, thanks so much for joining us. Anthony, you have a final word for Noah before we let him go?

Anthony Scaramucci: (36:26)
No. Noah, I loved it. I hope we can get you back on. I'm looking forward to the future with you because even though you've already built an oak, I think that oak is going to turn into a redwood or sequoia. I'd like to figure out a way to invest me some money in Noah actually.

Noah Kerner: (36:41)
Okay.

Anthony Scaramucci: (36:41)
God bless you. Okay. We wish you great success.

Noah Kerner: (36:44)
Thank you.

Anthony Scaramucci: (36:45)
Keep up the great work for everybody.

Noah Kerner: (36:46)
Thanks Anthony. Take care.

Sarah Kunst: How Diversity Leads to Better Investment Performance | SALT Talks #73

“The way that I've been flipping it… when [as a black woman] you have to be twice as good to get half as much, it means you *get* to be twice as good.”

Sarah Kunst, managing director of Cleo Capital, is an investor and entrepreneur who has worked at Apple, Red Bull, Chanel & Mohr Davidow Ventures. She is also a contributing editor at Marie Claire Magazine. She founded LA Dodgers backed Proday and has served as a senior advisor at Bumble where she focused on their corporate VC arm Bumble Fund and on the board of the Michigan State University Foundation endowment.

Growing up middle class in a 300-person Michigan town, it was understood that to go out and achieve more would require hard work. Early career positions offered exposure to tech heavy hitters like the Winklevoss twins and Jack Dorsey. Insatiable curiosity in their work and the Silicon Valley industry eventually provided the opportunity to break through as an emerging fund manager, raising a $3.5M venture fund in 2018. “That was the second largest, first time fund by a black woman, VC in America ever. Three and a half million, I'm not misspeaking.”

A career founded by building out early stage companies has seen multiple projects, even in the time of COVID. This includes identifying individuals out of work and bringing them together to generate ideas before ultimately launching them into companies. Diversity is key in these companies’ success. “We know that diversity drives better results… because they're going to be able to see around corners a lot better if everybody has a slightly different perspective on where the corner is.”

LISTEN AND SUBSCRIBE

SPEAKER

Sarah KunstSarah Kunst.jpeg

Sarah Kunst

Managing Director

Cleo Capital

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

John Darsie: (00:07)
Hello, everyone. Welcome back to SALT Talks. My name is John Darsie. I'm the managing director of SALT, which is a global thought leadership forum at the intersection of finance technology and public policy. And we're on the back half of a great SALT Talks double-header today after a great SALT Talk this morning with former Florida, Governor Jeb Bush, and we're very excited for this afternoon SALT Talk as well. Our SALT Talks are a digital interview series that we launched during this work from home period with leading investors, creators, and thinkers. And what we're really trying to do during these SALT Talks is replicate the experience that we provided our global SALT conference series, which our guests today attended our most recent international conference in Abu Dhabi in 2019 and was extremely impressive. So we're very excited to have her back on SALT Talks, but what we're really trying to do is provide a platform for what we think are big, important ideas that are shaping the future as well as to provide our audience a window into the mind of subject matter experts.

John Darsie: (01:03)
And we're very excited today to welcome Sarah Kunst to SALT Talks. Sarah is the founder and managing director of Cleo Capital, which is a venture capital firm that she founded. She's also an investor and an entrepreneur. She's worked at some of the world's leading companies across different sectors, including Apple, Red Bull, Chanel, and previously at Mohr Davidow Ventures. She also started her career briefly as a scout at Sequoia, one of the leading venture capital firms in the world. In addition to being a contributing editor at Marie Claire Magazine, she previously founded a Los Angeles Dodgers backed startup called Proday, and has served as a senior advisor at Bumble where she focused on their corporate VC arm at the Bumble Fund. She also serves on the board of the Michigan State University Foundation endowment, and Michigan State is her alma mater. So she followed sort of a non-traditional path into venture capital, which I'm sure we'll talk about.

John Darsie: (01:55)
Kunst has been named a future innovator by Vanity Fair, Forbes Magazine 30 under 30 and a top 25 innovator in tech by Cool Hunting. She has been recognized for her work in Business Insider as a 30 under 30 woman in tech and a top African-American in tech and PitchBook and top black VC to watch. And she was also honored as a top woman in STEM by Create & Cultivate and Marie Claire Magazine named her a young gun to watch. She has written for TechCrunch, Forbes, The Wall Street journal, Fortune, Entrepreneur.com and Marc Andreessen named her as one of his 59 Unknown Rock Stars in Tech, which he came out with a couple of years ago. Just a reminder, if you have any questions for Sarah during today's SALT Talk, you can enter them in the Q and a box at the bottom of your video screen and hosting today's talk is Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, a global alternative investment firm. Anthony is also the chairman of SALT. And with that, I'll turn it over to Anthony for the interview.

Anthony Scaramucci: (02:55)
Well, the only thing I can think of Sarah is I'm so happy that I wasn't competing with you for my spot at Harvard Law School in 1989. My resume sucked, I would have never gotten in up against this. I mean, this is incredibly impressive. So congratulations and really honored to have you here.

Sarah Kunst: (03:13)
Thank you.

Anthony Scaramucci: (03:15)
So I'm a little bit of the same mundane repetitive questions sometimes, but I always find this part of our talk fascinating. Tell us something about where you grew up, how you got raised, what you were thinking about as a kid and how you ended up doing what you're doing. What was the process that led you to where you are today?

Sarah Kunst: (03:38)
Yeah. Well, I mean like most venture capital investors, my first two jobs were on a firm. So grew up in a town in Michigan of 300 people and we used to ride our bikes through the irrigation because we didn't have fancy backyard pools, which turns out was probably not the best thing because it wasn't exactly organic farming. But I'm still here and my skin didn't fall off. So came from this tiny town and always had an eye towards... when I was young, I would just read constantly. I would go to the library and I would just pick an aisle and read my way through it and then read my way through the next aisle and read every magazine I could find.

Sarah Kunst: (04:17)
And as soon as somebody gave me the internet, I started playing around and learning how to code a little bit and was always just deeply curious, and had parents who were always really supportive of it, but made it clear to me that, Hey, we're nice, middle-class people and if you want more, you're going to have to work really hard. And so I always grew up with a ton of curiosity and a ton of understanding that if I wanted it I'd have to work for it. So I did not inherit $400 million from my dad, like your former employer. So I had to start somewhere.

Anthony Scaramucci: (04:50)
Hold on. It was 421 million, I think. No, I'm just kidding.

Sarah Kunst: (04:54)
I know I didn't even inherit the 21 million. So I started there and I worked at KFC in high school, which I still am trying to get on their board now because I think I'd be the only board member who actually worked there. And after high school went to Michigan State and I started working in tech because I needed to work. So worked at Apple, as a campus rep and that sort of opened my eyes to there's a whole business and marketing side of business. I was an advertising major in the tech industry. And the consumer internet was just starting to explode or you remember the day we got Facebook. And so those seeds were laid early. Went to New York after college. It was 2008, I worked in marketing at Chanel, which was a great job. I got amazing discounts, but it turns out 2008 was not exactly the right time to be in luxury marketing, so that didn't work well.

Sarah Kunst: (05:43)
And when that sort of started hearing names like Madoff and Bear Stearns falling, it became clear that that luxury was not going to be the place to be and I jumped over to the tech side. I ended up working for the Winklevoss twins, at a media startup they had at the time and got to get a really kind of front row seat to what was going on in the tech world. That was kind of post Facebook lawsuit, pre Bitcoin. I was incredibly early in crypto but I did not savour or mind nearly enough. But I have an email from 2011 where I said, I'm telling all my Tinder dates about Bitcoin, which is really kind of the email of an era.

Sarah Kunst: (06:29)
And I was in, and once I was in the tech world, I saw how innovative it was, how fast moving, candidly how fast you could make and lose a bunch of money. And I was hooked and worked in startups for several years, ended up as a venture capitalist at a big fund. Started a company, raised some money, lost some money. And when I was thinking about what to do next a few years ago, I'd become a general or a limited partner investing in venture funds at Michigan State University. And I just saw this hole in the market where early stage investors, especially who looked like me just didn't really exist. And I said, well, I have all this experience. I have a ton of passion for helping founders. Why don't I go start a fund? So I did it.

Anthony Scaramucci: (07:10)
Well, first of all, congratulations it's an amazing story. And I think it's all that we have a lot of young people that listen to these talks. And I think it's a lesson for them that you have to think very boldly and you have to be willing to take on the risks that you've been able to take on. So congratulations for all of that. Before I go to the next question though, tell me about Bitcoin for a second, your opinion of Bitcoin. What's your opinion... and I'm an old fogy, so I don't really understand it. We had the Winklevoss twins at our conference. I thought they did a magnificent job of explaining it, but put it in your words, do you like Bitcoin as an investment, do you see a future for that digital currency? And if so, why? And if not, why not?

Sarah Kunst: (07:50)
Yeah. I mean, I think if you want to day trade cryptocurrencies, you still certainly can, there are other cryptocurrencies that are maybe better than Bitcoin because there's more fluctuation. But the reality is that the world is only getting more digital and when you look at sort of Tyler Langlois, once described it to me, as Bitcoin is gold with wings. So it's sort of the ultimate hedge, it's your ultimate bug out bag but you can access it from anywhere. And we see that when you watch the amount of crypto that's been purchased by people in places like China, Venezuela, there's a huge understanding of that.

Sarah Kunst: (08:25)
But then the other thing is that as the world gets more digital, as there's less trust in our day-to-day lives, the ability to have a distributed ledger that allows us to, I don't have to trust you to take money from you because there was sort of the ultimate escrow in crypto, if done correctly. And so I think that will all cash go away and will all credit go away and will people only use crypto? I doubt it in the next 10, 20 years. But do I think that cryptocurrency which far predates Bitcoin is here to stay and has a real relevant place and the blockchain is a distributed ledger and kind of source of truth, have a place in our very digital and very kind of fake news world moving forward? Absolutely, I do.

Anthony Scaramucci: (09:14)
Okay. Well, good to know. I got to do some more homework on it personally. I'm obviously well behind everybody else. Silicon Valley, Wall Street, not just Silicon Valley, Wall Street, but many areas of our economy struggle with diversity and it's not just race, it's also gender. So you are a young black woman working in the industry. How hard was it for you to break in and what's the experience been like for you and how do we make it better? Because we obviously have to make it better. So how are we going to make it better?

Sarah Kunst: (09:46)
Yeah. I think that getting in wasn't particularly hard partially because the way I did it was such a side door, that it was a little Trojan horse ask. And I won't pretend that was my master plan, the website I worked out for the Winklevoss twins, that kind of got me into tech, was a nightlife website called Guest of a Guest. And so I wasn't coming into Google saying, I'm going to be your lead engineer. I was for years, just kind of a PR and biz-dev girl floating around New York. But the difference is that I would meet these people via Jack Dorsey, Garrett Camp, the Winklevoss twins, some of the early Facebook team, all of these people who went on to become huge tech names.

Sarah Kunst: (10:30)
And I wasn't just interested in going to a party with them. I would literally sit them down and ask them, one of the richest tech billionaires in the world before he became that. I remember when Nate was trying to hit on me. And I said explain to me what a down round is, which is when you raise a round of capital at a lower valuation than last round. And the poor guy was like, I'm half drunk and trying to hit on this girl and she's making me explain finance concepts. And it was like five years before I ended up in venture capital.

Anthony Scaramucci: (10:56)
Was he able to explain it half drunk?

Sarah Kunst: (10:59)
He did an okay job, but he's also never had a down round. So I guess it's partially that he didn't have the firsthand knowledge.

Anthony Scaramucci: (11:04)
John and I didn't know this, so I'm going to keep interrupting. Did you give him the Heisman or karate chop at the Adam's Apple? What did you give him?

Sarah Kunst: (11:11)
I let him walk me home. I shook his hand good night. And I went into my doorman building and said, don't let that man inside.

Anthony Scaramucci: (11:17)
All right. Good for you. We'll be teaching diversity training and combat skills and all that [crosstalk 00:11:25].

Sarah Kunst: (11:24)
Exactly.

Anthony Scaramucci: (11:25)
Good for you.

Sarah Kunst: (11:26)
So for me there was a lot of that to get in, but then once I was in, there was certainly a place, especially when I went out to Silicon Valley where you really ran into that glass ceiling. And it was clear that if you thought that you had an equal seat at the table, you were wrong. New York historically has been a much better place for female founders. I think it's a better place for diverse founders, but the reality is the real money in our industry is in Silicon Valley. And if you've following along some of the sagas on Twitter recently, Silicon Valley is still not great at diversity.

Sarah Kunst: (11:58)
And so for me, it was looking at that and saying, nowhere is great at diversity in America. So if we're going to go into investment banking, even female teachers are paid less than male teachers. Even though we think of it as a female profession, does that make sense? So what I decided to do was just sort of figure out a way in, and make friends, make allies and just keep going. And I raised a three and a half million dollar venture fund in 2018. That was the second largest, first time fund by a black woman, VC in America ever. Three and a half million, I'm not misspeaking.

Anthony Scaramucci: (12:33)
Well, good for you. I think there's something that you're doing. If you don't mind me saying, and I want you to react to it is you're pushing ahead despite the obstacles, you're not becoming overly sensitized to the obstacles, you recognize the injustice of them, but you've got your four-wheel drive moving over them irregardless of them, is that fair to say?

Sarah Kunst: (12:55)
Yeah. I mean, I think that there's nothing else you can do. What am I going to do? Just curl up in a ball and die. I have to do something to make money. I have to do something to build my career. And I still think that out of every industry, tech's one of the only industries where anyone can become a billionaire in five years. You can't just pop up from a state school or a college dropout and go make a bunch of money on Wall Street because you can't get through the door. There's such a high barrier of credentialism. And so I still think tech is the best place. It's just that even the best place in a country like America is still pretty crappy.

Anthony Scaramucci: (13:33)
But there's something very admirable value, this is my observation of your career. And when you spoke at SALT and things that you're doing, you don't have a chip on your shoulder, at least you don't appear to have a chip on your shoulder. When I was told the early part of my career, I'm not going to mention the firm or the name of the person, but they told me that I should be really landscaping their property as opposed to working inside the organization with them. And the person just literally flat out said that to me. And I was probably less emotionally mature than you are Sarah. And I got upset about that and it really bothered me.

Anthony Scaramucci: (14:06)
And so, of course I overcame it and I said, you know what? I got to go start my own business because this way I'll be able to have a better control of my destiny without those biases and prejudices. So have you done that? How have you managed because many people listen, the injustice is there. It's subjectively there many people get very upset about the injustice. And I'm not saying you're not upset about it, but you seem like you don't have that chip on your shoulder, which I think is a very healthy thing. I wish when I was your age, I didn't have it, frankly. And so how are you doing that?

Sarah Kunst: (14:39)
Yeah. One, shout out to my therapist, we spend a lot of time on this stuff because it is frustrating.

Anthony Scaramucci: (14:46)
We need to get a referral to the therapist. So just remember, when SALT Talk's over, I want the therapist's number. I know I'm not going to get the same therapist, but a comparable one, but go ahead, keep going.

Sarah Kunst: (14:55)
I like it. So, that's certainly a huge part of it, but I think I've had this conversation a lot with startup founders. And there's a scene in the black community. And I think other communities, marginalized communities have the same sort of ethos where you have to be twice as good to get half as much. And it's just deeply unfair when you think about that. But the way that I've been flipping it recently when I'm talking to founders, because that is still largely the case is, when you have to be twice as good to get half as much, it means you get to be twice as good. And so there is no one, you guys know a lot of emerging fund managers.

Sarah Kunst: (15:31)
There are very few emerging fund managers kind of White dudes who sort of showed up and ask a couple of people for money. And they got it because they went to the right school or grew up in the right neighborhood, who I would not be happy to go toe to toe with and look at my contacts, my track record, my network, what my founders think of me, my reach, my press presence, all of that stuff. There are very few people that I wouldn't win.

Sarah Kunst: (15:56)
And so if I have been forced to be this good, but I also am this good, great, I'm this good. And so to me constantly being angry about the way the world is, doesn't get you nearly as far. And then the last point I'll make is, in history class, in fourth grade or whatever, you have to write a report about the time of history that you would have most liked to live in. For me, it's literally every day, because even with what's going on in our world, our government, our everything, Black women have never had more rights than we have right now. We've never had more capital. We've never had more freedom. We've never had more autonomy. We've never had more potential. And that's on one hand, just deeply sad. But on the other hand it's, how lucky am I that I'm born now and not 80 years ago?

Anthony Scaramucci: (16:46)
Well, I mean, I'll add something to that, which I think is a very excellent perspective on your part, but you're also a pioneer and a role model for the future. And so, I did a lot of work in the gay community related to marriage equality and some of the people said to me, it was rough for me 30 or 40 years ago. It's easier for this generation. Maybe it is, or it isn't, I'll let the generation make the comment themselves. But the good news is those people felt rewarded by the work that they had done, that they were making it easier for future generations. So, God bless you for all of that. John is dying to ask questions. And I'm trying to big for John right now, I'm trying to put [crosstalk 00:17:30].

John Darsie: (17:30)
I'm just hoping that by the end of this talk I'm still employed. I stumble over reading the intro every time we do this show. And Sarah is obviously so intelligent and eloquent that I'm just hoping I don't get fired after we get done with the SALT Talk.

Anthony Scaramucci: (17:44)
You're not getting fired. I know that's why you have all the sympathy, baby pictures up there on the wall. He usually has this really big waspy bookcase that he's trying to impress people with. But now we're going with baby pictures. So maybe he does feel like he's getting fired, but don't worry. You're not getting fired. So two more questions, then we're going to turn it over to Mr. Darsie. Your startup, you worked in different stages at places, Apple, Red Bull, Chanel. How were those companies different and how are those companies similar? And I'm just wondering about the ethos of a successful business culture. Are there elements in each of these businesses, even though they're in very different sides of the economy, are there similarities in these businesses or not?

Sarah Kunst: (18:32)
Yeah, I mean, absolutely. So to speak specifically about Apple, Red Bull, Chanel, I worked at all of them by the time I was 24. And there's two kinds of common threads, Red Bull and Chanel are both largely privately owned. And not necessarily by the original founders, but they're still very tightly held. And then Apple, I worked there in college and so it was sort of right at the end of the Steve Jobs era. And that, well, a public company was so driven by his vision and the striving, those companies are... Apple's amazing on margins, really all of them are good, solid, fundamental businesses, but they're really marketing machines. Chanel is selling you things you can buy a 1000 other places, as is Apple, as is Red Bull.

Sarah Kunst: (19:21)
The reason that you're choosing them. And the reason that they're all category leaders is because they understand something about product in marketing that in just a drive for excellence in those areas that very few companies, either one, understand and two, are willing to double down on. And it's that consistent sort of, excellence is a practice. And you have to set a bar for yourself that's so high. And then anything that doesn't meet it, you have to reject and you can't rest on your laurels. And so I think when you look at why and how these companies, particularly Chanel and Apple have managed to continue to just so out perform their peers. A friend of mine said, retail's in a free-fall with COVID and Chanel increased their handbag prices by $1,500 because they do that every year.

Sarah Kunst: (20:12)
So the best time to buy a Chanel bag is always today because next year it's going to be, the prices only go higher and they can do that because of the excellence and because of the brand integrity. And so it 100% sort of shaped the way that I view the importance of brand and legacy and reputation and integrity. Because if you have those as a company, you can keep thriving even when nobody else is. And if you don't, as soon as there's a downturn or a hiccup, you're going to be done for it.

Anthony Scaramucci: (20:42)
Makes total sense to me. I think it's again, another insight, somebody down on their dumps, they got fired from a job. Let's say they said something stupid on the job. And they got unceremoniously fired after 11 days maybe, something like that. What would you recommend to that person down in the dumps, that's been blown out of a situation?

Sarah Kunst: (21:07)
I used to be the queen of trying to fix things. Something would go wrong and like, how do we fix it? How do we salvage it? How do we fix it? And now I generally have, it's almost like falling knives, should you try to catch a falling knife? No. You'll end up stabbed, you'll let it fall. And so, I remind myself of this consistently when things fall apart, let them fall and that's not everything. That's not, I'm never going to pay rent again, whatever. That's, if you're doing your best and you're showing up and you're putting kind of Goodwill and good faith into something, and it's still not working and you do kind of the reasonable amount of work to make it work. And it just won't work. Then stop and consider that maybe you let it fall apart. And then the next thing, the next act, the next whatever is going to be 10 times better.

Sarah Kunst: (21:55)
And I think we intrinsically know this in maybe our dating relationships. How many of us have spent way too long? And then we are like, Oh my God, I should've dumped that person a long time ago when they first did X. And I'm so much happier with the new person, but we don't always translate that into our work lives or even things like with COVID. If you're trying to salvage the before, if you guys were trying to pack us all into, an Abu Dhabi conference room right now, this wouldn't work nearly as well as the talk series, which has maybe opened up a whole new way to reach people.

Anthony Scaramucci: (22:27)
I agree. So your message is try to go with the flow and evolve as you go. Don't worry about the fall. I think it's a good message. Okay. So I'm going to turn it over to Mr. Darsie. Go ahead John. We've got tons of questions for you, and it's really great to have you on Sarah.

Sarah Kunst: (22:47)
Thank you. Great to chat.

John Darsie: (22:48)
So Sarah, you worked as a scout at Sequoia briefly, and you worked for a couple of other venture capital firms. First of all, for people on the call who might not be familiar with the role of a scout in Silicon Valley, could you explain what that means? And then also, I know during the pandemic, it's very interesting we talked about this in our pre-call the other day, you started a fellowship program for people who have been laid off during the pandemic, which I think is ingenious, because what you have is so many talented people that have been laid off because of things purely out of their control. But if you're a company looking to hire tech talent right now, it's actually a great time to be hiring because of all these talented people who are now out there on the street, talk about what you did with that fellowship. And what motivated you to do that, after you just explain to people what a scout does.

Sarah Kunst: (23:34)
Yeah. So scout investing is an esoteric little area of venture investing. And it started, kind of 2008, 2009 when Facebook blew onto the scene, and if you were in college then, or you were kind of right around that 17 to 23 year old age range in the call, 2005, you were very aware of Facebook. If you weren't, you had no idea that it existed. And if you've seen the movie, The Social Network, you kind of see some of that play out where all these big venture funds are like, wait, what is this thing? And by the time they knew about it, in an ideal world, as a VC, you own maybe 20% of a company at the first round of funding. And you want to buy that for maybe a half a million, a million bucks.

Sarah Kunst: (24:17)
If the company has grown to millions of users, and that seems percent of the company is going to cost you astronomically more. And so scout investing came out of the insight that the rise of the consumer internet meant that VCs couldn't see every single company on day one anymore, or day zero. But that, because they invested in all these startups, they had this long tail of people who weren't yet personally liquid. They're not rich, they're coming out of college, they're joining a startup, they're making a little bit of money, but they have this massive network. And they know which of their really smart friends are starting companies and going to work for companies. And so scout investing is basically angel investing on somebody else's dime. So when I was a scout at Sequoia, I was angel investing. Just like many of you might, the difference is I hadn't worked in finance first. So I couldn't just go into my bank account. I was going into Sequoia's bank account, which is much bigger, so it's much better.

Sarah Kunst: (25:11)
Bu that's what scout investing is. And over the life of, since scout investing has been introduced, there's been amazing returns. Jason Calacanis, who's a pretty high profile angel investor. He invested in Uber and Twitter through a scout vehicle. So it wasn't his own capital. He was making a little bit on the back end once the money came back. But those early dollars that turned into in the case of Uber or a 50,000 X return. A lot of that ended up going to Sequoia. And so it's a great deal for Sequoia, and it's a great deal for Jason because investing other people's money when you don't have any, is far better than not investing at all. And so I was a part of Sequoia's program and loved it so much that it's even a part of my fund now.

John Darsie: (25:57)
Fantastic. And talk about Chrysalis for a minute. So I thought that was a brilliant idea to take all of this great tech talent that has been laid off as a result of the pandemic, again, because of things beyond their control and bring them all together to help incubate new startups and to help each other find new jobs and things like that. Talk about that program, why you launched it, what the result was and what it taught you about the industry.

Sarah Kunst: (26:22)
Yeah. So, I remember in 2008, early 2009 just the world, all of a sudden fell apart. New grad, working, and all of a sudden my friends who hadn't yet gotten jobs, there were no jobs to be had. And people who worked at companies they were downsizing and when I went to switch jobs, the landscape could not have been more different than then what I would intern in New York in 2006 and money grew on trees. And so seeing that, I ended up at a startup and I ended up at a startup partially because the bigger obvious companies to move to weren't hiring. And I'm so happy that I ended up on that path instead of saying, Hey, I'm kind of done at Chanel maybe I'll go to Louis Vuitton. And then just being on this other rollercoaster that took me in a very fancy, but totally different direction that I don't think was the right path.

Sarah Kunst: (27:16)
So fast forward to the spring, when in one month tech lost 30,000 jobs. So companies like Lyft, Airbnb, there's layouts everywhere. There's hiring freezes, sales teams for almost everybody were just slashed. And it reminded me so much of that 2008 moment and some of the world's richest venture capitalists, would go on Twitter and say okay, it's time to build. And then everyone's like, great. What do we build? How, and they're like, I don't know, I'm on my yacht. It's time to build, you go figure it out. And I looked at that and I was like, I don't have a yacht yet, but I know how to build. And I know how to hold space for people to come together. And I know how it feels to be like, Oh my gosh, my entire plan, my entire life, my salary, everything just got blown up. What does this mean about me? Not understanding that it has nothing to do with you and it has everything to do with macro economic circumstances far outside of your control.

Sarah Kunst: (28:13)
And so I thought, I can't give these people money. I can't fix a pandemic. But what I can do is create a space, we largely use Slack and we created a space and Tech Crunch wrote about us. We had 100 of applicants, we ended up accepting a few over 100 people. We had everybody from a CFO of a publicly traded company to literal rocket science PhDs, tons of tech workers across all different disciplines, all different geographies. We had people from Israel. We had tons of people from America, people from all over the world. And so we all came together and I said, okay, guys, you got to just start generating ideas.

Sarah Kunst: (28:51)
Because these are all people who are deeply successful in their careers and they were great at building startups for maybe Series A on, but that zero to one. That idea of space, it's not hard to do well, but if you've never had to do it before, then you just truly don't understand it. So we literally, I just made them start using their idea muscle. Every day, without fail you had to log into Slack and share five ideas, they can be terrible ideas. They could be great ideas. They could have something to do with tech. They could have nothing to do with tech. You just had to start throwing out ideas and talking with other people about ideas. Then after a couple of weeks, they started to spend more time with each other, chatting, getting to know people, doing little calls around ideas and teams started to form.

Sarah Kunst: (29:36)
And then we took them through the Google kind of sprint process design sprint of bringing an idea into the world quickly, they started testing ideas> By the end of the six week program, we had over 20 projects that have been started over 10 of them are actual companies. They're C Corps, they are incorporated. We've had multiple companies get into accelerators. We've had a lot of people get jobs through networking in the program. Some have gone into venture capital now themselves. And we have people who are earning money and revenue for their companies. And these are all people who came into the program with no thought in their mind, March 1st or even March 31st of 2020 that they were going to get laid off and become a startup founder.

John Darsie: (30:25)
Well, that's incredible. It's great to hear. Something that we try to do at SALT, as well as make mutual introductions and to incubate the type of idea generation that you did in such a short time post pandemic. And congratulations on building that out so quickly. I want to talk about investment trends for a minute and your fund, Cleo capital you're invested, I think in 20 plus different startups, what types of investment themes were you focused on pre pandemic? Do you still believe in all of those themes and are there any new themes or acceleration of different trends that you've identified as a result of the pandemic that you're particularly excited about putting money to work in those channels?

Sarah Kunst: (31:06)
Karen Levy from boxes is one of my investors and he sat on Twitter and I deeply agree with it that what we're seeing right now during COVID is the acceleration of seven years worth of digital transformation for companies happen in a number of months. And will there ever be offices again? Of course there will be, when the pandemic end, they all do eventually. But will it ever be okay to say, no, you can't call in on video for this. Even if you have a really good reason to no, you can't possibly do this job remote. No, the only way we can get work done is by all being in person 40 or 60 hours a week. I think those days are over. And when you think about it, what are work hours 9:00 to 5:00? Why is it eight hours? Well, because there's 24 hours in the day and Henry Ford needed three shifts to make Model T's around the clock. That was 1905. So now we're 105 years later and some random guy's, random idea to maximize output of factories is still what governs our day to day, the majority of our lives.

Sarah Kunst: (32:17)
And so I think that acceleration is somewhat permanent. I think that very few investors, venture investors are investing in companies now that are strictly around COVID because pandemics don't last forever. Companies, I invest at pre-seed right which means that most of my companies are at least 10 years away from selling our IPO. And there may be only a few years away from going public via SPAC, but we're still not there. And so the idea that I want to invest in companies that are building for the moment instead of building for the next decade is just not going to be accurate. So that being said, I think the other sort of pandemic in this country, that's coming to stark relief this year of racism and social injustice has also accelerated some trends where people are saying, Hey, AI. It's always a joke every year or so some new fancy organization releases an AI bot on the internet and says, Hey Twitter is going to train it.

Sarah Kunst: (33:20)
But then 24 hours, the bot is basically a deeply racist, sexist, homicidal maniac. And that is without fail because when you just learn from Twitter or when you just learn from people in the world, you realize the lowest common denominator is really low. So is a company that does AI for good. Suddenly feel more relevant, post the protest this summer? Yeah, I think so. But it was always relevant. It's just that nobody was focused on that. Does the bot for pandemic detection? Is that going to be interesting if it also works for other, social health issues, public health issues? Sure. If it literally only works for the very specific strain of SARS-CoV-2 then that's probably not going to be very relevant in even three or four years.

John Darsie: (34:09)
So I want to talk about seed stage investing for a little bit. Late stage venture investing growth capital is, I wouldn't say straight forward, but you have a data set. You have a company history to go off of, and you can do it in a more robotic way in terms of identifying companies that are still private. But if it basically shown, promise that they're going to be a successful company. Seed stage investing, and there's a lot more art to it, I would guess than there is science where you're having to identify certain character traits and founders, you're having to evaluate different ideas. What are the prevailing characteristics that you look for in companies and in people that you're investing in at a very early stage?

Sarah Kunst: (34:51)
You're absolutely right. With a later stage company, you're sort of looking at historical performance and guessing that the future results are going to hold relatively. And it's almost more like private equity at a really early stage. With startups, it's basically going into a hospital nursery and looking at babies and guessing which ones are going to be successful adults. And so it is a lot more nebulous. And when you think about that analogy, what you want to know is less about the baby's height or weight or whatever, responsiveness to light. What you want to know is one of the baby's parents like? What environment is this baby going to be raised in? And it's kind of the same as startups where you're around saying, is this founder coachable? Who else is on the team? What does the market look like? Who have they found to get around them as advisors? How do they?

Sarah Kunst: (35:47)
It's a lot of kind of blue sky questions and sort of feeling through, is this founder going to be responsive when a pandemic hits, when a new legislation hits, when Google decides to get into their space or are they going to be super dogmatic and say here's the path I'm following the path no matter what. And you're like, okay, but the bridge ahead of you is out. So are you sure you don't want to take a different path? You're going to fall through and they're like, no, no, I'm good. This is the path. So I look for kind of, I would say a lot of neuro-plasticity. I want people who are learners, who take advice, who take other people's opinions, who think fast, who are nimble. And for me, that also means, we know that diversity drives better results. So I also want to see a diverse team and that doesn't mean 10 people who look like me around the table. It means a diverse team because they're going to be able to see around corners a lot better if everybody has a slightly different perspective on where the corner is.

John Darsie: (36:48)
So we have a question from one of our viewers about scouting. So a lot of what you described as scouting is that as a young person or somebody from a unique background, you might have special insights into different companies that are being launched that might not be on the radar of the top tier private equity for venture capital firms. Our question is about international scouting. So you came to SALT Abu Dhabi in 2019, you were at Milken Abu Dhabi as well. And I know you attend a lot of events and you speak at a lot of events and you're obviously a great speaker. What do you see as the opportunity internationally? In terms of scouting startups, do you see sort of a rise in entrepreneurship and some markets that aren't traditional hubs for entrepreneurship, whether it be in Africa, the middle East Asia, and are you looking to get involved in any of those markets?

Sarah Kunst: (37:40)
Yeah, I mean, absolutely. I think that you'd have to really not be able to read the tea leaves. You'd have to have never gone to a world history class in your life to think that Silicon Valley will always be the hub of innovation. We also know if we're being totally honest with ourselves, even our president knows that China's sort of the new hub of innovation right now. Silicon Valley still has a massive edge but there's a lot more neck and neck there. And very few startups, very few unicorns in Silicon Valley, China, or anywhere else in the world, aren't getting a ton of their engineering talent from India, from Russia, from former USSR countries. And so there is innovation everywhere. Estonia is a country of 3 million people. And most of you couldn't find it on a map if I gave you 100 bucks. But Skype came out of there and now it's this massive powerhouse. They have the most advanced government in the world.

Sarah Kunst: (38:37)
So innovation, I am not at all the person who coined this, but talent is equally distributed and opportunities aren't. And I think that the same way, John, you and I kind of came up in an era where maybe for our parents' generation, the idea that China would be an economic powerhouse was crazy. But then for us, it feels weird to think that that wasn't always the case. I think that our children and certainly our grandchildren someday are going to be like, what do you guys mean you didn't think that Africa was going to be a massive powerhouse? What do you mean you didn't think the middle East would be a massive powerhouse? When you look at the populations of the world, a lot of Asia is aging out. And a lot of Europe, the average age is getting a lot younger. Meanwhile, in places like Turkey, you have the majority of the population is under the age of 25. And in most of Africa, that's the case.

Sarah Kunst: (39:28)
And so there's so much more one, just more people and more ability to innovate because, the smartphone penetration in the U.S. is so high, but you can go to countries where they're just getting started with those things. And so there is a worldwide sort of, I think moment that we are quickly moving towards just a lot more innovation. And I think that if you are not aggressively looking at your strategy to get allocations, to get capital in some of those markets and to fund people from those markets and to help support people who sort of come here for education or jobs like boomerang back and start companies there, wherever there is. You are missing the boat by so far, and it's not a boat. It's the fanciest out in the world because this will be the trillion dollar opportunity, in the next 20 years. And as I think I've said before, I really like yachts.

John Darsie: (40:27)
There you go. I think you do these long-term seed stage investments. So I'm timing it out as price, six or seven years until you have your yacht. I'll be coming to you around then.

Sarah Kunst: (40:37)
That's [crosstalk 00:40:37] more than five years from being a billionaire in my industry.

John Darsie: (40:41)
There you go. So I wish you'd told me about Bitcoin in 2011 on Tinder.

Sarah Kunst: (40:46)
Where were you on Tinder?

Anthony Scaramucci: (40:49)
Why don't you take your pictures down and give it up ad go join Sarah. Okay. I can see where this is going Darsie.

John Darsie: (40:55)
Maybe, but on that theme of international entrepreneurship and technology development, we have an interesting SALT Talk coming up in a couple of weeks with a guy named David Halpert. His fund is called Prince Street, but he coined this term called digital decolonization, where it's basically the idea that all of these countries, rather than allowing Google and Facebook and Apple to come in and swallow their tech industries domestically, there's sort of a tech nationalism that's on the rise where these governments are looking to provide a platform for companies domestically to be successful. And so Google, for example, just bought a large stake for many billions of dollars in reliance industries in India is an example of that.

John Darsie: (41:36)
And it'll be fascinating, you and I have traveled a lot internationally, and it's just so exciting to do our SALT conferences abroad and to travel and talk to people in these different places. Because like you said, the demographics in places like Southeast Asia are exploding in a very positive way. And in 20 years, like you said looking back at some of these things, it's going to seem obvious. But right now people aren't necessarily as focused on it as they should be.

Sarah Kunst: (42:01)
Yeah, I absolutely agree. And my thought, if I were sort of talking to some of these countries concerned about the digital decolonization issue and I think that India and China provided a pretty good groundwork for this. I think that there's something to be said for letting these big companies come in and train your workforces and build up connectivity and sort of get people to understand that you always want to learn on somebody else's dime. The startup work I did for the Winklevoss twins, it was probably some of the worst sloppiest work I'll do in my life. Sorry, Cameron and Tyler, because I was 23 and learning. And I would have much rather learned on their dime than learning now, when I'm having to run my own shop and pay myself my own salary. So, I think some of that happens in this digital decolonization where these countries are hopefully letting these companies in really learning from them, but keeping an escape patch so that they can also say, Marie Kondo style, thank you for your service, you no longer bring me joy. Goodbye. We're going to start our own, whatever it is.

John Darsie: (43:09)
All right. Well, Sarah, it's been a pleasure having you on. Anthony, do you have a final word for Sarah? You're ready to replace me now? Two minutes later.

Anthony Scaramucci: (43:21)
No, I just want to say to her, if I ever get fired again, because anything can happen in my life. I'm calling you for the referral to a therapist. I'm going to ask you for a job, Sarah, what else can I do in a situation like this?

Sarah Kunst: (43:33)
You can always come be my intern.

Anthony Scaramucci: (43:35)
Say it again.

Sarah Kunst: (43:36)
You can always come be my intern.

Anthony Scaramucci: (43:38)
Okay, great. I would look forward to that. Okay. At some point that may be a better job than what I got now. So you never know, you never know what's going to happen, Sarah. But I want to congratulate you on what you're doing and your courage. But more than anything, I want to congratulate you on your attitude and your spirit. And so may that take you as far as you want to go, Sarah. God bless you. Thank you for joining us today.

Sarah Kunst: (44:02)
Thank you.

Matt Salloway: AR, VR & Artificial Intelligence | SALT Talks #71

“We want to be able to invest in companies that can change the world.“

Matt Salloway is an international business executive, venture capitalist, investor and attorney. He serves as the Chief Executive Officer of GSI Ventures, a top 50 Global Family Office, with a focus on venture capital and portfolio market expansion into the MENA region.

GSI Ventures stands for Growth, Sustainability, and Integrity – pillars that drive the firm’s investment philosophy. GSI deploys capital through a diversified investment approach across a variety of cross-border asset classes, while serving as a reliable partner that seeks to make sustainable and impactful allocations. His strategy also looks to the US for next-generation technology, where it can be grown and subsequently introduced to GSI Ventures’ home country of the Kingdom of Saudi Arabia. This is in lock step with Saudi Vision 2030, a strategic framework to reduce the Kingdom’s dependence on oil and diversify its economy.

Matt is also the Co-Founder and Managing Partner of SIP Global Partners (“SIP”), an independent, cross-border venture capital firm anchored by a top global corporate. Based in Japan, the US, and the Middle East, SIP targets market-expansion and value-add investments in high-growth US technology startups. It invests primarily in US companies driving the "Global Connected Economy" in sectors such as AR/VR/XR, artificial intelligence, machine learning, edge computing, digital media, network infrastructure (5G) and enterprise software. Matt is also a film producer.

LISTEN AND SUBSCRIBE

SPEAKER

Matthew Salloway.jpeg

Matt Salloway

Chief Executive Officer

GSI Ventures

MODERATOR

anthony_scaramucci.jpeg

Anthony Scaramucci

Founder & Managing Partner

SkyBridge

EPISODE TRANSCRIPT

Rachel Pether: (00:08)
Hi everyone and welcome back to SALT Talks. I'm Rachel Pether. I'm a senior advisor to SkyBridge Capital, a global alternative investments firm, as well as being the emcee for SALT, a thought leadership forum and networking platform that encompasses business, finance and politics. SALT Talks is a series of digital interviews where we speak to some of the world's foremost investors, creators and thinkers. And just as we do at our global SALT events, which, unfortunately, we haven't been able to do this year, we aim to empower really big important ideas and provide our audience a window into the mind of subject matter experts.

Rachel Pether: (00:47)
Today, I'm very excited to be welcoming Matt Salloway to SALT Talks. Matt's the CEO of GSI Ventures, which is a top 50 Global Family Office that focuses on venture capital and business development or company expansion into the MENA region. He's also the co-founder and managing partner of SIP Global Partners, an international venture firm with offices in New York and Tokyo. Previously, Matt was the founder and managing partner of Salloway Law Group, an international law firm based in Manhattan, and he's also worked as a consultant with McKinsey and a research associate at Harvard Business School. And if that's not enough, Matt is also a successful film producer, with some of his credits including The Butler, starring Oprah Winfrey and Forest Whitaker; The Ides of March, starring George Clooney and Ryan Gosling; and The War With Grandpa, which actually opens in the U.S. this week, starring Robert DeNiro.

Rachel Pether: (01:44)
Just a quick reminder. If you have any questions for Matt during today's session, just enter them in the Q&A box on your Zoom screen. And with that, Matt, welcome to SALT Talks.

Matt Salloway: (01:55)
Thank you, Rachel. It's a pleasure to be here and so thankful for the opportunity.

Rachel Pether: (02:01)
No, we're very happy that you're joining us today. And we have so many subjects that we could go into, because you do wear a number of hats, but I'd really like to start with GSI Ventures, which is the Family Office that you run for a prominent Saudi. So, maybe you could tell me a bit about your journey and what took you to the Kingdom originally.

Matt Salloway: (02:24)
Sure, I'd be happy to. Just as background, I grew up in Boston, so spent most of my life there before moving to New York, where I've been living for about 16 years. Again, as you mentioned, trained as an attorney and then now got into what I am doing. And GSI is really a single family office that's focused on managing the assets and the affairs for this family. GSI stands for Growth, Sustainability and Integrity. Those are our core pillars and values that we live by. For me, getting into Saudi Arabia was sort of a very fortuitous experience. I was an attorney before, as I mentioned, and I started at a firm called O'Melveny & Myers, where I was working... Mostly corporate law, doing private equity and mergers and acquisitions, venture capital.

Matt Salloway: (03:21)
In 2004, when I started, it was really one of the most active times in the private equity market, with leveraged buyouts. I was representing companies like Apollo and JP Morgan Partners, and it was really great training ground. But for me, I really wanted to get into counseling, advising, guiding, really serving as a personal advisor that could help clients meet their goals. And being at a large firm was great training for me, but it wasn't necessarily where I wanted to spend the rest of my career. So, I ended up launching my own law firm, which I've now transitioned into doing the Family Office, but the law firm was really focused on helping high net worths, international families, companies, meet their goals.

Matt Salloway: (04:07)
And I actually had a great-uncle who was a very successful prominent lawyer in a small town in the United States and I used to hear stories about how he really added so much value to the lives of his clients and I wanted to replicate that. That was sort of the same type of thing that I wanted to do, and obviously New York City is a much, much larger, bigger place than a small town, but I wanted to provide that same type of guidance and counsel and I was fortunate to start working with clients in that world and started representing a lot of international families, and one of which still with today. A wonderful family, very humble, very sophisticated, but shares the same values, and I was just excited to get that opportunity to start working together.

Rachel Pether: (04:58)
So, let's take that acronym that you just mentioned, GSI. The growth, the sustainability and the integrity. What does that actually mean in practice? So, what types of investments are you looking at? And maybe you can also talk about the growth aspect, particularly in Saudi Arabia.

Matt Salloway: (05:16)
Sure. So, we started the Family Office in 2016. So, we've been evolving, as has the world been, and especially in Saudi, you see a lot of the changes that are occurring. But primarily, the goal of the Family Office is to manage the affairs of the family, to have the right portfolio allocation focused on capital growth, obviously capital preservation, and having the right diversification strategy, because as you may know, a lot of families in the Middle East and even internationally sometimes do get very concentrated in one part of the world or one asset class, and being fortunate to be based in the United States, a lot of our focus and my focus is helping to find the right opportunities globally and especially in the States and Europe, where we can really diversify the portfolio.

Matt Salloway: (06:06)
So, growth, sustainability are the core pillars of the Family Office. So, growth obviously is a very clear path and most Family Offices share that same vision. They want to make sure that the capital is going in the right direction. A lot of families get bogged down in spending patterns and also, again, concentration in areas that may be too [inaudible 00:06:30] liquid or not provide the right balance, and as we see in the economy, things change. It can change very quickly and you need to make sure you have the right balance in place.

Matt Salloway: (06:39)
Sustainability, integrity are also very core pillars. Integrity, I'll start with first. That's just a foundational aspect of how we do business, the people we want to work with, really sort of the way we want to have that reputation of being the right partners and the right investors. Sustainability is important as a long term goal. We've done some... Although we're mostly focused on our portfolio and our... Growing sort of that, those buckets, we're also focused on impact investing and we've participated in a... Couple years ago, a class at Harvard that brought together some of the largest international families in the world with two professors there, and we've wanted to be somewhat of a catalyst for that philosophy in the region, telling people that it is important to consider ways that you can use your resources to do good for the world and make a difference. It's not all about the bottom line. Although that is very important, it's nice to have some buckets where you can have impact on your society and the global marketplace, as try to do at GSI.

Rachel Pether: (07:53)
I'd love to come back to that point on impact later, and also sort of weave that into the work that you're doing on the film side. But you mention the concentrated portfolios, and one thing I've noticed in the Middle East is there is a huge home bias here, right? So, a lot of people are investing in the region. And I know that part of your mandate is also to bring companies to the Middle East, so how do you balance that between sort of the diversified portfolio but also not having so much of a home bias? How do you manage those two pieces?

Matt Salloway: (08:26)
Yeah, it's a great question. I think the way that we look at our investing is somewhat of a strategic. So, when we invest into technology, and specifically in the United States, we look for ways that we can take that technology as a strategic partner and grow it into the region. So, there's somewhat of a... It's, in a way, a great way to improve our investment chances because we have great infrastructure in the region, and to be able to take an investment that we think is best in class and then introduce it into a country like Saudi Arabia, which is a difficult market to penetrate unless you have on-the-ground resources, and be able to bring the best in class technology into the country, which is very much aligned with what they're trying to do in Vision 2030, which I know we'll probably talk about a little later.

Matt Salloway: (09:19)
But we want to be able to invest in companies that can change the world, and that's been a big focus of GSI. It's been a big focus of SIP, of investing in the next generation of world class transformational technology. And that technology is not only a good investment, but it also can improve the economy of the countries that we're trying to grow in. It can add jobs. It can improve the quality of life. It can make a real difference in the region, and that's how we see ourselves as somewhat of a strategic partner, where we're not necessarily overlooking the home country where we want to have a lot of influence and connectivity. But it also is a way that we can diversify our investing and get access to best in class technology because there's also an interest in growing those companies globally.

Rachel Pether: (10:16)
You mention SIP, which is one of the other hats that you wear, SIP Global Partners, and that's tied to the Japanese institutions. What do you see happening with Japan with regards to technology and are you bringing some of those into Saudi Arabia as well?

Matt Salloway: (10:34)
Sure. So, SIP was founded about a year ago to specifically address what we saw was the opportunity in Japan. Now, historically, Japan has been a leader in innovation and technology. In the 1970s, 1980s, I remember as a kid having the Panasonic television, the Sony Walkmans, these very sleekly designed and the hardware was really innovative. That has changed over time in Japan and you really haven't seen significant amount of innovation coming out of Japan in the last 20 to 25 years. So, why is that? I mean, it's hard to understand because Japan is the third largest economy. Japan has a very sophisticated workforce. Japan has just as much intellectual property as other countries. It's a stable democracy. So, why are they not innovating at the same extent? [inaudible 00:11:36] Excuse me.

Matt Salloway: (11:36)
And the reason, at least in what I've heard and what I've seen, spending a lot of time there, is that, first of all, there's a culture that's somewhat risk-averse and it's better to not fail than to succeed, in a sense. I mean, that's somewhat of a underpinning philosophy. I personally, as an American, have lived by the Teddy Roosevelt, who used to say, "Far better is it to dare mighty things even though checkered by failure than to dwell in the perpetual twilight that knows not victory or defeat." That's how a lot of Americans live. We'll take risks. And a lot of other countries too. But Japan is a little bit more risk-averse.

Matt Salloway: (12:17)
So, all that being said, that is starting to change and evolve in a positive way. So, I'll give you just a couple of statistics. There's a university called Keio University in Japan which was the university that gave the country the most entrepreneurs. So, if you were going to go into a start-up, you normally would graduate from Keio, not the University of Tokyo. So, I think 10, 15 years ago, 30% of the entrepreneurs were coming out of Keio and maybe 2% were coming out of University of Tokyo in that realm. That has actually switched in recent years. So now, University of Tokyo is producing a lot more entrepreneurs that are going into start-up companies.

Matt Salloway: (13:03)
So, as that's starting to shift and as you're starting to see more money being put into venture capital domestically in Japan, there is starting to be more of a focus on innovation and technology. Part of that is focused on the essential need for them to innovate because of the aging problem. Japan has, I think... The median age is 48 years old. It's the second oldest demographic in the world. As the country continues to age, there is going to be an impact on the economy. So, there is a real need for the country to start innovation and that's where we believe there's an opportunity for us to come in as SIP.

Matt Salloway: (13:49)
We are an independent venture capital cross-border technology company. Japan has mostly corporate venture capital investors. Fifty percent of the money that's going into Japanese technology is coming from CVC, corporate venture capitals, in Japan. So, as an independent venture fund, which we are, we believe that there's a strong opportunity to bring best in class technology, which the country's hungry for, which the country needs, from other places like where we're based in the United States, into the country where we have a very strong infrastructure and connectivity.

Matt Salloway: (14:26)
So, that's a bit long-winded, but a bit about our thesis into Japan, where the opportunity is, how things are now starting to evolve. And we're very excited about what we're doing there and the future of Japan's growth and innovation.

Rachel Pether: (14:43)
Yeah, that's really interesting points that you made on the demographic side as well, because I guess when you look to the decades when they were strong, the seventies, the eighties, the nineties, the median age was much lower then. So, I wonder if that sort of plays into the cultural aspect as well. But it sounds like, from what you're saying, you are now seeing a new wave of entrepreneurs that aren't so scared about failing.

Matt Salloway: (15:08)
Yeah. [crosstalk 00:15:09] It's changing slowly and I would caution... Even though [inaudible 00:15:13] again, my opinions. But as COVID has come in unexpectedly, it may slow a bit, but we are seeing people leaving and going into start-ups because in Japan, it was very accepted to just go to a large corporate and spend your entire career there. It was very stable. It's prestigious. It's safe. So, you go and you work for a conglomerate and you spend your career there. But now, it's becoming more accepted and you're seeing a lot of changes that are happening. Slowly, but it's occurring.

Rachel Pether: (15:46)
Yeah. They were the sort of ultimate salary man, wasn't it?

Matt Salloway: (15:51)
Yes.

Rachel Pether: (15:52)
Your job for life kind of aspect. I also wanted to... Talked about Saudi and Japan and maybe go a bit deeper into geopolitics. We actually had... I don't know if you saw the SALT Talk. We had Dr. Kai-Fu Lee on a previous SALT Talk and he was talking about artificial intelligence and how China and the U.S. were the clear front-runners in terms of an aggregate score, which is research plus implementation plus monetization. How do you see the tensions...? You know, you're on the ground in the U.S. How do you see the tensions between America and China as it relates to AI? And I guess that's part of the broader question about how geopolitics sort of intersects with venture capital?

Matt Salloway: (16:39)
Yeah. It's a great question and we see it every day playing out with news flashes and... I guess let me take the geopolitical question. The way that we see it is really there's a bifurcation in the world in terms of how countries are making alliances. And they're not necessarily strict formal alliances. They're more loose. But if you want to look at it... And I'm giving generalizations here... Look at it from a broad perspective, you've got China, Russia, Iran, Pakistan, all sort of on one side of the world. And then you've got... And again, broad generalizations. You've got the United States, Japan, Saudi Arabia, Europe, Israel. You've got sort of this sort of loose affiliation and that sort of relates to inward and outward investment flows, intellectual property, transfers and exchanges, knowledge transfers. It really relates to a lot of various aspects of business and collaboration.

Matt Salloway: (17:47)
So, I think, number one, with China and seeing what's happened with Firma and the changes... I mean, we've seen, statistically, tremendous change from the United States investing in China. I think... Again, I'm trying to recall numbers, but I think it was 20 billion was invested a number of years ago into China. Now, it was five billion most recently. And same with Chinese investment into United States has really, has had to decrease. So, there's now opportunities for other people and other players to step up. Number one, we see Japan as a very interesting country that could fill some of that gap. And again, that's why we're very bullish and very involved in Japan, so Japan can now start investing more into the United States. There's also the opportunity for the U.S. to invest into Japan. Again, very large... Third largest economy. Very stable country in terms of government, democracy. Very, sort of, sophisticated workforce.

Matt Salloway: (18:50)
The other thing I would mention is Israel. And with the Abraham Accords, which was a recent piece of agreement between the United... I'm sorry. Between Israel and the United Arab Emirates, where you are, Rachel, as well as Bahrain. I think it's a tremendous opportunity for growth in the Middle East. Israel, just taking a step back, is really the size of New Jersey. So, it's a small, small country. It has nine million people. It's 72 years old. It's a relatively young country, but statistically, per capita, it has the most venture capital technology and start-ups in the world and we've seen some tremendous technologies come out of Israel. You've seen Waze, the navigation technology. There's a mobile [inaudible 00:19:47], the recent huge acquisition that happened for autonomous driving. There's a company called PillCam, which is a medical technology, which you take the pill and it can video your diagnostics for health care. EXO, there's an exoskeleton company which can help people without limbs walk.

Matt Salloway: (20:12)
There's... And just, historically speaking, as a side note, instant messaging came out of Israel. The zip drive, the SanDisk zip drives came out of Israel. Operating systems for Microsoft. So, it's a really tremendous place, and I think having now this collaboration together between countries will be significant for the future of development of the venture capital ecosystem.

Rachel Pether: (20:40)
And so, when you're looking at some of these cross-border transactions, particularly bringing some of the verticals into Saudi Arabia, what are some of the top three verticals that you're looking at in terms of inward and into Saudi?

Matt Salloway: (20:55)
So, I guess let me... I don't know, again, in terms of the viewers, if they know a lot about Saudi Arabia, and I didn't speak about it and I'd love to give a little context to answer that question. So, Saudi Arabia has historically... There's... To give people a little background on Vision 2030, which was created a number of years ago, which was focused on finding ways to diversify the kingdom away from oil assets, to make sure the economy could sustain. So, Vision 2030 had all these reforms and goals, some very aspirational, but tremendous plan for the country and the future. As part of that, we're seeing a lot of the impact of those plans and goals and government support.

Matt Salloway: (21:52)
So, I want to talk, I think, about two areas that I see as being the most areas of... Which answers this question in terms of verticals, of growth in Saudi Arabia. I think the first is technology venture capital and the second is entertainment and tourism. I'm generalizing and grouping these together. But if you look at venture capital and technology... So, Saudi Arabia was never... In recent years, was not a start-up hub, but it's starting to become a start-up hub. In recent years, it's become the number three most active economy in MENA in terms of venture capital investing and technology, behind the Emirates and Egypt. So, it's starting to see a little bit more growth trajectory in that area, and that's interesting because Saudi Arabia is the largest economy in the Middle East and it has, I think, 70% of the population is under the age of 30 or 35. So, very young demographic. People that are very technologically advanced and with the government really supporting technology and entrepreneurs.

Matt Salloway: (23:14)
PIF created the large... One of the largest [inaudible 00:23:17] funds, [inaudible 00:23:18] that's putting close to a billion dollars or over a billion dollars, I think, into local, regional start-ups. The Saudi Venture Capital Company, SVC, was created with $750 million to invest into the region. So, there's a lot of government assistance that's being helped and pushed to encourage start-ups and technology and we're seeing the results. So, I think in 2020, there was 95 million invested in Saudi start-ups, which, with COVID and some of the just world events, that's incredible. That's the largest ever, a tremendous increase. I think in 2015 it was seven million. So, you see a really big shift.

Matt Salloway: (24:03)
In terms of the industries in technology and venture capital that we're seeing, I'd say there's a few. The first is e-commerce. That's been a very active area. A company called Jahez, which is a grocery delivery company... They recently had one of their largest rounds, this year. I think it was around $36 million, or they've raised 36 million for the company. Another company and area that we're seeing growth in Saudi is education technology. There's a company called Noon, which is... Noon Academy, which raised $13 million recently, which is a online educational company. There's a lot with financial technology, e-payments and digital payments and e-wallets, those types of things, that the country is focusing on. Cybersecurity is another area that the country is focusing on.

Matt Salloway: (24:58)
So, those are some of the areas in technology and venture capital. We as a venture capital firm are also a beneficiary of some of the government initiatives. The government set up, through SAGIA, which is the Saudi Arabia General Investment Authority, a venture initiative where it's trying to attract the best global venture funds into Saudi Arabia, and we recently were granted, as part of that program, to get a license and be involved. So, technology, venture capital, those areas are really growing significantly.

Matt Salloway: (25:35)
The other area, very quickly, is the entertainment and tourism. So, I'm sure... I don't know if most of the viewers have been to Saudi, but historically, it was very hard. You had to get the right visa. Even myself, I had to have a special visa. They created a system where 49 countries around the world can now visit Saudi Arabia as a tourist for 90 days. And you can get this very easily and quickly online. So, there's a real focus on bringing people into the country.

Matt Salloway: (26:06)
On the other side, there's a focus on keeping people in the country. And Saudi Arabians... Having worked with families there for the last 10 years, people travel. A lot of the country spends time in Europe and the United States and Dubai, so they spend a lot of money elsewhere. The government is focused on trying to keep the people in Saudi longer during the year and spend more money, spend more of their earnings in the actual country. So, there's been a huge focus on tourism and entertainment. As examples, the country opened movie theaters. Thirty-five year moratorium was on movie theaters in the country. Now there's movie theaters. There's now live music. When I was there, there were live music concerts. The WWE signed a 10-year deal with the government, so they're bringing in very well-known players. Formula One was there recently. They're building a live music hall. So, there's a tremendous amount of progress, I'd say, in that space.

Matt Salloway: (27:09)
One last point. Seasons, which is the sort of large malls and shopping areas that have been created all across the country, are a result of the government and getting people... And I've been to the Seasons a few times. Bringing the best restaurants, the best stores, into the country and subsidized significantly by the government. But you walk around and people are very happy they're able to get some of the food and products that they used to get in Europe and the United States. They can now get it in Saudi. So, it's a really exciting time and there's a lot of change and progress.

Rachel Pether: (27:46)
No, I completely agree. I've only been going there for a couple of years, but on every successive trip, you notice at least 4,000 things that have changed from the last time. Conveniently, you talk about opening movie theaters, which is a very nice segue way to another piece that I want to talk to you about. We've had a lot of audience questions come in as well, so I'll go to those in a minute. But I want to pivot from the use of technology to do good to looking at film and how that can positively affect society. I did mention, but I'm going to mention again, that you have some pretty impressive movie credits on The Butler, The Ides of March and The War With Grandpa.

Rachel Pether: (28:27)
So, what led to your interest in film, because this seems to me quite separate from the Family Office [inaudible 00:28:34] things. So, I'd love to know more about what brought that into your life.

Matt Salloway: (28:39)
Sure. So, for me, film has always been a tremendous vehicle and medium to inspire people, to educate them, to change the world, in a sense, in some small ways. So, I've always been very passionate about film. In some ways, it's like venture capital from an investment perspective and looking at investment structures. And being a lawyer, when I started my firm, I was doing a lot in film in terms of distribution, film finance, representing people in the business. But it's a really incredible area to influence society. And as an example, The Butler, which we made with Forest Whitaker and Oprah Winfrey, was a true story about a butler who served for seven presidents in the United States. And the story is really a journey through the civil rights movement, culminating with Barack Obama becoming president.

Matt Salloway: (29:38)
And my mother... A lot of what I do has also been influenced by my family, and my mother was quite involved in the civil rights movement in the United States. My parents are also very involved in philanthropy. My grandmother started a nonprofit in the 1950s with some other women in Boston, helping mentally ill, homeless people, battered women. My parents actually now run that same organization in their retirement, all volunteer. So, I was raised with some of those values of wanting to have impact and make a difference, and that's part of what drives me. It drives me, obviously, in the Family Office. It drives me in the venture fund and it drives me across the board in film. All of these are ways that we can make a difference. Obviously, still being successful as a business person and meeting our business goals, but having positive impact on the people, on the world, on a society that we're interacting with.

Matt Salloway: (30:37)
So, that's the way, for me, film has been really an amazing vehicle for that. We have a bunch of other projects that are coming out. In addition, War with Grandpa, as you said, is starting on Friday. It's coming out across the United States. It's a heartwarming family comedy with Robert DeNiro, Uma Thurman, Rob Riggle, Christopher Walken, Jane Seymour. It's directed by the SpongeBob creator. So, it's a really, really wonderful story that's based on children's book about a grandfather that moves back in with his daughter and her family, and he takes his grandson's room and they start a bit of a war against each other. And we're excited for that to be released.

Matt Salloway: (31:22)
We're also working on a film that's called Worth, which is the story of Ken Feinberg, who was the 9/11 special master and really had to determine the value of human life. He was entrusted by President Bush and Congress in awarding monies to 9/11 victims' families, and he had to go through the process of interacting with families to figure out what was the value of that human life that was lost, which was a tremendous... Tremendous story, which we hope to release next year on the 20th anniversary of 9/11. And then we're working on a couple other projects. One is the story of the first female White House journalist, Connie Lawn, as well as a sequel to Dances With Wolves that we're excited about.

Matt Salloway: (32:10)
So, again, very broad and diverse, but a nice balance of opportunities that really make a difference, hopefully, in the world.

Rachel Pether: (32:22)
That's fabulous, and I think The War With Grandpa, probably many people have experienced that during COVID, haven't they? I know I would say 50% of the people I know have moved back in with their parents or somehow the family's been consolidated again. So, I'm sure that will resonate with a lot of people.

Rachel Pether: (32:40)
We have had so many questions coming in from the audience, so I am going to address them now. Broadly, they sort of fall into film and venture capital, so I'll start with some of the venture capital focused questions. In your opinion, what makes a unicorn, given that you see these deals all over the world?

Matt Salloway: (32:59)
Yeah, it's a great question, and obviously the... It's the Holy Grail for what venture capitalists look for. I think I read a statistic that unicorns... Your chances of becoming a unicorn are... Out of five million start-up investments, three become unicorns. So, it's very, very competitive and obviously that's what we aspire to. I think there's a couple... There's probably two points I'd make. The first is I've always believed in timing being a huge part of life, of business, and I don't know if a lot of the viewers know Wayne Gretzky, but he was really one of the most famous professional hockey players, professional athletes. And he used to say that, "I skate to where the puck is going, not to where the puck has been." And I think that's a huge part of becoming a successful start-up, is knowing where technology is going and being able to follow your instincts and follow the data to make that decision.

Matt Salloway: (33:59)
I think the second part of that is... And I've created a silly acronym for the way I think about unicorns. It's an investment that I don't want to miss, M-I-S-S. And that stands for really four things. One, management. So, who are the people that are going to be driving this opportunity? For me, I've invested, as a fund and as a Family Office, in people that we have longstanding relationships with. One of our portfolio companies is someone I've known for 20 years and he's one of the most successful venture capitalists in the United States. But he knows how to start a company. He knows how to also bring it to fruition. It's not just about having a great idea. It's being able to execute. So, it's the management team.

Matt Salloway: (34:49)
"I" stands for integrity. We talked about this earlier, but it's all about your reputation. It's all about trusting the people you're investing in. There's so much that you are putting into as investors in private equity, hedge funds, venture capital. You're entrusting your resources to other people and we've seen a lot of people get burned. We've seen there are a lot of unethical and unscrupulous people, so you really have to do the best you can to trust who you're working with. And it's about that belief in who you're partnering with.

Matt Salloway: (35:26)
"S" and "S," the last two. "S" is sales. So, having the right sales strategy. You can have a phenomenal idea, but it doesn't mean that you're going to be able to sell it. And there's a lot of reasons how you sell. But you have to be passionate in the way you sell. You have to have the right people, the right connections, the right strategy. And then, the last thing is size, and I think you can have a great idea that you can sell, but it has to be sold to the right size, a sizeable market, in order for it to be a unicorn and to be profitable.

Matt Salloway: (35:57)
So, you have to have those, I think, those factors. Those are the four factors that I look for when I'm thinking about a unicorn.

Rachel Pether: (36:06)
Excellent. Thank you. I think that's the lawyer in you creating acronyms for everything, but it's good that you've got it in a structure. And we've got a question from Ken and I'm going to read out his name because he's such a great SALT Talk supporter, so thank you for your question, Ken Lustig. Matt, what are some of the ways that you help your portfolio companies develop opportunities for their products or technologies in Saudi Arabia? Can you give some tangible examples on that?

Matt Salloway: (36:35)
Sure. I think it ranges from a variety of alliances and partnerships. The first is the most basic, which is saying, "Look, you want to grow into Saudi. Let us give you some advice. Let us introduce you to the right people, the people that we think are knowledgeable in this space. Let us be a resource for you." Then it can get a little bit more active where we'll help set up an office and create a somewhat of a joint venture or partnership where we will help create the operations to manage this business. And again, it depends on the sectors, it depends... This is a broad answer, but our goal is to really open up access to a marketplace that is quite significant and also very difficult to get into. They're now changing and attracting a lot of foreign investment and people... It's becoming easier to do business in Saudi, but you still really need on the ground assistance.

Matt Salloway: (37:45)
And we see the same thing, obviously, in Japan. We see Japan as a springboard, also, to the rest of Asia. So, if a company can grow into Saudi, if it can grow into Japan, it can then also start growing into the rest of the region, which is also significant. And the same... Same is the case for the Middle East. There's a lot of opportunities throughout MENA for growth, depending on your technology company and product.

Rachel Pether: (38:15)
And you did touch on, before, the Abraham Accord and the relationships there between UAE and Bahrain. Do you think there's opportunities to look forward to there within Saudi as well, with some easing of diplomatic tensions? And how do you see that sort of Saudi/Israel partnership evolving?

Matt Salloway: (38:35)
Sure. I mean, it's... Look, this is only my personal perspective. I have no inside information. But it sounds, from what I've read and what I've seen, that there's a real growth in collaboration and it sounds like, hopefully, optimistically. For me, the more countries that can be allied and doing business together, the better it is for the entire world for us to grow the right kinds of technology. But from what I've heard... And I think there was an interview with one of the members of the royal family recently, talking about Israel and the technology. I read it online on one of the... It was Bloomberg or one of the other news outlets. So, I think that there's continuing to be a greater dialogue. Also, with Iran and some of the controversies and the complexity of the region, I think there's more reasons for countries to be closer in partnership and working together. So, I'm optimistic. I think it looks like there are other countries that are also in the region that might... Oman, that may follow as well. So, it's a really interesting story to watch.

Rachel Pether: (39:55)
Excellent. Thanks [inaudible 00:39:56] so much for that. And we've got a quick question on Japan as well. The way you're... When you're looking at the Japanese venture capital system, are you seeing it concentrated in certain areas, maybe such as automation? And if yes, could you give some specific examples of what you're seeing there?

Matt Salloway: (40:16)
Yeah. I mean, it's a really interesting question. I think there are a couple areas where there is a strong area of growth. Cybersecurity is one area where I think... Where we've actually had... My partners in Japan have brought companies, great technologies, into the region. Cybersecurity was also very important for the Olympics, which didn't happen, but the government was very focused on finding and creating best in class technology practices in the country. So, cyber's one area. I would say aging, digital. For the aging problem, there's a digital health care component. So, because you don't have enough people to care for the aging population demographic, there's a lot of advances that are happening in digital health which relates to AI, being able to create... I know that I read about some products that were helping care for the elderly, which there may be some automation in there, that are being developed.

Matt Salloway: (41:27)
So, I think the country is... It's still very strong in robotics. It's still very strong in automation, in infrastructure. The bullet train, obviously one of the most advanced technologies, which has been around for a while. But I think they're starting now to broaden and to get... To have interest in best in class technologies globally that are outside of their traditional scope, and that's where... Again, where we've come in as SIP. My two partners in Japan are... One of them has been in Japan for many, many years. He was the CEO of a start-up that became public. He was the first foreign hire in Netscape. His father was actually the first venture capitalist in Japan. He brought the LP system into Japan in the seventies and co-founded JAFCO, which is a very storied institution.

Matt Salloway: (42:21)
So, we have a lot of expertise on the ground there from a venture capital start-up perspective and we're also anchored by one of the largest corporates in Japan that wanted access to technology. So, with all of sort of our expertise there, we believe we're very poised to bring a lot of diversity and interests into this massive market.

Rachel Pether: (42:45)
Can you give me some examples of some of the portfolio companies that SIP has invested in to date?

Matt Salloway: (42:52)
Sure. So, we have four companies, three that we have officially announced and one we're announcing later this month. But we've tried to focus on early growth stage, Series A, Series B, companies that are globally focused, and we believe that we get access to a lot of these companies not only because I talked about integrity and our reputation and our capital, but because a lot of the founders want access to these massive markets. So, we're getting the best in class access to deal flow, to best in class technology.

Matt Salloway: (43:29)
So, the companies that we've invested in... One is a company called Croquet, which is a web infrastructure. It's an operating system, co-founded actually by Alan Kay, who was the father of the personal computer. He was Steve Jobs' mentor. And it's now being run by David Smith, the former CIO of Lockheed Martin. Company's fascinating. We were... We have a board seat. We're one of the first investors in this company now, in this version of the company. We also have an investment in a company called Parallel Wireless, which is a 5G technology co-founded by Steve Papa, who is a multi-unicorn founder. I actually met him when I was... That year I spent at Harvard Business School. Got to know Steve and have kept a relationship. He founded Endeca, which he sold to Oracle for over a billion dollars. He's one of the founders of Toast, another unicorn. Really fantastic venture capital investor and also operator.

Matt Salloway: (44:30)
We also are an investor in a company called Fable, which is a animation design tool which we're very excited about. And the fourth company, which we'll release more later this month, is an AR technology that was 300 times oversubscribed. It was a very competitive investment. We led that round and it's really by one of... Co-founded by one of the top gaming technologists in the world.

Rachel Pether: (45:03)
Incredible. And on the SIP and also, I guess, GSI as well, we've had a few questions coming in. I'm going to group them together. Sorry everybody. But we've had a few questions coming in on the co-investment and syndication and LP front. How do you normally structure your deals and how do you go about finding other LPs and co-investment club deal partners, etc.?

Matt Salloway: (45:28)
Well, we... You know, we look for... We have been blessed to really create a large... A very strong network of Family Offices and investors. Some strategic, some that are people who are operators or have access to strategic partnerships which are quite attractive. But we've been blessed, having built, I think, a strong reputation. As Warren Buffett likes to say, I think it takes 20 years to build a reputation and 20 seconds to ruin it, which we've... Number one, not only because it's the right thing to do, which is really what drives us being good partners, having integrity, being reliable... And it's why we've had such a great strong network and co-investment partners. But it's also about your reputation and once you lose that, that's all you really have.

Rachel Pether: (46:27)
Yeah. You've shared a number of really great quotes during this discussion, but that one from Buffett was definitely a good one. We are over time, but I really like this question, so I'm going to take an executive decision and ask it to you anyway. Are you ever going to make a science fiction movie and combine your knowledge of film production and technology? And if so, which science fiction movie would you want to remake?

Matt Salloway: (46:56)
Wow. That's a fantastic question. So, the answer is hopefully one day. I think some of the technologies that we're seeing could be quite relevant in the cinematic world. I would say that there's actually a film that we're currently developing which is a strong AI technology-based film, which is just completely fortuitous. But we're actually developing this film currently with two partners, and it's a fascinating story and it does leverage cutting edge technology. So, I think that this will be an area where I will marry sort of my knowledge and connectivity in the cutting edge technology to the filmmaking world.

Rachel Pether: (47:47)
Excellent. Well, thank you so much, Matt. It's been a pleasure speaking to you today. I knew it would be just as much fun as ever, so thanks so much for your time and sharing your insights with us.

Matt Salloway: (48:00)
Thank you, Rachel. It's been an honor to be with you and I'm so thankful for the opportunity.